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CH~ PT ER I. 
INTRODUCTION. 
CHAPrER I 
I N T R Q D U ~ T I O N 
In S::Outh Africa, as: in other countries with a large underprivileged 
population group, the. problem of malnutrition and its- associations and 
complications assumes considerable importance. Until the socio--economic 
problems involve.dare solved, attention must be directed to early diagnosis, 
treatment and prophylaxis· of malnutrition and its associations. 
At the Red Cross Children's Hospital, Cape Town, a consi.dera:ble 
percentage of admis:si.ons· are for marasmus and kwashiorko.r. Anaemia is a 
frequent association,, (Walt, I.959) sometimes contributing to the mortality 
(Walt, Holman and Naidoo, 1957). 
In 1.959 it was· decide.d to investigate the aetiology of the anaemia in 
kwashiorkor at the hospital because this- was a controversial issue which 
limited effective~ therapy (A:l tmann and Murray, 1948; Ada.ms,, I.954;:- Woodruff, 
1955; Walt, Holman and Hendricks·e, 1956;, Foy and Kondi, 1957,. Trowell and~ 
Simpkiss, I.957; Shnier and Metz, 1959). 
These early studies showed that a protein diet of high biological 
value did not cure the anaemia unless specific..haematinics; were also 
administered. Iron deficiency was found in nearly every case and a high 
proportion of the infants showed varying degrees of folate deficiency. No 
unequivocal vita.min B12 deficiency was found (Friedman, 1960; 1962). 
Lanzkowsky, (1960) showed that iron deficiency was prevalent in 
underprivileged:. but otherwis:e. healthy non-White. infants. in Cape Town. From 
this it seemed possible that both the iron and. folate deficiencies; 
encountered in kwashiorkor were a manifestation of wide-spread deficiencies 
occurring in healthy underprivileged infants rather than a s;pecific effect 
of kwashiorkor. 
2. 
In ordar to investigate this relationship and to acquire further 
information regarding the aetiology of folate deficiency in kw&shiorkor, 
an investigation was carried out in 1963 on healthy underprivileged infants 
and underprivil.eged infants with gastroenteritis (Friedman, McKenzie, 
Turner and Wittmann, 1964 a, b). 
Laboratory methods for diagnosing folate deficiency were by then 
available. The estimation of Formimino-L-glutamic acid (Figlu) excreted 
in urine after an oral L.-histidine. monohydrochloride (histidine) load was 
one of these methods.. This was; regarded as a s.ensitive,, specific and 
reliable teat of folate deficiency (Luhby, Cooperman and Teller, 1959 b). 
Moreover, a simplamethod was available for eatimating Eiglu (Kohn, Moll.in 
and Rosenbach, 1961). For these reas-ons the Eiglu tes:;t after the. adminis:;tra"" 
tion o:f oral histidine was chosen as a_ laboratory parameter for investigating 
folate deficiency. 
By means of this meth0,d it was- shown that approximately 64% o,f healthy,, 
underprivileged- infants: had a positive Figlu test. This implied that a 
considerable number of these infants had low folate reEerves. If this were 
so, it seemed worth whil.e acquiring further information regarding the 
incidence, aetiology, signific_anc,e and need for prophylaxis· of latent folate 
deficiency in healthy underprivileged infants:. This had particular relevance 
to the possible development of folate deficiency in kwashiorkor and marasmus. 
This investigation will be prefaced by a review of information 
available at the time of commencement of the study (1963). Material 
published thereafter will ba refe.rred to only when the particular subject 
under review is not discusse.d again in later chapters:. 
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BRIEF HIS TORI CAL REVIEW OF THE RECOGNITION 
OF THE ROLE OF FOLIC A~ID DEFICIENCY IN THE 
PRODUCTION OF MEGALOBLASTIC ANAEMIA. 
The fundamental role of folic acid and vitamin B12 deficiency in the 
production of the megaloblas;tic an~emias was only recognise,d when these 
vitamins-were prepared in synthetic form in L945, (Angier et al.) and in 
1948 (Rickes, Brink, Koni'uszy, Wood and'. Folkers,. L948; Smith, 1948} 
re.speczively. This was the result of many valuable contributions made 
throughout the nineteenth and the- firs.t half of the. twentieth c:entu:des .. 
Recognition of. pernicious; anaemia. 
Early in the nineteenth century, physicians reported case histories 
of patients suffering from obsc:ure forms o,f anaemia (Combe, I.82:4;: 
Channing, I.842) which were subsequently recognised as cases of vitamin B12 
(Combe, 1824) and folate (Channing , 1842) deficiency. Addison (1849; 
1855) and Biermer (1872): were independently reBponsible for precise clinical 
des:criptions of a new entity la,ter to be. known as Addison-Biermer perniciOJUs 
anaemia. This was a puzzling idiopathic anaemia distinguishable from 
chlorosis and other causes o,f secondary ana.emia which were. recognis:ed at 
the time. The cours~was progressive and the outcome nearly always fatal. 
Following the recognition of the function of the bone marrow in blood 
formation,(Bizz:ozexo, cited by Ewing,, 1904) Pe.pper (1875) and Cohnheim CI.876) 
inde.pendently s.tudie,d post mortem specimens o,f the bone marrow in pernicious 
anaemia. Cohnheim (1876) made most important his;tological observations. He. 
identified megaloblasts and megalocytes and suggested that the megaloblastic 
erythropoiesis wa s the essential cause o f t he anaemia. 
4. 
The macrocytic appearance of the red c.ells was noted by Lepine 
(r876; 1877) and contemporary investigators appreciated other changes in 
the red cells · in this condition (Ewing, 1904). In 1-880 Ehrlich described 
the presence of megaloblasts in blood smears as a characteristic, of 
pernicious anaemia •. He has been credited. with the introduction of the term 
"megaloblasta: (Dacie and White, l949l. 
The introduction of a. me,thod of bone, marrow biopsy suitable, fo,r us-e 
on patients ( Ghedini, 1-908 l enabled: Zad.ek (1922} to compare the bone. marrow 
with the blood. of pa.tient& in all phases of perni~ious. anaemia. He confirmed. 
that the erythropoi~is in the bone. marrow was megalobla:.stic (Cohnhe.im, 
I.876; Ehrlich, l89l), and- that macroc.ytos:is d.evelopecI. as a resul.t. Like 
other investigator& (cited by Muir, l8941 but unlike aohnheim (1876) and. 
Rindfleis~h (l890J, he believed that the megaloblastosis was a secondary 
phenomenon - possibly a manifestation of the haemo.lytic nature of pernicious 
anaemia. 
Aetiology of pernicious and other macrocytic anaemias; •. 
In all this time there had been much speculation about the a.etiology 
of pernicious anaemia, (Ewing, 1904) but little advance in knowledge. In 
1926, Minot and Murphy produced evidenc·e whi~h atrongly s,11gg~sted tha1t 
pernicious anaemiac. was a-:. deficiency diseais:e. Prompted by eairlier and unrelated 
experimental work carried o.ut on dogs by Robscheit-Robbins and Whipple,, (I.925) 
they suc.cessfully treated pa tie.nts suffering from pernicious anaemia with a 
s;tandard diet low. in fat and containing 12D-2.40 g .. of liver per day as well 
as 120 g. or more of beef' or mutton and 300 g. of vegetables. Patients were 
permanently maintained in remission as l.ong as liver the.ra,py was continued •. 
These, findings had far-reaching results • . 
In the first place, Castle, (1929) conducted important experiments: 
which finally established pernicious anaemia as a defi'ci·ency di'=e ..,,, ase .• In 
da.ing so,. he confirmed a l.ong suspec-te.d relationshi:p between this anaemia 
and food (Combe, I.824;: Habershon, 1863; Elders, 1.922). 
He and his c9llea:gues concluden that a factor in normal gastric juice 
(the intrinsic factor) combined with a dietary factor (the extrinsic factor) 
to produce a haemopoietic factor which was, hae:matologically effective in the 
treatment o:;f pernicio.us anaemia.. They believed that the essential defect 
leading to the Qevelopme.nt of pernicious anaemia was the lack of the intrinsic 
factor (Castle, 1929~ Castle and Townsend, 1929; Casxle, Townsend and 
Heath, L930) • 
For many years it had been thought that npernicious- anaemiatt occurred 
in associa-tion with pregnancy,, gastrointes;t;inal dis,ea-sas, infee,tion, ne.o-
plasia and worm infestation (Rwing, 1.904). Liver therapy was successfully 
used in patients with pernicia.us anaemia of pregnancy, (Strauss and Castle, 
1932 a; Wills and Mehta, 1930) tropical macrocytic anaemia (Wills, 193,1) 
and pernicious anaemia of sprue (Castle and Rhoads, 1932). 
Further study of these conditions by Wills in particular, but by 
Strauss and Castle as well, led to the realisation that there- was a distinc-
tion between pernicious anaemia. and these other macrocytic anaemias. 
Clinical differences; we'Te noted. by Wills and Mehta (1,930). and Bennett, 
Hunter and Vaughan (1932). Moreover, the pathogenesis and the therapeutic 
requirements of the other macrocytic anaemias· appeared different from those 
of pernicious anaemia.. The concept o.f the extrinsic factor deficiency 
developed from these. observations which were as follows: 
A single course. of live.r without maintenanc.e therapy was; effective in 
curing pernicious anaemia of p~-e-gnancy (Strauss and Castle, 1932 a}. 
Marmite., an autoI.ysed yeast preparation, rich in vitamin B complex, 
6. 
especially B1- and B2_ (Wills, 1.931 r 1-9341 was as e__ffec ti ve as liver in 
treating tropical macrocytic anaemia which included the macrocytic anaemia 
of pregnancy (Wills, L931). I.twas also effective in the treatment of 
macrocytic anaemia of sprue (Castle and Rhoads, L932) and steatorrhea 
(Va.-ughan and Hunter, l932J. But it was ineffective in treating p-ernicious 
anaemia unles·s it was combined with the intrinsic factor (Strauss and 
Castle, 1932). 
Finally it was shown that Marmite could cure a macrocytic anaemia 
induc~A in monkeys . by feeding them a deficient diet similar to that taken 
by patients who developed tropical macrocytic anaemia (Wills and Bilimoria, 
1932). 
On the above evidence, the aetiology of some of these ma:crocytic 
anaemias seemed different from the aetiology of pernicious anaemia and was 
attributed in m.ost cases. to a dietary deficiency of extrinsic factor 
(Wills, I934; Strauss and Castle, 1932). 
The clinical and aetiol.ogical differences between pernicious anaemia 
and other macrocytic anaemia:S3 therefore justified their differentiation 
(Wil.ls, 1-934) • 
The extrinsic factor was at o,ne stage believed to be vitamin B2 (Wills, 
1-934; Strauss and Castle, 1932; Strauss and Castle, 1933) because of a 
similar distribution in a wide variety of foodstuffs (Strauss, 1934) •. 
This was subsequently disproved (Wills, l934~ Strauss, 1934)~ Though 
still thought to be a member of the vitamin B complex, the nature 0£ the 
extrinsic factor was not specifically determined (Minot, 1935). 
As a result of the work of Minot and Murphy (1926 ) and Castle, 
Townsend and Heath (1930), it was believed that the intrinsic and extrinsi~ 
factors combined to form a haemopoietic princip1-e which was store.d in the 
liver .. The efficacy of liver therapy in alL macrocytic a!laemia:s; led. 
Castle and Ham (1936) to consider that these, incLuding perniciou& anaemia, 
ultimately resulted from a~ deficiency of the single active principle. stored 
in the Ii ver al though the a.etiology o.f Ii ver principle deficiency could 
be different (Unitarian Hypothesis}. To pernicious anaemia it re.sulted 
from an intrinsic factor deficiency and required permanent replacement 
therapy. In other macrocytic ana-emias the de.ficiency arose as the- reS'.Ul t 
of low intake of the extrinsi~ factor, malabs:orption of extrinsic or 
haemopoietic factors or des±ruction of intrinaic,, extrinsic or haemopoietic 
factors (Castle and Ham, 1936;, Strauss and Castle, 1932).. Maintenance 
therapy was usualLy not required in these cases because of the transitory 
nature of most of the aetiological mechanisms •. 
Other possible causes of macrocytic anaemia that were suggested were 
inability to store (Wintrobe and Shumacker, I933) and to utilis:e liver· 
principle (Minot, 1935). 
The validity of the Unitarian Hypothesis of Castle and Ham (1936) 
was questioned, when Wills. and Evans (1938) demonstrated that purified 
extracts of liver, effective in the... treatment of pernicious anaemia, were 
ineffective in nutri.tional. macrocytic. anaemias though they could be cure.d 
by Marmite or crude liver ex.tracts~ This led the investigators to suggest 
that there might be two extrinsic factors •. 
The concept of megaloblastic anaemim. 
Following the description of megalo.blastic erythropoiesis in pernicious 
anaemia (Cohnheim, 1876; Ehrlich, 1880; Zadek, 1922), there was, contro-
versy about the meaning and importanc e of megaloblasts. S:Ome morpho-
logists (Doan, Cunningham and S:abin, 1925;, Maximow, 1927;: Sabin, 1928), 
did not distinguish between normal primitive erythroid:.precursors and 
8. 
megaloblasts and as a consequence found megaloblas,ts in normal p·ersons, 
and in conditions besides pernicious anaemia_. 
The introrluction of an improved method for bone marrow biopsy 
(S:eyfarth, 1923) and a me.thod of bone marrow aspiration (Arinkin, 1929), 
led to more frequent examination of the bone marrow and therefore to 
greater familiarity with normal haemo.poiesis;. Morphologis:ts were- able. 
to de;fine the megaloblast precis.ely and'. to recognise. it as a. patho.lo.gical 
~ell distinct from normal erythroid precursor.sand. a characteristic of 
diseases: caused by a . deficiency of Ii ver principle (Naegeli, l93l;, Ferr.a ta, 
I..933; Segerdahl, I.935~ Jones, I.938f Rohr, 1937; Scott, 1939; Jones, 1943). 
This morphol.ogical c.oncept was. further suppo.rted by the 0-bservation that 
megaloblastosis was often associated with similar changes in the white cell 
precursors and megakaryocytes (Tempka and Braun, l932f Jones, 1936v Rohr, 
1937 ;, Rohr, I.949) •. The rapid disappearance of these haemopoietic abnormali-
ties following liver therapy provided further confirmation that the 
megaloblast was a pathologic.al cell and that megaloblastic haem())poi.esis was 
a_primary rather than a CDmpensatory abnormality in pernicious. an~emia 
(Peabody, L927; Rohr~ 1937). The success.of liver therapy was due to the 
replacement of the, factor required by the cellular metabolism of haemopoietic 
precursors for normal haemopoiesis (Eeabody, I..927)~ 
The study of the bone, marrow in different phase,5 of remission induced 
by liver therapy, ied. to a be.tter understanding of the origin and dynamics 
of megaloblastosis and an appreciation of the diagnostic importance of 
l!.esser and inte.rmediate dagrees of megaloblastosis (Lambin and de Weerdt, 
1938; Davidson, Davis and Innes, 1942 a; Zuel~er, Newhall and Hutaff, l947; 
Dacie and Wh1te, 1949). 
Nore fre4uent examination of the bone marrow showed_ that macrocytosis 
did. not specifically occur in a:ssocia.tion with megaloblas:tic erythropoies:is 
but coul.d also be present in association with normoblastic erythropoie.sis : 
(Jones, 1.9431, il though megaioblastos;is was always to be found in dis:eases 
caused. by liver factor defi?iency, macrocytosis was not a consis,tent feature 
(5:egerda:hl, 1.941.;. Davidson, Da.vis and Innes, 1.942.b;. Call.ender, 1944,)'. Thus· 
examination of the bone marrow was accepted as the. diagnostic. and therapeutic 
guide and. the cone.apt of megalobI.aatic anaemia:. replace.d that of mae:rocytic 
anaemia (Davidson and Davis:, 1947). 
Folic acid metabolism .. 
F'or many years investigators were keen to identify the active liver 
principle. In 1.940 Snell. and Peterson observed that Lactobacillus: ca:sei 
(L. .casei) required a grow.th factor found in yeas·t and liver. This;; factor 
could be a ·dsorbed onto charcoal. and was therefore called the "norite &l.uate 
factorrr. In l.941 Mitchell, Sne.11 and Williams concentrated a factor from 
spina.ch which was require.d for growth by both L. casei and Stre!)tococcus; 
facaelis (S.faecalis)., It was abundantly present in green I.eaves and was 
therefore called fol.ic acid. Hogan and Parrott (L939;. 1940)~ induced an 
anaemia in chicks, unde.r defined dietary conditions, which could be cured 
with liver extracts. They thought tha.t the anaemia could be attributed to 
a deficiency of an unidentified vitamin, . possibly of the B complex group 
found· in liver. Later Pfiffne.r, Binkley, Bloom, Brown, Bird, Emmett, Hogan 
and O'Dell (1943), isolated a compound from liver which was active for 
L.casei and al.so haematologically active in chicks.. Another compound 
identical to this was obtained by Stoks-:tad (1943) from liver (liver L..casei 
fae,tor). 
Later Angier, et al. (1945) synthesised a compound which w.as identical 



























































































p-aminobenz:oic acid and a single L-glutamic acid radicle (Fig •. 1) and was 
calle.d pteroylglutamic acid (Angier, et al. . 1946). Pteroyiglutamic acid 
(PGA) was later found" to have the same biologicaL properties as folic acid 
(Metz, l963). 
At first it was thought that EGA.. was the naturally occ.urring food 
folate and that it was biol.ogicall.y active (Jukes, L955). However, it was 
later shown that food folate consis.ted o,f conjugated and. unc.onjugated. forms 
of PGA... and its derivatives (Jukes and Stokstad, I.948; Luhby and c·ooperman, 
i963). When folic acid or its: derivatives were conjugated with '{ -glutamic 
acid peptide chains of vary.ing length, they were known as conjugated or 
polyglutamate forms (Jukes, 1955)., The conjugated forms constituted the 
bulk of food folate (Jukes and Stokstad, l948;, Bird, Bres$Ler, Brown, 
CampbelL and Emmett, L945), particularly the reduce.d forms· (Herbert, 1967). 
Less than one quarter of food. folate wa$ in the monoglutamate form (Herbert, 
1967). A frae,tion of food. folate might be present as PG£ (Butterworth, 
Santini and Frommeyer, L963) but this; was unc,ertain (Herbert, I.967). 
The c.onjugated (polyglutamate) forms o,f fol.ic acid and its derivatives: 
could be converted to monoglutamates by enzymea known as conjugases (Bird, 
Bressle.r, Brown, Campbell. and Emmett, L945;: Bird, Binkley, -Bl.oo.m, Emmett and 
Pfiffner, l.945). C.onjugas:es were wid.el.y distributed in nature, and hog 
kidney, liver and. small intestine , and beef liver were rich sources (Bird, 
Binkley, Bloom , Emmett and Pfiffner, L945). They coul.d be present in small. 
quantities in the succus ente.ricus of humans (Klipstein, I.967). 
The biological value of the different forms of folate. is unknown 
(Butterworth, I.968) primarily because there is insufficient information 
regarding the. absorbabili ty of the different forms , of fol.ate.: (Herbert, l.967). 
CONVERSION of FOOD FOLATE to TETRAHYDROFOLATE 
AND ITS COMPLEXES 
FOLATE CONJUGATES in FOOD l (~) 
FOLIC AC LO 
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lI. 
A.. little is known of the chemic.al form in which folate is, absorbed. 
It was believed that folate was absorbed in the monoglutamate form (Herbert, 
1967; Klipstein, 1967} and that intestinal conjugases might convert folate 
polyglutamates: to monoglutamates to facilitate their absorption (Klipstein, 
1967). Others found that folate could be absorbed in the conjuga±ed farm 
(Herbert, L967) as diglutamate, triglu.tamate (Baker, Frank, Feingold, Z:iffer, 
Gellene., Leavy and Sobotka, I965) o-r heptaglutamate (Cooperman and Luhby ,, 
1965). The suggestion was made that folate was best absorbed as tri-
glutamate (Baker, Frank, Sobotka, Pey-Ping, , Cohen, Janowitz, Ziffer and 
Lee.vy, 1964) •. 
Although the monoglutamate (Whitehead and Cooper, 1967), the 
triglutamate (Baker, Frank,, Feingold, Ziff er, Gellene, Lee-vy and Sobotka, 
1965), and he:2taglutamate forms (Cooperman and Luhby, 1965} were absorbed 
as such from the gut, the diglutamate form was apparently altered to a 
me-tabolicalI.y active form by the gut (Baker, Frank, Feingold, Zi.ffer, 
Gellene., Leavy a:nd S.obotka, 1965). 
It is, now acknowledged. that folic acid is rapidly reduced in viv_o 
to the biologically active form, te-trahydrofoI.ate- (FH4 ) (Heunnekens and 
Osborn, L959;, Heunnekens,, I.966 ;, Stokstad and Koch, 1967). It combines: 
with c
1 
fragment~ to form six: tetraihydrofolate complexes (Heunnekens, 
1966), four of which are known to act as coen~ymes (Ghitis, 1966). 
These donate the c;
1 
fragments for incorporation into purines, pyrimidines 
and some amino acids, and in so doing, revert to tetrahydrofolate. By 
acting as a-. re.versible carrier of c
1
_ fragments, rn4 plays a fundamental 
role in nucleoprotein metabolism (Heunnekens and Osborn, 1959)~ The. 
conversion of food folate to the active coenzyme form and to te.trahydro.-
folate complexes. is diagrammatically represente.d (E.ig .. Z). 
12:. 
In accordanc-e with current ideas of nomenclature, the term fol.ate 
will_ be used henc_eforth to refer to the multiplicity of folate compounds 
whereas the term folic acid'. will be use-d only to r..afer to PGA. 
Aetiologica-J. diff·erentiation of the megal.oblastic anaemias 
(Yolate and vitamin B
12 
interreiatio:nships;). 
vfuen folic acid' was isaiated in I.94-5, , it was first thought to be either 
Castle's; ac:tive liver princip-J.e,, or the. extrinsic: factor,., Folic acid was us:ed 
in therapeutic trials on patients; with all typ.es of megaloblastic anaemia. 
First results were very encouraging even when it was use-d in the treatment 
of pernicious anaemia (&pies,, Vilte:::r, Koch and Caldwell, L945;; Moore, 
Bierbaum, Welc:h and Wright, 1945;: Darby, J:ones and Johnso:µ,, L946;. S:pie.s, 
1946) ., 
Although the efficacy of foli~ acid therapy in most macrocytic anaemias 
was later confirmed, the subsequent r..eauLts. o.f foiic aci.d treatment in 
pernicious anaemi were disa~po1nting (Vilter, V.iLter and &pies, L947). It 
was faund to be less e;ffective- in c.uring the haematoiogic_al and neurol.otical 
manifes:tations- o·f pernicious; anaemia than refined liver... extract (Vilter, 
ViI_ter and Spies, I.947; Heinle, Dingle anci W:eisberger, L947;: Spies and Stone, 
1947; Ross, Belding and- Paegal,, 1948; Wilkinson,, 1948 a:, b). More disxurbing 
was the o:bservation tha.t it might aggrava,te and even precipitate the neuro-
logical manifestations o)f pernicious anaemia (Heinle and Welch, L947; Ro_ss-, 
Belding and Eae.gal ,. 1948 ;, Wilkinson,, L948 a, b J .. 
The is:olation o_f another factor from live:c which was. haematologically 
active in pernicious anaemia - vitamin B12 - heI.ped to clarify :rome. of the 
aetioI_ogical and therapeutic problems, of the megaloblastic anaemias;. 
V.i tamin B
12 
was; isolated and c_rystallised by Rickes , , Brink, , Koniuszy ,. 
Wood and Folke.rs; (19481, following hel..pful :greliminary micro-biological 
studies by Shorb (l94?). Independently and a:t the same time vitamin B1:2 
was purified by Smith (1948). 
In therapeutic trials, intramuscular vitamin B1:2 was found to be" 
effe.ctive in curing both the neuro.logical and haematological manifestations 
of pernicious anaemia:. (Wes:t, 1948;: Berk, Denny-Brown, Finland and Castle,, 
1948) •. Later Berk, Cas:tle, Welch, Heinle, hker and Epstein (1948) identi-
fieQ vitamin B
12 
as Castle's extrinsic factor and suggested that the function 
of the intrinsic factor was to absorb vitamin B
12 
from the gut. Thus it 
was shown that two extrinsic factors present in liver, folic acid and 
vitamin B
12 pla,yed fundamental roles in the production of me.galoblastic 
anaemia., This: confirmed. an earlier suggestion made by Will.s.; and Evans (1938). 
In 1935 Minot and Castle established the criteria for using the 
reticulocyte response under' controlled conditions, as a measure of therap~utic 
efficacy of haematinicsp They found that each therapeutic substance could 
provoke onl.y one the:rapeutic response.. Thus it was possible to com:racre the 
efficaicy of two te.st subs±ances, in submaximal doses; by using them in sequence. 
on the same patient and comparing their effect on tha reticulocyte res~onse. 
(The. metho..d of the do.uble. reticulocyte response"). 
Once vitamin B
12 and folic acid w.ere available for clinical use, this 
metho..d of controlled therapeutic trial was used i n t he ae t io.logical differen-
tiation o.f the megaloblastic anaemias. In order to prevent poss:1.bI.e neuroloS 
gical damage, vitamin B
1
2. was~ adminis-tered first (Mellin, L957 /58; Herbert, 
L959) ., This method of ae.tiol.ogica:l diagnosis: coul.d only be us·ed on anaemic 
patients and as· it was· time-consuming it was impractical for use o.n sick 
patients (Mellin, 1957/58; Chanarin, Mellin and Anderson 1958 a.). Moreover, 
it was often difficult to interpret the result~ because the physiological 




were.. therapeuticall..y interr..elate-d, especially when used in pharmacological 
doses (Vilter, Horrigan, MilelI.er, Jarrold, "'\[ilter, Hawkins: and Seaman, 
1950· Herbert, 1959). This had been established when folic acid was found 
to be effective. in impro..ving vitamin B
12 
deficiency (Moore,, Bierbaum, 
Welch and ffi:-ight, 1945; Wilkinson , . 1948 a, b) and vitamin B
12 
to be 
effectiv~ in improving folic acid deficiency (Killander, 1.958). It was 
clear that the development of precise laboratory techniques· for the 
aetiological differentiation of the megaloblas:tic anaemias would have 
advantages ... 
The introduction of a microbiological assay of vitamin B
12 
wa::s a 
useful contribution towards this end (Shorb,, L948;:: Hutner, Erovaso-1.i,, 
Stokstad, Hoffmann, , Belt, Franklin and Jukes,, L949;: Roas:, 1-950,. Rose.nthal 
and. Sarett, l952'; Hutner, Bach and Ross., l956). It was hoped that diag-
nostic accuracy would be further improved by the introduction of laboratory 
me.thods for measuring folate. This was not easily achie,ved and only became 
possible in the Iate 1950's: (Chanarin, Mollin and Anders:on, l958a;. Herbert, 
Wasserman , Frank, Pasher and.Baker, 1.959; Baker, Herbert, Frank, Pasher, 
Hutner , Wasserman and Sobotka, 1959;; Luhby, Cooperman and Teller, (1959b}., 
LABORATORY DIAGNOSIS OF FOLATR DEFICIENCY. 
It was· shown that L.casei (Snell and Peterson, 1940), s:. faecalis· 
(Mitchell, Snell and Williams, l94ll and P~cerevisiae (Sauberlich and 
Baumann, 1_948) particularly, as well as a: large number of la_ctic acid 
bacteria, required folate compounds for their growth (Jukes and Stoks.tad_, 
l948). 
The growth response. de.pended. on the. form of folate provided, s.tl.nce 







































































































































































































































































(Jukes and Stoks:tad, 1948).. The diagram (Fig .. 3) illustrates rec:ent know-
ledge regarding the grow.th re::quiremen ts of the three:. bac..teria •. 
As early as, 1947 attempts wexe made to utilise this information in 
the standardisation of a microbiological. assay for blood and plasma folate 
(Schweigert and Pearson, 1947). This was no.t satisfactorily achieved until. 
twelve years later,as a re.sult of which indirect methods 0£ assessing folate 
nutrition were introduced in the meantime. The direct methods eventually 
developed, and the relevant indirect methods used, were as follows:-
Dire.ct Me.thoda. 
Fola±e microbiological assay~. 
The greatest practical difficul.ty in the development of a micro-
biological assay for folate was the I.ow level of "folate" found in blood 
(Schweige_rt and Pearson, 1947) and plasma or serum (Schwe<l.gert and Pe.arson, 
1947;, Chanarin, . Andexson and Mollin, 1.958) using S. faecalis as the: assay 
organism.. The use of L •. casei as the organism made no differenc.e to the 
results obtained in bloo<l (Schweigert, 1948) or serum (Spray and Witts, 
1.952;, S:pray, 1952) .. This . limited the. clinical applica:.tion of the metho.d'. 
(Nieweg, Faber, de Vries and Kro.ase, . l954; Girdwond, 1953). 
After earlier studies, Toennies, ITsciin and Phi:llips introdu~ed an assay 
procedure for folate in L956 which overcame mes t of the practical difficul.-
ties. In L953 they haQ obtaineQ a gond growth of L.c.asei in dialysates 
prepared from blood haemolysates. Their resul.ts were substantially higher 
than those previously reported (Toennies, Frank and Gallant, 1-953) •. Thus 
the assay they introduced in I-956 involved the useo:t' L.e-as.ei as the as1Ea.y 
organism .. 
Another important modification resulted from earlier investigations 
16. 
which had suggested that ttfolate" might be lost during the assay procedure 
(Toennies, Frank and Gallant, 1953). Ascorbic acid was thus added to the 
buffer to prevent loss of the 11 thermolabile folate" from auto-oxidation 
while it was heated in the assay procedure or stored at low temperatures. 
Finally they showed that in contrast to the findings with red cell 
haemolysates there was little 11 folate activityu in preparations of washed 
red cells or plasma or serum. However, haemolysis of red cells had to be 
complete and had to occur in the presence of plasma before "folate activity" 
could be successfulI.y measured. This suggested to them that the plasma 
contained a factor (probably conjugase) which made 11folate 11 in red cells 
available to the assay organism. 
With these modifications "folaten blood levels in normal subjects were 
high enough to allow further investigations of the clinical application of 
the method (Toennies, Frank and Gallant, 1956). 
At this stage there were still theoretical objections most of which 
were based on doubt about the natur~ of the L..casei growth factor in the 
blood. It had been shown that in the absence of folate various purines and 
pyrimidines, as well a~ PABA acted as growth factors for the assay organism 
(Chanarin, 1958) •. 
Moreover, chromatographic procedures had shown that the 11 folate 
active" material of blood haemolysates was not recognisable as folic acid 
or any other folate compound chemically defined at that stage. The 
"folate active" material supported the growth of L.casei but not 
S.faecalis (Usdin, Phillips and Toennies, 1956). This pattern was 
unlike that of folic acid but was compatible with the pattern found 
when folate triglutamates were provided (Jukes and Stokstad, 1948; 
Stokstad, 1954). 
17. 
Thus although there was no evidenc_e to the contrary, there was no, 
proof that the L..casei growth factor was a folate. Nor was there evidence 
that these Ievels of rrfolaten related to folate nutrition except in the 
case. of some animal experimental studies (Schweigert, 1949~ Toennies, 
Frank and Gallant, 1956). 
These theoretical ~bjections were overcome as the result of two 
important contributions. The first was the demonstration that the micro-
biological assays of 11 folate active" material in serum (Baker, Herbert, 
Erank, Pasher, Hutner, Wasserman and Sobotka, 1959; Herbert, Wasserman, 
Frank, Pasher and Baker,, 1959), or whole blood (Grossowicz, Mandelbaum-
Shavit, Davidoff and Aronovi tch, L962; Grossowicz, Rachmilewi tz, Tiak and 
Zan, L962) had clinical applicru.tion in the diagnosis- of folate deficiency. 
The second was made after experimental observations by Donaldson and 
Keresztesy (1959) and Larrabee, Rosenthal, Cathou and Buchanan (I961), 
when Herbert, Larrabee- and Buchanan (1.962),, identified the L-.casei growth 
factor in serum as a fol.ate compound - N5-methyl FH4 • This compound, like. 
fola te triglutamates was me.tabolical1-y available to L. casei but not to 
S.faecalis. Folate present in red c;ells was later identified as 
N5-methyl FH4 and its conjugates, the majority of the folate being in the 
conjugated form ( Noronha and Aboobaker, 1963)"' By t hes.e means the growth 
factor for L_..casei was identified as a folate compound. 
The serum L-.c.asei folate assay., 
In spite o£ theoretical o.bjections and ini tiaL practical difficulties, 
Baker, Herbert, Frank, Pasher, Hutner, Wass,erman and Sobotka (.1959) 
continued to devel.op the serum L-. cas-ei folate assay. In contrast with 
previous results (Toennies, Usdin and Phillips, 1956), they showed that 
the levels of folate in serum in normal subjects (7.5 to 24.0 ng./ml) were 
18. 
high enough to make the assay a practical procedure (Elferbert, Baker, Frank, 
Pasher, Sobotka and Wasserman, L960). They believed that by using serum 
rather than bl.ood· the grow.th of L..casei could be attributed to ,rfolaterr 
rather than to other growth factors possibly present in red cells. 
Thus the. assay develo:ped by Baker, Herbert, Frank, Fasher, Hutner, 
Wasserman and S:obotka (1959) incorporated two of the modifications sug-
gested by Toennies, Usdin and Phillips (1956) - ascorbic acid protection 
and the use of L..casei as the assay organism. 
Conflicting results were obtained in initial clinical studies. 
Herbert, Baker, Frank, Pasher,, s:obotka and Wasserman (1960), and Gooper 
and Lowenstein (1961) were impressed with its clinical applica.tion. On 
the other hand, Waters and Mallin (1961) and Cooperman, Luhby and Avery 
(1.960) were, unimpress-ed with the val.ue o.f the test in differentiating 
between normal and folate deficient subjects·. When the method was, mo.dified 
by the addition of' still higher concentrations o.f ascorbic; acid to pro,tee,t 
folate from the vagaries c:llf uneven heating during autoclaving (Herbert, L96l; 
Waters and Mallin, 196L; Waters and Mallin, L963), the validity of the 
serum L.,casei folate assay was more generally accepted. 
It could be used to differentiate be.tween normal and folate 
deficient subjects (Davis and Kelly, 1.962)~ In the diagnosis of megalo-
blastic anaemia due to fola te deficiency t he agreement between serum L.casei 
folate assays and bone marrow morphol.ogy was good but not absol.ute (Waters 
and Mallin,, I.961..). Occasional patients had. normal serum L.casei folate 
levels in association with mega:loblastosis due to fola.te deficiency 
(Cooper and Lowenstein, 1961.). This problem was most often encountered in 
pregnancy (Waters and Mallin, 1..961). 
The megaloblastosis o.f vitamin B
12 deficiency could be.. dis:tinguished 
from that caused by folate deficiency by means of the serum L •. casei 
folate assay (Waters and Mo1Iin, I.961;, Stevens, Me.tz:, Brandt and 
v •. Broekhuizen,. 1962;: Gough, Read, McCarthy and Waters , L963). In this 
context the test was especiall.y useful because vitamin B12 deficiency did 
not lead to a non-specific lowe.ring of serum L.casei folate levels. On 
the contrary there was evidence. that folate. utilisation was impaired in 
vitamin B12 deficiency (Herbert and Zalusky, 1962) and that this led to 
an elevation of serum L.casei folate levels (Waters and Mellin, L961). 
For this reason minor degrees of folate deficiency in association with 
vitamin B12 deficiency might not be diagnosed unless serum L.casei folate 
assays were repeated following treatment with vitamin B12 • Also, in the 
presence of vitamin B12 deficiency a low serum L •. casei folate level meant 
associated folate deficiency~ 
Tha test was a very sensitive index: of folate deficiency because 
low. serum L.casei folate l.evels preceded the development of megaloblastic 
change (Herbert, l.962a) ... Furthermore, the test was specific for folate. 
deficienc.y provided that broad spectrum antibio.tics were not administered, 
for they could interfere with the growth of the. assay organism and might 
result in s.puriously I.ow serum L •. casei folate levels (Walers and Mellin, 
1961). 
Summary. 
During the course of twelve years a microbiological assay of folate 
in serum and plasma had been developed in &}lite of practical and theoretical 
difficulties. It could be used to differentiate between normal subjects 
and patients with me.galoblastic ana.emia due to folate deficiency •. 
The agreement of serum L .• casei folate levels with megaloblastosis, 
2.0. 
due to folate deficiency was good but not absolute and this was especially 
noted in pregnancy. The tes·t was valuable in distinguishing megaloblastic 
anaemias due to folate from those due to vitamin B
12 
deficiency because 
the latter resulted in a disturbance of folate utilisation which elevated 
rather than lowered serum L..casei folate levels. The test was very 
sensitive, but specific for folate deficiency provided that broad spectrum 
antibiotics were not administered. 
Whole blood folata assays. 
It was believed that folate bypassing substances mi.ght be present 
in red c..ells though the likelihood was decreased, when Usdin, Phillips and 
Toennies (1956) failed to identify thymine and thymidine aa constituenta 
of red cells. This encouragea.=Grossowicz and his colleagues to evaluate 
whole blood as well as serum folate levels as diagnostic parameters, 
e ~pecially as folata levels w2re much higher in blood than in serum. 
Grossowicz and his colleagues developed.= the whole blood folate 
assay method introduced by Toennies; Usdin and Phillips (1956) and 
examined its clinical application. They introduced minor modifications 
(Grossowicz;1 Mandelbaum-Shavit, Davidoff.:- and Aronovitch, 1962) but followed 
the important recommendations made by Toennies, Usdin and Phillips (1956). 
L.casei was used as the assay o.rganism but they also examined the value of 
S.-. faecalis and P. cerevisiae. They employed asc;orbic acid protection and 
haemolysed the red cells in plasma to ensure that the plasma factor made 
all the red cell folate available to the assay organism. 
They showed that the whole blood method was a sensitive test of 
folate deficiency (Izak, Rachmilewitz, Sadovsky,_ Bercovici, Aronovitch, 
21. 
and Grossowicz,. 1961.). Bloo.d folate. levels particularl.y with L-.casei 
were of diagnostic value in nutritional megp.loblastic anaemia and were 
regarded. as more reliable than serum folate 1.evels (Grossnwic.z,, 
Rachmil.ewitz, Izak and Zan, 1962). 
These investigators showed that the test harl application in the 
diagnosis of folate deficiency, but there was still insufficient information 
to a:ss:ess ita reliabil.ity in regard to diagnosis and differential diagnosis 
of the megaloblastic anaemias .•. 
Red c..ell L.. ease.i fol.ate assays. 
Hansen and Weinfeld (1.96Z) and Herbert (196Za}, used whole blood 
(corrected for haematocri t l or r:ed cell. L.casei fol.ate assays in preference 
to whole blood L. casei fol.ate assays.. This approach bid greater meaning 
becaus:e: uncorrected whole blood L .. cas:ei fol.ate levels could vary with the 
haematocrit regardless of folate nutrition. The red cell r._.casei folate 
assay was found to be a reliable index of fol.ate deficiency (Hansen and 
Weinfeld, 1962), aond o.f d.epleted fol.ate. stores (Herbert, 1.962a). 
In the pres-e.nce of vitamin B12 deficiency, reQ cell L_.casei fol.ate 
levels could be low in the absence of fol.ate deficiency, possibly because 
vitamin B12 was necessary for the trans.f.er o,f fol.ate into the developing 
red cell precursors (Hansen and Weinfeld, 1962J .. Unlike the serum L.casei 
folate assay this method had limita:.tions in the differential diagnosis: of 
the megaloblastic anaemias. 
Summary. 
On the basis of relatively little experience it was shown that the 
L..casei assay o.f fol.ate in red cells had value in the diagnosis of folate 
deficiency.. Moreover, low red. cell. L.casei fol.ate levels indicated a 
significant depletion of fola.te stores. The test had Ii ttle diagnostic 
value when vitamin B12 de.ficiency was present •. 
22. 
Indirect methods. 
While direct microbiological folate assays seemed impractical, 
indirect methods· were introduced to investigate folate nutrition..- Two of 
these method&wera relevant and were as follows:-
l. The folic. acid. clearance test. 
2-. Figl.u excre..tion after o.ra:l histidine. 
The folic acid clearance test. 
This was similar in c.oncept to the folic acid utilisation tests 
used by Bethell, Meyers, Gould, Swendseid, Bird and Brown (1947) and 
Spray, Fourman and Witts (l951), and technically similar to methods used 
by Schweigert (l948)i Spray and Witts (1953) and Butterworth, Nadel, Perez-
Santiago, Santini and Gardner (1957)~ However, the folic acid clearance 
test was developed and investigated as a diagnostic parameter of folate. 
defi.ciency by Chanarin and his asso.ciate.s., It was based on the principle 
that folate deficient subjects should remove intravenously injecte.d folic 
acid from the circulation more. ra-:pidly than normal subjects. They adminis-
tererl 15 pg./kg. of folic acid intravenously and then measured the serum 
S. faec.alis activity of blood samples: taken 3, L5 and 30 minutes after the 
injec~tion (Chanarin, Mallin and Anderson, 1958a). 
The folic acid clearance test using S:.fae.calis as the as.say organism .. 
It was shown that rapid folic acid clearance tests were not the 
result of increased urine loss (Chanarin, Mallin and Anderson, L958a; 
Girdwood and Delamare, 1961.;, Chanarin and:. Bennett, 1962b) and. could be 
slowed by the prior injection of folic acid (Chanarin, Mallin and 
Anderson, L958ar Girdwood and Delamora, L96l) .. Eolic acid clearanc..e 
rates were very rapid in patients with megaloblastic anaemias due to, 
23. 
folate deficiency and diffe:re.d markedly from those found in normal subjects; 
(Chanarin, Mollin and Anderson, 1958 a, b; Sneehy, Santini, Angel and 
Guerra, l.962~;, Mollin and Waters, L962;, Metz:, Stevens, Krawitz and Brandt, 
l.961). The 15 and 30 minuta samples were particularly useful (Chanarin, 
Mollin and Anderson, 1958b). 
Chanarin and c~lleagues suggested. that in folate defic:iency the 
rapid foli~ acid clearance tests coul.d be attributed to tissue folate 
deficiency because folic acid clearance curves remained rapid after 
megal.oblastic haemo~oiesis returned. to normal (Chanarin, Mollin and. 
Anderson,. 1958a), and because rapid folic acid clearance curves could 
precede the development of megaloblastosis (Chanarin, Mollin and" 
Anderson, 1958b). 
The use. of the test was subject to certain limitations, notably in 
pregnancy, in vitamin B12 deficiency, in iron deficiency and in some 
drug-induced megaloblas..tic anae.mia·s3. It was shown that normal non-anaemic 
pregnant women could have rapid .. folic acid clearances particularly as 
term approa·ched., Though. these curves were more rapid than usual they did 
not fall in the range seen in the megaloblastic anaemia of pregnancy 
except in some cases o.f twin pregnancy (Chanarin, MacGibbon, QtSullivan 
and Moll.in, L959l. Similar findings were reported by Girdwood and 
Delamora (1961). The reason for these curves in pregnant women was, not 
known. They were not thought to be the result of blood volume changes 
alone (Chanarin, MacGibbon, O'&ullivan and Mallin , L959; Girdw.ood and 
Delamare, 1961) though they could have been related to foetal demand for 
folate (Chanarin, MacGibbon, Q'Sullivan and Mollin , 1959; Gird.wood and 
Delamore, L96L) or latent maternal fol.ate deficiency develnping in preg-
nancy (Chanarin, MacGibbon, O'Sullivan and Mollin, l.959). Thus the rapid 
24 .. 
folic. acid clearance test was believed to indicate. either folate defid.ency 
or increased demand for folate. Contradictory findings in pregnant women 
were noted by Grossowicz, Aronovitch, Rachmilewitz , Izak, Sadovsky and 
Bercovici (1962) who found normal folic acid clearance test°' in both 
anaemic and non-anaemic pregnant women when using the same technique as 
Chamarin, Mollin and Anderson (1958a). Luhby, Feldman, Sale,rno and Cooper-
man (1963) did not find the test useful as a paramete.r of folate deficiency 
in pregnancy. 
Abnorma:lly fast clearance curves were found_ in megaloblastic anaemia 
resulting from vitamin B12 deficiency (Chanarin, Moll.in and Anderson, 1958a,bt 
Herbert and Za.J.usky, 1962) particularly in the presence of severe anaemia 
(Chanarin, Mollin and .Anderson,. l958a., b). This; was thought to be, the 
r.esult of disturbed folate metabolism in vitamin B12 deficiency (Herbert 
and Zalusky, 1962; Chanarin, MolJ.in and Anderson, L958b). 
In iron deficiency moderately rapid clearanc.es were found which they 
thought might have been due to associated folic acid deficiency (Chanarin, 
MolJ.in and Anderson, 1958 a _, b). 
On the other hand, Chanarin and his associates found that certain 
drugs such as primidone and barbiturates could cause megaloblastic anaemia 
by interfering with folate metabolism without resulting in tissue folate 
deficiency. In these instances folic acid clearances were normal 
(Chanarin, Mellin and Anderson, L958 a, b; Chanarin, Elmes and Mollin, 
1958). 
The test was a sensitive test of folate deficiency because it could 
be abnormal before the development of megaloblastosis. (Chanar.in, Mollin 
and Anderson, 1958b; Met~,. Stevens, Krawitz and Brandt,, L96l; Cha:nar.in,, 
Bennett and Berry, 1962). 
25. 
The folic acid clearance test using L.casei as the assay organism. 
The folic acid clearance test was found to have the wame diagnostic 
value in megaloblastosis due to folate deficiency when folate was measured 
with L.casei instead of S.faecalis. To some extent the use of L.casei as 
the assay organism was advantageous because the folic acid clearance rate 
measured with L.casei was less rapid in vitamin B12 deficiency than when 
it was measured with S.faecalis (Mollin and Waters, 1962; Herbert and 
Zalusky, 1962). 
The folio acid clearance test using tritiated folic acid. 
The use of tritiated folic acid confirmed the pattern of the folic 
acid clearance test found in normal subjects using microbiological methods 
(Johns, Sperti and Burgen, 1961). Although use of tritiated folic acid 
showed that urinary loss of folate was underestimated when the micro-
biological method was used, rapid folic acid clearances could still not 
be attributed to increased urinary loss (Chanarin, Belcher, and Berry, 
1963). This test was also valid in the diagnosis of megaloblastic anaemia 
due to folate deficiency (Sheehy, Santini, Angel and Guerra, 1962; Mollin 
and Waters, 1962). It was rapid in the presence of vitamin B12 deficiency 
(Mollin and Waters, 1962). 
All folio acid clearance tests had practical disadvantages. Several 
blood samples were required as well as the administration of therapeutic 
doses of folic acid. 
Summary. 
The folic acid clearance test using either microbiological or 
radioactive methods was a good diagnostic parameter of megaloblastic 
anaemia due to folate deficiency. The test could not be used 
to differentiate between folate and vitamin B12 deficiency if 
26. 
S.faecalis was used as the assay organism. In this case the L.casei folio 
acid clearance test had greater diagnostic value. The application of the 
test was limited in the case of iron deficiency, and some drug-induced 
megaloblastic anaem:ias and perhaps in pregnancy. The test was a sensitive 
index of tissue folate deficiency because it could indicate the presence of 
folate deficiency before the development of megaloblastosis. 
The test had certain practical disadvantages. 
Figlu excretion after oral histidine. 
This test was developed following observations by Bakerman and his 
associatesin 1951, which led to an understanding of the interrelationships 
of histidine and folate metabolism. Bakerman, Silverman and Daft (1951) 
observed a significant excess of glutamic acid in the urinary amino acid 
pattern of rats suffering from drug-induced folate deficiency. This ~lu-
tamic acid excretion could be prevented or reversed by the administration 
of folio acid . Later it was shown that the excretion product was not 
glutamic acid but a precursor of glutamic acid (Silverman, Gardiner and 
Bakerman, 1952) which was identified as an intermediate of histidine meta-
bolism (Tabor, Silverman, Mehler, Daft and Bauer, 1953). It was found to 
have the properties of o( -formamidinoglutaric acid (Formimino-1-glutamic 
acid - Figlu) by Borek and Waelsch (1953). The glutamic acid precursor 
in the urine of folate deficient rats was then identified as Figlu by 
Seegmiller, Silverman, Tabor and Mehler (1954). The interrelationships of 
histidine and folate metabolism were clarified by the recognition that Figlu 
provided a formimino group for transfer to tetrahydrofolate (Miller and 







































































































































































































































N5-formimino FH4. and glutamic acid (Tabor and Rabinowitz,, 1956). When 
there was not enough FH4 , as in folate deficiency, excess Figlu was 
excreted in the urine. 
Meanwhile, the ste..ps o.f a major pathway O)f histidine de:gradation 
had been and were being defineod.. It was established that in this pathway 
histidine was degraded first to urocanic acid (Sera and Yada, i939; 
Mehler and Tabor, L953), then to imidazole propionic acid (Revel and 
Magasanik,_ 1958) and then to Figlu (Borek and Waelsch, 1953). The 
diagram (Fig~ 4) illustrates the interralationships of folate and histidine 
• 
metabolism .. 
This experimental data was applied by Broquist (1956) in an attempt 
to find a test for folate deficiency in humans. A compound similar to 
Figlu was found in the urine 0,f children re.ceiving folate antagonists a.s 
part of the treatment of Leukemia (Broq_uis-t, I..956 ;, Broquist and Luhby,.. 
L957J. The compound was finally identified as Figlu in L959 (Broq_uist 
and Luhby, I..959). 
Microbiological, chromatographic, en~ymatic and ele~trophoretic 
methods of estimating Figlu in urine were developed. It was agreed that 
of these, the enzymatic method was the most sensitive (Luhby, Cooperman 
and Teller, 1959b;- Knowles, 1962). The electrophoretic method of Kohn,_ 
Mollin and Rosenbach was relatively insensitive and concentrations of 
Figlu less, than lOQ pg./ml. could not be estimated (Knowles, l962). 
The clinical application of the test was investigated by Luhby 
and his colleagues. 
First of all it was established in a small number o,f patients that 
the test could be used to differentiate between normal and folate deficient 




1957). However, the test was relatively insensitive and in order to 
overcome this problem an oral dose of histidine was given before the 
collection of urine for Figlu estimation (Luhby, Cooperman and Teller, 
1959a). This modification was based on previous experimental work on 
rats in which it had been shown that a dietary histidine load resulted 
in an increase of Figlu excretion in folate deficient rats, but not in 
normal rats (Tabor, Silverman, Mehler, Daft and Bauer, 1953). 
In humans, the Figlu test after oral histidine could still be used 
with success to distinguish between folate deficient subjects and normal 
subjects and to distinguish between the megaloblastic anaemias due to 
folate and those due to vitamin B12 deficiency. Moreover, it was a 
sensitive and specific test for folate deficiency which could therefore 
be used in the diagnosis of subclinical folate deficiency, (Luhby, 
Cooperman, Teller and Donnenfeld, 1958; Luhby, Cooperman and Teller, 
1959 a,b). Unless otherwise stated, the Figlu test will refer to the 
Figlu test after oral histidine. 
The amount of Figlu excreted with (Carter, Heller, Schaffner and 
Korn, 1961) and without a histidine load (Luhby, Cooperman, Maclver and 
Montgomery, 1960) was in proportion to the severity of the folate 
deficiency. 
From this time until 1963 this experience with the Figlu test after 
oral histidine was only partly confirmed. 
Other investigators confirmed that the test could be used with 
validity to distinguish between normal and folate deficient subjects 
with megaloblastosis (Spray and Witts, 1959; Stevens, Metz, Brandt and 
v.Broekhuizen, 1962; Kohn, Mollin and Rosenbach, 1961; Chanarin, Bennett 
and Berry, 1962), or without megaloblastosis (Knowles, Prankerd and 
Westall, 1960; Grasbeck, Bj8rksten and Nyberg, 1961; Kohn, Mollin and 
29. 
Rosenbach, 1961; Zalusky and Herbert, 196l; Chanarin, Bennett and Be,rry,, 
1962') . , The use: of low. doses of histidine (2 g.), decreased the reliability 
of the test (Spray and Witts, l959). Occasionally negative tests were 
noted in folate deficiency for no apparent reason (Chanarin, Bennett and 
Berry, , 1962). 
The value of the, Figlu test a.fter oral histidine in dis.tinguishing 
between the megaloblastic, anaemias due to folate and tho·se due to vitamin 
B
12 deficienc.y was not confirmed in the long run in spite· of some, confirmatory 
evidence for Luhby's findings in the firs,t !)lace (~ray and Witts, 1959; 
Knowles, Prankerd and Westa:11-, I...960) .. Later, a. number of investigators. 
found p-ositive tests after oral histidine was adminisxered in cases> of 
vitamin B
12 
deficiency (Marshall and Jandl., 1-960;, Carter, Hell.er, S:Cha.ffner 
and Korn, 196li Zalusky and Herbert, L96l; Kohn, Mollin and:Rosenbach, 1961; 
~tevens, Metz, Brandt and v.Broekhuizen~ l962;, Chanarin, Bennett and Berry, 
1962; Knowles and Prankerd, 1962). The quantity of Figlu excre.ted in 
vitamin B
12 
deficiency was less than the excretion in folate deficiency 
(Carter, Heller, Schaffner and Korn, I96lr Stevens, Metz, Brandt and 
v. Broekhuizen, l96Z). 
These contradictory findings were difficult to evaluate at first 
since there had been little uniformity in the dose o.f histidine given, 
in the schedule of histidine administration, in the duration of urine 
collection and. in the. method of Eiglu estimation. Certain contributions 
helped to establish that Figlu could be excessive in vitamin B
12 deficiency. 
Hansen and Weinfeld (1962) used exactly the same experimental methods as, 
Luhby, Cooperman and Teller (1959b) and found positive Figlu tests after 
oral histidine in vitamin B
12 
deficiency~ Zalusky and Herbert (1961), 
30. 
and Hansen and Weinfel.d (1962), showed that excessive Figl.u excretion after 
oral histidine in vitamin B
12 
deficiency increased after folic acid therapy 
but greatly decreased after treatment with small doses ~f vitamin B12 • 
Chanarin (l963) found that vitamin B12 was as effective as folic acid in 
improving Figlu excretion after oral histidine in vitamin B12 deficiency. 
Finally, Herbert and Zalusky (1962) showed that vitamin B12 deficiency 
might block the conversion of N5-methyl FH4 to FH4 • This produced a 
diminution of available FH4 and provided an explanation of positive Figlu 
tests in vitamin B
12 
deficiency. 
Although some later studies did not ~onfirm the findings from which 
Herbert and Zalusky ( 1962 ). drew their:: conclusionff ( Chanarin and McLean, 
1967;: Chanarin and Perry,, 1968) it remains possible that the conversion 
of N5-methyLFH4 or its conjugates to FH4 is blockeu in vitamin B12 
deficiency (Kutzbach, Galloway and Stokstad, L967; Chanarin and McLean, 
L967~ Chanarin and Perry, L968J. 
Other investigators belie~ved that the function of glutamate 
formiminotransferase was inhibited in vitamin B12 deficiency (Knowles 
and Prankerd, 1962; Baker, Frank, Gellene and Leevy, 1964; Vitale and 
Hegstad, 1967) .. This would also lead to a disturbance of folate. 
metabolism in vitamin B
12 
deficiency and a diminution of available FH4 
resulting in positive Figlu tests; after oral histidine. 
The sensitivity of the Figlu test after oral histidine as a parameter 
of folate deficiency was confirmed_when other investigator~ found that 
excessive Figlu excretion preceded the development of megaloblaatosis due 
to folate deficiency (Zalusky and Herbert, 196L;, Knowles, Prankerd and 
Westall, 1960; Konn, Mellin and Rosenbach, 1.961;, Chanarin, Bennett and 



































































































































































































































































































































































































1962; Herbert, 1962a). 
However, it became increasingly clear that these results could not 
be attributed to folate deficiency without supporting evidence because the 
specificity of the Figlu test was no longer regarded as absolute. 
As may be seen in the diagram (Fig. 5) both folate deficiency and 
disturbances of folate metabolism may result in positive Figlu tests. 
Secondary disturbances of folate metabolism may arise from interference 
with enzyme function (folio acid reductase, glutamate formiminotransferase 




By 1963 positive Figlu tests after oral histidine not related to 
folate deficiency were described in the following conditions: 
1. Liver disease. 
A number of investigators noted positive .Figlu tests after oral 
histidine in liver disease which did not or only partly resulted from 
folate deficiency (Carter, Schaffner and Heller, 1960; Merritt, Rucknagel, 
Gardiner and Silverman, 1960; Carter, Heller, Schaffner and Korn, 1961; 
Merritt, Rucknagel, Silverman and Gardiner, 1962; Knowles, Shaldon and 
Fleming, 1963). These positive tests were explained on the basis of a 
disturbance of folio acid reductase (Carter, Heller, Schaffner and Korn, 
1961; Carter Schaffner and Heller, 1960) or glutamate formiminotransferase 
function (Carter, Schaffner and Heller, 1960; Carter, Heller, Schaffner and 
Korn, 1961; Merritt, Rucknagel, Silverman and Gardiner, 1962). This 
suggestion was made because liver disease could disturb enzyme function, 
and histidine and folate were mainly metabolised in the liver. 
2. Congenital abnormalities. 








excessive Figlu excretion after oral histidine was reported by Arakawa, 
Ohara, Kudo, Tada, Hayashi and Mizuno·, L96 3. 
3. Vi tamin B12 deficiency. 
Positive Figlu tests in this condition were discussed above. 
4. Miscellaneous conditions. 
Positive Figlu tests after oral histidine were reported in 
miscellaneous conditions like iron deficiency (Chanarin, Bennett and Berry, 
1962; Knowles, 1962), neoplasia (Kohn, Mollin a nd Rosenbach, 1961, 
Chanarin, Bennett and Berry, 1962), haemolytic anaemia (Chanarin, Bennett 
and Berry, L962), and sarcoidosis (Kohn, Moll.in and Rosenbach, 1961). 
These results were not fulLy explained, but associated folate deficiency, 
increased' demand for folate and unsuspected associated liver dis-ease were 
suggested as possible explanations (Kohn, Mollin and Rosenbach, 1961; 
Chanarin, Bennett and Berry, 1962). 
~s the Figlu test after oral histidine was not only a sensitiva but 
also a non-specific test, a positive Figlu test could be attributed to folate 
deficiency only if supported by confirmatory laboratory evidence or by a 
success1ul therapeutic trial with folic acid. 
It was clear from past therapeutic studies that large dos:es of folic 
acid could be. effective in the cas:e of vitamin B
12 
deficiency (Moore, 
Bierbaum, Welch and Wright, l945; Vilter, Horrigan, Mueller, Jarrold, Vilter, 
Hawkins and Seaman, 1950). Furthermore, excessive Figlu excretion after 
oral histidine resulting from secondary disturbances of folate metabolism 
such as occurred in liver disease could be improved with large doses of 
folic acid (Carter, Heller, Schaffner and Korn, L96l; Knowles, Shaldon and 
Fleming, l963). On the other hand, physiological doses of folic acid 
(10Q-20C1pg. daily) were effective in the treatment of folic acid deficiency 
33. 
yet did not provoke a therapeutic response in secondary disturbances of 
folate metabolism such as vitamin B12 deficiency (Hansen and Weinfeld , 
1962). Because in folate deficiency, 200 fg• of folio acid daily could 
convert positive Figlu tests after oral histidine to normal in the 
majority of instances (Hansen and Weinfeld , 1962), this dose was recom-
mended for use in diagnostic therapeutic trials. The dose (400 pg. 
daily), previously recommended by Marshall and Jandl (1960), could 
occasionally result in a therapeutic response in vitamin B12 deficiency 
(Hansen and Weinfeld, 1962). mherefore if a therapeutic trial was used 
as specific evidence for attributing the results of the Figlu tests 
after oral histidine to folate deficiency it had to be carried out with 
physiological doses of folio acid not exceeding 200 fg· daily. 
The Figlu test and its relationship to histidine metabolism. 
Urocanic acid, one of the intermediates in the degradation of 
histidine, was detected in the urine of humans by Acheson, Paul and 
Tomlinson (1958). The necessity to consider disturbances of histidine 
metabolism when using the Figlu test in the diagnosis of folate deficiency 
became apparent after a report by Merritt, Rucknagel, Gardiner and 
Silverman (1960). They identified urocanic acid in the urine of a 
patient probably suffering from liver disease, whom they were investi-
gating for folate deficiency, using the Figlu test after oral histidine. 
Later it was shown that normal subjects and patients deficient in 
folate and vitamin B12 , as well as those with miscellaneous haematolo-
gical conditions (Bennett and Chanarin, 1961; Bennett and Chanarin, 1962) 
could all excrete Figlu or urocanic acid or both after receiving a histidin 
34. 
l-0a:d~ The proportion of urocanic acid to Eiglu could vary from Oto 97% 
(Bennett and Chanarin, l96l). 
From the diagram (Fig. 5) it may be seen that a metabolic disxurbanca 
of histidine metabolism resulting in a dis.turbance of urocanase function 
coulrl result in ex~ssive excretion of urocanic acid in the urine. In 
theoe circumotances er.cess Figlu might not be excreted even when there was 
folate deficiency. The same applied when there was a disturbance of 
histidase function or an alteration in the metabolism of histidine itself. 
In certain pathological conditions a possible disturbance af urocanase 
function leading to exc.essive urocanic acid excretion in the urine, was 
reported. One of these was live.r diseas:e (Merr·i tt, Rucknagel, Silverman 
and Gardiner,, L962), and another was kwa:shiorkor (Whitehead and Arnstein, 
L961). 
It was no.t known whether the exce.ssive urocanic acid excration noted 
in folate deficien~y could be attributed to an effect of folate deficiency 
on urocanase function or whether tha two findings were unrelated. It was 
suggested that urocanasB required. foiic acid. or a derivative for its 
function in converting urocanic acid to Figlu (Baldridge, L958) or for its 
synthesis (Bennett and Chanarin, 1961.), or alternati::vely that urocanase 
function might be depresoed by the negative feed back caused by accumula-
tion of Figlu (Baldridge, L958~ Bennett and Chana:rin, L961; I962). A 
relationship between urocanase function and folate deficiency could not 
be demonstrated. in a subsequent study by Hoffbrand, Neale, Hines and 
Mollin ( L966 J. 
Ks disturbances of urocanase function might interfere with the 
interpretation of the Figlu test after oral histidine in the investigation 
of folate deficiency, it was sugges:ted that both urocanic acid and Figlu 
35,., 
should be estimated (Benne.tt and Chanarin, l962).. A modification o.f 
&ilverman, Gardiner and Condit's (1958) enzymatic method for estimating 
Figlu, alJ.owe.d the_ estimation of Figlu a:nd urocanic acid (Bennett and 
Chanarin, L962; Chanarin and Bennett, L962a) .. 
A rare congenital disturbance of histidase function was described 
by A:uerbach, Di George, Baldridge, Tourtellotte and Brigham (1962), and 
Ghadimi, Partington and Hunter b962). This had~ little practica,l applica-
tion in the investigation of folate deficiency. 
It was found that in pre.gnant women histidine a:.bsorption was 
prolonged, that there was increased urinary loss of histidine and 
probably increased utilisation of histidine for protein synthesis. These 
acquired disturbances of histidine metabolism in pregnancy lessened the 
efficacy of the histidine load and i;;-o rendered. the Figlu test unreliable 
in this condition (Berry, Booth, Chanarin and Rothman, 1963;: Chanarin, 
Rothma~ and Watson-Williams, L963). 
Summary. 
The Figlu test after oral. his±idine was de.veloped as the res.ult of 
certain experimental observations. It was found to be a good diagnostic 
test of megaloblastic anaemia due to folate deficiency. It could not be 
used in the differential diagnosis of megaloblastic anaemia due to 
vitamin B12 or folate deficiency. Although sensitive, it was non-specific, 
and therefore could only be. attributed to folate deficiency if supported 
by laboratory evidence or a . auccess£ul therapeutic trial with physiological 
doses of folic acid. Furthermore, disturbances. of histidine metabolism 
<:::0uI.d lead to errone~us interpretation of the Figlu test. But with the 
possible exception of pregnancy, these were not of great pTactical 
significance as long a:s both urocanic acid and Figlu were always estimated. 
36. 
THE CONCEPT OF BIOCHEMICAL FOLATK DEFICIENCY. 
This concept was developed following the use of laboratory methods 
of diagnosing folate deficiency and the demonstration of the evolution of 
nutritional folate deficienc.y in man (Herbert, L962a). 
l.t had been shown that the foiic acid clearance test (Chanarin~ 
Mo.llin and. Anderson, 1958b; Metz, S::.tevens, Krawitz, and Brandt, L96I.; 
C:hanarin, Bennett and Berry,, 1962), the serum L ... cas.ei folate assay (Cooper 
and Lowenstein, 196L), and the Figlu test after oral histidine (Luhby~ 
Coo~erman and Teller, 1959b; Knowles and. Prankerd, 1962; Grasbeck, 
Bjorksten and Nyberg,, I.961) could alI. indicate folate deficiency before. 
the development of megaloblastosis. This was illustrated in an interesting 
e.xperiment of Herbert's (L962a) in which he produce.d. fola te deficiency in 
himself by taking a daily diet af 5 fg .. of folate.. liter three. weeks,, 
serum L.casei folate levels were abnormally 1.ow.~ a£ter seven weeks, 
hypersegmentation of the neutrophils developed; after three: months;, excess 
Figlu a:fter oral histidine was excrate.d; and after four months, red cell 
r.. casei folate levels were. abnormally I.ow.. Clinical folate. deficiency in 
the form of megaloblasxic anaemia did not become apparent until approximately 
4t months from the start of the experiment. 
Diagnosis of subclinical folate deficiency. 
All these laboratory parameters could be used to diagnosa biochemical 
folate deficiency, and Herbert's. experiment clarified their application. 
The serum L.casei folate assay was the mat sensitive test, indicating folate 
deficiency long before stores were sufficiently depleted to result in 
megaloblastic anaemia. It was suggested that this test probably raflected 
dietary intake and absorption (Herbert, l962a). ~s the Figlu test after 
37. 
oral histidine and red call L.casei folate levels did not become abnormal 
until shortly before the development of megaloblastic anaemia, they appeared 
to be good indices of significant depletion of folate stores (Herbert,1962a). 
The folic acid clearance test was a more sensitive test of folate 
deficiency than Figlu excretion after oral histidine (Chanarin, Bennett 
and Berry, 1962). From this observation and those of Herbert (1962a) it 
was likely that the sensitivity of this test and that of hypersegmentation 
of the neutrophils came after the serum L.casei folate assay hut pefore 
Figlu excretion after oral histidine and red cell L.casei folate assays. 
These laboratory tests varied in their sensitivity as indices of 
folate deficiency as well as in their ability to differentiate between 
folate deficiency and vitamin B12 deficiency. So, too, the specificity, 
reliability and simplicity of the tests varied in the ways described above. 
Thus none of these parameters could be regarded as unequivocally superior 
as diagnostic parameters of both biochemical and significant folate 
deficiency. 
The prevalence and significance of biochemical (latent) folate 
deficiency in man was not known, but there was evidence that it might have 
considerable import~nce (World Health Organization Report). In an investi-
gation of the problem it would be important to utilise at least two of the 
laboratory parameters in the diagnosis of the condition and in the assess-
ment of its significance. The significance should be further assessed in 
relation to morphological and clinical studies. 
MEGALOBLASTIC ANAEMIA OF INFANCY AND THE ROLE 
OF FOLATE DEFICIENCY IN ITS PRODUCTION 
The development of understanding of megaloblastic anaemia in infants 
and the role of folate deficiency in its production followed the pattern 
38. 
of the earlier discussion of the condition in adults. Major advances 
were as followss 
First of all there were isolated reports of macrocytic anaemia 
occurring in infancy and, to a lesser extent, in childhood. The 
earliest of these was credited to von Stark (1909). Some of the earlier 
studies concerned infants who developed macrocytic anaemia while on a 
diet of goats' milk (Glanzmann, 1926). 
The next advance was the recognition that liver was haematologically 
effective in infantile macrocytic and pernicious anaemia (Faber, 1928). 
The aetiological concept of the macrocytic anaemias occurring in 
infancy was outlined by Parsons and Hawksley (1933). They believed th~t 
macrocytic anaemia of infancy was a rare disease, caused either by a 
deficiency of the intrinsic factor as in infantile pernicious anaemia or 
by a deficiency of the extrinsic factor, as in coeliac disease (Parsons 
and Hawksley, 1933), or goats' milk anaemia (Parsons, 1933). It could 
also result from failure to absorb the haemopoietic factor (combined 
extrinsic and intrinsic factor) as in dibothriocephalus latus infestation 
(Parsons and Hawksley, 1933). 
Bachman (1936) emphasised certain aspects of this concept. He 
reported a case of macrocytic anaemia of infancy which responded to 
a single course of liver therapy. He attributed the macrocytic anaemia 
to nutritional deficiency and possible malabsorption (the result of 
repeated gastrointestinal infection). From his experience and after a 
critical assessment of previous contributions, he clearly defined the 
entity of infantile nutritional macrocytic anaemia which he believed to be 
the most common cause of macrocytic anaemia occurring in infants under a 
39. 
year. However he was not convinced that a single case of true infantile 
pernicious anaemia had been reported. 
The megaloblastic nature of the haemopoiesis in infantile macrocytic 
anaemia was recognised by Veeneklaas (1942), Davis (1944) and Zuelzer and 
Ogden (1946). However, it was Zuelzer and Ogden (1946) who emphasized the 
diagnostic and therapeutic significance of megaloblastosis and who were 
mainly responsible for introducing the concept of infantile megaloblastic 
rather than macrocytic anaemia. 
Until 1946, 40 cases of infantile macrocytic anaemia had been described 
(zuelzer and Rut zky, 1953), but in 16 months Zuelzer and Ogden (1946) had 
recognised 24 new cases of megaloblastic anaemia occurring in infants. 
All of the infants appeared to be suffering from a similar syndrome. 
From a study of their clinical experience, they defined the condition 
of infantile megaloblastic anaemia which they believed occurred with 
relative frequency (Zuelzer and Ogden, 1946). They conducted successful 
therapeutic trials with liver and folio acid, the last of which had by 
then just become available. Thus they related the condition to folio 
acid deficiency which they believed might have resulted from dietary 
deficiency or the effects of infection. In the discussion below the 
condition they described will be referred to as infantile nutritional 
megaloblastic anaemia. 
Other megaloblastic anaemias due to other causes of folio acid and 
vitamin B12 deficiency (Maciver, 1962) and rarely to disturbances of 
pyrimidine metabolism (Huguley, Bain, Rivers and Scoggins, 1959), are 
known to occur in infants and children. Only the most important group -
infantile nutritional megaloblastic anaemia will be considered below. 
INFANTILE NUTRITIONAL MEGALOBLASTIC ANAEMIA. 
It is now clear that this can result from folate or vitamin B12 
deficiency. Other causes are speculative. 
40. 
Clinical presentation and the aetiology of 
infantile nutritional megaloblastic anaemia. 
Folate deficiency. 
The clinical presentation, defined by Zuelzer and Ogden (1946) was 
as follows: Infants from 2 - 16 months, but most frequently, infants from 
8 - 14 months were affected. Symptoms were related to the anaemia or 
preceding infection. Dietary intake was unsatisfactory in half the cases. 
The findings on examination were severe anaemia and its effects. Hepato-
megaly was always present, splenomegaly infrequently, and purpura occasio-
nally. Half of the infants were undernourished, a quarter had scurvy, and 
examination often showed evidence of infection. With occasional exceptions 
there was no evidence of underlying organic disease. Macrocytosis and 
hypersegmentation of the neutrophils were often observed on blood smears, 
but the essential and diagnostic feature of the condition was megaloblastic 
haemopoiesis which specifically and permanently responded to a single 
sourse of liver or folio acid therapy. The absence of underlying organic 
disease in the majority of cases, and the permanent cure afforded by 
treatment with folio acid suggested a relationship to a temporary deficiency 
of folic acid which in many cases appeared to be nutritional in origin. 
In the next few years, approximately 100 further cases similar to 
those described by Zuelzer and Ogden (1946) were reported from the U.S.A., 
Italy, England, Holland and France. By 1953 the incidence, particularly 
in the U.S.A., had declined (Zuelzer and Rutzky, 1953), but the condition 
was then frequently reported from countries with large underprivileged 
population groups (Adams, 1954; Walt, Holman and Hendrickse, 1956; Walt, 
Holman and Naidoo, 1957; Shnier and Metz, 1959; Kho and Odang, 1959; 
Maciver and Back, 1960; Metz, Brandt and Stevens, 1962; Velez, Ghitis, 
Pradilla and Vitale, 1963). In this group, the presentation in slightly 
41. 
older infants and in association with malnutrition and infection was 
emphasiz:e.d (Walt, Holma:n and Naidoo,,, L957;: S.1mier and Metz, 1959; 
Maciver and Back, 1960). 
In L946, when ~uelzer and Ogden conducted their successful 
therap--eutic studies with folic acid, this substance was beli'eved to, be 
the haemopoietic factor or Castle's extrinsic factor. Thus it was 
believed that infantile nutritional megaloblastic anaemia c:ouLd be 
specificalLy attributed to folic acid deficiency even though liver therapy 
had als~ proved successful. 
It was later realised tha.t there were. two extrinsic factors pres:ent 
in liver, folic acid and vitamin B
12 
which, . when deficient, could both 
result in megaloblastic anaemia. These factors were therapeuticalLy 
interrelated, and though most effective when used specifically, could 
produce ha,ematological improvement in megaloblastic anaemia caused. either:. 
by folic acid or by vitamin B
12 
deficiency, espec.ially i .f used in pharma::-
col.ogical doses (Wilkinson,, l948 a:, b;, Vilter, Horrigan, Mueller,. Jarrold, 
Vilter, Hawkins and Seaman, I950;: Killander, 1..958). 
Therefore it was necessary to carry out further therapeutic. trials 
with folic acid and vitamin B
12 
to determine the aetioTogy o,f nutritional 
megalo.blastic anaemia of infan~y.. This was not a: succ:ess-ful method 
because. not alL invesxigato.rs compared the therapeutic efficacy of both 
factors used in sequenc.e under controlled.conditions as Minot and Castle 
(1935) had suggeste.d. The,$'~ who did, found most cases could be attributed 
to folic acid deficiency (Luhby and Wheeler, L949;, Zuelzer and Rutzky, 
1953). OccasionalLy folic acid was present with vitamin B
12
_ deficiency 
and rarely uncomplicated vitamin B
12 
deficiency was· responsible for the 
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condition (Zuelzer and Rutzky, 1953). Those who used only vitamin B12 
as the therapeutic agent found they succeeded with it and concluded 
that vitamin B12 deficiency also played a significant role in infantile 
nutritional megaloblastic anaemia (McPherson, Jonsson and Rundles, 1949; 
Sturgeon and Carpenter, 1950; Shnier and Metz, 1959; Maciver and Back, 
1960). 
Laboratory methods clarified the problem. It was shown that 
vitamin B12 in pharmacological doses could be used successfully to treat 
patients with megaloblastic anaemia, in spite of normal serum vitamin B12 
values (Metz, Brandt and Stevens, 1962) and low serum L. casei folate levels 
(Zalusky, Herbert and Castle, 1962). Moreover, serum vitamin B12 levels 
were normal in the great majority of cases of infantile nutritional megalo-
blastic anaemia (Adams and Scragg, 1962; Kandi, MacDougall, Foy, Mehta 
and Mbaya, 1963; Kende, Ramot and Grossowicz, 1963; Metz, Brandt and 
Stevens, 1962). A few of these infants had subnormal vitamin B12 levels 
(Adams and Scragg, 1962; Metz, Brandt and Stevens, 1962; Kende, Ramot 
and Grossowicz, 1963) but these were not necessarily the result of 
vitamin B12 deficiency because Mallin and Waters (1962) had shown that 
severe uncomplicated folate deficiency might result in subnormal vitamin B12 
levels. 
In infantile nutritional megaloblastic anaemia there was unequi-
vocal evidence for folate deficiency. Serum L. casei folate levels were 
low (Herbert, Baker, Frank, Pasher, Sobotka and Wasserman, 1960; Kandi, 
MacDougall, Foy, Mehta and Mbaya, 1963), whole blood L.casei folate 
levels were low · (Kende, Ramot and Grossowicz, 1963) and Figlu excretion 
with and without oral. histidine was exc,essive.., (Luhby, Cooperman, 
Maciver and Montgomery, 1960f Luhby, Cooperman, Maciver and Montgomery, 
L962). 
From these observations folate deficiency was shown to have... been 
primaril.y responsible for producing infantile nutritional megaloblastic 
anaemia, as had been suggested_ by Zuelzer and Ogden (L946). 
Goats' milk anaemia. 
The.. presentation of this macrocytic anaemia was similar to that 
described:. by Zuelz.er and Ogden (L946) but wa:s often more. sev.ere:. and 
occurre.d at an earlier age (Collins, 1.962). 
E.s early as l933 Parsons had suggested. that extrinsic factor 
deficiency might be the caus:e of the sev.ere... macrocytic ana_emia. occurring 
in infants who, had been fed on a diet of goats' milk.. This was partly 
confirmed when Gyorgy (r.934) demonstrated the: therapeutic efficacy of 
yeast and:. liver therapy in this condition. As before, therapeutic trials 
failed to determine whether the anaemia was due to folate or vitamin B12 
deficiency, because both folic acid (Gasser, l948) and vi_ta,min B12 
(Real.e and Feliciangeli, 1958) ,. produced- positive results. 
Initial laboratory studies performed on goats' milk to estimate 
its folate and vitamin B12 content, were unhelpful. because of the imper~ect 
methods then available for assaying folate (Collins, Harper, Schreiber 
and Elvehjem, 1951). Once the assay method was improved it was. shown 
that the folate content of goats} milk. was extremely low (Naiman and 
Oski, 1964;. Becraft and Holland, I.966), whereas the vitamin B12 content 
was comparable to that found. in human milk (Nicol- and Davis, l967). 
44. 
Infants with this anaemia had low serum L.casei folate levels (Becroft 
and Holland, 1966), but normal vitamin B
12 
levels (Wise, Lovric and 
C1'Gorman Hughes, L963 ;1 Be croft and Holland, 1.966). This:. anaemia: therefore 
appeared to be an example o.f severe dietary folate deficienc:..y and shoul.d 
probably no,t be distinguished' from infantile nutritional megal0,blastic 
anaemia. The earlier and more severe presentation characteristic of this 
anaemia appeared to reflec-t the severity of the_ dietary folate deficiency 




In Italy, Gerbasi (1940) Pecorella,. Burgio and Aversa (L947), and 
Arna-to (1952), described' an infantile megaloblas.tic anaemia associated 
with neurological manifestations such as pyramidal and extrapyramidal 
lesions.. Later a' similar syndrome was reported by Jadhav, Webb, 
Vaishnava and Baker (l962) in India., The principal. neurological 
marnifeatations they described were disturbed. levels of consciousness,. 
developmental. regression and involuntary movements. Hyperpigmenta.tion 
was an important association. 
The.re wa$ good, evidenc.e. for attributing these megaloblas:tic 
anaemias to vitamin B
12 
deficiency.. Low Levels of serum vitamin B
12 
were found. in the a:ff'ected infants and their mothers, and in the breas;t 
milk they received. (Jadha:v, Webb,, Vaishnava and Baker, L962;. Maciver, . 
L962). S:O~ too, a singLe cours.e of therapy with physiological. (Jadhav, 
Webb, Vaishnava. and Baker, 1962), and small_ oral doses of vitamin B
1,2 
cured the condition (Burgi()), Russo and LoJacono, L956;, Jadhav, We:bb, 
V.aishnava and Baker, 1962_) .. 
Later Kaul, Prasan and Chowdhry (1963), described a . similar neuro-
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logical syndrome with hyperpigmentation in Indian infants which was not 
associated with megaloblastosis or consistent evidence of vitamin B12 
deficiency. Other investigators confirmed the existence of a syndrome of 
neurological manifestations, hyperpigmentation and megaloblastosis due to 
vitamin B12 deficiency, though they did not find that megaloblastosis was 
always present (Srikantia and Reddy, 1967). They suggested that the megalo-
blastic anaemia might be a late manifestation of the condition (Srikantia 
and Reddy , 1967). 
In some parts of the world infantile nutritional megaloblastic anaemia 
had been ascribed to vitamin B12 deficiency. Its clinical manifestations 
may be different to those found in other forms of infantile nutritional 
megaloblastic anaemia but there is no agreement on this at the present time. 
Vitamin C deficiency. 
The association of megaloblastic anaemia and scurvy ~as noted both in 
adults and children (Jennings and Glazebrook, 1938; McMillan and Inglis, 
1944; Zuelzer and Ogden , 1946; Aldrich and Nelson, 1947). 
Initially a specific role for vitamin C in the production of this 
megaloblastosis could not be demonstrated and as a result it was concluded 
that vitamin C and folate deficiency were often aswociated (Zuelzer, Hutaff 
and Apt, 1949). After a series of experiments on monkeys, May and his 
coileagues concluded in 1953 that vitamin C deficiency resulted in increased 
demand for folate. This led to the production of megaloblastic anaemia 
when folate supplies were insufficient (May, Nelson, Lowe and Salmon, 1950; 
May, Hamilton and Stewart, 1953). 
Further studies, most of them on adults, produced controversial 
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resuLts. Rome investigators believed that vitamin C deficiency could be 
specifically responsible for the megaloblastosis , which sometime~ occurred 
in scurvy (Bronte-Stewart, I953$ Brown~ l955), but oxhers ascribed it to 
a:ss·ociated dietary folate deficiency (Zalusky and Herbert, L96Ia;, Chaz:an 
and Mistilis, L963). Dietary conditions were not always controlled in 
some of the earlier studies and these came in for criticism (Zalusky and 
Herbert, 1961a). At present there are two schools of thought on the 
aetiology of the megal.oblastic anaemia sometimes seen in s·curvy. Cox., 
MeynelL~ Northam and Cooke (1967) believed that the megaloblastosis 
resulted from a disturbance of folate metabolism caused by vitamin C 
deficiency. The se,Veri ty depended. on the degree. of this disturbance and 
the degree of associated· fola te depletion. Without associated fola te. 
deple.tion the anaemia was cured by the administration of vitamin c: alone, 
but when it was; present, vitamin C by itsel.f had no effect. There. was 
some biochemical evidence for the belie£ that vitamin C might play a role 
in folate metabolism.. It was·· thought tha.t vitamin c: protected folic acid 
reductase and so ensurad that fola te co enzymes w.ere ma'intained in 
sufficiently high concentration (Vilter, L964). 
The other view suggested by Zalusky and Herbert (1.961a) and 
Chazan and Mistilis (1963) wa s that megaloblastic anaemia in s.c.urvy only 
resulted from ass:ociated folate deficiency. Although the experiment of 
Zalusky and Herbert (L961a) was welL control:Led, their e.vidence was based 
on the investigation of only one patient. Chazan and Misti:Lis (l963) did 
not carry o.ut controlled studies;. The view suggested. by Cox:, Meynell, 
Northam and Cooke (L967) adequately explains the controversial findings, 
but there may be criticism of the dietary control in their experiments. 
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/ 
The role· of vitamin C deficiency in the production of megaloblastic 
anaemia still. requires further investigation .. 
Vitamin K deficiency. 
It was . reported that malnourished infants with megaloblas-tic 
anaemia (Majaj, Dinning, Azzam and Darbyi l963) and l.ow serum L.casei 
folate levels (Majaj, 1966) responded to treatment with vitamin E. The 
improvement foll.owing vitamin E: therapy wa~ associated with a rise in 
serum L~casei folate levels. Thus it was believed that the anaemia could 
be attributed to a secondary disturbance of folate metabolism caused by 
vitamin E deficiency, although other explanations were also considered 
(Majaj, 1966). Up until 1964 there was no biochemical proo.f of a . 
relationship between vitamin E. and fol.ate metabolism (Vilter, I964). 
Whitaker, Fort, Vimokesant, and Dinning (1967) carried out a 
controlled study and showed that vitamin E. produced a therapeuti~ response 
in anaemic infants with kwashiorkor which o.ccurred both in the presence. 
and absence of megalobla&tic anaemia. On the other hand Asfour and 
Firz.li (1965) found that the administration of vitamin E did no,t have. a 
beneficial effect in undern~urished.infants with iron deficiency and I.ow 
serum vitamin E~levels. En interrelationship between vitamin E and 
vitamin B
12 
has also been suggested (Oski, Myerson, Barness and Williams, 
1966). 
There was evidence that vitamin E might be therapeutically effective 
in the anaemia of kwashiorkor, but the role of this deficiency in the 
production of infantile megaloblastic anaemia and its., relationship to 
folate matabolism ~till had to be established. 
Summary . 
The classical pattern of infantile nutritional megaloblastic anaemia 
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haffi been described, as. welL as the clinical difference& observeQ in 
underprivileged. communities, among infants receiving goats' milk and thosa 
with vitamin B
12 
deficiency. The common form of infantile nutritional 
megaloblastic anaemia was shown to have resulted from folate de:0.ciency in 
the great majority o,f cas-es. In Italy and India a megaloblastic anaemia 
due to vitamin B
12 
deficiency was des.cribed. The role of vitamin C" and· 
vitamin E deficiencies; in the: production of infantil.e megaloblastic 
anaemia has not yet been proved. 
The aetiol.ogy ~f folate deficiency in the nutritional megaloblastic anaemia 
of infancy. 
Evidence for the belief that folate deficiency in infantile megalo-
blastic anaemia was nutritional in ori.gin was both negative and positive. 
On the negative side there. was an absence of any underlying organic disease 
in the infants with this condition, and on the positive side there was the 
therapeutic efficacy of a single course of oral. folic acid (Zuelzer and 
Ogden, L946). 
In some. instances this belief was furthersupported by a history of 
inadequate or incorrect dietary intake (Zuelzer and Ogden, 1946~ Luhby, 
1959). Moreover, the macrocytic anaemia which developed in infants who 
had received a diet of goats' milk was believed to be an example. of pure 
dietary deficiency (Zue.J.z-er and Ogden, 1946). The subsequent report$ of 
megaloblastic anaemia in infants from underprivileged communities in · 
association with the clinical features of malnutrition further emphasised 
the nutritional character of this megaloblastic anaemia (Walt Holman and 
Naidoo , l.957 ;. Shnier and Metz,, l.959;, MacI.ver and Back, 19€0). 
Megaloblastic anaemia also occ.urred in infants given caloricall.y 
adequate diets (Zuelzer and Ogden, 1946). It was believed that the 
folate content of all milk was low (Collins, Harper , Schreiber and 
Elvehjem , 1951) and that infants on a milk diet especially formula milks 
unsupplemented with vitamin C received less folate than other diets 
provided (Zuelzer and Rutzky , 1953). Luhby (1959) concluded from this 
that infants on a milk diet could either have low folate reserves or more 
commonly folate reserveE within the lower limits of normal. For this 
reason normal infants were predisposed to the development of folate 
deficiency. 
However, in well nourished and most malnourished infants megaloblas-
• tic anaemia seldom developed on the basis of dietary deficiency alone, 
especially in the younger infants (Zuelzer and Rutzky, 1953; Luhby, 1959). 
It usually resulted from inability to compensate for the effect of super-
imposed stress factors such a~ vitamin C deficiency (May, Nelson , Lowe and 
Salmon, 1950; Zuelzer and Rutzky, 1953) or infection (Zuelzer and Rutzky, 
1953; Luhby, 1959). This occurred either because folate reserves were too 
low or even when these were normal because the effect of the stress factor 
such as infection was too severe (Zuelzer and Rutzky, 1953; Luhby, 1959). 
The significance of infection as a stress factor was appreciated in infants 
from both good (Zuelzer and Ogden, 1946) and poor socio-economic circum-
stances (Walt, Holman and Naidoo, 1957; Shnier and Metz , 1959; Maciver and 
Back, 1960). Of the infections, gastrointestinal infection was particularly 
important because it also could result in a reduction of folate intake and 
absorption (Zbelzer and Rutzky, 1953). May, Stewart,. Hamilton and Salmon 
(1952) found that infection could result in folate deficiency and so induce the 
development of megaloblastic anaemia in monkeys maintained on what was · 
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believed to be an adequate folate intake. 
Other aetiological factors . for the development of folate. deficiency 
such as intestinallmalabsorption, alterations in intestinal bacterial 
flora_ and the size of maternal stores were conside.re.d but not further 
investigated. (Zuelz,e.r and Ogden, L946;; May, Nelson, Lowe and Salmon,, 
1950) .. 
Summary. 
The evidence for the nutritiona-l nature.. of the. fblate - deficienc_y 
in infantile megalo1blastic anaemia was based on clinica-l and therap'eutic 
studies. The most important factors resul_ting in megaloblastic anae.mia 
were tho.ught to be a combina.tion of poor d.i.etary intake in associatio.n 
with stresa factors which increaaed the demand for folate, or interfered 
with its utilisation. Of the stress factors vitamin C deficiency and 
infection were regarded as the most important. Infection alone could. 
result in megaloblaatic anaemia if severe enough. Pure. dietary folate. 
deficiency was uncommon but did occur in infants fed~ a diet o.f goats· milk, 
occasionalI.y in older infants, and in association with severe malnutrition. 
The role. of maternal fola:.ta deficiency, intestinal malabsorption and 
altered. intestinal bacterial flora were. considered" but not studied. 
Prevalence of nutritional megaloblas;tic anaemia of infancy. 
By L963 infantile nutritional megaloblastic anaemia was still 
prevalent in countries with large underprivilege.d population groups. In 
Jamaica it accounted for 6.3% of all pae,d.iatric admissions (Macive.r and 
Back, l960). In South America, approximately 40% (Vele~, Ghitis, Pradilla 
and Vitale, 1963), and in Kenya, approximately 17% (Kandi, MacDougall, 
Foy, Mehta and Mbaya, L963) of malnourished infants had megaloblastosifu 
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of varying saverity. 
S.outh Africa was no exception. Nine percent (9%) of paediatric 
admissions (Walt, Holman and Naidoo, L957) and 8.5%, of alL maln0-urished 
infants, had megaloblastic anaemia (Shnier and Metz, 1959). 
Mortality in megaloblastic anaemia. (infantile nutritional megaloblastic anaemia) 
Although the condition may easily be cured, it has been a:-ssociated 
with a high mortality reported as follows: 
10% (Kende,, Ramot and Grossowic:z, 1.963);: 12% (Mac Iver and Back, 1960:);, 
24% (Walt, Holman and Hendrickse, L956 ); 25% (Zu.alzer and Ogden, . 1946~;: 
40%' (Kh0- and Qdang, L959 l. 
Occ_asi0-nalLy deaths, ware due to anaemia and.. its. effects, but usually 
they wera attributed to the. s:evere associated infection.. It had been 
reported that megaloblastic anaemia predisposed to infe_ction because of 
the Leuc~paania and reduced antibody synthesis associated with this 
condition (L.uhby, 1959). On these grounds megaloblastic anaemia, might 
also have contributed to the mortality. 
The condition was still prevalent in 1963 and still associated with 
a significant mortality. It was clear there had to be early diagnosis 
and treatment. 
Prophylaxis of folate deficiency in infants-. 
Investigators recommended a balanced diet to include Iiver~ kidney, 
mea:t and lea£y vegatables as, pro,phyla-xis against fol.ate: deficiency 
(Zuel~er and Rutzky, 1953f Luhby, L959;, Maciver and Back, 1960). This 
recommendation could not be applied in the pre..vention of megal.oblas,tic, 
anaemia in unde-rprivil.eged~ infants. 
Others suggested that prophylactic folic acid should be used in 
stress situations such as gastroenteritis and recurrent infection (Zuelz-er 
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and Rutzky, 1953; Luhby, 1959; Kende, Ramot and Grossowicz, 1963; Wise, 
Lovric and 0 1 Gorman Hughes, 1963). But this had practical disadvantages . 
Investigators thought that the routine prophylaxiswifhfolic acid in infancy 
was unnecessary and ignored it (Zuelzer and Rutzky, 1953; Castle, Elvehjem, 
May, Welch, Zuelzer and Butler, 1951). This may have been because they 
worked in a country where the standard of living was generally high and 
where the incidence of the condition had declined . The decrease in 
incidence of the condition in the United States of America was ascribed to 
the addition of ascorbic acid to formula milks (Zuelzer and Rutzky, 1953) . 
The concept of judicious routine prophylaxis with folio acid gained 
favour when it was established that the daily physiological adult require-
ment of folic acid, 50 pg. (Herbert, 1962b) or less (Knowles, Prankerd 
and Westall, 1961) was lower than the amount capable of precipitating 
neurological damage in patients with unsuspected vitamin B12 deficiency 
(Davidson and Jandl, 1959; Herbert, 1962b). 
It was necessary to reconsider the advisability of routine prophylaxis 
with folic acid in the case of infants from underprivileged communities 
when malnutrition, infection and megaloblastic anaemia were prevalent . 
LABORATORY DIAGNOSIS OF FOLATE DEFICIENCY IN INFANCY 
Only a few studies using laboratory methods to diagnose folate 
deficiency were carried out on infants before 1963 . 
Normal values for these parameters were determined and their appli-




Whole blood and serum L.casei folate levels in normal infants were 
found to approximate adult levels (Grossowicz-, Mandelbauni-Shavit, Davidoff 
and Aronovitch, L962;, Kende, Ramot and Gross:owicz, 1.963). Normal infants 
given a histidine load of Q.12 g. pe.r l.b. body weight in three divided-
doses four hours- apart, excreted- lass than 30 pg./ml.. of Eiglu in a 
24-hour urine collection (Luhby, L963). Figlu was estimate~with the 
sensitive enzymatic method of Tabor and W:-yngarden (l9581. 
Tests3 of folate deficiency. 
Biood (Kende, Ramot and Grossowicz, 1.963) and serum L~casei folate 
assays, (Kondi, MacDougall, Eoy, Me.htaand Mb~ya, 1.963; Herbert, Baker, 
Frank, Pasher, Sobotka and Wasse.rman, l960; Dormandy, Waters and Mollin,, 
1963! and the KigLu te.st after oral histidine (Luhby, ~o~per.man,, Maciver 
and Montgomery,, L962 ,J wer.·e alL found to be good tests- of megaloblas:tic 
anaemia due to folate deficiency. The value of these tests in distingui-
sning betw:een vitamin B
12 
and folate deficiency in infancy was not 
investigated. 
BIOCHEMICAL(LATEN~FOLATE DEFICIENCY IN INFJl:NCY. 
rn infants and children as in aduLts; fblate deficiency could be 
dia·gnosed on the results of laboratory parameters before the development 
of megaloblastic anaemia. This was, shown by three. groups of investigators:. 
Kende, Ramot and Grossowicz. (l963) demonstrated that heal.thy Is.raeli 
infants of good socia.-economi~ circumstances;had significantly higher blood 
L •. casei folate levels than a . comparable gro,up o.f infants, with a: poorer 
socio-economic background. Dormandy, Waters, and Mollin (l963) found that 
infants of more than twelve months, with coeiiac disease, had. low serum 
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L .. casei folate levels, excessive Eiglu excretion after oral histidine , 
and morpholo gical evidence of folate deficiency before the development 
o:f anaemia_. ilthough this also applied to coelia_c infants of less: than 
twelve months, a fair p-ercentage.. of a control group of infants in this 
age group had low serum L.casei folate levels and increas:ed Eiglu 
excretion after ora:l histidine. This implieu that in infants of less than 
twelve months, folate deficiency might be relatively common and nox 
necessarily aetiologically related to coeliac diseas:e. 
In 1962 Luhby, Go~perman, Maclver and Montgomery showed that Figlu 
excretion, a:tter oral his±idine, was excessive in folate. deficiency before 
u.he d.evelo,pment of megaloblastic anaemia:. 
In infants, just as in adults, folate deficiency could be diagnosed 
by means of biochemical tests before the development of overt megaloblasti~ 
anaemia. 
It was found that the sensitivity of some ~f thes~ tests was 
different according to their use on infants . or adults. Herbert (1962a) 
demonstrated a greater sensitivity of the serum L.casei folate assay when 
it was compared with Figlu excretion after oral histidine in the diagnosis 
of folate deficiency in adults_. But in infants Luhby, Coo~pe:rman, Maclver 
and Montgpmery (1962) found Figlu excretion after oral histidine a more 
sensitive test than serum L.casei folate assays. This was confirme.d by 
Dormandy,, Waters and Mollin (1963) when they studied control infants of 
les:s than 12 months.- About a third of these had low serum L.casei folate 
levels, and 75% h~d positive Figlu tests. 
There app-eared~ to be. two poS'sible explanations for these contradic,tory 
results. On the one hand, differences in methodology might have- be.en 
responsible. C.ooperman, Luhby and AYe:ry (1960) had. been dissatisfied_ 
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with the serum L.casei folate assay as a method of diagnosis. Perhaps 
their conclusions were based on studies performed before satisfactory 
modifications for assaying serum L.casei folate levels were introduced. 
Dormandy, Waters and Mollin (1963) used a histidine load comparatively 
larger than that used in adults and exceeding the load recommended by 
Luhby, Cooperman, Maciver and Montgomery (1962). They thought that this 
might have been an important factor in young infants, where hep~tic enzymes 
might ha¥e been immature (Dormandy, Waters and Mollin, 1963). 
On the other hand, Herbert (1962a) induced folate deficiency in only 
one subject under strictly controlled experimental conditions. If in 
infants as in some adults with vitamin B12 deficiency, there were both 
a disturbance of folate metabolism and associated folate deficiency, then 
it was conceivable that the Figlu test after oral histidine might provide 
evidence of folate deficiency before the serum L.cawei folate assay. 
The prevalence and significance of latent folate deficiency in infancy 
was unknown. 
SUMMARY 
The existence of a condition of biochemical folate deficiency was 
demonstrated in infancy. In some infants this was related to socio-
economic circumstances. In the diagnosis of latent folate deficiency in 
infants and children the Figlu test, after oral histidine, appeared to be 
a more sensitive test than the serum L.casei folate assay, but this 
required further investigation. The clinical import~nce of latent folate 
deficiency in infancy still had to be established. 
CHAPrER III 
ASSESSMENT OF THE PROBLEM AND THE OBJEJTS OF THE THESIS 
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CHAPrER III. 
ASSESSMENT OF THE PROBLEM AND THE OBJECTS OF THE THESIS. 
In a preliminary study carried out in Cape Town and r eferred to in 
Chapter I, approximately 64% of healthy, underprivileged infants had 
positive Figlu tests after oral histidine (Friedman, McKenzie, Turner and 
Wittmann, 1964a). Luhby, Cooperman and Teller (1959b) had reported that 
the Figlu test after oral histidine was a sensitive, specific and reliable 
test of folate deficiency. From their findings it seemed likely that there 
was a high incidence of biochemical folate deficiency in the population 
group studied in Cape Town. The later findings reviewed above had made 
it plain that this inference had to be reconsidered. 
Dormandy, Waters and Mollin (1963) suggested that an excessive dose 
of histidine given to infants might result in spurious positive Figlu 
tests. At the time the preliminary study was undertaken, information on 
the recommended dose of histidine for infants was not available in Cape 
Town. From data later available it was found that the dose used (2.5 g.) 
was larger than that recommended for infants by Luhby, Cooperman, Maciver 
and Montgomery (1962) and Luhby (1963). However, in the same study, a 
proportion of healthy, underprivileged infants were giTen a lg. histidine 
load. After this dose, 39% had positive Figlu tests. As this histidine 
load fell within the recommended range, it seemed that at least in 39% 
of cases the positive Figlu tests could not be ascribed to the effect of 
overloading with histidine. 
The method of estimation of Figlu used in this study (Kohn, Mollin 
-
and Rosenbach, 1961) was only semi-~uantitative, and insensitive in 
comparison with others (Knowles, 1962). Moreover, an important weakness 
was the necessity for a five-hour urine collection. In infants it was 
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dffficult to ensure complete urine collection in these circumstances. 
This method was also used by Dormandy, Waters and Mellin (1963). They 
found that 75% of control infants under a year excreted excessive Figlu 
after a 3 g. histidine load. These findings were comparable to the 64% 
positive results found in healthy, underprivileged infants given a 2.5 g. 
histidine load in Cape Town. It seemed unlikely that the positive results 
could be attributed only to a semi-quantitative method and incomplete 
urine collection. 
On these grounds it was believed that the observation in Cape Town 
was valid and that at least 39% of healthy, underprivileged infants had 
positive Figlu tests after oral histidine. 
Meanwhile other investigators did not confirm the initial experience 
of Luhby, Cooperman and Teller (1959b) and showed that the Figlu test after 
oral histidine was not a specific test for folate deficiency (Zalusky and 
Herbert, 1961; Carter, Heller, Schaffner and Korn, 1961; Kohn, Mollin and 
Rosenbach, 1961; Chanarin, Bennett and Berry 1962). It was shown that a 
positive Figlu test could only be attributed to folate deficiency if 
supported by other laboratory evidence or by a successful therapeutic trial 
conducted with physiological doses of folio acid. 
In Cape Town, in a study carried out on underprivileged infants with 
gastroenteritis (Friedman, McKenzie, Turner and Wittmann, 1964b) it was 
found that positive Figlu tests after oral histidine agreed well with 
bone marrow morphology. In healthy, underprivileged infants, a therapeutic 
trial with folio acid (400 Fg· orally daily) was used to determine whether 
positive Figlu tests after oral histidine could be attributed to folate 
deficiency (Friedman, McKenzie, Turner and Wittmann, 1964a). With one 
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exception, all infantS' given a therapeutic trial with folic acid, 
subsequently excreted normal quantities of Figlu a£ter oral histidine. 
Unfortunately it was shown that the result of a success:ful. therapeutic 
trial with folic acid coulQ onLy be used as unequivocal evidence for 
attributing positive Figlu tests to folate deficiency if it was conducted 
with 100-200 fg .. of folic acid daiLy. In addition, the therapeutic, trial 
was not controlled by a comparabl.e s;tudy in infants not given folic acid •. 
The experience of other investigators with the Eiglu test a£ter 
oral histidine in infancy (Luhby, Cooperman, . Maciver and Montgomery~ 
L962;, Dormandy, Waters and Mallin, 1.963) encouraged.. belief in its value 
as a parameter of folate deficiency in infancy. But the greater sensitivity 
of the test compared with the serum L.casei fol.ate assay found in infants;; 
as compared with adults, was- puzzling and required investigation~ 
Although fol.ate deficien~y was favoured as a possible explanation 
for the results, it was believed that the positive Figlu tes;ts. after oral 
h:imltidine in the study in Cape Town could not be confidently attributed to 
this deficiency. Their interpretation require.d clarification. 
From the work reviewed above, it appeared that there was interest in 
the concept of biochemical fol.ate deficiency and its possible importance 
to adults and infants. There appeared to be good reason for believing that 
many healthy underprivileged infants might have biochemical fol.ate deficiency. 
a) It wa:s believed that normal infants on a milk diet received Iess 
fol.ate than other diets provided (Zuelzer and Rutzky, 1953) and that they 
could as a result develo,p subclinical fol.ate deficiency (Luhby, 19591. 
b} In healthy underprivileged infants the effects of underfeeding 
and fauLty feeding practices might further reduce fol.ate intake. Further-
more, most milks in South Africa were not suppl.emented with ascorbic acid. 
59. 
For these reasons it was anticipated that latent folate deficiency might 
be wide spread in healthy underprivileged infants. 
c) The use of laboratory methods for investigating folate deficiency 
had shown that infants could suffer from biochemical folate deficiency 
before the development of overt megaloblastic anaemia (Luhby, Cooperman, 
Maciver and Montgomery, 1962; Dormandy, Waters and Mollin, 1963; Kende, 
Ramot and Grossowicz, 1963). This might have resulted from inadequate 
dietary intake and in some infants was shown to have been related to 
socio-economic circumstances (Kende, Ramot and Grossowicz, 1963). 
d) The incidence of positive Figlu tests after oral histidine (39%) 
in healthy underprivileged infants in Cape Town seemed to be in accord 
with the above findings and suggested that there was possibly a high 
incidence of latent folate deficiency in healthy underprivileged infants 
in Cape Town. 
Infantile nutritional megaloblastic anaemia could result from 
diminished folate intake or increased demand for folate. Most commonly 
it resulted from inability to compensate for the increased demands for 
folate caused by infection and other stress factors. If in South Africa, 
widespread biochemical folate deficiency were present, then it might 
have been an important factor in the development of infantile megalo-
blastic anaemia commonly associated with malnutrition and infection. 
Because infantile nutritional megaloblastic anaemia due to folate defici-
ency was frequently found in South Africa, and because it was still 
associated with a fairly high mortality, it seemed important to find out 
more about latent folate deficiency in underprivileged infants, especially 
with regard to its relationship to the development of megaloblastic anaemia. 
60. 
Thus the study was undertaken to investigate: 
1. The incidence, aetiology, significance and need for prophylaxis 
of biochemical folate deficiency in healthy infants from poor 
socio-economic circumstances. 
From the review above it was clear that the laboratory parameters 
for diagnosing folate deficiency in infants as well as adults differed in 
sensitivity, specificity and reliability. It would therefore be necessary 
to use more than one parameter in the diagnosis of biochemical folate 
deficiency and in determining its significance. The last would be further 
established in relation to clinical and morphological studies. 
Aetiological studies of folate deficiency would include an attempt 
to study the influence of maternal on infant folate nutrition and the role 
of malabsorption in determining biochemical folate deficiency because 
little was known of these aspects. However, knowledge concerning the 
absorption of folate under physiological conditions was incomplete and 
therefore the application of absorption studies even with folio acid might 
be limited. 
From all these studies inferences regarding prophylaxis of the 
condition might be possible. 
In view of the uncertainty regarding the value and application 
of the Figlu test after oral histidine in the diagnosis of folate deficiency 
in infancy, a sensitive method of measuring Figlu after a standard dose of 
histidine would be used as a diagnostic parameter in the above study in 
order to investigate 
2. The interpretation and validity of the Figlu test after oral histidine 
as a parameter of biochemical folate deficiency in healthy under-
privileged infants. 
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DESIGN OF STUDY 
One hundred healthy Coloured women were studied for folate 
deficiency from the 32nd to 40th week of gestation. At birth, umbilical 
cord blood samples (cord blood samples) were taken and afterwards their 
infants were studied for folate deficiency at four intervals until 
sixteen months. 
As this prospective study did not provide sufficient information 
to make the interpretation of positive Figlu tests after oral histidine 
possible, further additional studies were undertaken. In these,maternal 
folate nutrition was not assessed, and infants were investigated only 
once, unless they were participating in a therapeutic trial. Infants 
under 7i months were selected because, from the data in the prospective 
study, positive Figlu tests were most common in this age group. With 
one exception, only male infants were studied to facilitate ease of 
urine collection. 
Several approaches were adopted in planning the investigations 
necessary to try and establish the meaning of the positive Figlu tests. 
The first was comparing the results of the Figlu test after oral histidine 
with those of other parameters of folate deficiency. The second was 
determining if there was an aetiological reason for folate deficiency 
in infants with positive Figlu tests. The third was assessing the effects 
of folic acid administration on Figlu excretion. The fourth was deter-
mining whether the positive tests could be attributed to the effect of 
diseases or deficiencies known to cause secondary disturbances of folate 
metabolism. In addition,. an attempt was made to establish normal values 
in white (European) infants and to investigate ' the pattern of Figlu 
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B. CONTROLLED THERAF.WTIC STUDY IN 46• COLOURED INFANTS 2i - 5 MCNTHS OF /,GE 
Purpose of investigation 
The determination of: 
health and development 
folate deficiency 
significant folate deficiency 
the effect of folic acid treatment on 
Figlu excretion 
a possible aetiology for folate deficiency 
in infants excreting Figlu in excess 
coincidental deficiencies and diseas e 
affecting Fi g lu excre t ion 
the effect of no n- specific factors on the 
results of the Fi g lu test 
Histo ry 
Examina t ion 
Method of investigation 
L. casei serum folate assays 
L . casei red cell folate assays 
Figlu excretion after oral histidinex · 
Uroc anic acid excretionx 
Haemo globin levels 
Re -estimation of Fi g lu excretion after oral 
histidine ~allowing therapeutic trial, with 
either pharmacolo ~ical doses of folic acid 
and oral iron or ora l iron t herapy a lone 
Milk L. casei fola t e levels 
Serum iro n levels 
Se rum iron binding capacity 
Se rum v itamin B 2 levels 
In complete urine co l lections (creatinine 24-hour 
collections ) . 
The valid ity of ex pres sing Figlu resu l ts in 
/.Jg. / ml. r ather t han ~ • • / 24 hou r s . 
The Figlu and folic acid clearance test s (S . faec al is a nd L . casei ) ~ere 
performed on 7 additiona l infants wt o did not participate i:i t h is tri a l. 
x Figlu estimations with method of Cha na r in s nd 8e:ir.ett1 / </(,~.,_ 
excretion in African infants. Finally, the rel a tionship of Figlu 
excretion to non-specific factors like incomplete urine collection and 
urine concentration was examined. 
At the same time the incidence and severity of folate deficieney 
in infancy was determined from the results of the laboratory and mor-
phological parameters used to investigate this deficiency. Maternal, 
dietary and absorption· studies were carried out to determine the aeti-
ology of folate deficiency in healthy,underprivileged infants. The 
details of these investigations are set out in Tables 1 and 2. 
CONDUCT OF THE STUDY 
Selection of Subjects. 
In the prospective study all healthy Coloured women in the last 
trimester of pregnancy attending the maternity hospitals associated with 
the University of Cape Town, were interviewed. The nature and purpose 
of the trial was explained to them and they were promised as little 
inconvenience as possible. Mothers and infants were provided with free 
transport and free accommodation during the hospitalisation necessary 
for the 24 hour urine collection from the infants. Selection was made 
on the basis of maternal health and parental co-operation. 
In the additional studies selection was determined by the infant's 
health and parental co-operation. Mothers were approached at infant 
welfare clinics and the Red Cross Children'§ Hospital. The superintendent 
of a foster home gave permission for the study of seven infants there. 
Composition of the groups. 
In the prospective study, 86 of the original hundred infants were 
investigated at least once. Eighty-four were present on the first 
-
TABL ':: 3 
COMP0 5 IT I O~ OF fRC5?SC T:V ~ ~T ~y -~----~----------------- --------
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E 
---------------- -------------r------- --- ---- ----- ---- -- •-• ·---. ---- ---Nu•bec:O:<udi•d F u•~~'.".-a"""'.''.' i;" i afao<,; _• < le.o< ~"'"_ 
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r-· 
--
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1-------------------- - -- ---------------·- - ---------- --- - - --
I n t e r i m P eriod t----------------·---·--- ---------------- -----· -- ---- -----
Exclusions (16) Inclusions (2) 1------------------- -+---------------------------
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Temporary withdra wa l 
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- - ---------- --·------- -- ----- - -- -------- --- ------- -- -- -·------
Number to study a t Visit 2 = 85 + 2 - 16 = 71 F======================================================-=====~·:-=-=~---
---------- ----------·-·-·--------------- ----------- ---- -------- -
VISIT 2 : Age 4t - 7t mon ths --------------·---·------------------ --- ---- . --
Numbers studied - 71 1--------------------------------------- ---·-- -------
I n t e r i m P e r i o d 
Exclusions (37 ) Inclusions (4) 1------------------+---------·-----------·-Consent withdrawn 





Pa rents give c ons e nt 
agai n 4 
1----------- -----·----~---- ---·-·-----~--------~ Number to study at Visit 3 71 + 4 - 37 
-------------- -------- ------ --- ----------------
VI SIT 3 : _Age 7t - l Ot mont hs 1--------- --------- --------------------- - ------~ 
Numbers studied - 38 1---------------- - ---- -----·----·----------- -------·--------
I n t e r i m p e r i 0 d 
Exclusions (19) Inclusions (20) 
--Consent wit hdra wn 3 .. 
16 Re-a dmitted to Discharged from study .. 
study 20 
-Number to study a t Visit 4 38 + 20 - 19 39 
------------------------------------------------~--VISIT 4 : Age l Ot - 16 months 
Num bers studied - 39 
Data not analysed 
Al terati on made by inv e stiga to r : ex pla ined in text 
occasion, 71 on the second, 38 on the third and 39 on the fourth. Of 
the 86 infants, 16 were investigated on all four occasions, and a further 
41 on three occasions. 
The lack of homogeneity of the sample resulted initially from 
permanent or temporary withdrawal of consent by the parents. In these 
circumstances there seemed no point in further investigation of infants 
who showed little or no evidence of folate deficiency after two consecu-
tive visits. By arrangement with the investigator after visit two, 
20 infants were not required again until visit four, and after visit 
three, 16 infants were discharged from the study. A further 9 infants 
were dismissed from the study after receiving a therapeutic trial with 
folio acid after visit two. The details are presented in Table 3. 
In all, 125 infants were investigated in the additional studies. 
The group comprised 113 Coloured infants (60 + 46 + 7), 8 Africans and 
4 Whites(Table 2). 
Method of study. 
Maternity hospitals 
The mothers were investigated at their antenatal visits to the 
maternity hospitals. The nursing staff notified the investigator when 
delivery was imminent so that cord blood samples could be taken. 
Red Cross War Memorial Children•s Hospital/Foster Home/Private Home 
Infants were admitted to a Metabolic Research Unit where infection 
was minimal and the nursing staff was experienced in the collection of 
24 hour urine samples. In a few cases infants were admitted to a general 
ward. Strict precautions were taken against infection, and the nursing 
staff were instructed how to manage the urine collection. After the 
clinical assessment, the first histidine dose was administered and the 
24 hour urine collection was begun. On the next day, at least two and 
usually four hours after a feed, a venepuncture was performed. Infants 
were discharged when the urine collection was completed. In the additio-
nal studies a few infants were brought back a week later as out patients 
for a folio acid clearance or absorption test. 
After each visit parents were encouraged to bring their infants 
back to the hospital in the event of illness, with a view to providing 
free medical care and ensuring that the programme had no harmful effects 
on the infants. A good number of the parents took advantage of this 
arrangement. The same principles were applied to infants studied in a 
foster home (7) and a private home (1). 
There were no side effects unequivocally attributable to this 
study. It was possible that the histidine might on occasions have aggra-
vated, if not caused, diarrhoea. In addition, the break in routine,and 
investigations carried out in a strange environment,may have disturbed 
some of the infants, particularly those over the age of six months. It 
was very difficult to assess these impressions without the benefit of a 
controlled study. On the completion of this investigation, the infants 
were given iron and folic acid according to their requirements. 
BROCEDURES 
a) Mothers 
After a venepuncture a 15g. load of histidine was administered in 
orange juice. Three hours later urine was passed and discarded. For the 
next five hours all urine was collected into bottles containing lee. of 
concentrated hydrochloric acid. On completion of the collection, more 
acid was added if the pH was not less than 4. The urines were stored 
0 at O c. 
65. 
b) Cord blood samples 
These were collected at birth, or as soon afterwards as possible. 
A sterile knife was used to make an incision through 'the separated cord. 
The placenta was elevated and the cord blood allowed to drain into a test 
tube. Care was taken to avoid milking the cord. 
c) Infants 
1. Figlu excretion after oral L-histidine monohydrochloride (histidine). 
Histidine (0.12g./lb. or 0.26g./kg) was weighed out in three 
divided doses on a Mettler scale which was checked for accuracy. The 
crystals were dissolved in hot water and brought to the required tempera-
ture with cold water or orange juice. The doses were administered four 
hours apart, and feeding was withheld for one hour before and after histi-
dine administration. _ 
The nursing staff was given a time schedule for the administration 
of histidine and the feeds. They were asked to record the number and 
nature of stools passed, and, if relevant, the time and amount of vomiting 
and urine leakage. The urine was collected into perineal bags into which 
catheters were inserted for the extraction of urine. The nurses were 
successful in putting the bags on girls as well as boys, but collection 
from the former always required greater care. The 24 hour urine collec-
tion was begun after the administration of the first histidine dose. 
Urine was regularly extracted and discharged into a bottle containing 
lee. of concentrated hydrochloric acid. At the conclusion of the test, 
urines were further acidified if the pH was not less than 4 as assessed 
with the use of Merck's Reagenzien indicator paper. 
Urine was first stored at 0°, but approximately six months later 
0 
aliquots were taken and stored at -20 C. Thereafter aliquots of the 
24-hour urines were always stored at -20°c ab initio. 
66. 
Urine collections were excluded from the study if vomiting occurred 
in relation to the administration of histidine, or if there was a signi-
ficant urine loss. A loss in excess of 10 - 15% of the total 24 hour 
urine volume was regarded as significant. The amount of urine lest by 
leakage was estimated by measuring the amount of water required to produce 
a similar sized stain on the sheets. 
2. Figlu excretion without oral histidine 
In 24 infants, samples of urine were collected before the admini-
stration of histidine. These were stored at a pH of less than 4 at 
-20°c. until assayed. 
3. Collection of blood 
Throughout the study all blood samples collected from adults, 
umbilical cords and infants, were taken with needles, syringes and test 
tubes free of folate, vitamin B12 and iron. 
4. Venepunctures 
These were performed at least two, and usually four hours after 
a feed. With two exceptions only superficial veins were used. In the 
prospective study where four admissions were contemplated, only one 
attempt at venepuncture was made. Thus blood samples were not always 
obtained, nor was sufficient blood always available for completion of 
the intended tests. The same procedure was followed in the additional 
studies, except with infants on whom folio acid clearance and absorption 
tests were performed. In these cases it was sometimes neceswary to 
repeat the attempt to obtain blood. 
5. Bone marrow examination (28 infants). 
Bone marrow aspirations were taken from the greater trochanter of 
the femur following sedation and injection of local anaesthetic at the 
site. The standard aseptic precautions were observed. li.ane marrow 
examinations were performed if mothers consented, and if significant 
folate deficiency was suspected on clinical or biochemical grounds. 
In this study the clinical criterion was chronic or recurrent gastro-
enteritis in association with undernutrition. The biochemical criteria 
were low serum L.casei folate levels and positive Figlu tests. 
6. D-Xylose (xylose) absorption tests 
Xylose was administered as a 10% solution in water and given in 
a dose of 0.5 g./kg. body weight not exceeding a total dose of 5 g. 
It was administered after a four hour fast, and five hours before the 
end of the 24 hour urine collection for Figlu. For the first two hours 
after xylose administration, feeding was withheld, but later infants 
received milk and fluid ad libitum to ensure adequate urine volume. 
The urine passed during these five hours was separately collected. 
After a small aliquot, approximately 2cc. was taken to estimate xylose, 
the remainder was mixed with the rest of the urine collected for Figlu 
estimation. Xylose did not seem to interfere with the estimation of 
Figlu. The test was performed on 22 infants, 15 infants in the pros-
pective study in the age range 9 - 16 months, and 7 in the additional 
study group, age range 3t • 7 months. 
7. Folio acid studies 
A standard solution of folio acid for intramuscular injection 
("Folvite", Lederle) was used for the folio acid absorption and 
clearance tests. 
(i) Folic acid absorption tests (12 infants) 
The procedure was modified slightly from that of 
Chanarin, Anderson and Mollin (1958). L.casei was used as 
the assay organism. In the week following their admission for 
68. 
24 hour urine collection for Figlu estimation, the infants received 
15 mg. of folio acid intramuscularly on two successive days at the 
infant welfare clinics. After an interval of 36 - 48 hours following 
the last dose, and a week after the original Figlu test, they attended 
the hospital as out-patients for the absorption test. The mothers were 
instructed to give a glucose feed at 5 a.m. on the morning of the test 
and afterwards only small glucose feeds when necessary during the four 
hour period before the commencement of the test at 9 a.m. At the start 
of the test a blood sample was taken for serum L.casei folate estimation. 
The infants received 40 fg./kg. body weight of folio acid given orally 
in water. Further blood samples were taken for folate estimation at 
one and two hours after the administration of folio acid. 
(ii) Folio acid clearance tests (Chanarin, Mollin and Anderson, 1958a). 
L.casei was used as the assay organism in all the tests (21). 
In nine of these tests the sera were also assayed with S.faecalis through 
the help of Dr. Metz . 
The infants attended as out-patients one wee~ after the urine col-
lection for Figlu,during which time blood samples had not been taken. 
A solution of folio acid containing approximately 100 pg./ml. was pre-
pared in the following way: 18 mg. of 11 Folvite 11 (1.2cc.) were injected 
into a bottle containing 180 ml. of sterile half normal saline for 
intravenous administration (Baxter) and well mixed. Blood was taken 
for serum folate and other haematological investigations and followed 
by an injection of folio acid (15 pg./kg.) through the same needle if 
possible. Further blood samples were taken 3, 15 and 30 minutes after 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































visible external jugular veins , capillary or scalp vein samples were taken . 
Only folate free capillary tubes or disposable scalp vein sets were used 
for this purpose . 
8. Therapeutic trials . 
These were conducted with both small and pharmacological doses of folic 
acid . The success of the therapy was assessed by ques t ioning the mothers a nd 
observing the effect on serum folate levels . Subjective improvement was 
regarded affi definite if the mother said that there had been an improvement 
and descri bed its n a ture convincingly. Clinical and laboratory criteria were 
used to ass ess objective improvement . (Table 4). 
The a dvancing age of the infants during the first therapeutic trial 
and the small number available in the second trial on younger African infants , 
meant these trials had to be repeated before the effect of folicacid on Figlu 
excretion could be interpreted . The details of the therapeutic trials under -
taken are summarised in Table 4. The symptomatic benefit of folic acid 
t h erapy was also assessed in all infants who were given folic acid at the end 
of the investigation . In the controlled therapeutic trial on 46 iinfants , the 
two therapeutic schedules were prescribed alternatively . 
CASE MATERIAL AND COMMEi~T 
Mothers . 
During pregnancy the women were cared for by the obstetricians . Most 
of them received p rophylactic iron and some vitamin B
12
• One received 
folic acid a n d in her c ase the mother/infant folate relationship was not 
considered . 
Haematological and nutritional values were analysed in the 












































































































































































































































































Thirty-eight out of the 86 were mildly anaemic (haematocrit 30-35 
volumes%), and three others were moderately anaemic (28-29 volumes%)• 
These criteria for assessing anaemia in pregnancy were used by Benjamin, 
Bassen and Meyer (1966). Haematocrit rather than haemoglobin concen-
tration was used to determine anaemia as some of the haemoglobin esti-
mations were made when the colorimeter readings were too high. 
About half the mothers were hypoalbuminaemic. This finding was 
described in normal pregnant women (Report of a W.H.O. Expert Committee, 
1965). 
Only three women had low serum iron levels but the incidence 
might have been higher if the women had been asked to discontinue their 
medication a few days before the blood taking. Vitamin B12 deficiency 
was not encountered and vitamin B12 administration almost certainly 
explained the high level sometimes noted. 
Infants 
One infant was excluded from the study because of cerebral birth 
trauma. The 86 infants studied were healthy though they suffered from 
the disadvantages associated with their socio-economic conditions. Thus 
nutrition was variable and infection not uncommonly encountered. In 
addition there was a fair incidence of associated deficiency disease like 
iron deficiency and rickets. Parasitic infestation was also encountered. 
1. Infant nutrition 
The pattern of infant feeding in the group was fairly standard, 
but many infants were exclusively or partly breast fed. After 7! months 
there was a marked decline in breast feeding. From 4! - 7! months most 
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NUTRITIONAL PATTERN in the 4 AGE GROUPS 
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INCIDENCE OF LOW SERUM ALBUMIN LEVELS IN INFANTS 
Age 
(months) 
2i - 4i 
4i - 7i 
7i - 1ot 
lOt- - 16 






INCIDENCE OF RICKETS 
Numbers of infants 
with serum albumin 




Numbers Incidence Total T
otal 
Studies of of incidence' (months) infants rickets 
numbers of rickets 
2-; - 4i Prospective 84 12 121 19 
Additional 37 7 
4t 7t Prospective 70* 7 lOp 15 
Additional 35 8 
7i - lOt- Prospective 38 2 38 2 
lOt- - 16 Prospective 38* 1 38 1 
* Information not available in one. 
Conclusion: Pros:eective studi -
Twenty two infants showed clinical evidence of rickets at one 
or other visit during the 16 months. Fifteen out of 72 infants 
examined on one occasion in the additional studies showed 
clinical evidence of rickets. 
MEAN HAEMOGLOBIN LEVELS in the 4 AGE GROUPS 
n= 108 n = 90 11 
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2Y4- 4Y2 41/2 -71/2 7Y2-.103!4 
AGE in MONTHS 
RANGE 8.4-13.1 7.7-13.7 7.5-13.3 7.5-12.3 
S.D. ± 1.0 ± 1.2 + 1.4 ± 1.3 
S.E. of MEAN ± 0.1 ±0.1 ± 0 .3 ± 0 .2 
Fig . 8 
TABLE 10. 
INCIDENCE OF ANAEMIA AND LOW SERUM IRON LEVELS IN THE 
FIRST 16 MONTHS OF LIFE 
Age Number of Incidence Investigation (months) investigations of abnormal results 
Haemoglobin g./100 ml. 2i - 4t 108 60 (56%) 
4t - 7t 90 61 (68%) 
(NormaI>ll.l g./100 ml.) 7t 10'¢ 28 20 (71%) 
lOi - 16 30 25 (83%) 
Serum iron levels 2-¢ - 4t 67 39 (58%) 
(Normal: 4t - 7t 
68 45 (66%) 
7t - 10'¢ 15 14 (93%) >64. 9 Jlg./100 ml.) 10'¢ - 16 2? 22 (88%) 
M.C.H.C. VALUES IN THE FIRST 16 MONTHS OF LIFE 
Age Mean Range Standard Standard error (months) deviation of 
mean 
2t - 4t 33 25 - 36 ± 1.7 + 0.2 
n = 108 
4i- - 7t 32 26 - 36 ± 1.8 ± 0.2 
n = 90 
7t - 10'¢ 31 28 - 34 + 1.7 + 0.3 
n = 28 
lOi - 16 30 27 - 32 ± 1.8 + 0.3 -












































































































































































































































































































3. Iron deficiency. 
Mean haemoglobin concentration (Fig.8), mean corpuscular haemo-
globin concentration (MCHC)(Table 10), and serum iron levels steadily 
decreased with age (Fig.9). At lei - 16 months, approximately 80% of 
infants were anaemic and about the same proportion had low serum iron 
levels (Table 10). 
Both in the maternal and in the infant studies, there was seldom 
enough blood to make estimations of iron binding capacity possible. 
Where percentage saturation data was available it did not negate the 
diagnosis. of iron deficiency based on serum iron levels alone. 
4. Rickets 
Twenty-f±Te percent (25%) of infants (22 out of 86) in the pros-
pective study had unequivocal clinical criteria for diagnosing rickets 
at some stage in the 16 months. In the additional studies where the 
infants were seen only once, the incidence was approximately 20% (15 ou~ 
of 72; rable 7). 
5. Infestation 
The incidence of parasitism was in the region of 18% in the 
prospective study, but this incidence might well have been higher had 
stools been examined more frequently (Table 8). 
ANALYSIS OF THE DATA 
Definition of criteria. 
1. Socio-economic circumstances. 
By South African socio-economic standards all the infants came 
from underprivileged homes. However, within the group of infants studied, 

















































































































































































































































































































































































































INFANTS WITH SIGNIFICANT INFECTION AT THE TIME OF INVESTIGATION 
Infant 
Kge 
Nature of infection Organism isolated Pyrexia (months). 
M.R. 6 Meningitis and N. Meningitides I..01 .. 4 °F 
septicaemia 
13 Dysentery Shigella. flexneri III apyrexial 
N.v.W. 6 Bronchopneumonia l00°F 
F.U. 2.8 Chronic gastro- apyrexial 
enteritis 
C.F. 2 •. 8 Chronic gastro- Salmonella c· o apyrexial 
enteritis 2 
*· 
98.8°F T.de B .. 6 Chronic gastro- Salmonella 
enteritis· 
w.s. 3.3 Acute severe Salmonella B.O. apyrexial 
gastroenteritis 
* not identified any further. 
71. 
received meat. Some infants were given cod liver oil, vitamin prepa-
rations and patent medicines. The accuracy of the data concerning 
supplementary feeding was uncertain (Table 6). 
Throughout the study some two-thirds of the infants belonged to 
a better nourished group, their weight percentile being more than the 
9th percentile (Fig. 6). Mean weight percentile decreased with increasing 
age (Fig. 7). Moodie, Wittmann, Truswell and Hansen (1965) showed that 
in underprivileged infants the percentage of underweight infants increased 
with growth. This could be related to increasingly insufficient milk 
feeding. This might be the explanation of the decrease in mean weight 
percentile noted with advancing age in this study. 
Although about a third of the infants were undernourished, hypo-
albuminaemia was seldom found (Table 7). This was compatible with the 
findings of Wittman~,Moodie, Fellingham and Hansen (1967) who showed that 
weight for age could be a more sensitive criterion of nutritional develop-
ment than serum albumin levels. 
2. Infection. 
Approximately half the infants were investigated at a time they 
had infection aost of which was trivial. A small proportion were pyrexial 
at the time, but the temperature never exceeded l00.8°F.(Table 8). Six (6) 
infants were investigated at a time they had mild or moderate infections. 
The temperature here did not exceed 101.4°F. (Table 9). All grades of 
infection were treated in infants during interim periods. Of these the 
most notable were three cases of Salmonella gastroenteritis, one case of 
herpes stomatitis with local spread, specific E.coli (0127) diarrhoea, 
measles and pertussis. One infant had to have a tracheotomy for measles 
complicated by stridor and bronchopneumonia. 
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defined by the hospital social worker (D.B.) who also classified 
27 groups of parents in the prospective study ac~ording to their 
socio-economic circumstances. The criteria used were as follows: 
all infants from good socio-economic circumstances were in the care 
of their mothers. The average income was R66.44 per month (£38,0.0d.) 
The entire income was available for the maintenance of the family and 
there was no period of unemployment. 
In the group from average socio-economic circumstances the 
monthly income was approximately R54.52 (£31.8.0d.) but only R36,52 
(£21,3.0d.) was available for the maintenance of the family. Infant 
care was undertaken by the mother or some other responsible person. 
There was no history of present unemployment, though this was a factor 
in the past. 
The approximate income in those from poor socio-economic circum~ 
stances was Rl6.40 per month (£9.6.0d.) Infants were seldom cared for 
by the mother. Unemployment and the use of earnings for purposes besides 
the maintenance of the family were common. 
Although not used as a criterion for classification, the size of 
the family was usually bigger as the income was lower. 
2. Nutrition. 
All infants weighing less than the Boston 10th percentile were 
taken to be suffering from first degree malnutrition. Second degree 
malnutrition (60 - 75% of the Boston 50th percentile) and third degree 
malnutrition ( < 60% of the Boston 50th percentile) were defined 
according to recommendations made by Gomez, Galvan, Cravioto and 
Frenk (1955). 
74. 
In the analysis of the data it was sometimes necessary to use 
weight percentile as a number rather than as a grade of nutrition. 
Percentiles had to be allotted arbitrarily in two circumstances. When 
weight for age fell between two percentile standards, the nearest exact 
percentile was estimated. All infants with a weight for age ratio less 
than the third percentile were taken to be on the 2nd percentile. 
3. Infection. 
The effect of infection was assessed according to an infection 
score. Whenever possible, this was determined on the basis of both 
history and exa.p1ination, but sometimes it had to be allotted on the basis 
of history alone. A- doubtful or mild infection was designated a half, 
moderate infection, one, and severe infection, two. For the purposes 
of this study diarrhoea was regarded as infective in origin, even when 
proof was lacking, because usually it was part of an infective episode 
or else a short and transient phenomenon associated with mild fever. 
4. Age. 
When used in the analysis of the data, age was expressed in 
months and weeks, the latter calculated to a single decimal point. 
Thus, for example, 4 months and 1 week was expressed as 4.3 months. 
DIFFICULTIES 
Subjects for study. 
After three months attendance at infant welfare clinics, parents' 
consent was obtained for the investigation of only four white infants 
to determine normal values. As these four infants did not come from 
good socio-economic circumstances, the value of the findings as criteria 
of normality were doubtful. In the same period consent was obtained 
75. 
for the investigation of eight African infants. Further studies of 
these groups were not practical. 
About 10% of all Coloured parents agreed to the investigation. 
Though the search for subjects was time consuming, the study was a 
practical possibility in this group. 
Procedures. 
1. Serum folate assays. 
Certain factors might have affected the reliability of some of 
the results obtained. 
There were late notifications of impending delivery resulting in 
delay in obtaining cord blood samples. It was also found that mothers 
sometimes fed their infants during the 2 - 3 hour fasting period before 
the taking of blood for serum folate assays. When this was discovered, 
.venepunctures were delayed for two to three hours, but it was not known 
whether some infants were fed without the knowledge of the investigator. 
To overcome this problem, venepunctures were no longer performed at - the 
commencement of the period of hospitalisation but next morning after a 
strictly controlled period of fasting. The change was made when half 
of the first visits in the prospective study had been completed. Other 
factors that might have affected the reliability of some of the serum 
folate assays were storage of sera without ascorbic acid,administration 
of antibiotics, blood sampling from capillary rather than venous sites 
and haemolysis. Thus the effect of all these factors had to be investi-
gated before the results of all serum folate assays could be accepted 
for analysis. 
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2. The Figlu test after oral histidine. 
The histidine was first given in three divided doses eight hours 
apart, but later at 4-hourly intervals as a result of information 
received from Dr Luhby (1963). The change was made when half the first 
visits in the prospective study were completed. It was found that the 
administration of histidine in one dose as against three made no dif-
-~erence to the results (Chanarin, 1964). So the departure from suggested 
technique in a small percentage of tests was not taken to be important. 
In view of the unpleasant taste of the histidine and the necessity 
to give it repeatedly to infants in the prospective study, it was admini-
stered through a stomach tube. In the additional studies it was usually 
given in orange juice with a teaspoon and only given through a stomach 
tube if the infant refused to take it. As administration through a 
gastric tube was more efficient, this might have accounted for the 
slightly higher incidence of positive tests in the prospective study. 
3. Bone marrow examination. 
A temporary inability to produce an effective enzyme (Tabor and 
Wyngarden, 1958) necessitated the use of Figlu results from the first 
visit as a guide to the need for bone marrow examinations at visit two 
in the prospective study. For this reason bone marrow examinations 
were not always performed on infants with the highest Figlu excretion. 
4. Folio acid clearance test. 
There were tec~nical problems involved in the frequent sampling 
of blood from the infants and in the complete administration of the 
folio acid dose. The problems of blood sampling could be overcome to 
some extent by using capillary and scalp veins. The problem of admini-
stering the dose was more difficult to approach. 
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The infant had to be sufficiently co-operative to allow first 
the withdrawal of blood for basal haematological investigations, then 
the injection of folio acid through the ·same needle, and then the 
alternate injection and withdrawal of a couple of ml. of blood to 
ensure that folio acid did not remain in the syringe or needle. If the 
infant was not co-operative during this rather lengthy process, an 
unknown quantity of folio acid was sometimes injected into the tissues 
and the test has to be excluded on this account. 
In the next series of tests, the procedure first adopted (Pro-
cedure I) was changed (Procedure II). In order to reduce the length of 
the process, a straight injection of folio acid was given, and any folio 
acid that might have remained in the needle or syringe was ignored. 
The results of Procedure II differed from those of Procedure I so that 
it seemed that the amount left in the needle and syringe might have been 
critical. In future it seems important to give the folio acid as a 
straight injection but to make allowance in the initial calculation for 
the amount likely to be left in the needle and syringe. 
Analysis of the data. 
1. Erratic attendance. 
A large proportion of the parents did not keep their appointments. 
The necessity for frequent and sometimes repeated re-booking created 
problems of bed space. Hence Figlu tests excluded for technical reasons 
could seldom be repeated, and it became necessary to carry out investi-
gations in the presence of trivial infection. It also resulted in the 
necessity to divide the age groups for analysis in the following way: 
2t - 41 months, 4! - 71, 71 - loi, and 10! - 16 months, to allow all 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2. Incomplete information or investigation. 
Tests sometimes had to be excluded for technical reasons and 
investigations were sometimes incomplete because the blood could not be 
obtained,or not obtained in sufficient amounts. Occasionally infor-
mation was incomplete. In each situation all available information 
has been analysed. The exclusions made and the reasons for these are 
detailed in the Table (Table 11). 
3. Selection in the sample. 
Mean results and incidence of positive results studied in the 
age group 7! - lei and lei - 16 months might have been affected by the 
selection exercised by the investigator for reasons already mentioned. 
These will be remarked on, whenever relevant, in the presentation of 
the results. 
4. Age. 
To overcome the effect of physiological changes that might have 
occurred with advancing age during the period of investigation, data 
was separately analysed in the four age groups. 
5. Associated deficiencies and diseases. 
The effect of infection, iron deficiency, rickets and parasitic 
infestation had to be considered in the analysis of the data. 
6. Methodology. 
Two methods were used for measuring Figlu in infants. The data 
related to these methods were separately analysed. There was a delay in 
obtaining all the results from the last studies conducted on the 46 and 
the 7 infants. With the exception of a detailed analysis of the health 
of the infants in these studies, all the data will be presented, but 
statistical analysis could only be performed on the more important data. 
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Overall difficulties. 
Difficulties with methods, the erratic attendance of the 
parents, and difficulties in obtaining subjects for study, proved 
very time consuming. This was complicated by the fact that 
attention could not be focused on the study alone. While in the 
pathology department considerable concessions were made, but later 
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The determination of Figlu in urine 
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Microbiological assays for folate 










































(a) Storage of sera ••••••.•••••.••••••••••• 
(b) The effect of feeding on serum L.casei 
folate levels ......................... . 
(c) The effect of sampling from capillary 
and venous sites on the results of 
serum L.casei folate assays 
(d) The effect of penicillin and sulphadiazine 
on serum L.casei assays •••••••••••••••• 
(e) The effect of delay in collecting cord 
blood samples on serum L.casei folate 
ao ti vi ty .............................•. 
(f) The effeot of haemolysis on serum L.casei 
folate levels ••••••••••••••••••.••••••• 
Normal values 
Abnormal values ............................... 
Folic acid absorption •.................•....•......• 
Results ...................................... . 
Discussion ..................................... 
Felic acid clearance test 
Results ....................................... 
Discussion 
Whole blood and red cell L.casei folate assay 
Procedure 
Normal range •................................• 
Accuracy of method ........................... . 




Estimation of total milk folate 
Estimation of true milk folate 
Procedure ..................................... 





The determination of vitamin B12 in serum by micro-

































Assay procedure ••• 
Accuracy of the method •••• 
Normal range •••••••••• 
Biochemical methods . . . . . . . . . . . . ....................... . 
Serum iron estimations •••••••••••••••••••••••• 
Accuracy of the serum iron method •••••••• 
Iron binding capacity ••••••••••••••••••••••••• 
Measurement of d-xylose in blood and urine 
Creatinihe estimation in urine 
Accuracy of the method •••••• 
Total protein and serum albumin •••• 
Serum glutamic-oxaloacetic transaminase 
Occult blood test ..................... 
.... 
Bacteriological methods 





















THE REPRODUCIBILITY IN COUNTING SEGMENTATION OF NEUTROPHILS. 
Smear Reading 1 Reading 2 Difference % difference• 
l 10 5 5 67 
2 5 3 2 50 
3 4 3 1 29 
4 4 3 1 29 
5 4 3 1 29 
6 4 5 1 23 
7 11 6 5 59 
8 0 5 5 200 
9 5 5 0 0 
10 15 5 10 100 
11 6 4 2 40 
12 5 4 1 22 
13 4 3 1 29 
14 7 2 5 111 
15 8 8 0 0 
t6 2 4 2 67 
17 13 6 7 74 
18 8 3 5 91 
19 6 4 2 40 
20 5 2 3 86 
21 4 3 1 29 
22 5 3 2 50 
23 6 0 6 200 
24 10 5 5 67 
25 6 3 3 67 
Z6 7 5 2 33 
27 4 2 2 67 
28 8 8 0 0 
29 7 7 0 0 
30 10 1 9 164 
31 4 0 4 200 
32 5 4 1 22 
33 6 4 2 40 
Mean difference 3 
Mean% difference 63 




Blood was collected into sequestrene tubes for the measurement 
of haemoglobin concentration, volume of packed red cells and percentage 
of reticulocytes. Haeaoglobin was measured as oxyhaemoglobin in a Klett-
Summerson photoelectric colorimeter. At regular intervals a commercial 
standard was used as a reference to ensure the reliability of the 
readings. The volume of packed red cells was measured, using a micro-
haematocrit technique, and reticulocytes were counted by a dry method. 
Blood films were made from blood obtained by venepuncture before mixing 
it with sequestrene. They were stained with May-Grunwald-Giemsa's 
solution and then examined. Unequivocal macrocytosis was not seen in 
the films of infants and adults in this investigation. 
For these tests standard methods were used (Dacie, 1956; Dacie 
and Le~is, 1963) and normal values were taken from Wintrobe (1967). 
PERCENTAGE HYPERSEGMENTATION OF THE NEUTROPHILS 
The examination of the blood films included the determination of 
the percentage of neutrophils having 5 or aore lobes to their nuclei. 
A 400-fold magnification was used but this was increased to a thousand-
fold where there was uncertainty about nuclear separation of the neutro-
phils. Lobes that were clearly separate or connected by a definite 
chromatin bridge were counted individually. All smears were counted 
in duplicate. Those which showed evidence of hypersegmentation on one 
or both occasions were examined a third time because reproducibility 
between these repeat examinations was initially poor (Table 12). Hyper-
segmentation was present if more than 3% of neutrophils had five or 
more lobes (Herbert, 1959; Chanarin, Rothman and Berry, 1965). 
[ a] 
[ b] 
Plate 1:- Photomicrograph of the bone marrow of M.R. showing 
(a) Giant stab cell; 
{b) Giant metamyelocyte in association with early 
megaloblastic change in erythroid precursor. 
(Magnification x 800) 
Plate 2:- Photomicrograph of the bone marrow 
of M.R. showing early megaloblastic 
changes in erythroid precursors as 
well as evidence of iron deficiency. 
[a] 
(Magnification x 800) 
Plate 2 (continued):- Photomicrograph 
of the bone marrow 






The lobe average was an alternative method of assessing hyper-
segmentation (Herbert, 1962a). The use of this method necessitated the 
identification and enumeration of the number of lobes in a hundred neu-
trophils. The result was expressed as the mean lobe count per cell. 
Chanarin, Rothman and Berry (1965) preferred the counting of hyperseg-
mented neutrophils to the identification and enumeration of nuclear lobes 
in a hundred neutrophils. This preference arose because it was sometimes 
difficult to distinguish--between separate and folded nuclei. Percentage 
hypersegmentation appeared to be the more accurate method and was there-
fore used in this study. Edwin (1967) showed that percentage hyperseg-
mentation was a more accurate parameter of nuclear segmentation than the 
lobe average but found that both these parameters were relatively inaccu-
rate, especially if based on a single count. He introduced the use of 
a segmentation index which he believed was a better index of nuclear 
segmentation than lobe average or percentage hypersegmentation. 
BONE MARROW EXAMINATIONS 
Bone marrow films were stained with May-GrUnwald-G~msa 1 s fluid 
and then examined. Particular attention was paid to the presence of 
megaloblastic changes in all elements (Zuelzer and Ogden, 1946). Three 
grades of megaloblastosis were recognised. 
Grade 1: Megaloblastosis. 
Approximately 5% of the myeloid series were giant forms and/or 
intermediate megaloblasts were present in convincing numbers. The photo-
graphs(Platesl:?) are illustrations of the giant myeloid cells and early 
erythroid changes seen in ·one patient in this study. 
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Grade 2: Megaloblastosis. 
This was characterised by the presence of both giant myeloid cells 
and intermediate megaloblasts in greater numbers than in Grade 1 as well 
as the presence of occasional true megaloblasts. 
Grade 3: Megaloblastosis. 
This was defined as florid megaloblastic change involving both 
red and white cell series. 
Giant metamyelocytes were larger than 18 p (Dawson and Bury,1961) 
and showed morphological characteristics described by Zuelzer and Ogden 
(1946). 
The bone marrows were independently examined by two observers 
and a representative group by a third. 
Discussion. 
Zuelzer and Rutzky (1953) and Maclver and Back (1960), believed 
that the giant myeloid cells were pathognomonic of folate or vitamin B12 
deficiency and that they were diagnostic of megaloblastosis in the 
absence of characteristic red cell changes. Other investigators reported 
these cells in the presence of iron deficiency (Foy and Kondi, 1952; 
Davidson, 1954; Tasker, 1959; Dawson and Bury, 1961; Hansen, 1967), 
chronic infection (Dawson and Bury, 1961), infection (Hansen, 1967) and 
neoplasia (Dawson and Bury, 1961). Although some investigators believed 
that the presence of giant myeloid cells in these conditions could be 
attributed to associated folate or vitamin B12 deficiency (Tasker, 1959; 
Dawson and Bury, 1961), this was uncertain. 
In view of the iron deficiency and infection commonly encountered 
in this study, there was uncertainty until recently as to whether giant 
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myeloid cells alone could be used as evidence of megaloblastosis and, 
if so, in what numbers they had to be present for a valid morphological 
diagnosis. Contributions from other investigators were helpful. 
It was reported that giant metamyelocytes were seldom found in 
great numbers when not the result of folate or vitamin B12 deficiency 
(Dawson and Bury, 1961). Later, Hansen (1967) reported that giant 
myeloid cells could only be used as evidence of folate or vitamin B12 
deficiency if they constituted 5% or more of the myeloid series. This 
was recently confirmed by Hoffbrand and Newcombe (1967). They found low 
leucocyte folate levels in all patients whose bone marrows were normo-
blastic but contained more than 5% of giant metamyelocytes. 
The criteria used for diagnosing megaloblastosis on the basis of 
giant myeloid cells were based on the findings of Hansen (1967) and 
Hoffbrand and Newcombe (1967). 
BIOCHEMICAL MNI'HOIS FOR INVESTIGATING FOLATE DEFICDNCY 
PRINCIPLE OF ENZYMATIC METHOD OF FIGLU EST I MAT IO H 
[ Tabor & Wyngarden, 1958] 
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BIOCHEMICAL MEI'HODS FOR INVESTIGATING FOLATE DEFICIENCY 
THE ESTIMATION OF FORMIMINO-L-GLUTAMIC ACID (FIGLU) IN URINE 
Two enzymatic methods and one eleetrophoretic method were used 
to measure Figlu in urine. 
Determination of Figlu in urine (Tabor and Wyngarden,1958; 
Luhby and Cooperman,1964). 
Principle. 
In the degradation of Figlu to glutamic acid, the formimino group 
is transferred to FH
4 
by N-formimino-1-glutamate: tetrahydrofolate 5-formi-
minotransferase (glutamate formiminotransferase). The N5-formimino FH
4 
so 
formed is further changed to N5,N10-methenyl FH
4 
by N5-formimino-tetrahydro-
( ) 5 10 folate ' cyclodeaminase cyclodeaminase. N ,N -methenyl FH
4 
has a peak 
absorption at 350 mp and the amount formed is directly proportional to the 
amount of Figlu in solution. During the enzymatic reaction, N5,N10-methenyl 
10 FH
4 
is converted nonenzymatically to N -formyl FH
4
• This is reconverted 
to N5 ,N10-methenyl FH
4 
by acidification. The reactions employed in the 
enzymatic determination of Figlu are shown diagrammatically (Fig.10). 
Preparation of the enzymes (glutamate formiminotransferase 
and cyclodeaminase; T-C enzyme). 
Step A. Preparation of acetone powder. 
Approximately 5 kg. of fresh hog liver were obtained from the 
abbatoirs on the morning of commencement of the procedure. The liver was 
chopped into i-" pieces an:d weighed into 50g. portions. Each portion was 
homogenised for 1 minute with 250 ml. of acetone (technical grade: National 
Chemical Products, South Africa) at room temperature in a Kelvinator homo-
genis~r (± 3,000 r.p.m.). The homogenate was filtered through Green's 
Hyduro Filter Paper in a Buchner funnel and then dried by a fan at room 
temperature. The filter cake was rehomogenised with 250 ml. of acetone, 
85. 
filtered and dried as before. The cake was powdered while moist and 
allowed to dry overnight at room temperature. The acetone powder was 
0 
stored over a drying agent P2o5 
in ~acuo at -20 C. 
Step B: Preparation of a particle free solution by ultracentrifugation. 
Two hundred g. of acetone powder were gently stirred with 2,000 ml. 
of distill~d water for 20 minutes at room temperature. The slurry was 
filtered through muslin and the residue discarded. The filtrate was 
centrifuged at 20,000 g. for 15 minutes and the supernatant solution 
collected. From this stage onwards all procedures were carried out at o0 c. 
Step C: Ammonium sulphate fractionation. 
Ammonium sulphate was added to the supernatant in small quantities 
with continuous stirring till a final concentration of 21.4% was obtained. 
0 The solution was left at 0-4 C. for 1 hour to allow precipitation. There-
after it was centriiuged for 15 minutes at 20,000 g. The precipitate was 
collected and suspended in approximately 50 ml. of distilled water and 
then stored overnight. 
The suspension was spun at 30,000 g. for 2 hours. The precipitate 
was collected and dissolved in 38 ml. of 0.2 M.sodium acetate by magnetic 
stirring for 2 hours. During this time the container and its contents 
were placed in an ice bath. The solution was cleared by low-speed centri-
fugation in a refrigerated centrifuge and the residue discarded. The 
0 enzyme was stored at -20 C. 
Reagents. 
1 M K2HP04 
{pH 7.18) 
Figlu (California Corporation for Biochemical Research, Los Angeles, 
California). 
Figlu solution in water (1 pmole/ml. of solution. Stable at o0 c. for 
up to 3 weeks). 
FH4 (Nutritional Biochemicals Corporation, Cleveland, Ohio). 
TABLE 13. 
TESTS, STANDARDS AND CONTROLS FOR ESTIMATING FIGLU. 
(Tabor and Wyngarden, 1958). 
Reagents Urine (ml.) Standard (ml.) Enzyme (ml.) 
Control Sample + Control Sample + Control Sample + 
Water * 0.70 0.45 0.70 0.45 0.80 0.55 
Buffer 0.10 0.10 0.10 ()).10 0.10 0.10 
Urine 0 0.10 0.10 
Figlu o.10~ o.10~ 
Enzyme 0.25 0.25 0.25 
FH
4 
0.10 0.10 0.10 0.10 0.10 0.10 
Perchloric 0.30 0.30 0-30 0.30 0.30 0.30 
acid 
3 standards were set up containing 0.1, 0.4, 0.8 micromoles of Figlu/ml. 
+ All sample tubes set up in duplicate. 
0 Neutralized • 
• Distilled de-ionized water. 
KOH 
86. 
solution (4.4 mg./ml.). This was made 
2-mercaptoethanol, 0.53 ml. of FH4, of 0.4 N KOH 
(0.4 N). 
Perchloric acid - 10% w/v in water. 
Assay Procedure. 
up of 18 ml. of 1.1 M 
0.47 ml. of H20 and 1 ml. 
Urine was incubated in phosphate buffer with a mixture of the 
enzyme and FH
4
• The mixture was then acidified and the concentration of 
N5,N10-methenyl FH
4 
calculated from the optical density at 350 mp. The 
details were as follows: 
The solutions were pipetted into 10 x 75 mm. test tubes according 
to the details in Table 13. They were well mixed and then placed in the 
dark for! hour at 25°c. Perchloric acid 0.3 ml. of lofo solution was then 
added to each of the test tubes and the contents mixed again. The . test 
tubes were re-covered with aluminium caps and placed in a boiling water bath 
for 1 minute. They were then rapidly cooled in iced water. After centri-
fugation, the protein free supernatant was decanted and the optical density 
of this read at 350 mr in a Zeiss spectrophotometer in semimicro quartz 
cuvettes with a 1 cm. light path and a capacity of 1.5 ml. A tungsten 
light source was used. 
The enzyme control mixture was used to set the zero of the 
instrument,and the optical density of the enzyme sample at 350 mr was 
then determined. Likewise, the Figlu standard and test sample solutions 
were read against their control tubes. The optical density of the enzyme 
sample was subtracted from the readings of the Figlu standard and test 
samples respectively. 
A standard curve was constructed by plotting optical density at 
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was obtained up to 1.0 p.moles/ml. (Fig.11). Since this gave optical density 
readings above 1.5, solutions were appropriately diluted if unknown readings 
were obtained above this figure. Results were expressed in pg. of Figlu 
per ml. of urine by converting rmoles to fg· and correcting for neutralisation 
and dilution of urine when necessary. 
Discussion of the Method. 
(i) Isolation and preparation of the enzymes. 
Enzyme preparations were not always of sufficient activity for use 
in the test. Low activity of the final preparation was due to inactivation 
of the enzyme during the preparation of the acetone powders from hog liver 
(Step A). Various possible factors which could have affected the production 
of active enzyme during the acetone powder stage were investigated. It was 
found that the age of the pig made no difference. Only one breed of pig was 
used, and they all received the same stall feeding. Livers used were always 
fresh and activity was not improved by carrying out the entire procedure at 
o0 c. or by using frozen livers,or de-ionized distilled water instead of 
distilled water, or pure instead of technical grade acetone. There was an 
impression that the procedure was more successful in summer than in winter 
months, but this was not further investigated. 
Comparatively large amounts of the enzyme were required to assay 
the urine. In view of the difficulties with consistent production of the 
enzyme, delay between repeat assays was at times inevitable. In particular, 
this affected the assays performed on infants who attended for the first 
and second assessments in the prospective study. Many of these repeat 
estimations were only performed after storage of the urine for 6 - 10 months. 
Figlu was stabl~ in urine for at least 6 months at pH 2-3 if stored at 4°c. 


































COMPARISON OF RESULTS OF ASSAYS FOR FIGLU CARRIED OUT 
ON 56 URINES USING ENZYMES OF HIGH AND LOWER ACTIVITY 
Figlu Jlg./ml. , 
Standard curve slope Standard curve slope 
(1.680 O.D.units/micromole/ml. (1.620 and 1.418 O.D.units/ 



























































TABLE 14 (contd.) 
Figlu f'lg./ml. 






























+ S.D. - 30.6 
+ S.E. of mean- 4.1 
Difference of means t • 0.018 
P > 0.90 
Standard curve slope 
(1.620 and 1.416 O.D.units/ 



























+ - 30.2 
+ 4.1 
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Cooperman and Teller, 1959b). But at pH 5 or higher, urine could only be 
kept for short periods at -10° to 25°c. without loss of Figlu activity 
(Luhby, Oooperman and Teller, 1959b). Thus, if the urine pH was greater 
than approximately 7.5 after storage, repeat assays could not be considered. 
This meant that the results of 14 out of 77 urines at visit 1, 3 out of 
65 at visit 2, and 1 out of 35 at visit 3 in the prospective study, were 
based on a single assay done in duplicate. In the additional studies, 
repeat duplicate estimations were performed on 67 out of 72 urines. 
Towards the end of the investigation the enzyme preparation was only 
sufficient to allow a single assay on a single sample in 5 urines. Figlu 
excretion was normal in these 5. 
Difficulties in the production of active enzyme preparations 
resulted in the use of a crude liver enzyme preparation for quantitation 
of Figlu (Chanarin and Bennett, 1962a). There was no difficulty in the 
production of this crude liver enzyme, and greater amounts were produced 
much more easily. 
(ii) Tests of enzyme function. 
The standard curve showed a linear relationship between Figlu 
concentration and optical density up to 0.8 pmoles/ml. of Figlu solution 
(Fig. 11). The slope of the curve (1.680 optical density units for 
1 p.mole/ml. of Figlu solution) gave a conversion factor of 0.057 pmoles of 
Figlu per optical density unit. This was within the accepted range of 
0.050-0.060 pmoles of Figlu per optical density unit (Luhby and Cooperman, 
(1964). 
Enzyme preparations which yielded curves with slopes below this range 
(1.620 and 1.418 optical density units for 1 pmole/ml. of Figlu solution) 
and conversion factors greater than 0.060 fmoles of Figlu per optical den-











TABLE 15 . 




,,ug . /ml. 
54 . 5 
1.4 
5 . 0 
17 . 0 
8 . 7 
36 . 4 
1.0 
12 . 1 
0 . 3 
Figlu 
Expected Observed added to 
urine recovery recovery 
;ug . p g . /ml . p g . /ml . 
17 . 4 71.9 68 . 7 
17 . 4 18 . 8 19 . 3 
17 . 4 22 . 4 26 . 8 
17 . 4 34 . 4 31.3 
17 . ~ 26 . 1 26 . 7 
69 . 6 106 . 0 99 . 5 
69 . 6 70 . 6 80 . 8 
139 . 2 151 . 3 132 . 9 
139 . 2 139 . 5 141.6 
Mean% recovery = 101 
Range 
S . D. 
S . E. of mean 
= 87 .8 - 119 . 6 
=± 10 . 4% 
= :!: 3 . 5% 
Recovery 
% 
95 . 6 
102 . 7 
119 . 6 
91.0 
102 . 2 
93 . 9 
114 . 4 
87 . 8 
101.5 
TABLE 16. 
REPRODUCIBILITY BETWEEN DUPLICATE ESTIMATIONSEOR FIGLU.* 
Urine Figlu pg./ml. Difference % difference 
Reading 1 Reading 2 13-g. /ml. 
1 68.1 69.2 1.1 1.6 
2 55.6 57.4 1.8 3.2 
3 61.3 65.0 3.7 5.9 
4 65.0 62.1 2.9 4.6 
5 25.8 28.3 2.5 9.2 
6 28.3 31.6 3.3 11.0 
7 109.0 105 .9 3.1 2.9 
8 115.8 111.l 4.7 4.1 
9 113.2 115.8 2.6 2.3 
10 67.1 67.3 0 .2 0.3 
11 55.5 53.5 2.0 3.7 
12 60.8 62.1 1. 3 2.1 
13 62.9 64.5 1.6 2.5 
14 28.l 25.7 2.4 0.9 
15 30.4 29.9 0.5 1.7 
16 108.0 107.8 0.2 0.2 
17 2~.2 29.8 o.6 2.0 
18 27.9 27.9 o.o o.o 
19 37 .9 34.9 3.0 8.2 
20 38.6 3a.4 0.2 0.5 
21 15.4 13.0 2.4 16.9 
22 12.1 13.1 1.0 7.9 
23 22.1 21.l LO 4.6 
24 23.7 20.9 2.8 12.6 
25 33.4 42.0 8.6 22 .8 
26 32.e 33.4 o.6 1.8 
27 26.2 27.0 0.8 3.0 
28 26.1 26.7 0.6 2.3 
29 37 .0 35.7 1.3 3.6 
30 37.2 35.8 1.4 3.8 
Mean ditference jUg./mL - 1.9 
Mean% difference = 4.9 

































REPRODUCIBILITY BETWEEN REPEAT ASSAYS FOR FIGLU 
ON 100 CONSECUTIVE URINES. 
Figlp .ng./ml. Difference % difference 
Reading 1 Reading 2 pg./ml. 
Figlu < 21 ,ig./ml. 
o.o 2.0 2.0 200.0 
2.1 4.1 2.0 64.5 
2.6 0.1 2.5 178.5 
3.3 3.3 o.o o.o 
3.5 0.7 2.8 133.3 
4.1 3.9 0.2 5.0 
4.2 2.9 1.3 36.1 
4.5 4.0 0.5 11.8 
4.5 5.1 o.6 12.5 
5.0 17.8 12.8 112.3 
5.2 5.2 o.o o.o 
5.9 0.7 5.2 157.6 
6.o 7.4 1.4 20.9 
6.2 0.5 5.7 167.6 
6.3 11.4 5.1 57.3 
6.4 3.9 2.5 4e.o 
6.8 3.1 3.7 74.0 
7.7 11.0 3.3 35.1 
8.0 8.2 0.2 2.5 
8.7 10.8 2.1 21.0 
11.0 13.4 2.4 19.7 
11.1 12.9 1.8 15.0 
11.5 11.8 0.3 2.6 
12.3 2.6 9.7 129.3 
12.5 7.6 4.9 49.5 
13.1 13.a 0.7 5.2 
13.6 1·~.1 i.5 10.4 
13.6 17.4 3.8 24.7 
14.1 15.1 1.0 6.8 
14.4 12.6 1.8 13.; 
~ 
TABLE 17 (contd.) 
Urine Figlu flg./ml. Difference % difference ~ 
Reading 1 Reading 2 pg./ml. 
Figlu < 21 pg./ml. (contd.) 
31 14.4 13.4 1.0 7.2 
32 l!-4. 8 12.0 2.8 20.9 
33 14.0 1a.5 3.7 22 .. 3 
34 15. 2 12.1 3.1 22.6 
35 15. 6 16.4 0.8 5.0 
36 16.0 14.2 1.8 11.9 
37 16.2 23.0 6.8 34.7 
38 16.4 16.4 o.o o.o 
39 16.6 15.7 0.9 5.6 
40 17.7 13.4 4.3 27.9 
41 18.8 18.4 0.4 2.2 
42 19.0 17.9 1.9 10.1 
43 20.1 19.1 1.0 5.1 
44 20.2 15.0 4.4 24.0 
45 20.5 15.4 5.1 28.3 
46 20.6 10.8 9.0 62.4 
47 20.9 18.6 2.3 11.6 
Figlu 20-69 pg. /ml. 
1 20.5 20.9 0.4 1.9 
2 21.2 20.9 0.3 1.4 
3 21.6 23.0 2.2 9.7 
4 22.2 29.3 7.1 27.5 
5 23.4 21.0 2.4 10.8 
6 24.4 23.8 o.6 2.5 
1 24.6 40.9 16.3 49.7 
9· 24.9 32.8 7.9 27.0 
9 25.1 16.0 9.1 44.2 
10 27.1 24.7 2.4 9.3 
11 27.a 28.2 0.4 1.4 
12 28.2 27.9 0.3 1.1 
13 28.6 31.6 3.0 10.0 
14 29.1 23.7 5.4 20.5 
TABLE 17 (contd.) 
Urine Figlu pg./ml. Difference % difference ~ 
Reading 1 Reading 2 /dg./ml. 
Figlu 20-62 ~g.LmL (contd.) 
15 29.8 i3 5 . Q 5.2 16.0 
16 3l.8 34.7 2.9 9.0 
17 33.8 34.1 0.3 0.9 
18 34.1 24.1 10.0 34.4 
19 34.2 26.1 8.1 26.7 
20 35.2 25.8 9.4 30.8 
21 36.6 31.3 5.3 15.6 
22 37.2 40.7 3.5 9.0 
23 38.4 41.3 2.9 7.3 
24 39.9 37.8 2.1 5.4 
25 41.4 43.7 2.3 5.4 
26 41.4 62.9 21.5 41.2 
27 41.9 40.7 1.2 2.9 
28 43.1 41.2 1.9 4.5 
29 47.0 46.9 0.1 0.2 
30 48.6 38.9 9.7 22.1 
31 53.2 37.1 16.1 35.6 
32 55.0 69.1 14.1 22.7 
33 55.3 67.3 12.0 19.6 
34 58.1 56.2 1.9 3-3 
35 59.9 60.6 0.7 1.2 
36 62.5 56.6 5.9 9.9 
37 63.1 63.6 0.5 7.9 
38 63.5 61.4 2.1 3.4 
39 64.6 63.1 1.5 2.3 
40 66.2 43.0 23.2 42.5 
41 66.7 62.1 4.6 7.2 
42 68.7 67.2 1.5 2.2 
figlu 62.0-128 &1g.Lm1. • 
1 69.3 62.9 6.4 9.7 
2 71.9 84.2 12.3 15.7 
3 73.4 67.9 5.5 7.8 
TABLE 17 (contd.) 
Urine Figlu ~g./mL Difference % difference 
Reading l Reading 2 ;,ig./ml. 
Figlu 62.0-128~g.Lm1.(contd.) 
I 
4 84.0 69.6 14.4 18.8 
5 84.6 84.6 o.o o.o 
6 88.2 68.7 19.5 24.8 
7 101.5 102.8 1.3 1.3 
8 107.5 107.9 0.4 0.4 
9 108.8 125.2 16.4 14.0 
10 123.6 123.2 0.4 0.3 
11 127.7 101.4 26.3 22.9 
Overall reproducibility between repeat assays of 100 urines. 
Mean difference fg./ml. = 4.6 
Mean% difference = 26.4 
Figlu< 21 pg./ml. 




Figlu 20-69.0 ?g./ml. 
Mean difference ;ug./ml. • 5.4 
Mean% difference • 14.4 
Figlu 62.0-128 Jlg./ml. 
Me~n difference.ftlg./ml. = 9.4 
Mean% difference ~ 10.5 
% difference = 
Method: 
Reading 1 - Reading 2 X 100 
Mean of readings 
Tabor and Wyngarden, 1958. 
~ 
(iii) Accuracy of the method. 
The mean percentage recovery was 101.0% and the range 87.8-119.6% 
(Table 15). 
The final result of studies conducted to determine reproducibility 
will be expressed as mean difference as well as mean percentage difference 
( Rl - R2 x 100). Th' d b th d . t 1 is seeme necessary ecause e secon is no on y mean of R 
a measure of reproducibility but also of the concentration of the test 
substance. 
In duplicate assays the mean percentage difference was 4.9 and 
the mean difference was 1.9 fg./ml. (Table 16). 
In repeat assays for Figlu the mean percentage difference and the 
mean difference (Table 17) were as follows: 
Classification 





< 21 p.g./ml. 
20-69 fg• /ml. 







Normal infants could not be investigated in this study. Since the 
experimental method used here was standardised by Luhby (1963) and Luhby 
and Cooperman (1964), it seemed reasonable to use their criterion of nor-
mality. This was Figlu excretion in excess of 30 Fg./ml. or 35 mg. per 
24 hours. They found this criterion applicable to both infants and adults. 
This was puzzling because the 24 hour urine volume of infants is a fraction 
of that of adults. It was possible to surmise that an infant excreting 
90. 
35 mg. per 24 hours, would have to excrete levels higher than 30 pg./ml. 
to compensate for the smaller urine output. For t ·he same reason, a result 
which was positive in terms of concentration (30 pg./ml.) could be normal in 
terms of total Figlu output (mg. per 24 hours). In reply to this question, 
Dr. Cooperman (1967) stated that they found the use of concentration of 
Figlu in urine (pg,/ml.) entirely satisfactory as a criterion of biochemical 
folate deficiency in infancy, provided their recommendations regarding 
histidine administration and urine collection were followed. In their 
experience only infants with folate deficiency excreted more than 30 rg./ml. 
of Figlu. Their study included the investigation of infants of less than 
six months. They ~referred the use of Figlu concentration (fg./ml.) to that 
of total Figlu output (mg. per 24 hours) as a criterion of normality because 
complete urine collections were difficult in infants. In the case of infants 
excreting extraordinarily large urine volumes, Dr. Cooperman suggested that 
the result should then be expressed as total Figlu output. He suspected 
that the abnormal value would then exceed 35 mg. per 24 hours. In the light 
of their experience 30 rg./ml. was used as the criterion of normality in 
this study. 
When the data were analysed, it was clear that a considerable 
proportion of infants excreted Figlu in excess of 30 rg./ml. These results 
did not correlate with those using other parameters of folate deficiency. 
It therefore seemed desirable to compare the results of the assays performed 
here with those of Dr. Cooperman to ensure that the criterion of normality 
was not being invalidated by possible differences in assay techniques. 
Thus 5 urines previously assayed here were also assayed by Dr. Cooperman 
in New York. 
TABLE 18. 
COMPARISON OF THE RESULTS OF FIGLU ASSAYS PERFORMED 
IN NEW YORK AND CllPE TOWN. 
* 
Urine New York Cape Town 
_.,.ug./ml. ,,.ug./ml. 
s .. c .. 11..3 15.4 
c.c. 21.5 38.3 
A.C. 53.3 71.4 
A..P. 80.0 146 .2. * 
M.L 84.1 123.7 
The validity of this result was in doubt since the 
standard graph was lower than those previously obtained 
and could not be checked as ho further T-C enzyme was 
available. With the usual standard graph, result would 
have been 122.7. 
91. 
The comparison of the results showed that the readings in New 
York were approximately 30 - 40% less than those in Cape Town (Table 18). 
There were several possibilities which could have explained the difference, 
though the reason was not finally ascertained. The urines were lost in 
transit and not refrigerated for a period of 2 weeks before being assayed 
by Dr. Cooperman. This might have resulted in some fall off in Figlu 
concentration. The values for optical density at 350 mp. obtained by the 
investigator, either fell within the accepted range given by Luhby and 
Cooperman (1964) or within a range shown to give comparable results. 
Therefore the standardisation of the method did not appear to be the 
responsible factor. It was found that the standard curves were different 
when two different Figlu preparations were assayed by the same enzyme 
preparation (Fig.11). However, both fell within the accepted range. Using 
Figlu preparation A the slope was 1.e70 optical density units for 1 pmole/ml. 
of Figlu solution (conversion factor 0.050 fmoles of Figlu per optical 
density unit). With Figlu preparation B. the slope was 1.710 optical 
density units per pmole per ml. of Figlu solution (conversion factor 
0.056 pmoles of Figlu per optical density unit). These differences were 
not great enough to be solely responsible for the discrepancy between the 
results of assays in New York and Cape Town. Dr. Cooperman (1967) noted 
that the actual Figlu concentration in commercial preparations w~s often 
less than claimed. 
In view of a possible difference in methodology accounting for 
the higher results in Cape Town, the upper limit'of normal was arbitrarily 
increased by a third to 45 pg./ml. It was thought that this bias against 
positive results would compensate for any possible difference in assay 
PRINCIPLE OF ENZYMATIC ASSAY OF FIGLU 
[Chanarin & Bennett, 1962a] 
FOLIC ACID 
















H10 - FORMYL FH4 
Fig . 12. -~--------------1 
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technique. The criteria used for determining positive, borderline and 






> 44.9 flg./ml. 
30-44.9 p.g./ml. 
< 30 pg./ml. 
Application. 
All urines in the prospective study and the additional studies 
exeept those from 46 infants participating in the controlled therapeutic 
study and 7 infants on whom folic acid clearance tests were performed, 
were assayed using the method of Tabor and Wyngarden (1958). This method 
was also used to measure Figlu in the urine of infants not given a histidine 
load. The normal value for Figlu excretion without oral histidine was 
<10 fg./ml. (Luhby and Cooperman, 1964). 
Determination of Figlu in urine (Chanarin and Bennett, 1962a). 
Principle: This method differs from the previous one in that a crude rather 
than a purified enzyme is used. Thiw crude liver preparation contains the 
enzymes necessary to convert folic acid to tetrahydrofolate as well as to 
transfer the formimino group 
formimino FH
4 
thus formed is 
(Fig.12). 
from Figlu to tetrahydrofolate. The N5-




A substrate buffer solution which contained 
a) KH2Po4, 20m-moles (2.72 g.). 






.H2o, 2m-moles (0.42 g.). 
c) Mgso4. 7H2o, 2m-moles (0.49 g.). 
d) TPN (NADP) 12 ,umoles (0.01 g.). 
e) Folic acid 55 ;mioles (0.024 g.). 
93. 
The solution was adjusted to pH 6 with KOH (O.lN). The volume was made 
0 up to 100 ml. with water and the solution stored at -20 C. Only distilled 
de-ionized water was used for this solution and for the assay procedure. 
Stock Figlu solution (152 pg./ml; pH 6). The test was standardised 
with 0.4 ml. dilutions of the stock standard Figlu solution. 
Stock folinic acid solution (272.5 fg./ml. at pH 7). 
Crude liver enzyme preparation. 
Potassium phosphate buffer (0.1 M; pH 6). 
Perchloric acid (10% w/v in water). 
Preparation of the crude liver enzyme. 
Approximately 2 kg. of fresh chicken liver was immediately frozen 
0 at -20 C. Next day the liver was sliced with a scalpel into 2-mm. portions. 
Eighty (80) ml. of 0.1 M potassium phosphate buffer were added to each 
50 ml. of packed liver portions. The mixture was homogenised for 
15 seconds in a Kelvinator homogeniser. The homogenate was centrifuged 
for 10 minutes at 30,000 g. and the sediment discarded. The supernatant 
was dialysed against distilled water at o0 c. The pH was adjusted to 6 
with KOH (0.1 N) and the dialysate centrifuged at 30,000 g. for 10 minutes. 
0 Thereafter the supernatant was aspirated and stored at -20 C. The whole 
procedure was carried out at o0 c. 
The assay procedure. 
The original assay procedure (Chanarin and Bennett, 1962a) was 
slightly modified from the method of Tabor and Wyngarden (1958). 
Liver and substrate solution were incubated at 3~ 0 c for two hours. 
































































































































































































































































































































































































































































































































test tubes and mixed by inversion (Table 19). After incubation for a 
further 2 hours at 37°c., 10% perchloric acid was added. The tubes were 
re-covered with aluminium caps and the solutions thoroughly mixed. There-
after the test tubes were placed in a boiling water bath for 1 minute 
and immediately cooled in ice cold water. The precipitate was sedimented 
by low speed centrifugation and the optical density of the supernatant 
read at 350 mr in a Beckman DB spectrophotometer using a 1-om. light path. 
Test urine and standard samples were read against the enzyme 
control which was placed in the reference position. The urine controls 
were read against distilled water and the value obtained subtracted from 
the corresponding readings of the test urines. 
The optical densities of the standard solutions were plotted 
against concentration of Figlu in fg./ml. The amount of Figlu in the 
test urine (fg./ml.) was determined from the standard curve. 
Discussion. 
(i) Modification. 
In the original method of Chanarin and Bennett (1962a), 1.5 ml. 
of 3 N HCL was added to the final incubation mixture. This was mixed 
and allowed to stand for 15 minutes. The mixture was then filtered and 
the optical density of the clear filtrate read at 350 mf. Using this 
procedure in the study, the filtrate remained turbid and could not be 
completely cleared even after low-speed centrifugation. A combination 
of 10% perchloric acid (1.5 ml.) and heat coagulation (1 minute at 100°c.) 
resulted in a clear supernatant after centrifugation (Tabor and Wyngarden , 


























































































































































































































REPRODUCIBILITY BETWEEN REPEAT ASSAYS FOR FIGLU 
ON 118 CONSECUTIVE URINES. 
Urine Figlu (histidine derivatives) pg./ml. Difference % difference ~ 
Reading l Reading 2 pg./ml. 
l 13.7 21.l 7.4 42.5 
2 2.0 4.1 2.1 10.0 
3 10.3 12.4 · 2.1 18.6 
4 6.2 5.8 0.4 6.6 
5 7.2 4.4 2.8 48.3 
6 19.5 17.4 2.1 11.4 
1 22.9 22.5 0.4 1.8 
8 32.6 34.2 1.6 4.e 
9 7.4 10.7 3.3 36.7 
10 27.8 28.8 1.0 3.5 
11 6.4 6.o 0.4 6.5 
12 8.6 11. 7 3.1 30.7 
13 14.9 12.0 2.9 21.5 
14 22.4 23.4 1.0 4.4 
15 18.8 21.9 3.1 15.3 
16 9.2 12.0 2.,;6 26.4 
17 39.6 44.4 4.8 11.4 
18 23.2 22.4 o.8 3.5 
19 64.7 50.e 13.9 24.0 
20 37.0 41.6 4.6 11.7 
21 12.2 9. 4 2.8 25.9 
22 14.1 9.3 4.8 41.0 
23 84.5 86.6 2.1 2.5 
24 33.9 3"3 .. 1 o.8 2.4 
25 7.0 8.1 0.9 12.2 
26 1.1 l.9 0.8 53.3 
27 26.2 26.8 o.6 2.3 
28 32.2 33.7 1.5 4.6 
29 17.9 17.0 0.9 5.2 
30 - 18.5 17.e 0.7 3.9 
31 29.4 26.5 2.9 10.0 
32 16.7 17.2 0.5 3.0 
33 38-3 39.e 1.5 3.e 
TABLE 20 (contd.) 
Urine Figlu (histidine derivatives) pg./ml. Difference % difference ~ 
Reading 1 Reading 2 pg./ml. 
34 75.9 70.3 5.6 7.7 
35 27.8 26.4 1.4 5.2 
36 12.6 9.8 2.8 25.0 
37 1.0 1.2 0.2 18.2 
38 4-3 3.0 1. 3 36.1 
39 9.7 8.7 1.0 10.9 
40 21.8 17 .4 4.4 22.4 
41 14. 5 10.5 4.0 32.0 
42 8.4 5.7 2.7 38.6 
43 7.0 13.2 6.2 61.4 
44 25.6 25.0 o.6 2.4 
45 4.3 4.6 0.3 6.8 
46 14.0 11.5 2.5 19.7 
47 0.4 2.1 1.7 141.7 
48 64.7 70.0 5.3 7.9 
49 19.1 19.2 0.1 0.5 
50 15.0 14.9 0.1 0.7 
51 46.2 46.4 0.2 0.4 
52 156.3 162.2 5.9 3.7 
53 12.6 10.6 2.0 17.2 
54 58.0 59.7 1.7 2.9 
55 16.6 18.5 1.9 10.8 
56 186.o 193.2 1~2 3.8 
57 8.0 3.6 4.4 75.9 
58 43.5 40.6 2.9 6.9 
59 2.5 3.2 0.7 25.0 
60 33.e 34.2 0.4 1.2 
61 9.2 11.4 2.2 21.4 
62 21.7 22.2 0.5 2.3 
63 67.5 83.2 15. 7 20.9 
64 31.7 31.5 0.2 o.6 
65 12.8 18.2 5.4 34.8 
66 5.2 4.1 1.1 23.9 
67 6.4 1.0 5.4 146.0 
68 22.2 22.8 o.6 2.7 
TABLE 20 (contd.) 
Urine Figlu (histidine derivatives) pg./ml. Difference % difference ~ 
Reading 1 Reading 2 p.g./ml. 
69 30.2 25.~ 4.7 16.9 
70 5.1 4.2 0.9 19.6 
71 60.0 59.0 1.0 1.7 
72 5.2 2.3 2.9 7e.4 
73 30.6 30.6 o.o o.o 
74 2.9 3.8 0.9 27.3 
75 8.6 9.7 1.1 12.1 
76 7.0 9.1 2.1 26.3 
77 52.0 53.1 1.1 2.1 
78 1.0 0.7 0.3 37. 5 
19 38.4 42.4 4.0 9.9 
80 31.2 30.4 o.e 2.6 
81 12.4 7.5 4.9 49.5 
82 12.5 13.3 o.8 6.2 
83 150.1 164.0 13.9 8.9 
84 141.2 106.5 34.7 28.0 
85 25.7 17.4 8.3 38.6 
86 94.8 94.0 0.8 0.8 
87 14.7 18.7 4.0 24.0 
88 8.5 8.7 0.2 2.3 
89 102.7 117.6 14.9 13.5 
90 4.4 10.6 6.2 82.7 
91 3.6 3.4 0.2 5.7 
92 23.2 25.2 2.0 8.3 
93 15.0 17.0 2.0 12.5 
94 15.0 20.8 5.8 32.4 
95 10.9 7.8 3.1 33.3 
96 13.8 13.3 0.5 3.7 
97 5.2 12.2 7.0 80.5 
98 21.6 21.7 0.1 0.5 
99 91.1 88.5 2.6 2.9 
100 13.5 17.5 4.0 25.a 



















TABLE 20 (contd.) 





































Mean difference • 3. l µg. / ml. 
Mean% difference • 19.1 
•%difference • Reading l - Reading 2 X 100 Mean of readings 




















(ii) Tests of Enzyme function. 
The standard curve showed a linear relationship between Figlu 
concentration and optical density up to 114 pg./ml. of Figlu (Fig.13). 
During the test if folinic acid was used in the absence of Figlu 
in solution or in urine, there was stoichiometric conversion to N5 ,NlO_ 
methenyl FH
4 
which occurred during heating in the presence of perchloric 
acid. This could be used as a test of efficiency of enzyme activity. 
A solution of folinic acid (M.W. • 473.6) containing 272.5 fg./ml. (0.575 
p-moles/ml.) and Figlu (M.W. = 174) containing 152 fg./ml. (0.874 pmoles/ml.) 
were prepared. The enzymatic conversion of folic acid to N5, NlO_ 
methenyl FH
4 
was compared with that of the nonenzymatic conversion of 
5 10 folinic acid to N, N -methenyl FH
4 
(Fig.13). The results were comparable 
in the range of 0.0 - 0.655 umoles which was equivalent to O - 114 fg./ml. 
of Figlu. From this it could be deduced that enzyme activity was in the 
optimal range. 
(iii) Purity of Figlu solution. 
Since the activity of the enzyme was optimal, the standard 
folinic graph could be used to establish the purity of the Figlu prepa-
ration. 
(iv) Accuracy of the method. 
The mean percentage difference between repeat assays was 19.1 and 
the mean difference between repeat assays 3.1 pg./ml. (Table 20). 
Normal values. 
The normal values for infants using this method and a dose of 
histidine of 0.26 g./kg. (0.12 g./lb.) had not been determined. Therefore 
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according to the method of Chanarin and Bennett (1962a) contains urocanase 
which converts urocanic acid to Figlu. Thereafter .the same principles are 
employed as before (Fig.12). 
Reagents. 
Stock urocanic acid solution (100 pg./ml. at pH 6). The other 
reagents were the same as those listed for the estimation of Figlu using 
the method of Chanarin and Bennett (1962a). 
Assay procedure. 
This was modified slightly from the method of Tabor and Wyngarden 
(1958). In order to destroy Figlu the urine to be tested was adjusted to 
a pH of 11 - 12 using a measured amount of 1 N NaOH. The mixture was 
0 allowed to stand at 25 C. for 4 hours. The pH was then adjusted to 6.0 
with a measured amount of 1 N. HCL. 
The subsequent assay technique was the same as that described for 
the estimation of Figlu (Chanarin and Bennett, 1962a), except that urocanic 
acid standards were used and appropriate correction had to be made for the 
urine dilution. Results of urocanic acid were expressed as pg./ml. or 
mg. per 24 hours. 
The amount of true Figlu in urine could be determined by subtracting 
the urocanic value from the total amount of histidine derivatives estimated 
in the first part of the procedure. 
Discussion. 
(i) Assay procedure. 
The optical densities at 350 mp for a series of urocanic acid 
standards differed from those obtained with the Figlu standards (Fig.14). 
Thus it was necessary to compensate for this before subt~acting the 
96. 
this study Luhby and Cooperman's (1964) criterion of normality (30 fg./ml.) 
was used. In this case there was no reason for modifying it to 45 pg./ml. 
Later in the study it was apparent that the use of a criterion 
of normality for Figlu excretion in mg. per 24 hours would be desirable. 
This was artibrarily determined by using Luhby and Cooperman 1 s criterion 
of 30 pg./ml. as a standard of reference. Infants excreting more than 
30 fg./ml. in unconoentrated urine prior to receiving therapy with folio 
acid and/or iron excreted more than 10 mg. of Figlu per 24 hours. Thus 
results were classified as follows: 
Classification 
Positive result (lower limit) 




30 µg./ml. and 10 mg. per 24 hours 
30 rg./ml. or 10 mg. per 24 hours 
< 30 rg./ml. and <10 mg. per 24 hours 
This test was used to assay all the urines of the infants parti-
cipating in the controlled therapeutic trial (46) and in 7 infants on whom 
folio acid clearance tests were performed. All the results were the mean 
of repeat assays, each done in duplicate. 
The determination of Figlu in urine (Kohn, Mollin and Rosenbach,1961). 
Principle. 
A sample of urine is subjected to electrophoresis on cellulose 
acetate membranes in a pyridine-acetic acid buffer (pH 5.3). Figln and 
glutamic acid migrate to the same position and can be located with nin-
hy~rin. bXposure to ammonia converts Figlu to glutamic acid and the 
increase in the ninhydrin colour is compared before and after exposure to 
ammonia on two separate membrane strips. Estimation of the concentration 
of Figlu is by visual comparison with a Figlu standard. 
98. 
The cellulose acetate strips were dipped in ninhydrin solution 
and allowed to dry in air. They were then placed between two sheets of 
filter paper, covered by two pieces of cardboard to hold them flat, and 
then heated in an oven at 90 - 100°c. for five minutes. Thirty (30) minutes 
later the strips were examined with the aid of transmitted light. A semi-
quantitative estimation of the amount of Figlu present was obtained by 
comparing the intensity of the colour of the urine standard spot with that 
of a test urine after allowing for the presence of glutamic acid on the 
non-ammoniated strip. 
Normal values. 
These were defined as a difference of intensity of the ninhydrin 
positive spot with and without treatment with ammonia vapour less than that 
of a urine standard containing 100 fg./ml. of Figlu (Dormandy, Waters and 
Mollin, 1963). 
Application. 
This test was only used to assess Figlu excretion in the urine of 
the pregnant women and all determinations were always performed twice. 
ESTIMATION OF UROCANIC ACID IN URINE 
An enzymatic and a chromatographic method were used to measure 
urocanic acid in urine. 
Determination of urocanic acid in urine Chanarin and Bennett 1 62a; 
Bennett and Chanarin,1962. 
Principle. 
Total histidine derivatives expressed as Figlu are first determined 
according to the method discussed under determination of Figlu (Chanarin 
and Bennett, 1962a). Figlu in urine is destroyed and urocanic acid is then 
estimated. This is possible because the crude liver enzyme prepared 
TABLE 21 
THE. EFFECT OF IlKALINIZATION (pH 11-12.) AND STANDING (4 hrs. at 25°c) 
ON THE RECOVERY OF FIGLU AND UROCANIC ACID IN URINE. 
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urocanic acid value from the total amount of histidine derivatives to allow 
final expression in terms of Figlu. 
The optical density at 350 mp for a series of urocanic acid 
standards was 0.0067 optical density units per µg. of urocanic acid. This 
compared with 0.0092 optical density units per p.g. of Figlu. 
From these values the contribution of urocanic acid to total 
histidine derivatives (expressed as Figlu) could be calculated and thus 
by difference the original concentration of Figlu could be established. 
(ii) Modification. 
In the method of Chanarin and Bennett (1962a) urocanic acid was 
separately estimated after Figlu was destroyed by autoclaving the urine 
at an alkaline pH. It was shown by Tabor and Wyngarden (1958) that if 
urine at pH 11 - 12 was left for 4 hours at 25°0., 97% of Figlu was degraded, 
but urocanic acid remains stable in these circumstances. In this study it 
was shown that when urine, originally containing both Figlu and urocanic 
0 acid, was adjusted to a pH of 11 - 12 and then left for 4 hours at 25 C., 
the amount of histidine derivatives recovered was slightly in excess of the 
amount of urocanic acid originally in the solution. Since this derivative 
was probably urooanic acid, the mean recovery of urooanic acid in these 
circumstances was 103% (Table 21). 
Normal values. 
This method had not been used to determine normal values on 
24 hour urines collected from infants given a histidine load of 0.26 g./kg. 
(0.12 g./lb.). 
Spector, Falcke, Yoffe and Metz (1966) administered 10 g. of 
histidine to healthy well nourished infants from 6 - 24 months, and 
101. 
collected urines for 8 hours thereafter. Normal values,using the method 
of Chanarin and Bennett (1962a) were less than 10 rg./ml. 
Vanier and Tyas (1966) used a high voltage electrophoretic method 
for measuring urocanic acid. Urine was collected for 6 hours following 
a histidine load of 0.1 - 0.3 g./kg. Normal values for infants in the 
first year of life were up to 50 pg./ml. 
Application. 
This method was used for estimating urocanic acid excretion in 
46 infants participating in the controlled therapeutic trial and 7 infants 
on whom folic acid clearance tests were performed. Urocanic acid in urine 
was only estimated in infants who excreted total histidine derivatives in 
excess of 30 fg./ml., b~cause only in these infants was it l~kely that the 
excretion of Figlu alone might be excessive. In these circumstances the 
results were separately expressed as urocanic acid and Figlu. In all 
other circumstances the results were expressed as the sum of the two 
histidine derivatives. 
Determination of urocanic acid in urine (Whitehead, 1964). 
Principle. 
A standard method of ascending chromatography (Smith, 1958), was 
used to separate amino acids in urine using a butanol, acetic acid and 
water solvent. Urocanic acid was located with Pauley's reagent. 
Reagents. 
l. Butanol/acetic acid/water: 120/30/50 (by volume). 
2~. Pa~ley·1 e reagent: 
a) 9 g. of sulphanilic acid in 90 ml. concentrated HCL made up to llitre. 
b) NaN02 (5% w/v). 
c) Anhydrous sodium carbonate (10% w/v). 
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Fig . 15 
102. 
One volume of a), 1 volume of b) and 2 volumes of c) were mixed 
before use as described by Smith (1958). 
3. Urocanic acid (L.Light and Co. Ltd.). A stock standard solution 
containing 2.2 mg./ml. in 0.1 N HCL and urine was prepared. 
Procedure. 
A slightly modified procedure was used. Thirty (30) fl• of each 
test urine collected after histidine loading were applied 3 cm. from the 
edge and 4 cm. apart on Whatman No.l chromatographic paper (25 x 28 cm.). 
Care was taken to produce as small a spot as possible by applying small 
aliquots at a time and drying with a hair dryer between applications. 
Ascending chromatography was performed in a closed chromatographic jar 
for 15 - 20 hours. The sheets were then dried at room temperature. · The 
paper was cut into strips and these dipped into Pauley 1 s reagent. They 
were then dried on blotting paper. Urocanic acid appeared as a pinkish-
red spot with a RF value of 0.5 - 0.53. 
Standards were set up each time the test was performed. Standard 
solutions of urocanic acid in urine and 0.1 N HCL covering the range of 
220 pg./ml. - 2,200 fg./ml. were treated in the same way as test urine. 
Occasionally other Pauley positive spots not corresponding in RF 
Talue to urocanic acid were noted. These were rather faint and were not 
quantitated or further identified. 
The densities of the urocanic acid spots were measured in a Joyce 
Loebl chromoscanner. A graph was constructed by plotting integration 
units against known concentrations of urocanic acid (Fig.15). The 
results were expressed in pg./ml. Urines having a concentration of 
urocanic acid greater than 2,200 pg./ml. were repeated in dilution. 
103. 
Discussion . 
Whitehead (1·964} advocated the use of an elution method for 
quantitating urocanic acid in urine . The chromoscan method of 
quantitating urocanic acid was introduced here because it was not 
possible to achieve reproducible results with the elution method . 
Application . 
This method was used to estimate urocanic acid excretion in 
all infants in the prospective study, in 4 White and 8 African infants . 
MICROBIOLOGICAL ASSAYS FOR FOLATE 
104. 
MICROBIOLOGIC.AL ASSAYS FOR FOLATE 
THE SERUM L.CASEI FOLATE ASSAY 
(Waters and Mollin, 1961; Waters and Mollin, 1963) 
Principle. 
A folic acid dependent organism is grown under controlled nutritional 
and environmental conditions in both known quantities of folic acid and 
unknown quantities of folate in serum. The quantity of folate present in 
the unknown serum is determined by comparing the bacterial growth in serum 
with that in known quantities of folic acid. With all microbiological 
assays attempts are made to maintain sterility throughout. 
Requirements. 
Folate free glassware, test tubes, syringes, needles and aluminium caps. 
Care was taken that all glassware and equipment 'l"ie!'e' sterile and 
folate free. This was achieved by thorough cleansing in hot water with 
soap followed by numerous rinses in hot water and afterwards in distilled 
water. Thereafter the glassware and equipmentw€re autoclaved three times 
while immersed in distilled water and rinsed again in glass-distilled 
de-ionized water. The glassware and equipmentwere dried and sterilised 
in a hot air oven at 160°C.for 6d minutes. 
Glass-distilled, de-ionized water. 
This was used for washing glassware and equipment, for making up 
solutions and in the assay procedure. The distilled water was de-ionized 
in an Elgastat de-ionizer (B 107) with Elgalite mixed-bed resin (c.403). 
Sera. 
Venepunctures were performed according to the method previously 
described. Blood was allowed to clot at room temperature for approximately 
2 hours. Sera were separated and then stored at -20°c. until assayed. 
TABLE 22. 
DIFCO FOLIC ACID CASEI MEDIUM (Code 0822) 




















































Bacto-Folic Acid Casei Medium (Difeo, Code 0822; Table 22) was 
made up immediately before required. It was free of folate but contained 
all the other requirements necessary for the growth of L.casei ATCC 7469. 
Maintenance of stock culture, and initial preparation of the inoculum. 
Lactobacillus casei ATCC 7469 was maintained in dried gelatin discs 
and was stored in a desiccator over phosphorous pentoxide at room tempera-
ture. A fresh gelatin disc containing the dried organism was placed in 
10 ml. of Difeo microinoculum broth the day before the assay procedure 
0 and incubated at 37 C. for a total of 30 hours. 
Phosphate buffer and ascorbic acid (O.lM; pH 6.1). 
This was constituted as follows: 26.7 ml. Na2HPo4
(14.2 g./litre) 
73.3 ml. KH2Po4
(13.6 g./litre) and 280 mg. ascorbic acid. 
Stock standard folio acid solution(5 mg./%.) 
A stock folio acid solution was prepared by dissolving 10 mg. of 
highly purified folio acid (L.Light and Co. Ltd.) in a little of buffer 
solution, Na2HP04
• The volume was then made up to 200 ml. with water. 
This was dispensed in small quantities in 3 xi" tubes and kept frozen 
at -20°c. 
Procedure. 
Phosphate buffer (3.6 ml.) was added to 0.4 ml. of the serum to 
be tested. The mixture was autoclaved for 2t minutes at 15 lq./sq.in. 
and the coagulum precipitated thereafter by low speed centrifugation. The 
supernatant (0.5 ml.) was added to each of four 6 x 5/8" boro-silicate 
tubes. The volume in each of these tubes was made up to 2 ml. with water. 
A further 2 ml. of double-strength basal medium were delivered to each of 
the 4 tubes resulting in a dilution of 1 in 80 of the original serum. 
106. 
Standards were prepared in triplicate. They were made up in water 
to a volume of 2 ml. from the 5 mg.% PGA solution. They contained O.O, 
0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2 and 1.4 ng. of PGA per tube. In 
addition 3 test tubes containing 2 ml. of distilled water to be used as 
uninoculated blanks were also prepared. Double-strenth basal medium 
(2 ml.) were delivered to all of these tubes. 
The tubes were all covered with aluminium caps and autoclaved at 
10 lb./sq.in. for 10 minutes. They were then cooled and one test tube 
of the four from each serum and the three test tubes with distilled water 
prepared with the standards were set aside as blanks. The remaining 
tubes were placed at random in stainless steel test tube racks. 
The bacterial cells from the inoculum culture set up the day before 
assay were washed 3 times in 6 ml. of normal saline and afterwards 
suspended in 6 ml. of normal saline. A measured aliquot of this final 
suspension was added to 10 ml. of saline to provide an inoculum of 
standard optical density (0.04). 
All test tubes (except the blanks) were inoculated with 1 drop of 
this prepared inoculum of L.casei using a syringe and a spinal needle 
with squared off point. Following inoculation, all test tubes were 
incubated at 37°c. for 18 hours. 
The optical densities of the bacterial growth in the folio acid 
standard tubes and test sera were read against their blanks in a Unicam 
photoelectric colorimeter using an Ilford 625 filter ( ~ = 510-590 mf.)• 
The optical densities of the folio acid standards were plotted against 
the amount of folio acid per tube, and the concentration of folate in 




































REPROBUCIBILITY BETWEEN 100 CONSECUTIVE 
REPEAT .L.CASEI SERUM FOLATE ASSAYS 
Serum folate levels ng./ml. Difference 
Reading 1 Reading 2 ng./ml. 
16.6 19.9 3.3 
9.4 10.8 1.4 
17.9 18.0 0.1 
7.0 e.o 1.0 
9.2 10.0 0.8 
4.0 4.4 0.4 
9.0 12.7 3.7 
5.0 5.6 0.6 
21.6 24.2 2.6 
11.4 14.0 2.6 
8.0 8.6 o.6 
1.5 1.5 o.o 
11.4 12.4 1.0 
2.7 2.7 o.o 
1.8 1.8 0.0 
14.5 14.0 0.5 
6-3 5.0 1.3 
28.2 27.6 o.6 
4.0 5.9 1.1 
1.2 1.2 o.o 
2.7 2.3 0.4 
4.3 4.0 0.5 
3.5 4.2 0.7 
23.0 14.5 0.5 
1.9 2.2 0-3 
1.5 1.3 0.2 
4.9 4.7 0.2 
3.1 3.4 0-3 
3.0 3.4 0.4 
3.0 3.0 o.o 
20.2 22.4 2.2 
11.1 14.9 3.0 



































TABLE 23 (contd) 
Sera Serum folate levels ng./ml. Difference % difference 
Reading 1 Reading 2 ng.Lma.. 
34 18.1 20.6 2.5 12.0 
35 23.4 24.6 1.2 5.0 
36 19.8 23.2 3.4 15.0 
37 1.8 3.3 1.5 58.8 
38 9.7 10.9 1.2 11.7 
39 2.3 2.6 0.3 12.2 
40 12.1 11.8 0.3 2.5 
41 6.6 6.6 o.o 0 
42 2.6 2.6 o.o 0 
43 14.0 11.0 3.0 24.0 
44 2.4 2.4 0.0 0 
45 4.1 4.7 o.6 13.6 
46 2.1 2.8 0.7 28.6 
47 2.1 2.5 0.4 17.4 
48 14.8 16.0 1.2 7.8 
49 3.2 3.8 o.6 17.1 
50 4.8 6.2 1.4 25.5 
51 3.2 3.8 o.6 17.1 
52 6.2 8.1 1.9 26.6 
53 7.0 7.5 0.5 6.9 
54 21.9 28.0 6.1 24.4 
55 25.0 27.4 2.4 9.2 
56 2.6 2.9 0.3 10.9 
57 23.4 27.4 4.0 15.7 
58 17.9 21.8 3.9 19.6 
59 15.9 20.9 5.0 27.2 
60 16.0 17.6 1.6 9.5 
61 10.6 11.4 o.8 7.3 
62 18.6 19.4 0.8 4.2 
63 21.2 22.4 1.2 5.5 
64 4.5 4.8 0.3 6.5 
65. 4.1 4.6 0.5 11.5 
66 2.6 3.4 o.8 26.7 
67 6.6 7.8 1.2 16.7 
68 4.8 5.0 0.2 4.1 
TABLE 23 (contd.) 
Sera Serum folate levels ng./ml. Difference % difference 
Reading 1 Reading 2 ng./ml. 
69 5.4 6.1 0.7 12.2 
10 6.0 7.2 1.2 18.2 
71 5.4 6.6 1.2 20.0 
72 5.6 10.6 5.0 61.7 
73 6.9 9.4 2.5 30.7 
74 21.6 25.8 4.2 17.7 
75 9.4 10.5 1.1 11.1 
76 13.3 20.1 6.8 40.7 
11 14.1 20.7 6.6 37.9 
78 13.2 19.2 6.o 37.0 
19 16.4 24.4 8.0 39.2 
80 2.5 2.8 0.3 11.3 
81 17.6 18.l 0.5 2.8 
82 4.8 5.5 0.7 13.6 
83 3.5 3.6 0.1 2.8 
84 8.1 9.2 1.1 12.7 
85 4.7 5.3 o.6 12.0 
86 11.3 11.6 0.3 2.6 
87 6.5 7.8 1.3 18.2 
88 14.8 16.7 1.9 12.1 
89 7.7 12.4 4.7 46.8 
90 6.2 10.1 3.9 47.9 
91 1.1 4.8 3.7 125.4 
92 3.1 1.4 1.7 61.8 
93 3.6 6.6 3.0 58.8 
94 3.2 5.6 2.4 54.5 
95 5.0 10.0 4.2 53.1 
96 4.1 5.7 1.6 32.7 
91 3.3 4.6 1.3 32.9 
98 0.7 12.4 3.7 35.1 
99 1.6 2.7 1.1 51.1 
100 5.1 6.1 1.0 17.9 
MEAN i DIFFERENCE 19.4 





































REPRODUCIBILITY BETWEEN REPEAT L.CASEI SERUM 
FOLATE ASSAYS IN THE RANGE O - 4.6 ng./ml. 
Serum folate levels ng./ml. Difference % difference 
Reading l Reading 2 ng./ml. 
1.5 1. 5 0 0 
2.7 2.7 0 0 
1.8 1.8 0 0 
1.2 1.2 0 0 
2.3 2.7 0.4 16.0 
1.9 2.2 0.3 14.6 
1.3 1.5 0.2 14.3 
3.1 3.4 0.3 9.2 
3.0 3.4 0.4 12.5 
3.8 3.8 0 0 
1.8 3.3 1.5 58.8 
2 • .5 2.6 0. 3 12.2 
2.6 2.6 0 0 
2.4 2.4 0 0 
2.1 2.8 0.7 28.6 
2.1 2.5 0.4 17.4 
3.2 3.8 o.6 17.1 
2.6 2.9 0.3 10.9 
2.5 2.8 0.3 11.3 
3.5 3.6 0.1 2.8 
1.4 3.1 1.7 75.6 
i.6 2.7 1.1 51.2 
3.3 3.9 o.6 16.7 
2.3 3.2 0.9 32.7 
1.3 1.6 0.3 20.7 
3.4 1.9 1.5 56.6 
4.0 3.6 0.4 10.5 
4.1 2.4 1.7 52.3 
2.3 4.2 1.9 58.5 
2.4 2.4 0 0 
2.2 2.7 0.5 20.4 
3.9 3.4 0.5 13.7 
3.4 3.3 0.1 3.0 
3.7 3.4 0.3 s.5 
TABLE 24 (contd.) 
Sera Serum folate levels ng./ml. Difference % difference 
Reading 1 Reading 2 ng./ml. 
35 3.0 3.4 0.4 11.1 
36 2.0 2.2 0.2 9.5 
37 3.5 3.8 0.3 8.2 
38 3.9 3.5 0.4 10.8 
39 2.0 3.2 0.4 13.3 
40 2.2 2.5 0.3 12.8 
41 3.3 3.8 0.5 14.1 
42 2.6 4.1 1.5 44.0 
43 2.0 6.2 4.2 102.4 
44 2.1 2.2 O~l 4.7 
45 3.5 3.6 0.1 2.8 
46 1.2 1.6 0.4 28.6 
47 3.4 3.8 0.4 11.1 
48 3.2 2.5 0.7 24.6 
49 3.2 2.6 o.6 20.7 
50 3.0 2.7 0-3 10.5 
51 2.1 4.4 2.3 70.8 
52 2.2 4.6 2.4 70.6 
53 1.9 4.4 2.5 79.4 
54 1.9 3.1 1.2 40.0 
55 3.6 3.2 0.4 11.8 
56 3.3 2.3 LO 35.7 
57 3.5 1.6 1.9 74.5 
58 3.1 2.7 0.4 13.0 
59 3.6 2.8 1.2 25.0 
60 3.2 3.7 0.5 14.5 
61 4.0 2.8 1.2 35.3 
62 3.e 2.7 1.1 33.e 
63 3.7 2.6 1.1 34.9 
64 1.6 1.6 o.o 0 
65 3.4 1.2 2.4 95.7 
66 2.4 3.2 0.0 28.6 
67 3.4 3.7 0.3 e.5 
68 2.3 2.7 0.4 16.0 
69 l.9 1.2 0.7 45.2 
TABLE 24 (contd.) 
Sera Serum folate levels ng./ml. Difference % difference 
Reading 1 Reading 2 ng./ml. 
70 3.2 2.4 0.8 28.6 
71 2.8 2.0 0.8 33.3 
72 2.8 3.1 0.3 10.2 
73 1.9 1.6 0.3 17.1 
74 2.2 2.3 0.1 4.4 
75 3.8 3-3 0.5 14.1 
76 2.8 3.2 0.4 13.3 
77 1.4 1.2 0.2 15.4 
78 3.1 1.8 1.3 53.1 
79 2.0 2.6 o.6 26.1 
80 3.0 3.8 0.8 23.5 
81 3.e 2.7 1.1 33.s 
82 1.2 0.7 0.5 52.6 
83 2.4 1.8 o.6 28.6 
84 3.6 3.6 o.o 0 
85 2.4 2.8 0.4 15.4 
86 2.0 1.5 0.5 28.6 
MEAN% DIFFERENCE 24.6 
MEAN DIFFERENCE ng./ml. 0.7 
107. 
were expressed as ng./ml. after carrying out the appropriate calculation. 
Where the serum folate activity was higher than the range covered by the 
standards (0 - 1.4 ng./tube) the assay of the serum was repeated in 
dilution. 
With few exceptions,which will be referred to when relevant, 
results were always expressed as the mean of two assays each done in 
triplicate. The assays were so arranged that about half of the sera 
being assayed were duplicates from the previous run. In this way the 
sera as well as the standards were used to check the accuracy of the 
assay. 
Discussion of the L.casei folate method. 
Accuracy of the method. 
Reproducible results were only achieved once a commercial basal 
medium and a standardised inoculum size were used (Table 23; Table 24). 
Reproducibility of repeat assays 
for folate 
Reproducibility of repeat assays for 







Spray (1964) reported a mean % difference of 12% between repeat assays 
for folate using L.casei as the assay organism. 
Reliability of the method. 
It was necessary to investigate several factors which might have 
affected the reliability of some of the serum L.casei folate assays. 
(a) Storage of sera. 
Many of the sera from the mothers and from the umbilical cord 
samples were stored for approximately a year without ascorbic acid 
protection. Some investigators reported that the addition of ascorbic 
acid to sera was essential to prevent loss of L.casei folate activity 
TABLE 25. 
THE EFFECT OF ASCORBIC ACID PROTECTION ON FOLATE ACTIVITY 








Serum folate ng./ml. 
~ Sample A Sample A 





Significance of differences: 








Sample A was stored with ascorbic acid 7 mg./ml. 
Sample B was stored without ascorbic acid. 
THE EFFECT OF STORAGE (-20°c.) ON FOLATE ACTIVITY (L.CASEI) 
IN SERA STORED WITHOUT ASCORBIC ACID FOR 3 - 6 MONTHS. 
Sera Serum folate ng./ml. 
Sample A Sample B Sample B Sample B 
(24 hrs) (3 months) (5.5 months) (6.0 months) 
1 3.6 2.8 3.7 2.5 
2 6.7 4.9 5.3 3.0 
3 4.4 3.6 4.3 3.3 
4 4.3 3.e 4.a 4.1 
5 a.4 6.8 7.2 5.7 
6 4.4 2.9 3.9 2.3 
Mean 5.3 4.1 4· .. 9 3.6 
Significance of differences: 
F = 1.55 
P >0.05 
108. 
during storage at -20°0. (Waters and Mollin , 1963; Ohanarin and Berry, 
1964) and at -15°0. (Spray, 1964). On the other hand Herbert (1962~1966) 
and Davis and Kelly (1962) did not find it necessary to add ascorbic acid 
0 to prevent loss of L.casei folate activity in sera stored at -20 O. for 
periods up to 2 years and 10 months respectively. 
In view of these conflicting reports and because the sera were 
stored without ascorbic acid protection it was necessary to determine 
whether these folate estimations were reliable under the experimental 
conditions pertaining in this study. This was examined prospectively and 
retrospectively. 
In a prospective study 6 sera from control subjects were divided 
into two samples, A and B. Sample A was stored with ascorbic acid and 
then assayed on day 1 and then at monthly intervals. In only 3 cases was 
there sufficient serum to complete this procedure for a period of 3 months. 
Sample B was stored without ascorbic acid and assayed at 3, 5! and 6 months 
after storage. 
The effect of ascorbic acid protection on folate activity (L.casei) 0 of sera stored for 3 months at -20 O. 
The mean L.casei folate levels of sera after storage for 3 months 
were lower (5.8 ng./ml. - Sample A; 5.1 ng./ml. - Sample B) than the mean 
serum folate level of assays performed on day 1 (6.5 ng./ml. - Sample A). 
This was more obvious in sera stored without ascorbic acid protection 
(Sample B). The differences were not statistically significant (P:::,,.. 0.05; 
Table 25). 
The effect of storing sera (-20°0.) for 3-6 months without ascorbic 
acid protection, on L.casei serum folate levels. 
The mean serum L.casei folate level in 6 sera stored with ascorbic 
acid and assayed after 24 hours was 5.3 ng./ml. The mean serum L.casei 
TABLE 26 
RETROSPECTIVE STUDY OF INFLUENCE OF STORAGE (-20°c) ON FOLATE ACTIVITY (L.CASEI) 
Sera. Serum folate ng./ml. Duration of storage Difference in time 
prior to 1st a-ssay between 1st and 2nd assays 
Assay 1 Assay 2.. (months) (months) 
1 8.2 10.7 2.0: 4.o 
2 14.6 7.1 4.o 1.5 
3 14.4 14.o 4.o 2.D 
4 14.3 15.0 4.o 4.5 
5 26 •. 4 25.0 4.8 3.2 
6 7 • .1 4.1 5.0 2.D 
7 5.1 6 .. 8 5.0 2.5 
8 2.9 3.0 5 ... 0 2.5 
9 2.5 2 •. 5 5.0 3.3 
lQ 6.o 5 •. 6 5.5 3.0 
11. 2.7 2.4 5.8 1..2. 
12.. 4.3 4.3 6 •. 0 6.3 
13 4.8 4.6 6.3 2...5 
14 1 .. 7 2... 9 6 .. 3 5.7 
15 6 .. 4 5.0 6 .. 5 2.5 
16 5 •. 5 4.3 6.5 6.o 
17 3 .6 2.8 6.5 6.o 
18 15.4 21 .. 0 7.0 2.0 
19 16 •. 7 18 .. 6 7.0 3.5 
20 4.o 2 .. 8 7..-0 4.5 
21 3 .. 9 4.o 7 .. 0 4 .. 5 
2.2 15 .. 4 15 .. 9 7.0 4 .. 5 
Z:3 2.2 .. 6 15 .. 6 7.0 5 .. 0 
24 9 .. 6 9.5 7 .. 0 5.5 
25 3.9 4 .. 7 7 •. 0 5.5 
26 5.5 5.3 7.0 5 .. 5 
27 3.4 3.4 8.5 2.0 
28 2.8 2 • .2 8.8 3 .. 2 
29 2.9 2.9 8.8 3.5 
30 21 •. 3 29 •. 6 9.0 2.0 
TABLE 26 (contd.) 
Sera Serum folate ng./ml. Duration of storage Difference in time 
Assay 1 Assay 2 prior to 1st assay between 1st and 2nd assays (months) (months) 
31 9.8 11.8 9.0 2.0 
32 25.3 29.8 9.0 2.0 
33 2.4 3.2 9.0 2.5 
34 5.9 4.7 9.0 3.5 
35 3.1 2.6 9.0 3.5 
36 19.8 10.9 9.0 5.0 
37 18.8 21.4 9-3 2.2 
38 15.9 16.9 9.5 2.0 
39 16.5 14.7 9.5 2.0 
40 20.1 17.9 9.5 2.5 
41 6.3 5-3 9.5 3.5 
42 3.6 4.0 9.8 3.2 
43 3.7 5.9 10.0 2.0 
44 7.3 14.9 10.0 2.0 
45 4.7 4.9 10.0 2.5 
46 20.1 18.5 10.0 3.5 
47 4.2 2.9 10.0 4.0 
48 4.2 3.0 10.3 3.7 
49 3.4 2.3 10.5 2.0 
50 4.6 4.3 10.8 3.2 
51 5.2 7.1 11.0 2.5 
52 2.2 1.7 11.0 3.0 
53 3.7 4.6 11.0 4.0 
Mean 8.8 8.8 
TABLE 27. 



















Serum folate ng./ml. 
60 minutes after food Fasting 









Difference of means: 
t = 0.380 









folate level of the same sera but stored without ascorbic acid protection 
(Sample B), was lower after 3 months (4.1 ng./ml.), 5! months (4.9 ng./ml.) 
and 6 months (3.6 ng./ml.). 
The apparent loss of folate activity after storage of sera without 
ascorbic acid was not statistically significant (P > 0.05; Table 25), but 
might have been important in individual sera containing borderline concen-
trations of folate. Thus the effect of storage was also examined retro-
spectively. 
In a retrospective study there was no difference in mean L.casei 
serum folate levels of the sera· stored for 2 - 11 months before the first 
assay and for 1.2 - 6.3 months between repeat assays (Table 26). In 
individual sera containing concentrations of folate at the lower limit 
of normal (Samples 17, 20, 35, 47, 49), the "fall-off" of folate activity 
on stqnding did not appear to be beyond the limits of experimental error 
of the meth~d. As results were nearly always expressed as the mean of 
two assays, any effect possibly due to loss of folate in these sera on 
storage was further reduced. 
From these findings it seemed that the loss of L.casei folate 
activity which occurred in sera stored at -20°c. without ascorbic acid 
protection was unlikely to have been significant. 
(b) The effect of feeding on serum L.casei folate levels. 
The mean postprandial serum folate level was higher (5.6 ng./ml.) 
than the mean fasting serum L.casei folate level (5.0 ng./ml.) in 7 control 
subjects. This was not a statistically significant result (P > 0.05; 
Table 27). 
These findings were comparable with those of Matoth, Pinkas, Zaair, 
Mooallem and Grossowicz (1964) who found that milk feeding did not affect 
TABLE 28 
A COMPARISON OF FOLATE ACTIVITY (L. CASEI) 
IN SERA TAKEN FROM CAPILLARY AND VENOUS 
SITES IN THE SAME CONTROL SUBJECTS. 
Sera Serum folate ng./ml. 
Capillary Venous· 
1 4.2 4.4 
2 4.o 3.2 
3 8.8 8 •. 9 
4 6.3 7.6 
5 11.2 14.2 
Mean 6.9 7.7 
Difference of means:· 
t =: 0.348 
o. 70 <p <0.80 
THE EFFECT OF ORAL PENICILLIN AND SULPHATIIAZINE 
THERAPY ON SERUM FOLA~E ACTIVITY (L. CASEI) 
Sera Serum folate ng./ml. 
During therapy liter therapy 
(3 days) 
1. 6.2 5.0 
2 8 •. 9 4.3 
Mean 7.6 4.7 
110. 
whole blood folate levels in infants, and those of Frank, Baker and 
Hutner (1968) who confirmed that a fasting state was not essential for 
reliable serum L.casei folate results. Cooper and Lowenstein (1964) 
showed that food intake only materially affected the serum folate level 
if folate-rich foods were ingested. In this study the rise in serum 
• 
L.casei folate level after feeding was highest in the breast fed infant, 
but even this was not impressive. 
These findings differed from those of Cooperman (1967) who stated 
that serum L.casei folate levels should only be estimated after a six hour 
fast, and Reizenstein (1965) who showed that the L.casei folate levels in 
postprandial sera were significantly higher than those in sera collected 
after an overnight fast. 
(c) The effect of sampling from capillary and venous sites on the 
results of serum L.casei folate assays. 
The mean serum L.casei folate level was 6.9 ng./ml. when capillary 
samples were assayed and 7.7 ng./ml. when venous samples were assayed from 
the same control subjects. This was not a statistically significant 
difference (P >0.05; Table 28). 
(d) The effect of penicillin and sulphadiazine on serum L.casei assays. 
Only 1 infant who had a low serum L.casei folate level received 
antibiotics (penicillin and sulphadiazine) at the time of the estimation. 
Penicillin and sulphadiazine therapy did not lower mean serum 
L.casei folate levels in 2 control subjects (Table 28). Waters and Mollin 
(1961) also found that the administration of penicillin did not affect 
serum L.casei folate levels, but Reizenstein (1965) reported that penicillin 
cquld affect serum L.casei folate levels in in-vitro experiments. 
TABLE 29. 
THE EFFECT OF DELAY IN TAKING SAMPLES FROM 
UMBILICAL CORDS ON SERUM FOLATE ACTIVITY (L.CASEI) 
Sera Serum folate ng./ml. 
5 minutes 30 minutes 60 minutes 
1 17.5 16.5 22.7 
2 17.5 20.7 17.2 
3 15.0 17.6 14.6 
4 19.9 19.4 18.4 
5 13.4 19.6 19.5 
Mean 16.7 18.8 18.5 
Significance of differences: 
F = 1.10 
P > 0.05 
THE EFFECT OF HAEMOLYSIS 
ON SERUM FOLATE LEVELS (L.CASEI) 
Sera Serum folate levels ng./ml. 
Unhaemolysed sera Haemolysed sera 
1 8.4 7.7 
2 7.7 7.5 
3 3,5 3.5 
4 7.3 6.2 
5 3.6 3.6 
6 4.3 3.9 
7 4.4 4.4 
Mean 5.6 5.2 
Difference of means: 
t • 0.364 
0.70 < P < 0.80 
TABLE 30 
SERUM FOLATE LEVELS IN 51 NORMAL 























































TABLE 30 (contd.) 
Range 3.0-17.3 ng./ml. 
Mean 6.9 ng./ml. 
+ S.D. - 2.5 










The p-aminobenzoic acid in the medium probably protected against 
any effect of sulphadiazine on serum L.casei folate levels (Herbert, 
1961; Metz, 1968). 
(e) The effect of delay in collecting cord blood samples 
on serum L.casei folate activity. 
The mean serum L.casei folate levels from cord blood samples were 
16.7 ng./ml., 18.8 ng./ml. and 18.5 ng./ml. after a delay in sampling of 
5, 30 and 60 minutes respectively. These differences were not statis-
tically significant (P > 0.05; Table 29). 
(f) The effect of haemolysis on serum L.casei folate levels. 
Blood was collected from 7 control subjects and a proportion of the 
unhaemolysed serum was separated. Haemolysis was produced in the specimens 
and the haemolysed sera then separated. The mean serum L.casei folate 
level in unhaemolysed sera was 5.6 ng./ml. as compared to 5.2 ng./ml. 
in haemolysed sera. The difference was not significant (P > 0.05; Table 29). 
It was found that haemolysis could produce a spurious increase in 
serum L.casei folate levels (Waters and Mollin, 1961; Davis and Kelly, 
1962; Cooperman,1967). Thus the results in this study were unexpected. 
It might be that haemolysis in this experiment was not sufficiently severe 
or complete. Vanier and Tyas (1966) found that slight haemolysis did not 
significantly influence serum L.casei folate levels unless these were 
abnormal to start with. 
Normal values. 
Serum L.casei folate estimations were performed on normal volunteers 
drawn from the technical, Rursing and medical staff. The range was 
3.0 - 17.3 ng./ml. and the mean and standard error were 6.9: 0.4 ng./ml. 
(Table 30). The range of serum folate levels in 28 normal healthy 
TABLE 31 
SERUM FOLATE LEVELS IN 28 NORMAL 






























Range 2.9-9.2 ng./ml. 
Mean 5. 5 ng./ml. 
+ S.D. - 1.4 
































SERUM L.CASEI FOLATE LEVELS IN NORMAL SUBJECTS 
Investigators 
Cooperman, Luhby and Avery, 1960 
Waters and Mollin, 1961 
Hansen and Weinfeld, 1962 
Davis and Kelly, 1962 
Grossowicz, Mandelbaum-Shavit, 
Davidoff and Aronovitch, 1962 
Hogan, Maniatis and Moloney, 1964 
Spray, 1964 
Magnus, 1965 
Metz, Festenstein and Welch, 1965 
Reizenstein, 1965 
Herbert, 1966 
Temperley and Horner, 1966 
Vanier and Tyas, 1966 



























4.0 - 45.6 
2. 7 - 201.2 
5.9 - 21.0 
3.7 - 9.3 
2.7 - 18.5 
5.0 ... 25.0 
2.1 - 28.0 
3.0 - 11.0 
3.0 - 15.0 
2.5 - 7.4 
7.0 - 15.9 
2.1 - 9.5 
7.0 - 20.0 
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A COMPARISON OF REPRESEHTATIVE STANDARD CURVES FOR 
THE L. CASEI ASSAY 
0·2 0·4 
lA] COMPOSITE GRAPH of the means of 40 consecutive 
standard curves for the L. casei assay 
[Bl REPRESENTATIVE STANDARD CURVE for the 
L.casei assay [ Waters & Mollin; 1961.] 
0·6 0·8 
P. G. A. [ ng./ tube] 
Fig, 16 
1-0 1 ·2 1·4 
9 
112. 
Coloured nurses was 2.9 - 9.2 ng./ml. The mean and standard error were 
5.5: 0.3 ng./ml. (Table 31). A wide range of normal levels was reported 
from different laboratories some of which were comparable to those found 
here (Table 32). The reasons for reported differences in normal values 
were discussed by Mollin and Hoffbrand (1965) and investigated by 
Temperley and Horner (1966). The latter found that the normal range of 
serum L.casei folate levels was lower if bacterial growth in the standard 
solutions was increased by adding vitamin C to the medium or by allowing 
prolonged incubation. These differences were not great enough to explain 
the wide discrepancies in the reported normal ranges. 
The slope of the bacterial growth curve in the standard solution 
in this study was higher (30% to 40%) and showed a steeper rise than 
that found by Waters and Mollin (1961) (Fig. 16). The reasons for this 
difference were not determined but the finding might have a bearing on 
the difference in normal range between that reported by Waters and Mollin 
(1961) and that reported by this laboratory. 
Abnormal values. 
Waters and Mollin (1961) reported a normal range of 5.9 to 2lng./ml. 
for the serum L.casei folate assay. They found that levels of 3.0 ng./ml. 
or less were associated with unequivocal folate ·deficiency, whereas serum 
L.casei folate levels in the subnormal range (3.0 to 6.0 ng./ml.) could 
be associated with megaloblastosis, minimal megaloblastic change or 
normal haematological findings (Mollin and Hoffbrand, 1965). 
In view of their experience, serum L.casei folate values less than 
the lower limit of normal (3.0 ng./ml.) were regarded as evidence of 







































































































































































































































































































































































































































































































































































































FOLIC ACID ABSORPTION in 7 INFANTS 
DATA in DETAIL 
FIGLU FOLATE LEVELS ngJml. CLINICAL 
SUBJECT 
~24H. 
s,. µg. /ml. FOL.ATE BASAL I Hr. 2 Hrs. CONDITION 
M. dr L. 84.6 25.4 10.6 26 102 73 POST GASTRO·ENTERITIS 
M.E. 71.0 17.7 6.1 60 I 3 5 128 POST GASTRO-ENTERITIS 
C.E. 60.0 - 19.1 75 187 134 WELL 
L.F. 42.9 14.2 20.5 85 178 160 U.R.T. 
B.S. 21.9 - 8.0 18 II 2 99 WELL 
J . P. 16.9 - I.I 14 II 7 98 POST GASTRO-ENTERITIS 
M.L. 28.9 14.7 2.3 72 IS I 134 POST GASTRO•ENTERITIS 
MEAN 50 140 II 8 
S.D. ± 29.7 ± 33.1 ±29.3 
S.E. of M. * 11.4 t 12.7 * 11.3 
MEAN RISE in FOLATE ngJml. 
BASAL to I HOUR BASAL to 2 HOURS 
RANGE 75 - 112 RANGE 46 -84 
MEAN 90 MEAN 68 
S.D. ±14.2 S. D. ± 13.3 






























































































































































































































































































































































































































































































































levels were correlated with the results of bone marrow examinations per-
formed on infants not investigated in this study, it was found that 
unequivocal megaloblastosis was often associated with serum L.casei 
folate levels of 1.3 ng./ml. or less but could be associated with serum 
L.caS"ei folate levels of up to 2.3 ng./ml. From this it appeared that in 
this study serum L.casei folate levels of 1.3 ng./ml. or less were most 
likely to be associated with significant folate deficiency. 
FOLIC ACID ABSORPTION 
Serum folate levels after the administrationQf' oral folic acid 
were measured with L.casBi. 
Results . 
Two patterns of absorption were noted in the twelve infants studied. 
In seven there was a good peak rise in serum L .casei folate levels which 
occurred after the first hour(Fig.17). The mean rise from basal to 
1 hour was 90 ng./ml. (Table 33). 
In five there was a poor peak rise in serum L.casei folate levels 
and it occurred mainly after the second hour (Fig.1 8) . The mean rise 
from . the basal to the second hour was 32 ng./ml. (Table 34). 
Discussion. 
11Malabsorption of folic acid" . 
The reason for the apparent malabsorption of folic acid ful. five 
infants could not be determined. It could not be attributed or related 
to folate deficiency because serum L.cascei folate levels were normal and 
Figlu excretion was less than 45 pg./ml. in three of the f i ve infants. 
The other two infants vomited a considerable amount of the histidine and in 
their case the Figlu test could not be considered ( Table 34). 
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Gastroenteritis might have contributed to the poor absorption in 
some of the infants but this could not have been the only explanation 
(Table 34). 
It was also possible that mothers had administered milk and food 
to their infants during the period of supposed glucose water feeding from 
5 a.m. to 9 a.m. Even if this were so, it was unlikely that this explained 
the poor absorption, because both Baker, Frank and Sobotka (1964) and 
Chanarin and Bennett (1962c) permitted light meals before the folic acid 
absorptio~ test was performed. 
A technical reason for these results could not be found but this 
remained a possibility. 
Because these curves were not related to folate deficiency and 
because there might have been a technical explanation for them, they will 
not be further discussed. 
Felic acid absorption test. 
The range of absorption of folic acid (75 - 112 ng./ml.) in seven 
infants (Table 33) was comparable to tha t found in children (70 - 140 ng./ml.) 
by Luhby and Cooperman (1961). In both studies L.casei was used as the 
assay organism. 
Some of the folic acid absorption tests were carried out on infants 
while they were convalescing from gastroenteritis. Thus it was possible 
that the range and mean rise in serum L.casei folate levels after the 
administration of oral folic acid might have been higher if all infants 
were completely well at the time of investigation. It also meant that in 
the later analysis of the data,this complicating factor might have to be 
co nsidered when the relationship of folic acid absorption to folic acid 
deficiency was assessed. 
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FIGLU S.IRON FOLATE LEVELS ng./ ml. CLINICAL 
Wt. 0 /o g./100 1,1g./ ml. mg/24H µg/lO~I. BASAL 3 MIN. 15 MIN.l30MIN. CONDITION ml. 
45 12.0 8.0 6.0 - 9.4 100 50 30 WELL 
97 12 .2 23.2 8.4 80 13.2 214 75 58 WELL 
10 10.0 14.0 8.4 51 7.6 118 58 35 WELL 
60 12.4 42.S 12.8 - 9.6 - so 37 WELL 
10 11. 5 32 .6 19.9 - 4.4 83 43 20 U. R.T. 
40 - 70.1 19.6 34 4.8 115 52 41 WELL 
so 10.6 4.4 2.6 - 27.o' 92 26 29 WELL 
3 11.4 103.6 17.6 - 46.8 211 160 95 WELL 
MEAN 15.4 133 64 43 
s.o. ± 14.S ±55.5 ±41.2 ±23,7 
S .E.of M. ± 5.2 ± 21.3 ± 14.7 ± 8.3 
J 
IN FAN TS with NORMAL FOLATE NUTRITION 
FOLATE LEVELS ng./ ml. 
SUBJECT 
BASAL 3 MIN. IS MIN. 30 MIN. 
R. K. 9.4 100 50 30 
W.A. 13.2 214 75 58 
N. S. 7.6 118 58 35 
MEAN 10.1 144 61 41 
s .o. ± 2.7 ± 37.7 ± 13.0 + 14.9 
S.E.of M. ± 1.7 ± 22 . 2 ± 7.6 ± 8 .8 





F. F. 3.8 
R.A 5.8 
N.dt J . 5.8 
N.0 6.0 
FOLIC AC ID CLEARANCES - L .CASEI 
Hb. 
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<3rd II. 7 
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FIGLU • FOLATE LE VE LS ng./rnl. 
µgJml. ~24H. BASAL 3 MIN. 15MIN 30MIN 
27.2 7.3 6.4 65 32 19 
52 . 5x 21.5Y. 9.6 85 34 16 
24.2 7.4 9.6 118 59 35 
28 .9 22.B 2.4 98 40 21 
MEAN 7.0 91 41 23 
S. D. ± 3.3 ± 22 .3 ±12.4 ± 8.4 





U.R.T + G.E. 
U.R.T. 
INFANTS with NORMAL FOLATE NUTRITION 
FOLATE LEVE LS ng./ml. 
SUBJECT 
BASAL 3 MIN . IS MIN. 30 MIN. 
F. F. 6.4 65 32 19 
N .dt J . 9.6 118 59 35 
MEAN 8 .0 91 45 27 
S.D. ± 22 ± 37.6 ± 19.2 ± 11. 3 
S.E.of M. ± I. 6 ± 26,9 ± 13.7 ± 8.1 
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t = 2 .504 
0.02 <P<0.05 
115. 
Furthermore, the peak absorption of folic acid as measured here with 
L.casei in infants was lower than that found in adults (80-230 ng./ml.) 
by Ball (1966). However, no inferences could be drawn regarding a possible 
difference between absorption of folic acid by adults and infants because 
some infants were investigated in the recovery phase of gastroenteritis, 
and because serum L.casei folate assays from different laboratories were 
not necessarily comparable. 
The curves will be regarded as representative of normal for this 
population group and valid for the purposes of comparison. They may not 
be representative of normal folio acid absorption in infancy. 
FOLIC ACID CLEARANCE TEST 
The folate activity in serum following an intravenous injection of 
folic acid was measured with L.casei in twelve infants and with both 
L.casei and S.faecalis in six infants. 
Results. 
L.casei folio acid clearance curves. 
The mean and range of folic acid clearance curves obtained using 
procedures 1 and 2 (defined in Chapter IV) in all infants and in those 
with normal folate nutrition (viz. serum D.casei folate levels in the 
normal range and normal Figlu excretion) are shown in Fig. 19. The data 
is presented in detail in Tables 35 and 36. 
The mean folio acid clearance curve u s i ng procedure 1, was slower 
than that with procedure 2 but the difference was not statistically signi-
ficant (Fig. 20). The folio icid clearance test is associated with a high 
variance and when few tests are performed, differences have to be_ very 
great before they become significant. 
The mean folio acid clearance curve obtained in infants using pro-
cedure 1 was significantly faster (Fig.20) than that found in adults by 
Hogan, Maniatis and Moloney (1964). By these adult standards only 2 of the 
8 curves obtained in infants fell within the normal range (W.A. and A.H.A.; 
Table 35; Fig. 20). 
MEAN and RANGE of FOLIC ACID CLEARANCES 5.- FAECALIS 
PROCEDURE I 
1.V RG.A. 
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S.faecalis folic acid clearance curves. 
The mean and range of S.faecalis folic acid clearance curves in 
all infants and in those with normal folate nutrition (procedures 1, 2) 
are shown in Fig.21 and Table 37. The mean folic acid clearance curve 
using procedure 1 was slower than that obtained using procedure 2 (Fig.21; 
Table 37). 
The mean S.faecalis folic acid clearance curve obtained using 
procedure 1 (Table 37) was faster than the adult mean reported by Chanarin, 
Mollin and Anderson (1958a). They reported mean values of 127, 40 and 
20 ng./ml. at 3, 15 and 30 minutes after the injection of folic acid. 
Discussion. 
The more rapid mean folic acid clearance curves both with L.casei 
and S.faecalis found in the second group of infants (procedure 2) could 
have been due to a slightly lower dose of administered folic acid. In 
view of this technical difference, and clinical differences which will be 
discussed below, the clearance curves performed according to procedure 2 
might not have been representative of those found in healthy, under-
privileged infants. Therefore whenever these tests are discussed, they 
will be discussed separately from those of procedure 1. 
The clinical differences between the two groups were as follows: 
(a) Undernutrition: The second group of infants was less well nourished 
than the first, and two of them (F.F. and R.A.; Tables 35, 36) had the 
lowest weight percentiles (Wt.%) of all infants investigated using this 
test. It was not known to what extent undernutrition might have contributed 
to the more rapid folic acid clearances obtained when procedure 2 was used. 
However, it was noted that one infant, A.H.A. (Table 35) whose weight 
117. 
percentile was nearly as low as that or F.F. er R.A. had a very slew 
L.casei folic acid clearance curve. 
(b) Incidence of infection: (Tables 35, 36). Infection was noted in all 
the infants studied according to procedure 2, and in only one studied 
according to procedure 1. Infection was of a trivial nature and unassoci-
ated with pyrexia at the time of investigation. For this reason it seemed 
unlikely that it produced a greatly increased demand for folate. One infant 
with a low basal serum L.casei folate level (N.o.) had an L.casei folic acid 
clearance curve within the range found in healthy, underprivileged infants 
(procedure 1) despite the presence of trivial infection at the time of 
investigation (Tables 35, 36). This did not apply to the S.faecalis folic 
acid clearance curve (Table 37). 
(c) The administration of antibiotics: Three of the four infants studied 
according to procedure 2 received antibiotics (Table 36). Of the anti-
biotics administered, ampicillin (penbritin) was the only one likely to 
have affected the folic acid clearance test. However, the normal basal 
serum L.casei folate level in this infant (R.A.) made this an unlikely 
possibility. 
Last, the apparent difference between the folic acid clearance 
tests in infants (procedure 1) and adults was of interest. From the findings 
in this study it could be inferred that the infants concerned had lower 
folate stores than the adults investigated by Hogan, Maniatis and Moloney 
(1964). The normal basal serum L.casei folate levels in the infants did 
not exclude this interpretation because Einhorn and Reizenstein (1966) and 
Hogan, Maniatis and Moloney (1964) had shown that in certain conditions 
leading to folate deficiency, the L.casei folic acid clearance curve could 
be rapid in the absence of low basal serum L.casei folate levels. 
118. 
However, no inferences were drawn from the apparent difference 
between folic acid clearance curves in infants and adults for the following 
reasons: 
(a) Coincidental iron deficiency (Table 35): This deficiency was a common 
finding in infants in this study. It was shown that iron deficiency could 
be associated with a rapid S.faecalis folic acid clearance curve (Chanarin, 
Mallin and Anderson, 1958a) and Einhorn and Reizenstein (1966) believed it 
might result in rapid L.casei folic acid clearance curves. This second 
finding was not confirmed by Hogan, Maniatis and Moloney (1964). 
The effect of iron deficiency on the pattern of the folio acid 
clearance curves obtained in the infants studied could not be excluded. 
(b) Differences in techniques of assaying folate. 
It was shown that differences in the technique of assaying folate 
existed among different laboratories (Table 32). For this reason it seemed 
doubtful whether a comparison between the results obtained by Hogan, 
Maniatis and Moloney (1964) and those obtained here was valid. In this 
regard it was noted that the 15 minute serum folate level of the L.casei 
folio acid clearance test performed on control adults was reported by 
Chanarin and McLean (1967) as 55.3 ng./ml. This was comparable to that 
found in healthy infants here (Table 35) but markedly different from that 
(Fig. 20) reported by Hogan, Maniatis and Moloney (1964). 
Until folic acid clearance tests are performed on normal infants 
and normal adults and the folate levels determined by the same laboratory 
it will not be known whether there is a difference between infant and adult 
folate stores. However, the curves obtained will be regarded as represen-
tative of normal for this population group and valid for the purposes of 
comparison. 
WHOLE BLOOD AND RED CELL L.CASEI FOLATE ASSAY 
(Hoffbrand, Newcombe and Mallin, 1966) 
The differences between this and the serum L.casei method will be 
stated belowi The procedure has been slightly modified from the original 
method. 
TABLE 38 
RED CELL FOLKTE LEVELS IN NORMAL EUROPEAN SUBJECTS 


















Range 107 - 319 ng./ml.. 
Mean 208 ng./ml., 
S .D .. + 54 -
S.E- of Mean + 13 -
TABLE 39 
RED CELL FOLATE LEVELS IN NORMAL COLOURED WOMEN 
























Range 113-492 ng./ml. 
Mean 241 ng./ml. 
s·.n. :!: 79 


























REPRODUCIBILITY BETWEEN REPEAT ASSAYS FOR 
WHOLE BLOOD FOLATE (L.CASEI) 
Whole blood Folate ng./ml. Difference % difference 
Reading 1 Reading 2 
1 132 124 8 6 
2 14$ 100 48 39 
3 170 150 20 13 
4 124 168 44 30 
5 82 82 0 0 
6 28 32 4 13 
7 42 36 6 15 
8 78 104 26 29 
9 200 100 100 67 
10 40 50 10 23 
11 80 116 36 37 
12 46 58 12 23 
13 134 96 38 33 
14 76 92 16 19 
15 136 164 28 19 
16 128 84 44 42 
17 80 96 16 18 
18 118 140 22 17 
19 110 130 20 17 
20 50 62 12 21 
21 50 58 8 15 
22 112 86 26 26 
23 57 54 3 5 
24 106 132 26 22 
25 54 40 14 30 
26 146 132 14 10 
27 146 134 12 9 
28 142 152 10 1 
29 56 82 26 38 
30 90 132 42 38 
31 100 128 28 25 























TABLE 40 (contd.) 
Folate ng./ml. Difference 
Reading 1 Reading 2 
64 58 6 
108 98 10 
154 96 58 
100 64 36 
174 116 58 
28 42 14 
44 64 20 
144 176 32 
178 196 18 
72 90 18 
66 72 6 
170 140 30 
50 54 4 
48 34 14 
128 110 18 
60 70 10 
46 62 16 
138 10 68 
156 86 70 
108 98 10 
184 110 74 
Mean difference ng./ml. 25 

























Blood was collected into a test tube containing 1 drop of heparin. 
Whole blood (0.5 ml.) was slowly added to 4.5 ml. of distilled water con-
taining 1 g.% freshly added ascorbic acid. The haemolysate was prepared 
on the day of collection and stored at -20°c. until the day of assay. 
Then it was slowly thawed at room temperature, thoroughly mixed and an 
aliquot of 0.4 ml. added to 3.6 ml. of 0.1 M phosphate buffer containing 
280 mg.% of ascorbic acid (pH 6.1). The solution was autoclaved for 
2t minutes at 15 l~./sq.in. to precipitate the protein. The assay pro-
cedure was completed as previously described for serum L.casei folate assay. 
The concentration of folate in whole blood in ng./tube was deter-
mined from the standard curve for folio acid set up with each assay. The 
final result was expressed as ng./ml. after performing the appropriate 
calculation. The following formula was used to calculate the red cell 
folate level from the whole blood folate reading. 
(1 - PCV) 




The range of red cell folate levels in normal European subjects was 
107 - 319 ng./ml. The mean and standard error were 208 + 13 ng./ml. 
(Table 38). In normal Coloured women the range was 113 - 492 ng./ml. and 
the mean and standard error we-ne 241 ! 17 ng./ml. (Table 39). 
Accuracy of the method. 
The mean difference and mean percentage error between repeat assays 
were 25 ng./ml. and 25% respectively (Table 40). 
TABLE 41 
* REPRODUCIBILITY BETWEEN REPEAT AS SAYS FOR FOLATE IN MILK 
Folate ng./ml. 
Milk Reading t : Reading 2 Dif
ference % Difference 
1 10 6 4 48 
2 8 13 5 44 
3 17 21 4 2l 
4 16 22 6 31 
5 24 16 8 42. 
6 9 24 15 89 
7 17 I.7 0 0 
8 20 14 6 35 
9 29 22 7 2-8 
10 l.8 12 6 41 
11 36 2-7 9 2.-8 
12 2.5 22 3 10 
13 9 10 I. 12 
14 33 3l. 2 5 
15 16 14 2 13 
16 18 10 8 55 
17 10 7 3 33 
l.8 29 25 4 15 
l.9 30 40 10 27 
20 12 21 9 54 
21 10 12 2 l.8 
22:. 7 9 2 3u 
23 28 40 12 35 
24 10 L3 3 29 
25 37 44 7 17 
26 30 2D. 10, 41 
27 16 18 2 14 
28 24 32 8 29 
29 13 27 14 71 







TABLE 41 (contd.) 
Folate ng./ml. 












Mean difference ng./ml. 
Mean% difference 

















ESTIMATION OF TOTAL AND TRUE MILK FOLATE USING L.CASEI 
(Vanier and Tyas, 1966) 
Principle. 
Milk may contain substances other than folate which stimulate the 
growth of L.casei. In order to eliminate this, the true folate in milk is 
adsorbed on to charcoal. The supernatant is assayed and the activity of 
the non-folate growth factors determined. This value is subtracted from 
the total milk folate level to determine the true milk folate concentration. 
The differences between the assay techniques for folate in milk and 
serum will be stated below. 
Estimation of total milk folate. 
The total milk folate level was determined using the serum L.casei 
assay procedure,but 0.2 ml. instead of 0.4 ml. aliquots were used. 
Estimation of true milk folate. 
Procedure. 
Phosphate buffer (3.8 ml. of 0.1 M containing 280 mg.% ascorbic acid; 
pH 6.1) was added to 0.2 ml. of the milk to be assayed. This was autoclaved 
for 2! minutes at 15 lb./sq.in. 
The coagulum was spun down and the supernatant decanted into a 
tube containing approximately 16 mg. of activated charcoal. This was well 
mixed and allowed to stand for 20 minutes at room temperature. After 
centrifugation, 0.5 ml. of the supernatant fluid was added to each of 
four 6 11 x 5/8" borosilicate tubes. The procedure was followed as in the 
serum L.casei folate assay. 
Accuracy of the method. 
The mean dirference between repeat assays was 6 ng./ml. The mean 
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The determination of Vitamin B12 
in serum bymicrobiological assay. 
(Anderson,1964; Hutner, Bach and Ross, 1956) 
A vitamin B12 dependent organism is grown under controlled nutri-
tional and environmental conditions in both known concentrations of 
The vitamin B
12 
and unknown concentrations of vitamin B12 in serum. 
concentration of vitamin B12 present in the unknown serum is determined 
by comparing the bacterial growth in serum with that in known concentrations 
of vitamin B12 • 
Materials. 
Glassware and equipment: this was cleaned as described for the serum 
L.casei folate assay. 
The assay medium: This is shown in Table 42. 
The assay organism: The z. strain of Euglena gracilis was used. It was 
maintained by weekly subculture in the liquid stock culture medium 
recommended by Hutner, Bach and Ross (1956). 
The water bath: This differed in detail from that described by Anderson 
(1964), but it satisfied the important principles. It provided a 
uniform illumination of 50 ft. candles when measured in the recom-
mended way. It was covered with a black cloth during the incubation 
phase to eliminate outside light and to ensure that the assay tubes 
only received light from the strip lights below. It provided a 
0 steady temperature of 27 - 28.5 C. The constant circulation of 
distilled water throughout the bath helped to maintain a uniform 
temperature. 
Venepunctures: The needles, syringes and test tubes used were carefully 
cleaned to prevent contamination with vitamin B12 • The sera were 
separated and stored at -20°c. until assayed. 
122. 
Assay procedure. 
A 1 in 100 dilution of serum was prepared by adding 0.1 ml. of 
serum to 9.9 ml. of distilled water. Aliquots (2 ml.) were transferred 
to three 611 x 5/8 11 test tubes. This allowed each serum to be assayed in 
triplicate. Double-strength medium (2 ml.) was added to each tube. 
Ampoules of vitamin B12 solution containing 100 p.g./ml. ("cytamen 
100"; Glaxo Laboratories Ltd.) were used to prepare the standard solutions. 
Standards were set up in quadruplicate to contain O, 4.0, 8.0, 16.0, 24.0, 
32.0 and 40.0 pg. per tube. To these tubes 0.1 ml. of diluted serum with 
a low vitamin B12 concentration was added and the volume made up to 2 ml. 
with distilled water. Thereafter, 2 ml. of double-strength medium were 
added to each test tube. 
A solution was prepared for the future seven-day-old culture. 
Vitamin B12 (0.3 ml. of a solution of vitamin B12 containing 4 ng./ml.), 
4.7 ml. of Tryptone (Difeo) and 5 ml. of dou~le-strength medium were 
pipetted in sequence into three 6 11 x 5/8" test tubes. 
All tubes were plugged with cotton wool and heated in a boiling 
water bath for fifteen minutes. Thereafter they were rapidly cooled in 
cold water and distributed at random in the test tube racks. 
The inoculum was prepared from a seven-day-old culture. This was 
centrifuged for one minute and thereafter the supernatant was discarded 
and the cells washed three times by repeated centrifugation with fresh 
6 ml. amounts of a single-strength medium (double-strength diluted 1 in 2). 
The cells were finally suspended in 6 ml. of single-strength medium and 
well mixed. A 1 ml. aliquot was transferred to a tube containing 4 ml. 
of medium. The optical density of this 1 in 5 solution was determined by 
reading this against a sample of single-strength medium using the Unicam 
photoelectric colorimeter (SP 1300) and a red filter (Ilford 608). This 
TABLE 43. 
REPRODUCIBILITY BETWEEN REPEAT ASSAYS OF SERUM 
FOR ESTilvlATIONS OF VITAMIN B12 
Sera Serum vitamin B12 pg./ml. Difference % difference 
Reading l Reading 2 
1 1710 2065 355 19 
2 100 820 120 16 
3 540 590 50 14 
4 550 603 53 9 
5 180 190 10 5 
6 562 630 68 11 
7 244 320 76 27 
8 1030 1236 206 18 
9 400 451 51 12 
10 362 433 71 18 
11 84 82 2 3 
12 394 450 56 13 
13 532 602 70 12 
14 320 392 72 20 
15 540 511 29 6 
16 1000 740 260 30 
17 216 320 104 39 
18 320 464 144 37 
19 558 660 102 17 
20 376 440 64 16 
21 596 696 100 16 
22 366 403 37 10 
23 328 364 36 10 
24 752 856 104 13 
25 246 200 46 6 
26 550 620 10 12 
27 680 740 60 9 
28 620 710 90 14 
29 562 654 92 15 
30 504 616 112 20 
31 246 310 64 23 
32 224 264 40 16 
TABLE 412 (contd.) 
Sera Serum vitamin B12 pg./ml. Difference % difference 
Reading 1 Reading 2 
33 450 494 44 9 
34 510 556 46 9 
35 722 712 10 1 
36 230 272 42 17 
37 608 806 198 18 
38 684 646 38 6 
39 676 620 56 9 
40 530 564 34 6 
41 302 253 49 16 
42 1530 1485 45 3 
43 251 256 5 2 
44 400 357 43 11 
45 612 674 62 10 
46 928 880 48 5 
47 367 370 3 1 
48 1209 1358 149 12 
49 372 388 16 4 
50 840 852 12 1 
51 810 860 50 6 
52 370 362 8 2 
53 350 382 32 9 
54 620 616 4 1 
55 274 300 26 9 
56 364 320 44 13 
57 410 358 52 14 
58 434 348 14 22 
59 400 390 10 3 
60 270 275 5 2 
61 126 140 14 11 
62 102 135 33 28 
63 410 368 42 11 
64 616 624 8 l 
65 664 608 56 9 
TABLE 43 (contd.) 
Sera Serum vitamin B12 pg./ml. 
Difference % difference 
Reading 1 Reading 2 
66 322 350 28 8 
67 548 576 28 5 
68 650 406 144 46 
69 334 382 48 13 
70 736 740 4 0 
71 908 940 32 4 
72 446 360 86 21 
73 442 340 102 26 
74 726 690 36 5 
75 400 494 94 21 
76 192 236 44 21 
11 714 706 8 l 
78 320 346 26 10 
19 1044 1044 0 0 
80 1044 1008 36 4 
81 872 824 48 6 • 
82 712 692 20 3 
83 1632 1228 404 28 
84 542 690 148 24 
85 1244 1214 30 2 
86 580 544 36 6 
87 510 490 20 4 
88 968 860 108 12 
89 322 360 38 11 
90 954 900 54 6 
91 522 490 32 6 
92 730 692 38 5 
93 337 343 6 2 
94 364 350 14 4 
95 140 155 15 10 
Mean difference 61 pg./ml. 
Mean% difference 12 
123. 
reading was used to determine the dilution of the inoculum required to 
produce an optical density of 0.182 using a 1 cm . light path. 
All tubes containing the sera to be tested and the standard solutions 
were inoculated with one drop of the standardised suspension of Euglena 
cells using a syringe fitted with a No.20 spinal needle with a squared-off 
point. Three drops of the standardised suspension of Euglena cells were 
added to the inoculum culture tubes . The tubes were placed in the water 
bath for five days. They were removed on day six, well shaken and trans-
ferred to racks and read in cuvettes of 1 cm . light path in the Unicam 
colorimeter (SP 1300) using a red filter (Ilford 608) . 
· A standard curve was constructed by plotting the concentration of 
standards against their optical densities . The concentration of vitamin B12 
(pg . per tube) in the test sera was determined from this graph. The final 
result was expressed as pg . /ml . after performing the appropriate calculation. 
Each serum was assayed twice in triplicate and the result expressed as the 
mean of the two assays . 
Accuracy of the method . 
The mean difference between repeat assays was 61 pg . /ml. and the 
mean percentage difference was 12 (Table 43) . 
Normal range . 
This was 140 - 900 (Mallin, 1960) . 
TABLE 44 
REPRODUCIBILITY BETWEEN REPEAT ASSAYS FOR IRON IN SERUM. 
Sera Serum iron pg./100 ml. Difference % difference 
Reading l Reading 2 
1 114 115 1 1 
2 92 93 1 1 
3 136 123 13 10 
4 27 33 6 2 
5 153 144 9 6 
6 117 113 4 4 
7 49 45 4 9 
8 101 101 0 0 
9 123 115 8 7 
Mean difference pg./100 ml. • 5 



















REPRODUCIBILITY BETWEEN REPEAT ESTIMATIONS 
FOR CREATININE IN URINE 
Creatinine mg./100 ml. Difference % difference 

































Mean difference o.6 mg./100 ml. 



















Serum iron estimations (Trinder,1956). 
Accuracy of the serum iron method. 
The mean difference between repeat assays was 5 rg./100 ml. and the 
mean percentage difference was 6 (Table 44). 
Iron binding capacity (Henry, Sobel and Chiamori, 1958). 
Measurement of d-xylose in blood and urine. 
Xylose was measured in urine according to Roe and Rice (1948) and 
in blood according to Lanzkowsky, Lloyd and Lahey (1963). 
Normal values for xylose excretion in urine in infants were taken 
from Shapiro, Morgan and Cozetto (1963). These were 12+ (age in months 
X 0.1). 
Creatinine estimation in urine. 
Creatinine in urine was estimated according to Bonsnes and Taussky 
(1945) • . In this study compensation had to be made for the difference in 
the weights of the infants. Hence creatinine was always expressed as the 
ratio defined below. 
actual creatinine output . x 100 expected creatinine per kg. bodyweight 
Accuracy of the method. 
The mean difference between repeat assays for creatinine in urine 
was 0.6 mg./100 ml. and the mean percentage difference was 5.4 (Table 45). 
Total protein and serum albumin (Weichselbaum, 1946; Martin and Morris ,1949). 
Serum glutamic oxaloacetic transaminase (Mohun and Cook, 1957). 
Occult blood test (Ames Hematest). 
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BACTERIOLOGICAL METHODS 
Standard methods were used for the microscopic examinations and 
for the stool, urine and blood cultures (Baker, Silverton and Luckcock, 
1962). 
STATISTICAL METHODS 
Standard methods were used (Bailey, 1959). 
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AN INVESTIGATION OF MATERNAL FOLATE DEFICIENCY 
INTRODUCTION 
Investigators who studied the problem of megaloblastic anaemia and 
folate deficiency in pregnancy reported that the highest incidence of 
megaloblastic anaemia due to folate deficiency occurred after the thirtieth 
, 
week of pregnancy or in the postpartum phase (Giles and Shuttleworth,1958; 
Chanarin, MacGibbon, O'Sullivan and Mollin,1959; Gatenby and Lillie,1960). 
For this reason healthy women were investigated from the 32nd - 40th week 
of pregnancy in order to determine whether maternal folate deficiency 
contributed to the development of folate deficiency in their infants. 
Laboratory methods had been introduced for diagnosing folate 
deficiency even in the absence of megaloblastic anaemia. Three of these 
methods (viz. serum L.casei folate assays, Figlu excretion after oral 
histidine and hypersegmentation of the neutrophils) were used as para-
meters for diagnosing maternal folate deficiency. When thi~ study began 
(1963) and afterwards, laboratory methods were much used to investigate 
folate deficiency in pregnant women (Solomons, Lee, Wasserman and Malkin, 
1962; Berry, Booth, Chanarin and Rothman, 1963; Luhby, Feldman , Salerno 
and Cooperman, 1963; Ball and Giles, 1964; Chanarin, Rothman and Berry, 
1965; Metz, Festenstein and Welch, 1965; Lowenstein, Cantlie, Ramos and 
Brunton, 1966; Vanier and Tyas, 1966; Edelstein, Stevens, Brandt, Baumslag 
and Metz, 1966; Hansen, 1967; Temperley, Meehan and Gatenby, 1968) . 
However, it became increasingly clear that laboratory parameters for 
diagnosing folate deficiency before the development of megaloblastosis, 












































































































































































































































































































































CORRELATION of MATERNAL PARAM ETERS of FOLATE 
DEFICIENCY 
MEAN MATERNAL SERUM FOLATE LEVELS 
related to MATERNAL FIGLU EXCRETION 
,2', EXCESSIVE FIGLU EXCRETION NORMAL FIGLU EXCRETION 
UJ 
~ n=S 




















DIFFERENCE of MEANS 
t = 0.300 
0.70 <P < 0.80 
MEAN MATERNAL SERUM FOLATE LEVELS 
related to POLYMORPHONUCLEAR SEGMENTATION 




DIFFERENCE of MEANS 
t = 1.750 
O.OS<P< o.ro 
Fig. 2 2 
TABLE 47 
RELATIONSHI P OF HlIBMATOCRIT TO 
PARAMETERS OF FOLATE DEFICIENCY I N MOTHERS 
Classification 
(mothers) 
Low serum folate levels 
Normal serum folate 
levels 
Positive Figlu tests 
Negative Figlu tests 
Hypersegmentation of 
neutrophils 







n = 34 
35.5 
n =, 50 
35 • .0 
n = 5 
35.5 
n = 79 
35.5 
n = 7 
35.5 









t = 1.036 
0. 30 < P < O. 40 
t = 0.325 
0. 70 < P < O. 80 
No difference 
There is no statistical relationship between haematocrit levels and 
these parameters of folate deficiency in the mothers. 
RELATIONSHIP OF MATERNAL AND CORD SERUM FOLATE LEV.ELS' 
Classification 
(mothers) 
Low serum folate levels 







n = 27 
21.,6 




I STUDENT Is I 
t-Test 
Significance 
t = 1.680 
b.05 < P < 0.10 
Low maternal serum folate levels are associated with lower cord 
serum folate levels. The relationship is not statistically 
significant. 
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Accordingly, in the discussion below it was necessary to determine 
• how far the results obtained in this study could be used to diagnose 
maternal folate deficiency. This was necessary before maternal and infant 
folate interrelationships could be considered and assessed. 
RESULTS 
The results of the 86 women who brought their infants for study 
will be presented. 
Approximately 40% of the women investigated had low serum L.casei 
folate levels (34 of 84), but only 6% (5 of 84) had positive Figlu tests 
after oral histidine and 8% (7 of 85) had hypersegmentation of the 
neutrophils (Table 46). 
There was no statistical relationship between mean maternal serum 
L.casei folate levels and 
(a) Figlu excretion after oral histidine; 
(b) percentage hypersegmentation of the neutrophils (Fig. 22). 
None of the women with hypersegmentation of the neutrophils excreted 
Figlu in excess. 
There was no statistical relationship between mean haematocrit 
levels and 
(a) low serum L.casei folate levels; 
(b) positive Figlu tests after oral histidine; 
(c) hypersegmentation of the neutrophils (Table 47). 
There was no correlation between mean cord and maternal serum 
L.casei folate levels (Table 47). 
TABLE 48. 
SERUM L.CASEI FOLATE LEVELS IN LATE PREGNANCY 
(Unsupplemented) 
Investigators Stage of pregnancy Mean S.D. S.E.of Mean 
Ball and Giles, Last Trimester 
1964. (Normoblastic) 3.19 + 0.97 -
(Megaloblastic) 1.89 + 0.96 -
Temperley, 36th week 2.7 + 0.12 -
Meehan and 40th week 1.9 + 0.09 1968 -Gatenby, 
Cape Town 
Investigation 32nd - 40th week 3.9 + 2.1 + 0.2 
Range 
1.6 - 5.3 
0.3 - 4.0 
0.4 - a.7 
0.2 - 5.0 
1.2 - 11.7 
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DISCUSSION 
The results obtained by means of the laboratory tests used in this 
study will be discussed in sequence . In each case they will first be 
compared with those reported by other investigators . Afterwards the 
validity of each of these tests as diagnostic parameters of folate 
deficiency in pregnancy and their application in determining maternal 
and infant folate interrelationships will be discussed . ~~e value of 
other diagnostic methods for folate deficiency not used in the study will 
also be mentioned whenever relevant . 
Serum L. casei folate assays . 
In this study, 40% of women from the 32nd - 40th week of pregnancy 
had low serum L. casei folate levels . This incidence was within the range 
(25 - 80%) found by other investigators who studied healthy preghant 
women near term (Metz , Festenstein and Welch, 1965 ; Chanarin , Rothman 
and Berry , 1965 ; Edelstein, Stevens , Brandt , Baumslag and Metz , 1966 ; 
Lowenstein , Cantlie, Ramos and Brunton , 1966 ; Vanier and Tyas , 1966 ; 
Hansen , 1967) . 
The mean and range of serum L. casei folate levels was comparable 
to those reported by other investigators (Table 48) . 
For the above-mentioned reasons , it was necessary first to examine 
the validity of the serum L. casei folate assay as a parameter of folate 
deficiency in pregnancy before one could conclude that 40% of healthy 
pregnant women had biochemical folate deficiency in the last trimester 
of pregnancy. 
Investigators who carried out serial investigations for folate 
deficiency reported a decline in mean serum L. casei folate levels towards 
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term in pregnant women (Solomons, Lee, Wasserman and Malkin, 1962; Ball 
and Giles, 1964; Chanarin, Rothman and Berry, 1965; Metz, Festenstein and 
Welch, 1965; Edelst~in, Stevens , Brandt, Baumslag and Metz , 1966; Vanier 
and Tyas, 1966; Hansen, 1967). Similarly, an increasing number of women 
developed low serum L.casei folate levels as term approached (Chanarin 
and Rothman, 1964; Metz, Festenstein and Welch, 1965; Vanier and Tyas, 
1966; Hansen, 1967). 
These changes were noted in healthy pregnant women (Hansen, 1967); 
normal pregnant women (Chanarin, Rothman and Berry, 1965) and unselected 
pregnant women (Ball and Giles, 1964; Solomons, Lee, Wasserman and 
Malkin, 1962). 
It seemed that the pattern of decline in mean serum L.casei folate 
levels as term approached could be attributed to any of the following: 
(a) the development of maternal folate deficiency; 
(b) increased demand for folate; 
(c) the effect of increasing blood volume as pregnancy advanced. 
From the above studies it was not possible to exclude the effect of blood 
volume changes in producing this finding. This was supported by the 
finding that small (Willoughby and Jewell, 1966; Hansen and Rybo, 1967) 
and large doses of folic acid (Metz, Festenstein and Welch, 1965; Hansen 
and Rybo, 1967) did not result in a return to normal serum L.casei folate 
levels in all pregnant women. 
However, it did not seem that the low serum L.casei folate levels 
could be attributed to the effect of blood volume changes alone. The 
decline in serum L.casei folate levels towards term occurred in both non-
anaemic (Ball and Giles, 1964; Vanier and Tyas, 1966) and anaemic women 
(Ball and Giles, 1964; Solomons, Lee, Wasserman and Malkin, 1962). 
130. 
Also, serial studies performed during pregnancy using the folic 
acid clearance test (Chanarin, MacGibbon, O'Sullivan and Mollin, 1959) 
and red cell L.casei folate studies (Chanarin, Rothman, Ward and Perry, 
1968; Hansen, 1967) showed the same decline in mean values towards term 
as had been shown with the serum L.casei folate assay. The results with 
the first test could not be attributed to the effect of blood volume 
changes alone (Chanarint MacGibbon, O'Sullivan and Mollin, 1959; Girdwood 
and Delamore, 1961) and red cell L.casei folate levels should not have 
been affected by blood volume changes. · 
In addition to these arguments there was positive evidence for 
attributing the low serum L.casei folate levels to folate deficiency or 
increased demand for folate. It was shown that women with low serum 
L.casei folate levels in the last trimester of pregnancy still had low 
values in the puerperium when the physiological and metabolic stresses 
of pregnancy were removed (Metz, Festenstein and Welch, 1965; Edelstein, 
Stevens, Brandt, Baumslag and Metz, 1966; Hansen, 1967; Temperley, Meehan 
and Gatenby, 1968). 
The administration of small doses of oral folic acid (300 pg.daily) 
to non-anaemic pregnant women during pregnancy maintained serum L.casei 
folate activity at near normal levels in the postpartum phase in 84% 
of women as compared with 55% in a control group not given folio acid 
(Willoughby _ and Jewell, 1966). Physiological doses of folio acid 
(200 rg./day) also improved mean serum L.casei folate levels, but the 
percentage of women who still had low serum L.casei folate levels was 
slightly higher (Hansen and Rybo, 1967). 
As in the case of red cell L.casei folate levels (Chanarin, Rothman, 
Ward and Perry, 1968), there was a relationship between the L.casei serum 
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folate levels in early pregnancy and the subsequent development of megalo-
blastic anaemia (Temperley, Meehan and Gatenby, 1968). Moreover there was 
a good relationship between red cell L.casei folate levels and food folate 
intake (Chanarin, Rothman, Ward and Perry, 1968). 
From these findings it appeared that low serum L.casei folate levels 
were primarily the result of biochemical folate deficiency. However, there 
might have been two factors which limited the application of the test in 
assessing a relationship between maternal and infant folate deficiency. 
First, it seemed that low serum L.casei folate levels did not always 
indicate significant folate deficiency. Apart from Temperley, Meehan and 
Gatenby (1968), investigators did not find a relationship between low serum 
L.casei folate levels and haemoglobin concentration (Solomons, Lee, Wasser-
man and Malkin, 1962; Chisholm, 1966; Edelstein, Stevens, Baumslag and 
Metz, 1968). 
Moreover, low serum L.casei folate levels were not necessarily 
associated with morphological changes in the bone marrow (Lowenstein, 
Cantlie, Ramos and Brunton, 1966; Chanarin, Rothman, Ardeman and Berry, 
1965). Also the lower limit of reduced serum L.casei folate levels found 
in pregnant women with normoblastic marrows could overlap with those found 
in pregnant women with megaloblastic bone marrows (Ball and Giles, 1964). 
For these reasons the serum L.casei folate assay was regarded as an 
unreliable index of megaloblastosis (Chanarin, Rothman and Berry, 1965). 
To overcome this problem Giles (1966) compared labile serum L.casei 
folate levels with megaloblastosis. Although he observed a 95% correlation, 
his method was criticised on technical grounds (Chanarin, Rothman, Ardeman 
and Berry, 1965). Hansen (1967) claimed that serum L.casei folate assays 
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could be successfully used as an index of megaloblastic bone marrow 
morphology, provided abnormal levels were defined as being lower than 
those found in normoblastic pregnancies. This was not confirmed by 
Chanarin (1967). 
Thus, if low maternal serum L.casei folate levels did not always 
imply significant maternal folate deficiency and if it were correct that 
infants deprived their mothers of folate (Grossowioz, Aronovitch, Rach-
milewitz, Izak, Sadovsky and Bercovici, 1960; Baker, Frank, Pasher, 
Ziffer and Sobotka, 1960; Zachau-Christiansen, Hoff-Jprgensen and Kris-
tensen, 1962), it was possible that low maternal serum L.casei folate 
levels would not be associated with any restriction of foetal folate 
stores in the majority of cases. 
Second, there was uncertainty as to whether serum L.casei folate 
levels were always low in megaloblastic anaemia due to folate deficiency 
in pregnancy. Some investigators were impressed with the agreement of 
these two parameters in pregnancy (Lowenstein, Brunton and Hsieh, 1966; 
Lawrence and Klipstein, 1967). Other investigators found that serum 
L.casei folate levels could be low or normal in the presence of megalo-
blastic anaemia due to folate deficiency in pregnancy (Chanarin, Rothman, 
Ardeman and Berry, 1965; Varadi, Abbott and Elwis, 1966), and in the 
postpartum phase (Edelstein, Zail, Paulding and Metz, 1967). 
Most evidence was in favour of attributing the low serum L.casei 
folate levels in pregnancy to biochemical folate deficiency. However, the 
use of this investigation to determine whether maternal folate deficiency 
contributed to infant folate deficiency might prove disappointing for 
two reasons: 
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(i) low maternal serum L.casei folate levels might not neces-
sarily mean reduced foetal folate stores, and 
(ii) serum L.casei folate levels could sometimes be normal in 
spite of significant maternal folate deficiency which might 
have restricted infant folate stores. 
Red cell L.casei folate estimations. 
These were not performed in this study. Some investigators found 
that low red cell L.casei folate levels were a reliable index of signifi-
cant folate deficiency in pregnancy (Varadi, Abbott and Elwis, 1966; 
Hansen, 1967). However, other investigators noted that red cell L.casei 
folate levels could be normal in the presence of megaloblastosis due to 
folate deficiency in pregnancy (Chanarin, Rothman, Ward and Perry, 1968; 
Lowenstein, ~runton and Hsieh, 1966). Thus the red cell L.casei folate 
assays might have proved a better index of depleted maternal and therefore 
foetal folate stores but its application would also have been limited 
because red cell L.casei folate levels were not always low in the 
presence of significant maternal folate deficiency. 
The Figlu test after oral histidine. 
The incidence of positive Figlu tests after oral histidine found 
here (8%) was slightly lower than that reported by others who used the 
same method of estimating Figlu (Kohn, Mollin and Rosenbach, 1961). 
Karthigiani, Gnanasundaram and Baker (1964) reported an incidence of 18% 
positive Figlu tests after oral histidine in healthy pregnant women near 
term but an incidence of 9% in those with normoblastic marrows. The 
incidence reported by Husain, Rothman and Ellis (1963) was 20% in 
unselected pregnancies near term and in the puerperium. 
134. 
Using sensitive methods of estimating Figlu (enzymatic and high 
voltage electrophoretic methods) investigators conducted serial investi-
gations with this test during pregnancy. From a study of the pattern of 
Figlu excretion during pregnancy, it seemed unlikely that the positive 
Figlu tests after oral histidine could be attributed to uncomplicated 
folate deficiency. 
There was general agreement that there was a high incidence of 
positive Figlu tests in early pregnancy (Berry, Booth, Chanarin and Rothman, 
1963; Metz , Festenstein and Welch , 1965; Edelstein, Stevens, Brandt, 
Baumslag and Metz , 1966; Stone, Luhby, Feldman, Gordon and Cooperman, 
1967). This finding was not only different from findings reported of the 
other laboratory parameters used for diagnosing folate deficiency in 
pregnancy, but it also implied that biochemical folate deficiency developed 
before pregnancy was very far advanced. 
There was disagreement about the pattern of Figlu excretion after 
early pregnancy until term. Berry, Booth, Chanarin and Rothman (1963) 
noted a decline in mean Figlu excretion and a decrease in the number of 
positive Figlu tests after oral histidine. 
The decline in mean Figlu excretion after oral histidine during 
pregnancy was confirmed by Metz, Festenstein and Welch (1965) and Edelstein, 
Stevens, Brandt, Baumslag and Metz (1966). A decrease in the incidence of 
positive Figlu tests after early pregnancy was noted in White patients 
(Metz, Festenstein and Welch , 1965), but to a much lesser extent in 
African patients (Edelstein, Stevens, Brandt, Baumslag and Metz, 1966), 
where the incidence of positive results was as high as 60% near term. 
After a decline in positive Figlu results after oral histidine 
in the middle trimester, Stone, Luhby, Feldman, Gordon and 6ooperman (1967) 
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noted a high incidence (60%) of positive results towards term. Their 
data included results from women with obstetrical complications during 
pregnancy. 
The incidence of positive Figlu tests after oral histidine was 
again high in the puerperium (Berry, Booth, Chanarin and Rothman, 1963; 
Metz, Festenstein and Welch, 1965; Edelstein, Stevens, Brandt, Baufnslag 
and Metz, 1966). 
Those investigators who reported a decline in mean_Figlu excretion 
as pregnancy advanced, attributed it to the following: 
(a) increased used of histidine for protein synthesis (Chanarin, 
Rothman and Watson-Williams, 1963; Berry, Booth, Chanarin and 
Rothman, 1963); 
(b) increased transfer of urocanic acid to the foetus (Chanarin, 
Rothman, Ardeman and MtLean, 1965); 
(c) delayed absorption of histidine in pregnancy (Chanarin, Rothman 
and Watson-Williams, 1963); 
(d) histidinuria in pregnancy (Chanarin, Rothman and Watson-
Williams, 1963). 
These last two factors were of less importance, but all reduced the effi-
cacy of the histidine load and so 9ould render the Figlu test an unreliable 
test of folate deficiency in pregnant patients. 
The most important evidence against attributing the results of 
positive Figlu tests after oral histidine to folate deficiency was the 
poor agreement noted between the results of positive Figlu tests after 
oral histidine and those of other parameters of folate deficiency in early 
pregnancy (Hansen, 1967), late pregnancy (Lowenstein, Cantlie, Ramos and 
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Brunton, 1966; Chishelm and Sharp, 1964; Chanarin, Rothman, Ardeman and 
Berry, 1965; Edelstein, Stevens, Baumslag and Metz, 1968), and in the 
puerperium (Edelstein, Zail, Faulding and Metz, 1967). 
Other investigators reported a good agreement between Figlu excre-
tion after oral histidine and other parameters of folate deficiency 
(Stone, Luhby, Feldman, Gordon and Cooperman, 1967; Luhby, Feldman, 
. 
Salerno and Cooperman, 1963; Hibbard, 1964; Scott and Sommerville, 1965). 
Although still controversial, most of the evidence did not confirm 
the value of the Figlu test after oral histidine as a parameter of folate 
deficiency in pregnancy. Whereas in experimental nutritional folate 
deficiency, positive Figlu tests after oral histidine could be attributed 
to significant folate depletion, this did not appear to be the case in 
pregnancy. Moreover, the test could be an unreliable index of megalo-
blastosis because histidine metabolism could be disturbed in pregnancy. 
For these reasons the application of this test as a parameter of maternal 
folate deficiency in the subsequent assessment of maternal and infant 
folate interrelationships seemed very limited. 
Hypersegmentation of the neutrophils. 
The majority of women received iron supplementation during pregnancy. 
The incidence of hypersegmentation found here (8%) was best compared with 
that found in pregnant women receiving iron supplementation. Chanarin, 
Rothman and Berry (1965) found that 4 out of 50 healthy pregnant women 
given iron supplements developed hypersegmentation (8%). 
Again the value of this parameter in the diagnosis of folate 
deficiency was uncertain. It was reported that hypersegmentation was not 
an uncommon finding in late pregnancy amongst non-anaemic healthy women, 
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but that its relationship to folate deficiency in these circumstances 
was uncertain (Hansen, 1967) . Moreover, hypersegmentation of the neutro-
phils (more than 3%) could be found in the absence of megaloblastosis due 
to folate deficiency in pregnancy and vice versa (Chanarin, Rothman and 
Berry, 1965 ; Chanarin, Rothman , Ardeman and Berry , 1965) . 
Lowenstein, Cantlie, Ramos and Brunton (1966) , and Varadi , Abbott 
and Elwis (1966) showed that hypersegmentation of the neutrophils corre -
lated with other evidence of folate deficiency only if 5% or more of 
neutrophils showed hypersegmentation. I~ seemed that the ~ignificance of 
hypersegmentation as a parameter of folate deficiency in pregnancy still 
had to be established . Until such time it was best used as a guide to 
the possible presence of underlying folate or vitamin B12 deficienc
y 
(Chanarin , Rothman and Berry , 1965) . The application of this parameter 
as an index with which to assess the effect of maternal folate nutrition 
on infant folate nutrition also seemed very limited . 
Bone marrow examinations . 
Minimal megaloblastic bone marrow changes were found in 75% 
(Roberts, Waters and Mallin , 1963) , and 25% (Hansen , 1967) of non-anaemic 
normal women in the last trimester of pregnancy . The reason for this 
finding and its relationship to folate deficiency were unknown . Accordingly 
Chanarin (1967) did not diagnose megaloblastosis in pregnancy unless there 
were unequivocal changes in the red cell precursors . 
It was stated that none of the laboratory parameters for diagnosing 
folate deficiency in pregnancy could be reliably used to indicate megalo -
blastosis and therefore significant folate deficiency in pregnancy 
(Chanarin, 1967) . This opinion appears to be justified after an 
13a. 
evaluation of the reports on the use of laboratory methods in the diagnosis 
of folate deficiency in pregnancy. Moreover, the validity of some of the 
laboratory methods for diagnosing biochemical or morphological folate 
· deficiency in pregnancy ~..s~ still uncertain. This probably explained the 
poor agreement between the parameters of folate deficiency used in this 
study. For these reasons it seemed that unequiYocal megaloblastosis 
associated with supportive evidence of folate deficiency or a normal 
serum vitamin B12 level would have been the best test of significant folate 
deficiency in pregnancy. It might also have presented the best method of 
assessing the effect of maternal folate deficiency on infant folate stores. 
At the time the study was conducted this was not clear and as a conse-
quence, bone marrow examinations on healthy pregnant women were not 
thought advisable. 
SUMMARY. 
The actual observations noted in pregnant women in Cape Town were 
similar to those reported by other investigators who used comparable 
methods. The failure to demonstrate a relationship between the parameters 
of folate deficiency in this study could be explained on the basis of 
possible differences in the interpretation of these tests in pregnancy. 
Of the tests used in this study, the serum L.casei folate assay 
appeared to be the best parameter of maternal folate deficiency. However, 
its application in determining the effect of maternal on infant folate 
nutrition appeared to be limited because it did not appear to be a 
reliable index of significant maternal folate deficiency and therefore 
might not have been a reliable index of foetal folate stores. 
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The validity of the Figlu test after oral histidine and hyperseg-
mentation of the neutrophils as parameters of folate deficiency could not 
be established. Their application in future studies to test the effect of 
maternal on infant folate nutrition was therefore even more limited. These 
results will be examined in future chapters only because there are investi-
gators who believe in the val~e of these tests, particularly the Figlu 
test after oral histidine, as parameters of folate deficiency in pregnancy. 
The best criterion of significant folate deficiency in pregnant 
women would have been the presence of unequivocal megaloblastosis supported 
by confirmatory evidence of folate deficiency • 
• 
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THE INTERPRETATION OF THE FIGLU TEST AFTER ORAL HISTIDINE. 
INTRODUCTION 
The infants studied were healthy but underprivileged. Thus, asso-
ciated nutritional deficiencies and recurrent infection, mostly trivial, 
were often encountered in the group. It was therefore more unfortunate 
that infants from a high socio-economic group could not be investigated 
to establish a standard of normal Figlu excretion for the experimental 
conditions of the study. 
Since 1963 additional investigators had used the Figlu test after 
oral histidine as a parameter of folate deficiency in infants. There was 
little uniformity in: 
(a) the dose of histidine administered; 
(b) the length of period during which urine was collected; 
(c) the method of estimation of Figlu; 
(d) the population group examined; (Table 49). 
In this investigation the procedure of execution of the Figlu test 
after oral histidine and the method of estimating Figlu (Tabor and Wyn-
garden, 1958) were those recommended by Luhby (1963) and Luhby and Cooper-
man (1964). Accordingly, their criterion of normal Figlu excretion for 
infants given a histidine load was accepted. This was modified from 
30 pg./ml. to 45 pg./ml. to compensate for possible differences in assay 
technique (Chapter V). 
It was necessary to use a second method for measurement of Figlu 
in the study. A:n ' investigation carried out applying this method (Chanarin 
















INCIDENCE OF INFANTS EXCRETING FIGL IJ IN EXCESS OF 45ug/ml. ~ 
PROSPECTIVE 
2h to 4h months 4 Vz to 7l,1 months 
120 
100 













7l;z to 1Q3/4 months ,0J;4 to .16 months 
14·3°1o 1H °lo 
OVERALL INCIDENCE 
z1;4 to 41J2 months 41/i to 7~ months 
42·0•/o 
33-7°1o 
~ 40 32· 4°/. 




CONTROLLED THERAPEUTIC TRIAL. 
H Number of infants excreting Figlu in excess 
(a) Initial study. 
Age 
(months) 
2f - 5 
(b) Follow 
(months) 
3~ - 5i 




Figlu test 8 4 33 45x 17.a 
up study - after therapy. 




Figlu test 6 7 32 45x 13.3 
x One exclusion prior to therapy because of significant vomiting of 
histidine 
One exclusion after therapy because of high urocanic acid excretion 
probably interfering with the interpretation of Figlu test. 
II Method of estimation - Chanarin and Bennett(1962~). 
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INCIDENCE OF INFANTS EXCRETING FIGLU IN EXCESS OF 30!Jg/ ml. ~ 
PROSPECTIVE 
2h to 4h months 4 Yz to 7.Yl months 
120 
1il0 






ADDITIONAL STUD! ES 









7 rz to 10 t'4 months 10~ to 16months 
2B ·6°lo 27· B°lo 
OVERALL INCIDENCE 
2Y4 to 4Y'l months 412to 7Yl months 
61-4 °lo 
52· 0°/o 
Fig . 24 
141. 
and Bennett, 1962a) showed that infants who passed concentrated urine 
might have false positive Figlu tests if results were expressed as Figlu 
concentration (fg./ml.) rather than total Figlu output (mg./24 hrs.). For 
this reason a standard of normality comparable to that used with the 
method of Tabor and Wyngarden (1958) was defined in terms of total Figlu 
output (mg./24 hrs.). By using this criterion, spurious positive tests 
resulting from urinary concentration were avoided (Chapter V). 
The results using the different methods were separately analysed 
because the method of Figlu estimation and the criterion of normality were 
different. The method of Tabor and Wyngarden (1958) will be referred to 
as method A and that of Chanarin and Bennett (1962a) as method B. The 
results will be discussed simultaneously with a view to determining the 
interpretation of the Figlu test after oral histidine. 
RESULTS. 
Incidence of Positive Results (Fig.23; Table 50) . 
The incidence of positive results was greatest in the youngest 
group of infants. In this age group the incidence was lower when method B 
was used for estimating Figlu. 
Incidence of Positive Results(%) 
METHOD A METHOD B 




Studies 32.4 17.8 
Overall Study 
(Combined Studies) 42.0 
The incidence of positive Figlu tests after oral histidine 
declined with growth (Fig. 23; Table 50). 
INCIDENCE OF INFANTS EXCRETING FIGLU IN EXCESS OF 30J.Jg.jml. ~ 
PROSPECTIVE STUDY 
2V4 to 4Ylmonths 4Yzto 7.Ylmonths 7h to 10f4months 10~ to 16months 









67 · 5°/o 
55·4°1o 
ADDITIONAL STUDIES 
2Y4 to 4l2months 4}z to 7Yz months 
120t---~~~---+-~~~~---' 






~ 40 - 48· 6°1o 45 ·5°1o 
Fig . 24 
28 ·6°1o 27· B°lo 
OVERALL INCIDENCE 


















MEAN FIGLU EXCRETION IN J.J g.jml 
PROSPECTIVE 







RANGE : 2·3-175'0 2·8-170·4 
S.O: !36·5 t34·7 
S.E. of meon:t 4·2 ± 4·3 
ADDrTIONAL STUDIES 







S.D : t ·Z4·0 





71/2 to 1 Q3/4 months 10~4 to 16 months 
---
4·0-122-4 3-1- BD-4 
±23 ·4 ±19-7 
± 4·0 ± 3-3 
- - - - - selection 
OVERAL INCIDENCE 
21,f. to (1/2 months 4~ to 71/2 months 
2·3-175·0 
± 33-4 



























MEAN FIGLU EXCRETION IN mg/24hours 
PROSPECTIVE STUDY 
2h to 4h months 4Y2 to 7h months 7 Yz to 10 ~ months 10}1. to 16months 
RANGE·. 0-7-&S-!l 0-6-46·0 2-4-30.5 0-1-16-8 
S.D: ± 11·3 ±9-1 ±7-4 ±4-3 
S.E.of mean: ± 1-3 ± 1-1 ±1 ·3 ±0-7 
------ SELECTION IN SAMPLE 
ADDITIONAL STUDIES OVERALL INCIDENCE 
2h to 4Y2months 4~ to 71.i months 
n= 28 
211. to 4Yz months 412 to 7Yz months 
n= 10S 
0 --......IJ,,~~--'-----l~=U---...J 














MEAN AND RANGE OF FIGLU EXCRETION IN 45 INFANTS. 
(a) Initial study. 
Figlu pg./ml. Figlu mg./24 hrs. 
Mean Range S.D. S.E. of Mean Mean Range S.D. S.E. of Mean 
+ + 7.6 + + 0.8 22.7 1.1- - 2e.5 - 4.3 0.5-27.2 - 5.6 -
181.5 
(b) Follow up study - after therapy. 
Mean Range S.D. S.E. of Mean Mean Range S.D. S.E. of Mean 
24.e 1.2- + 2e.5 + 4.3 6.9 0.4 ... 26.6 + 5.e + 0.9 - - - -
152.9 
142. 
Incidence of Positive Results(%) 
METHOD A. METHOD B 
(Prospective Study) 
2t - 4} months 46.8 2} - 5.0 months 
loi - 16 months 11.1 3} - 5i months 
The incidence of positive results might have been higher had 
13.3 
30 pg./ml. been used as the criterion of normality (Method A; Fig. 24). 
Also, the incidence of positive results might have been higher using 
method B had Figlu excretion been measured in concentration (pg./ml.) 
rather than in quantity (mg./24 hrs). In these circumstances in the age 
group 3t - 5i months the incidence would have increased from 13% to 29%-~ 
It would not have made any difference in the age group 2i - 5.0 months.~~ 
Mean Figlu Excretion after Oral Histidine (Fig.25, 26; Table 51). 
The mean Figlu excretion was highest in the youngest age group. In 
this age group mean Figlu excretion was highest in the infants of the 
prospective study and lowest in those where Figlu was estimated with 
method B. 
Mean Figlu Excretion (pg./ml.) 
METHOD A METHOD B 







(Combined Study 45.5 
Groups) 
(Age 2i - 5.0 months) 
22.7 
~Borderline and positive tests together gave an incidence of 29% (13 of 45). 
~~In this group the borderline positive results were so graded because of 
total Figlu output and not because of Figlu concentration. 
143. 
Mean Figlu Excretion (mg./24 hrs.) 
METHOD A 











(Age 2} - 5.0 months) 
The mean Figlu excretion declined with growth although this was 
not obvious when Figlu concentration was measured over a time period of 
three weeks using method B. 




2t - 4! months 48.8 
10} - 16 months 21.5 
METHOD B 
2l - 5.0 months 
3! - 5! months 
Mean Figlu Excretion (mg./24 hrs.) 
METHOD A 
(Prospective Study) 
2! - 4! months 14.7 
lo! - 16 months 5.9 
METHOD B 
2} - 5.0 months 
3! - 5! months 
Range of Figlu Excret ion (Fig.25, 26; Table 51). 
The range of Figlu excretion was at its maximum in the youngest 
infants and comparable in the various study groups when Figlu was measured 
in concentration (rg./ml.). 
growth. 
144. 
Range of Figlu Excretion(pg./ml.) 
METHOD A METHOD B 







2.3 - 175.0 
4.4 - 103.6 
(Age 2i - 5.0 months) 
1.1 - 181. 5 
Range of Figlu Excretion (mg./24 hrs.) 
METHOD A METHOD B 







2.6 - 25.8 
(Age 2i - 5.0 months 
0.5 - 27.2 
The range of Figlu excretion after oral histidine declined with 
Range of Figlu Excretion (f!g./ml.) 
METHOD A METHOD B 
(Prospective Study) 
2i - 4t months 2.3 - 175.0 2i - 5.0 months 1.1 - 181. 5 
lOi - 16 months 3.1 - 80.4 3t - 5i months 1.2 - 152.9 
TABLE 52. 
FIGLU EXCRETION AFTER ORAL HISTIDINE IN EUROPEAN AND AFRICAN INFANTS 
Infants aged 2i - 4i months 
Infants Classification 
Figlu Excretion Mean Figlu excretion 
µg./ml mg./24 hrs. pg./ml. mg./24 hrs. 
N.H . African 48.2 9.2 
G.T. II 26.5 14.3 
J ._Q. II 9.0 4.6 35.6 10.9 
O.M. II 33.6 15.5 
w .s. II 60.5 
A.H . European 47.4 15.2 
L.M . II 14.2 5.4 30.3 10.3 
Infants aged 4t - 7i months 
A.M. African 96.7 30.9 
L.O . II 52.0 14.4 69.5 19.9 
M.M. ti 52.9 14.4 
A.v .D. European 64.o 14.1 
M.H. II 15.8 6.3 39.9 10.2 
145. 
Range of Figlu Excretion after Oral Histidine (mg./24 hrs.) 
METHOD A METHOD B 
(Prospective Study) 
2t - 4! months 0.7 - 65.9 2i - 5.0 months 0.5 - 27.2 
lOi - 16 months 0.7 - 16.8 3t - 5i months 0.4 - 26.6 
Fi lu Tests after Oral Histidine in African and 
White Euro ean infants Table 52. 
The number of infants investigated was small. 
Incidence of Positive Results (%) 
African 
62.5% (5 of 8) 
White 
50% (2 of 4) 
Maximum Mean Figlu Excretion after Oral Histidine. 
W:g· /ml. 
African White 
69.5 (4! - 7! months) 39.9 (4! - 7} months) 
mg./24 hrs. 
African White 
19.9 (4! - 7! months) 10.3 (2t - 4! months) 
Pattern of Figlu excretion. 
Urine was successfully collected from 50 of the 57 infants of the 
prospective study who were examined 3 - 4 ~imes during the first 16 months 
of life. During this period the following patterns of Figlu excretion 
were observed: 
a) Positive Figlu tests were evident throughout the period of investigation 
( 2). 
b) Positive Figlu tests became negative at some stage during the investi-
gation (15). 
TABLE 53. 
THE NUMBERS OF INFANTS EXCRETING UROCANIC ACID 
AND OTHER IMIDAZOLES IN EXCESS 
Age 
(months) 
2t - 4t 
4t - 7t 
7t - lOf 








Whitehead, R.G. 1964. 
Number with positive results 
Urocanic acid Imidazoles 
1 (F.U.) 0 
0 1 
0 0 
1 (M.R.) 3 
INTERRELATIONS OF NUTRITION, IMIDAZOLE AND FIGLU EXCRETION 
Infant 
Weight Serum 
percentile Albumin Imidazole Figlu 
g.% pg./ml. 
s.v.s. Trace 74.1 
K.G. <3rd 3.4 II 8.1 2nd degree 
malnutrition 
J.G. 55th II 33.5 
N.v.W. 80th II 24.1 
TABLE 54. 
INTERRELATIONS OF 
NUTRITION, UROCANIC ACID EXCRETION AND FOLATE NUTRITION 
Initial study 
Infant 
Age Weight Serum Urocanic Figlu 
Serum Bone 
(mths) percentile albumin acid folate marrow 
g.% pg./ml. pg ./ml. ng./ml. examination 
<3rd No 
F . U. 2.8 2nd degree 3.1 496 57.2 2.0 megalo-
malnutrition blastosis 
<3rd Megalo-
M.R. 13.0 2nd degree 1254 9.1 0.9 blastosis 
malnutrition ( 1 ) 
Follow-up study 
<3rd No 
F.U. 5 .8 2nd degree 96.2 megalo-
malnutrition blastosis 
<3rd Megalo-
M. R. 14.8 3rd degree 3.2 8o .4 1.8 blastosis 
malnutrition ( 1 ) 
I 
TABLE 55. 
RELATIONSHIP OF UROCANIC ACID TO FIGLU EXCRETION WHERE 
TOTAL HISTIDINE DERIVATIVES EXCEED 30 µg./ml. 
Investigation Urocanic acid Figlu excretion Interpretation 
excretion pg./ml. p g./ml. 
1 10.9 22.0 Both degradation 
products contributed 
2 15.9 14.9 to excess of total 
histidine deriva-
tives 




4 153.0 6.3 Urocanic acid solely responsible for 
positive result 
5 o.o 39.0 
6 3.5 54.3 
7 6.4 40.1 
8 1.1 32.3 Figlu excretion 
9 5.4 33.9 solely responsible 
10 2.4 31.6 
11 4.9 37.1 
for positive 
12 4.9 70.4 results. 
13 1.1 50.4 
14 0.0 30.6 
15 3.4 69.7 
16 1.1 30.5 
17 4.1 152.9 
18 5.9 88.5 
19 2.2 65.1 
20 5.9 52.9 
21 8.1 181.5 
22 2.2 31.3 
23 0.0 42.0 
24 6.6 83.2 
-
146. 
c) Negative tests throughout (23). 
d) Fluctuations from negative to positive results (10 infants). These 
fluctuations could not be related to the effect of growth, infection, 
known dietary or technical factors . 
THE RELATIONSH[P OF DISTURBANCES OF HISTIDINE METABOLISM 
TO THE FIGLU TEST AFTER ORAL HISTIIIINE . 
The effect on the incidence of positive Figlu tests. 
1) Urocanic acid excretion . 
Method of Whitehead (1964). 
Urocanic acid excretion was excessive in 2af 213 instances 
(Table 53). In one of these, excessive excretion ~f urocanic acid was 
accompanied by excessive Figlu excretion (Table 54). The other positive 
test for urocanic acid was not associated with excessive Fig lu excretion. 
In this infant the Figlu test would have been judged ap :un.1'eliable para-
meter of folate deficiency if urocanic acid had not been estimated (Table 54). 
Thus, a disturbance of histidine metabolism at the level of urocanic acid 
could have accounted for only one false negative Figlu test. 
In addition to these results of the investigations in the prospective 
study, urocanic acid could not be detected in the urine of 8 African and 
4 White infants. 
Method of Chanarin and Bennett (1962a). 
Urocanic acid was separately estimated only in those instances where 
the excretion of total histidine derivatives exceeded 30 pg./ml. It was 
only in these ca~es that the Figlu test after oral histidine might have 
been positive (24 out of 91 tests) . In only one of these 24 tests was 
urocanic acid excretion solely responsible for t h e excess ©f histidine 
derivatives (Table 55). 
A disturbance of histidine metabolism resulting in excessive 
excretion of urocanic acid could have interfered with the interpretation 


















EFFECT OF RICKETS OH MEAN FIGLU EXCRETION 
INFANTS 2V4 to 41/zmonths 
rickets no rickets 
n :93 






Difference of mean~ 
t = 0·286 
0·70< P<O·BO 
Fig. 27 
INFANTS 41/ito 7112 months 
rickets 
n = 1 S 
Differen ce of means 
t = 0·041 
P> 0-90 
.· no rickets 
147 . 
Thus , even with a sensitive method of estimating urocanic acid 
excretion (Chanarin and Bennett , 1962a), a disturbance of histidine 
metabolism at the level of urocanio acid rarely resulted in a false 
negative Figlu test in the infants examined . 
2) Urinary imidazoles . 
Method of Whitehead (1964) . 
Four (4) infants excreted imidazoles which were not identified 
and in three oases this might have resulted in false negative Figlu 
tests (Table 53) . 
Even if this were so, this would not materially have influenced 
the incidence of positive Figlu tests . 
3) Rickets . 
From the following findings it was unlikely that the histidinuria 
sometimes found in rickets was severe enough to interfere with the efficacy 
of the histidine load and so result in false negative Figlu tests . 
Figlu Method A (Fig . 27) . 
There was no significant difference in mean Figlu excretion after 
oral histidine in infants with or without rickets . The mean Figlu 
e~oretion was slightly lower in infants with rickets . 
Thirteen (13) infants who suffered from rickets and who excreted 
normal quantities of Figlu were retested after receiving treatment with 
Ostelin Forte . Two (2) of these subsequently excreted excessive Figlu 
after oral histidine . 
Figlu Method B. 
All infants suffering from rickets excreted normal quantities of 
Figlu . After receiving Ostelin Forte only one of the eight excreted an 










MEAN FIGLU EXCRETION PRIOR TO ORAL HISTIDINE IN INFANTS 
RELATED TO THEIR RANGE OF FIGLU EXCRETION AFTER ORAL HISTIDINE 
0 to 29·9 
RANGE OF 
RANGE : 0·0- 8·7 
S.O: :!: 2·9 
S.E. of mean :.±0 9 
30 to 4 4·9 
FIGLU [.ug. ml.] AFTER 
O· 9 - 8 ·1 
~2 · 6 
±1 · 0 
F = 1 10 
P > 0 · 05 
Fig. 28 
n=5 
45 to 104 
OR AL H ISTI 01 NE 




Relationship of Disturbances of Histidine Metabolism 
to Undernutrition. 
1) Urocanic Acid Excretion and Nutrition. 
Method of Whitehead (1964). 
The data were insufficient and therefore inconclusive \Table 54). 
Hypoalbuminemia (2.9 - 3.2 g.%) was noted in 5 instances in this study 
(Table 7). This was associated with excessive urocanic acid excretion 
in only one instance (F.U.; Table 54). However, both infants who excreted 
excessive urocanic acid were undernourished. 
The test was repeated on the two infants who originally excreted 
excessive urocanic acid. Although the infants remained underweight, 
excessive urocanic acid excretion was no longer evident. It was not known 
whether the degree of hypoalbuminemia had improved during this time and 
whether there had been any relationship to hepatic dysfunction (Table 54). 
2) Imidazole excretion and nutrition (Table 53). 
Method of Whitehead (1964). 
The data were insufficient and no inferences could be drawn. 
THE FIGLU TEST AFTER ORAL HISTIDINE AS 
A PARAMETER OF FOLATE DEFICIENCY. 
Comparison with other parameters of folate deficiency. 
A relationship could not be demonstrated between Figlu excretion 
after oral histidine and: 
a) Figlu excretion without a histidine load. 
Method A (Fig. 28). 
There was no statistical relationship between Figlu excretion before 
and after histidine loading. None of the infants tested excreted an excess 




















M EA H FOL ATE LEVE LS RELATE O TO RANGE OF FIGLU EXCRE TIOH 
















<JO J0-4119 45-90 >IO 












RANGE : 2·9-24·0 
S.O: ± 5·3 





F = 2 · 82 






F IGLU [1Jg./mlJ 
Fig . 29 
lB-16·0 2-4-20·5 3-0-JD-B 1-9-29-8 
±H 1'4·7 t 7·8 t10·2 
±0·5 !1-2 ±M ±3-3 
F = 2· 63 
p >0-05 
IN FAN TS ,Ol/4 to 16 months 
n=5 
<JO 30-45 >45 
2·1-11-4 J.6-12·5 1·8-6·6 
'! z.g ±3·4 t2-6 
± 0·6 t 1 ·5 ± 1·5 
F = 1-64 
p >0·05 
TABLE 56. 








n • 23 
8.8 
n • 4 
4.9 







F • 3.94 
0.01 < P < 0.05 
The overall differences are statistically significant. The only 
statistically significant individual difference is that between 
infants with negative and borderline positive Figlu tests. There 
is therefore no relationship between Figlu excretion in excess 
and serum folate levels. 























RANGE : 8·1-84·6 
S.O.: ! 32 ·9 
















RANGE : 13-9-63·9 
S.O : ±21-8 





0·80 < P<0 ·90 
Fig . 30 . L-~--------------
IN FA NT S 41/2 to 71,"z months 






















0·20 <P <O ·JO 
149. 
b) Mean serum L. casei folate levels . 
Method A (Fig . 29) . 
There was no statistical relationship between mean serum L. casei 
folate levels and Figlu excretion . Mean serum L. casei folate levels were 
higher in infants with positive Figlu tests in all age groups , but infants 
from loi - 16 months . 
Method B (Table 56). 
A statistical relationship between mean serum L. casei folate levels 
and Figlu excretion after oral histidine was not demonstrated . Using the 
analysis of variance , overall differences between mean serum L. casei folate 
levels in infants with positive, borderline and negative tests were signi -
ficantly different . However , the significant individual difference did 
not lie between infants with positive Figlu tests and those with either 
borderline or negative tests , but between infants with negative and 
borderline positive Figlu tests . 
When the ' Student ' s ' t - test was used to compare the difference 
between the mean serum L. casei folate level in infants with positive Figlu 
tests (4 . 9 ng . /ml . ) and the mean serum L. casei folate level of the combined 
group of infants with negative and borde~line Figlu tests (5.6 ng . /ml . ) , 
no statistical difference could be shown (t = 0 . 522 ; o . 60 < P < 0 . 70) . 
c) Percentage hypersegmentation of the neutrophils . 
Method A (Fig . 30) . 
A statistical relationship could not be demonstrated between mean 
Figlu excretion after oral histidine and percentage hypersegmentation of 
the neutrophils . 
RELATIONSHIP OF ' MEAN RBC FOLATE LEVELS TO RANGE 
OF Fl GLU EXCRETION IN INFANTS 










<30 30-IJ.·9 4S - 80 
RANGE: 149-427 179-362 148-1250 
S,0: t84·8 t 76·6 t336·4 
S.E. of mean : ± 22·9 t 38·3 ± 112· 1 



















MEAN and RANGE of 

































LL SQ w 
(/) 
0 S 
F IGLU < 30 µg./ml. 
IS 30 
' FIGLU > 4SfJg/ml. 
IS 30 









0 S IS 30 
1.V. P.G.A . 
MEAN FOLIC ACID CLEARANCES 
200 
ISO 
' ' ' ' ' 100 ' ' 
' ' ' 
so 
0 5 
Fig . 3 2 
' ' ' ' ' ' 
-- FIGLU >4St.Jg/ml. 
- - -- - -FIG LU< 30f.Jg./m1. 
- ·-·- ·-FIGLU 30-4Sµg/m1. 
' \ ·,' ·,-:-.::.------. - -- -·-·-·- . -·-
IS 30 
TIME ·,n MINUTES 
MEAN and RANGE of 
FOLIC ACID CLEARANCES RELATED to RANGE of FIGLU EXCRETION 
L.CASEI 
PROCEDURE I 
FIGLU EXCRETION < 30 µg ./ml 
SUBJECT FIGLU,ngt.MH 3 MIN. 15 MIN. 30 MIN. 
R.K. 6.0 100 50 30 
W.A. 8.4 214 75 58 
D.A. 2.6 92 26 29 
N.S. 8.4 118 58 35 
MEAN 131 52 38 
s.o. ± 56.5 ± 20.5 ± 13.7 
S.E. of MEAN ± 28.3 ± 10.3 + 6.9 
FIGLU EXCRETION 30-45 pg./ml. 
SUBJECT FIGLUmgb4H 3 MIN, I 5 MIN. 30 MIN. 
D.G. 12.8 - so 37 
G. R. 19.9 83 43 20 
MEAN 83 46 28 
s.o. - ± 4A ± 11.8 
S.E. of MEAN - ± 3.1 ± 8.4 
FIGLU EXCRETION > 45 µg./ml. 
SUBJECT FIGLU~ 3 MIN. 15 MIN. 30 MIN. 
A.H.A. 17.6 211 160 95 
A. K. 19.6 115 52 41 
MEAN 163 106 68 
S. D. ± 67.9 :!: 7 6.4 ± 38.5 
S.E.of MEAN ± 48.5 ± 54.6 ± 27.5 
SIGNIFICANCE of DIFFERENCE of MEANS 
3 MIN. IS MIN. 30 MIN. 
F = 0.61 F = I. 67 F = 2.02 
P > 0.05 P > ·o.os P > 0.05 
150 . 
d) Red cell L. casei folate levels. 
Method A (Fig . 31) . 
There was no statistical relationship between excessive Figlu 
excretion after oral histidine and mean red cell L. casei folate levels . 
The mean red cell L.casei folate levels were highest in infants with 
excessive Figlu excretion . None of the infants studied had abnormally 
low red cell L. casei folate levels. 
Method B. 





102 - 632 
452 - 553 
63 - 542 
Mean 
251 
n = 5 
496 
n = 4 
272 
n = 25 
In this study 2 infants had abnormally low ( < 100 ng . /ml . ) red 
cell L.casei folate levels (63 and 67 ng . /ml . ) . Both excreted normal 
quantities of Figlu after oral histidine . 
e) L. casei folic acid clearance test . 
Method A (Fig . 32; Table 57) . 
The mean L. casei folic acid clearance test was slower in infants 
with positive Figlu tests after oral histidine. The difference in the 
rates of clearance of injected folic acid at 3, 15 and 30 minutes in 
infants with normal , borderline and positive Figlu excretion tests was 
not statistically significant . 
TABLE 58. 
RELATIONSHIP OF FIGLU EXCRETION TO BONE MARROW MORPHOLOGY 
Subject 





N. V . w. 
u.v .s . 
























pg./ml . mg . /24 hours 
8. o 
10 . 4 
13 . 5 
25 . 0 
28 . 6 
29 . 7 
32 . 5 
32 . 6 
34 .8 
35 . 0 
35 . 3 
35 . 8 
38 . 3 
40 . 8 
45 . 1 
53 . 5 
57 . 2 * 
57 . 4 
57 . 8 
58 . 8 
62 . 9 
64 . 9 
74 . 1 
77 . 7 
92 . 6 
128 . 8 
136 . 8 
170 . 4 
8o . 4 
1.8 
4 . 7 
4. 4 
10 . 4 
9 . 7 
12 . 6 
6 . 2 
15 . 5 
9 . 0 
6. o 
5 . 9 
15 . 8 
14 . 7 
16 . 1 
14 . 7 
9 . 1 
14 .3 
15 . 6 
11 . 2 
15 .1 
7 . 9 
11 . 3 
12 . 7 
40 . 7 
18 . 4 
36 . 3 
46 . o 
Bone marrow morphology 
No megaloblastosis 
Megaloblastosis 
Also excreted urocanic acid (Whitehead , R. G. : 1964) . 
151 . 
This conclusion would not have been altered if Figlu in ~g . /24 hrs 
rather than Figlu in pg./ml. was compared with the rate of folic acid 
clearance (Table 57; Fig . 32). 
Method B (Fig . 34; Table 67). 
The amount of injected folic acid in this group of infants might 
have been insufficient (cf. Chapter IV) . The L. casei folic acid clearance 
curve in the infant excreting excessive Figlu after oral histidine (R . A. ) 
fell within the range found in infants excreting normal amounts of Figlu 
after oral histidine except at the 30 minute level. Here the value in R. A. 
was slightly lower than that found in infants with normal Figlu excretion . 
f) Bone marrow morphology . 
Method A (Table 58) . 
Bone marrow examinations were performed on 28 infants , one of whom, 
M. R. , had a repeat examination at the age of 13 months . At this stage the 
marrow showed unequivocal evidence of megaloblastosis and Figlu excretion 
was 80 . 4 fg . /ml . S . B. was the only infant of a comparable age group who 
excreted Figlu in excess (57 . 8 fg . /ml . ) and on whom a bone marrow examination 
was performed . No megalobla stosis was noted . Other infants in this age 
group excreted up to 74 . 2 fg . /ml . of Figlu without other evidence of folate 
deficiency,but bone marrow examinations were not performed on these infants . 
All other infants with positive Figlu tests after oral histidine, 
on whom bone marrow examinations were performed, were less than 7i months 
of age . Positive Figlu tests of up to 170. 4 pg . /ml . and 46 . 0 mg . /24 hrs 
were not associated with megaloblastosis . 
From these findings it was deduced that infants up to 7f months of 
age could have excessive Figlu excretion after oral histidine without 
TABLE 59 
THE RELATIONSHIP OF MATERNAL TO INFANT FOLATE NUTRITION 
(a) The relationship of maternal serum folate levels to mean Figlu 
excretion in infants 
Age Maternal Mean Test 
(months) folate levels Figlu excretion of Significance in infants 
pg./ml. significance 
2t - 4-i Normal 50.3 
n = 45 t = 0.634 
Low 45.1 'STUDENT'S' t-Test 
n = 30 0.,.-50 <P ~0.60 
4i - 7t Normal 54.6 
n = 36 t = 2.735 
II 
Low 31.9 0.001 <P<-0.01 
n = 27 
7t - 10-l- Normal 30.0 




o.40 <P ;c:0.50 n = 12 
lOf - 16 Normal 24.4 
n = 21 t = 1.813 
II 
Low 13.7 0. 05 < P "*O .10 n = 13 
n = Number 
Conclusion: 
Mean Figlu excretion is always higher in the infants of mothers with 
normal serum folate levels. 
The differences become statistically significant at the 4i - 7t months 
age group. It is unlikely that this result has any meaning. 
' T1U3LR 59 (Contd.) 
(b) The relationship of maternal Figlu excretion to mean Figlu 




Figlu excretion of Significance 
(months) in infants significance Excretion µg./ml. 
2-; - 4t Excessive 44.9 




n = 73 
Conclusion: 
There is no statistical relationship between these two parameters. 
(c) The relationship of hypersegmentation of maternal neutrophils 














n = 5 
49 .6 






t = o.401 
o.60<P<o.70 
There is no statistical relationship between these two parameters. 
In studies (b) and (c) the numbers involved did not permit study 
beyond the age group of 2i - 4t months. 
It is unlikely that Maternal Folate nutrition can influence that 
of the infant beyond 4t months of age, because, from Herbert's 
(196~a~ experiment, it appeared that folate stores were only 
sufficient for approximately 4! months (cf. Chapter I, page 36). 
TABLE 59 (Contd.) 
(d) Relationship of cord serum folate levels to infant Figlu excretion 
Age of infants Statistical method Significance 
(months) 
2i - 4t Correlation coefficient r = -0.027 r does not differ 
n = 60 significantly from 
zero 
4t - 7t II II r = +0.038 P > 0.10 
n = 53 
7t - lOi II II -0.383 
r is significantly 
r = different from zero 
n = 28 o .. oz < P < 0.05 
10-a- - 16 II II r = +0.465 
n = 29 0.01 < P < 0.02 
Conclusion: 
Although the correlation coefficient is greater than zero in 
the older infants, it is unlikely that this result has any 
meaning because -
(i) the correlation at best is a very poor one; and 











2-t; - 4t <30 






n = 10 
21.2 
n = 3 
20.7 








F = 0.13 
P > 0.05 
Conclusion: There is no statistical relationship between these two 
parameters. 
(b) Pattern of milk feeding in relation to mean Figlu excretion 
Age Nature of milk 
Mean Test 
Figlu excretion of Significance 
(months) feeding fg./ml. significance 
2-z; - 4t Breast 40.9 
n = 23 
Breast supplemented 41.0 
with bottle n = 9 Analysis 
Breast and 42.2 
F = 1.66 
bottle n = 56 
of 
P > 0.05 
Bottle supplemented 56.7 variance 
with breast n = 11 
Bottle 65.7 
n = 11 
4t - 7t Breast 53.8 
n = 5 
Breast and 43.9 
F = 0.24 
bottle 
II 
n = 32 P > 0.05 
Bottle 42.7 
n = 58 
Conclusion: There is no consistent relationship between mean Figlu 
excretion and the nature of milk feeds. None of the 
differences are statistically significant. 
*When both breast and bottle milk folate were compared with Figlu excretion 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































evidence of megaloblastosis . Information in the older age group was 
insufficient for definitive conclusions . 
An Aetiology for Foiate Deficiency and its Relationship 
to Posi tiv·e Figlu Tests after Oral Histidine . 
There was no relationship between Figlu excretion after oral 
histidine and : 
a) Maternal folate nutrition . 
Method A (Table 59) . 
There was no unequivocal relationship between mean Figlu excretion 
in the infants and maternal folate deficiency as assessed by serum L. casei 
folate levels , excessive Figlu excretion , hypersegmentation of the neutro -
phils. There was no convincing correlation between infant Figlu excretion 
and cord serum L. casei folate levels . 
b) Dietary fac tors . 
(i) Milk feeding . 
Method A (Table 60). 
Method B (Table 61) . 
This was assessed only in the youngest infants where milk was the 
exclusive or major dietary constituent . There was no statistical relation-
ship between mean milk L. casei folate levels and excessive Figlu excretion . 
(ii) Nature of milk feeding . 
Method A (Table 60) . 
There was no demonstrable statistical relationship between 
mean Figlu excretion and the nature of the milk feeding . 
(iii) Other dietary factors . 
Method A. 
The reduction of Figlu excretion with growth could not be 
attributed to the addition of cereal , mixed feeding , orange juice , vitamins , 
meat or cod-liver oil to the diet of the infants . 
TABLE 62 
RELATIONSHIP OF SOCIO-ECONOMIC CIRCUMSTANCES TO MEAN FIGLU EXCRETION 
Age 
(months) 
2i - 4i 
4i - 7i 
7i - 10-l-





















n = 3 
29.6 
n = 14 
33.2 
n = 10 
110.4 
n = 3 
38.0 
n = 14 
33.6 
n = 8 
44.8 
n = 3 
21.2 
n = 8 
37.5 
n = 5 
37.9 
n = 3 
17.3 
n = 12 
14.7 











F = 0.93 
P > 0.05 
F = 10.39 
P < 0.01 
F = 6.50 
P < 0.05 
F = 1.60 
P > 0.05 
Mean Figlu excretion is consistently higher in infants from poor s~cio-
economic circumstances. The overall differences are significant at 
4f - 7i and 7i - 10-l- months. 
In the analysis of the individual differences in the two groups, mean 
Figlu excretion in infants from poor socio-economic circumstances is 
significantly different from that in infants from average and good 
socio-economic circumstances in the age group 41 - 7i months. This 
consistent relationship is not demonstrated in infants from 7i - lOf 
months of age where the difference in result between infants from poor 
and average socio-economic circumstances is statistically significant, 
but not that between infants from poor and good socio-economic 
circumstances. 
It may be that there is an association between socio-economic circumstance
s 
and Figlu excretion, but it would need further investigation, involving 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RELATIONSHIP of FOLIC ACID ABS~PTION TO 


































FIGLU < 30 fJg./ml. 
FIGLU > 45 t,Jg./ml. 
















MEAN ABSORPTION of FOLIC ACIC 
RELATED to FIGLU EXCRETION 
-- FIGLU > 45µg./ml. 
------ FIGLU < 30µg./ml. 
2 














































































































































































































































































































































































































































































































































































































































































































































































































c) Socio-economic circumstances. 
Method A (Table 62). 
A statistical relationship could not be proved between mean Figlu 
excretion after oral histidine and socio-economic circumstances. 
d) Nutrition. 
Method A (Table 63). 
A relationship between mean Figlu excretion and nutrition could not 
be proved. 
e) Intestinal absorption. 
(i) Folio acid absorption. 
Method A (Fig. 33; Table 64). 
Folio acid absorption was not significantly different in infants 
wit~ positive Figlu tests. The mean rise in folate from the basal level 
to the first and to the second hour was slightly lower in infants with 
positive Figlu tests. 
(ii) Xylose absorption. 
Method A. 
These tests were performed on 21 infants on whom Figlu tests were 
successfully performed. 
9 infants excreted Figlu in excess of 45 /lg./ml. 
2 infants excreted Figlu in the range 30 - 45 fg./ml. 
10 infants excreted Figlu in amounts less than 30 pg./ml. 
Only .one infant with a positive Riglu test after oral histidine had 
abnormal xylose excretion (6%) which returned to normal (25.3%) after success-
ful treatment of the associated gastroenteritis. The Figlu test after oral 
histidine was still positive 3 months later. Three infants with negative 
Figlu tests and without evidence of folate deficiency had abnormally low 
xylose excretion. In one of these the urine output was unsatisfactory. 
TABLE 65 
THE RELKTIONSHIP OF FIGLU EXCRE1UQN~ TO INCREASED DEMAND FOR FOLATE 
(a) Increased erythropoiesis as judged by reticulocyte count(%) 
Age 
(months) 
2t - 7f 
Range of Figlu 
excretion 
;ug . /ml.. 
< 30 
30 - 45 
> 45 
Conclusion: 
Range of reticulocyte 
count 
0~ 1 4 . 1 
o . 6 - 2. 8 
0. 7 - 2. 6 
n = 23 
n = 6 






Infants who excrete excessive amounts of Figlu do not have increased 
erythropoiesis as judged by mean and range of reticulocyte counts . 
TABLE 65 (Contd.) 
(b) The effect of infection as judged by the number and severity 
of infections (Infection score) 
Mean Test 
Age Ilnfection Figlu excretion of Signific~nce 
(months)' score p g./ml. significance 
2t - 4t 0 42.6 n = 27 
i - 2 46.2 n = 69 Analysis of F = 0.18 
2i 4t 40.7 n =- 14 variance P :> 0.05 5 &>- 57 . 2 n = 1 
4t - 71 0 38.4 n = 15 ?. 
t 2 44.2 n = 54 II F = 0.11 
2i 4t 42.9 n = 20 p > 0.05 5&> 44.o n = 3 
7i - 101 0 15.0 n = 4 
t - 2 33.9 n = 19 II F = 1.18 
2t - 4t 19.6 n = 7 p .> 0.05 5 & :> 17.0 n = 1 
1~- 16 0 21 .o n = 3 1 2 26.1 n = 9 II F = 4.02 ~ -
2t 4t 32.3 n = 5 P< 0.05 5 & > 71 .3 n = 2 
Conclusion: 
There is no consistent effect of infection score on mean Figlu excretion 
except in the age group 10 i- 16 months. Here Figlu excretion is 
significantly higher in the group with an infection score of 5 and > 
than in all other groups. This analysis was complicated by the fact 
that M.R. one of the 2 infants in the 5 and::,.group had low Figlu and 
excessive urocanic acid excretion on one occasion and on another had 
high Figlu excretion without excessive urocanic acid excretion, when 
the test was repeated while she was still in t h is a ge group . If 
infection score is comp ared with the second of these results the above 
statistically significant result is obtained. If it is compared with 
the first result there is no statistical relationship between infection 
score and Figlu exc:rretion. For this reason and because the pattern is 
not consistent in the other a ge groups a relationship between infection 
















































































































































































































































































































































































































































































































































































































































































A relationship between Figlu excretion after oral histidine and 
malabsorption using the parameters in this study was not demonstrated. 
f) Increased demand for folate. 
(i) Increased erythropoiesis. 
Method A (Table 65). 
The range and mean reticulocyte counts were unrelated to Figlu 
excretion after oral histidine. 
Occult blood tests were performed on 20 infants. None of the 
infants with positive Figlu tests had positive occult blood tests. 
(ii) Infection score. 
Method A (Table 65). 
Method B (Table 61). 
A statistical relationship between mean Figlu excretion after oral 
histidine and infection score could not be proved. 
(iii) Growth. 
Method A (Table 63). 
Method B (Table 61). 
There was no relationship between rapid growth and excessive Figlu 
excretion. On the contrary, mean Figlu excretion appeared higher in 
poorly nourished infants. 
The Effect of Small Doses of Folio Acid on Figlu Excretion. 
Method A. (Table 66). 
Small doses of folio acid were administered (approximately 
50 - 300 p g. daily) to 4 infants who had not shown significant reduction 
of Figlu excretion after intramuscular iron therapy. There was a marked 
reduction in mean Figlu excretion after oral histidine, but the decrease 
in both concentration ( p g./ml.) and quantity (mg./24 hrs.) was not 




























FOLIC ACID CLEARANCES RELATED to FIGLU EXCRETION 
L.CASEI and S .FAECAL! S 
-- L.CASEI 
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FOLIC ACID CLEARANCES RELATED to FIGLU EXCRETION 
L .CASEI and s. FAECALIS 
PROCEDURE I 
INFANT with EXCESSIVE FIGLU EXCRETION >45 pg./ml. 
ASSAY FIGLU Sc.FOLATE LEVELS ng./ml. 
SUBJECT 
JJ g./ml. mgJ24 Hrs. BASAL 3 MIN. 15 MIN. 30MIN. 
4 . 8 115 52 41 
A.K 70.1 19. 6 
68 20 10 
INFANT with NORMAL FIGLU EXCRETION 
ASSAY FIGLU Sc. FOLA TE LE VE LS ng./ml. 
SUBJECT RGANISM JJ9.lmt. g/24Hr~. BASAL 3 MIN. IS MIN. 30 MIN. 
7.6 I 18 S 8 35 
N.S. 14.0 8.4 
123 I 8 
PROCEDURE I[ 
INFANT with EXCESSIVE FIGLU EXCRETION > 4SJJg/ml. 
ASSAY FIGLU Sc. FOLATE LEVELS ng./ ml. 
SUBJECT 
ISM µg./ ml. mg/24 Hrs. BASAL 3 MIN. IS MIN. 30MIN. 
9.6 85 34 16 
A.A . 51.2 21.0 
42 6 0 
FOLIC ACID CLEARANCES in INFANTS with NORMAL FIGLU E>CRETION 
ASSAY FIGLU S~.FOLATE LEVELS ng./ ml. 
SUBJECT 
ORGANISM JJ9,/ ml. mg(;MHrs. BASAL 3 MIN. IS MIN. 3QMIN. 
L .CASEI 6.4 65 32 19 
F.F. 27. 2 7. 3 
IS.FAECAL!~ - 57 14 3 
L.CASEI 9.6 118 59 35 
N.d~ J . 24 .0 7.4 
S.FAECALIS - 97 32 14 
L .CASEI 2.4 98 40 22 
N.O I 6. 2 12 .8 
S.FAECALIS - 64 13 -
MEAN 
l.CASEI 94 44 25 
S.FAECALIS 73 20 9 
TABLE 67 
155 . 
All individual infants showed reduced Figlu excretion when this 
was expressed in quantity (mg . /24 hrs) and three of the four infants 
showed reduction when Figlu excretion was expressed as concentration 
(rg . /ml . ) . 
THE FIGLU TEST AFTER ORAL HISTIDINE AS A PARAMETER 
OF SECONDARY DISTURBANCE OF FOLATE METABOLISM . 
Folic acid clearance test . 
Procedure 1 . 
Method A (Fig . 34; Table 67) . 
L. casei folic acid clearance curves were similar irrespective of 
the amount of Figlu excreted . 
The S. faecalis folic acid clearance curve was faster in the infant 
with a positive Figlu test (A . K. ) . The S. faecalis clearance curves in 
A. K. and N. S. fell within the lower l imit of the reported normal adult 
range (Chanarin, Mollin and Anderson, 1958a) with the exception of the 
5 minute and possibly the 15 minute level in A. K. 
Both infants were iron deficient but A. K. 1 s serum iron level was 
lower (Table 35) . 
Procedure 2 . 
Method B (Fi g . 34 ; Table 67) . 
L. casei folic acid clearance curves were comparable in infants with 
positive and negative Figlu tests excepting at the 30 minute level . Here 
the curve in t h e infant with the positive Figlu test (R . A. ) was slightly 
faster than those with normal Figlu tests. 
The S. faecalis folic acid clearance curve was faster in R. A. than 
in the other infants at all levels but particularly at the 3 minute level . 
TABLE 68 
RELATIONSHIP OF 
FIGLU EXCRETION TO METABOLIC DISTURBANCES OF FOLATE METABOLISM 
Age of infant 
(months) 
4i - 7i 
7i - 10-l-
10-! - 16 
* 
Relationship to vitamin B12 deficiency 
Range of vitamin B12 
pg./ml. 
118*;178 - 1236+ 
n = 107 
133*;146 - 1037+ 
n = 84 
165 - 993 
n = 35 
180 - 1936+ 
n = 34 
Mean S.D. 
+ 211.0 
482.8 ± 212.7 
571.4 ± 212.2 
+ 323.8 






There were two low readings in the whole series, one of which was 
found in an infant excreting >45 p.g./ml. of Figlu. 
+some of these infants with high readings received vitamin B12• 
This could not be established in all. 
156. 
The slightly faster clearance of folic acid using S.faecalis at 
all levels and especially at the 3 minute level was a consistent finding 
in 2 infants with positive Figlu tests . 
The folic acid clearance test is associated with a high degree of 
variation in normal values . The number of infants investigated was small 
and it was therefore not known whether the observation had any meaning , 
and if so , what relationship there was to associated iron deficiency . 
An unequivocal relationship between excessive Figlu excretion and 
the rate of folic acid clearance using S. faecalis as the assay organism 
was not demonstrated . It was unfortunate that it was not possible to 
carry out these tests on a greater number of infants and especially on 
infants who had both high Figlu excretion and high serum L. casei folate 
levels . 
An Aetiology for Disturbed Folate Metabolism and its Relationship 
to Positive Figlu Tests after Oral Histidine . 
a) Vitamin B12 deficiency . 
Method A (Table 68) . 
In this study only 2 infants were found to have a low vitamin B
12 
level . One excreted Figlu in excess of 45 pg . /ml . and had a serum 
vitamin B12 level of 118 pg . /ml. The other infant excreted normal quan-
tities of Figlu and had a serum vitamin B12 level of 133 pg . /ml . 
Four (4) infants in the prospective study and 3 in the additional 
study did not have vitamin B12 estimations at any stage . There was no 




No vitamin B12 deficiency was encountered in this group . 
RELATIONSHIP OF MEAH SERUM IRON LEVELS TO RAHGE OF FIGLU 
EXCRETION IN IHFANTS 
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UJ 20 ::I: 
0 
<JO J0-4S >45 <JO 30--1.5 >45 
F = 0·32 FIGLU [.ug/mlJ F = 0 · 19 
P > o. 05 P>0 ·05 
Fig. 35. 
TABLE 73 
THE EFFECT OF THERAPY ON FIGLU EXCRETION. 
INDIVIDUAL RESULTS. 
(a) Folio acid and iron therapy. 
Infant Figlu excretion ~g./ml. Figlu excretion mg./24 hrs. 
Before treatment After treatment Before treatment After treatment 
A.G. 37.1 70.4 12.2 13.7 
D.E. 69.7 30.5 12.5 7.3 
D.R. 65.1 16.7 16.3 6.8 
ll. J. 181.5 9.3 27.2 2.8 
Conclusion: Figlu excretion decreased in three out of four infants. 
(b) Iron therapy. 
Infant Figlu excretion fg./ml. Figlu excretion mg./24 hrs. 
Before treatment After treatment Before treatment After treatment 
P.L. 32 -3 33.9 13.6 15.3 
M.S. 31.3 12.9 10.6 9.2 
B.H. 52.9 16.0 22.2 7.0 
E.B. :x 42.0 83.2 21.0 23.3 
A.F. 17.4 39.0 5.6 11.7 
A.G. 19.6 152.9 7.2 22.9 
B.R. 4.4 88.5 1.5 26.6 
Conclusion: Figlu excretion improved in two out of seven infants. 
x Only infant where therapy was irregular. 
TABLE 74 
THE EFFECT OF THERAPY ON OTHER PARAMETERS. 
(a) Folio acid and iron. 








n = 3 
33 
n = 3 
18 











g./ml. n = 4 n • 4 
erum. iron 52.1 5a.1 
~g./lOOml. n = 2 n • 2 
Conclusion: Apart from a rise in mean serum folate level therapy did not 
produce any improvement on the parameters. 












Mean value before treatment 
10.5 
n = 4 
34 
n = 5 
67 
n = 7 
5.9 
n = 3 
61.0 
n = 2 
Mean value after treatment 
10.2 
n = 4 
33 
n = 5 
67 
n = 7 
5.2 
n = 3 
44.0 
n = 2 
Conclusion: Therapy had no beneficial effect on any of these parameters. 
159. 
Figlu excretion returned to normal in these cases and also iin 2 of the 
4 Kfrican infants given standard doses of folic acid . These data were 
used to assess the therapeutic effect of folic acid on other parameters 
but were imh~lpful. in determining the effect of folic acid on Figlu 
excretion. 
(ii) Infants less than 6 months. 
Method B (Fig . 37 ;. Table 73) . 
Felic acid and iron therapy . 
The administration of folic acid and iron to 4 infants with positive 
Figlu tests after oral histidine led to a marked decrease in the mean 
Figlu excretion in ,,ug . /ml . and mg . /24 hrs . This was not related to a 
change in mean 24 hour urine volume . The improvement was not statistically 
significant probably because only 3 of the 4 infants showed reduction in 
Figlu excretion . 
Iron Therapy .. 
Oral iron was administered to 7 infants with positive Figlu tests 
after oral histidine . These infants showed an increase in mean Figlu 
excretion (,,ug . /ml. and mg/24 hrs.) which was not related to a change in 
mean 24 hour urine volume . The increase in mean Figlu excretion was not 
statistically significant probably because Figlu excretion in individual 
infants either increased or de.creased after this therapeutic programme . 
Because oral iron appeared relatively ineffective as assessed by 
serum iron levels (Tables 74; 69), it was unlikely that in both groups 
of infants a coincidental increased demand for folate resulting from the 
TABLE 75 
* RELATIONSHIP OF CREATININE RATIO TO AGE 
Mean age Mean creatinine Test of Significanc,e (months) ratio, significance 
4.2 4-5.9 
n = 26 'STUDENT'S' t = 2 .. 162. 
4 •. 9 61..9 t-Test 
n = 26 0.02 <:e <0 •. 05 
* Actual creatinine mgs./24 hrs. X:.100. 
Expected creatinine/Kg./body weight 
Conclusion:. The increase in mean age was associated with a significant 
improvement in mean creatinine ratio. 





Mean Mean creatinine 
percentila ratio 
53 45 •. 9 
n = 26 n =- 26 
56 61-.9 






t =- 0 •. 353 
o. 70 <:e <0.80 
Conclusion~ The mean percentile in the group studied was, greater than 
the 50th percentil.e on bo,th occasions.. The minimal 
impro.vement in mean percentile value with age was not 
statistic.ally significant. It di·d not therefore contribute 
to the statistically significant improvement in c.re.atinine 
ratio previcmsl.y shown over this time period. 
160 . 
iron therapy given to iron deficient infants had any effect on the Figlu 
excretion . Mothers reported that infants showed a great reluctance to take 
the oral iron (Ferlucon) though they took the folic acid well . It seemed 
likely that ineffective administration of the iron played a role in the 
apparent inefficacy of iron therapy . There was no evidence that folic 
acid was not administered and mean serum L. casei folate levels showed a 
substantial rise (Table 74). 
Although the effect of the 2 therapeutic programmes on mean Figlu 
excretion was very different, neither the reduction of mean Figlu excretion 
after folic acid (pharmacological doses) and oral iron, nor the increase 
in mean Figlu excretion after oral iron was statistically significant . 
This difference in therapeutic effect might have become more or less 
obvious had greater numbers of infants been investigated . However , it 
was clear from this that the positive Figlu tests after oral histidine 
could not be attributed to folate deficiency but could possibly still be 
ascribed to a secondary disturbance of folate metabolism . 
THE FIGLU TEST AFTER ORAL HISTIDINE 
AND NON-SPECIFIC FACTORS . 
a) Incomplete urine collection . 
(i) Creatinine ratio . 
Method B (Table 75) . 
The mean creatinine ratio showed a significant increase parallel 
with growth . This was unrelated to the minimal associated nutritional 
improvement which occurred at the same time . 
(ii) Creatinine ratio as ah index of "completeness" of urine collection . 
(1) Relationship to 24 hour urine volumes . 
TABLE 76. 














n = 17 
353 
n = 9 
340 
n = 9 
334 
n = 17 
Test of 
significance 




t = 1.575 
0.10 < P < 0.20 
t = 0.081 
P > 0.90 
The lower creatinine ratios are associated with higher 
mean volumes. 
The differences are not statistically significant. 
TABLE 77. 
RELATIONSHIP OF CREATININE RATIO TO FIGLU EXCRETION 
Mean age Figlu 
Mean Test 
creatinine of Significance 
(months) excretion ratio significance 
4.2 Negative 40.7 Analysis of F = 3.22 
n = 16 variance 
Borderline 67.5 'STUDENT 'S' P > 0.05 
n = 1 t-Test 
Positive 56.3 ( Negative t = 2.197 
n = 8 compared with 0.02 < P < 0.05 positive group) 
4.9 Negative 58.4 Analysis of F = 0.28 
n = 15 variance 
Borderline 61.5 'STUDENT 'S' P >, 0.05 
n = 5 t-Test 
Positive 70.8 (Negative t = 0.725 
n = 6 compared with o.4o < P < 0.50 positive group) 
Conclusion: 
The mean creatinine ratio is consistently higher in infants with 
borderline and positive Figlu tests. The overall differences are 
not significant. 
In the age group 4.2 months, the maldistribution of numbers might 
have influenced the statistical result. Thus the mean creatinine 
ratios in the positive and negative Figlu groups were compared 
using the 'STUDENT 'S' t-Test. 
At 4.2 months, the · mean creatinine ratio was significantly higher 
in infants excreting Figlu in excess than in those excreting 
normal quantities. At 4.9 months, the mean creatinine ratio in 
infants with positive ·Figlu tests was not significantly higher 
than in infants with normal tests. 
TABLE 78 
NON-SPECIFIC FACTORS POSSIBLY INFLUENCING FIGLU EXCRETION 
Correlation of Figlu excretion with 24-hour urine volumes 
Age of infants 
(months) 
2t; - 4t 
4t - 7i 
7i - 10-l-
10-l- - 16 
Conclusion: 
Statistical method 
Correlation coefficient r 
" " r 
II II r 
" " r 
Result 
= -.146 
n = 104* 
= -.314 
n = 92 
= -.348 
n = 35 
= -.333 
n = 35 
Significance 
r does not differ 
from zero. 
P > 0.10 
r differs from 
zero. 
0.02 < P < 0.05 
r does not differ 
from zero. 
0.05 < P < 0.10 
r does not differ 
from zero 
0.05 <> P < 0.10 
The correlation coefficient only differs from zero at the age group 
4i - 7i months. At best this is a very weak correlation and on the 
basis of the statistical result alone is unlikely to have much mean-
ing. There is no correlation between these two parameters in any of 
the other age groups. 
* The infant who excreted both urocanic acid and Figlu in excess was 
not included in this analysis. 
161 . 
Meth od B (Ta~le 7~). 
There was no statistical relationship between creatinine ratio and 
mean 24 hour urine volume . Lower mean 24 hour urine volumes were associated 
with higher creatinine ratios . Thus , the volume of the 24 hour urine 
collection was not necessarily a reflection of "completeness'' of urine 
collection. Small urine volumes were probably the result of urine concen-
tration rather than incomplete urine collection . 
(2) Relationship to Figlu excretion. 
Method B (Table 77) . 
The mean creatinine ratio was consistently higher in infants with 
positive or borderline positive Figlu tests after oral histidine . In 
using the analysis of variance no statistical relationship between Figlu 
excretion and mean creatinine ratio was evident . However, using the 
1 Student 1 s 1 t - test it was possible to show that at 4.2 months mean creati-
nine ratio was significantly higher in infants with positive Figlu tests 
than in infants with negative Figlu tests . The infants with borderline 
Figlu excretion were not considered in this statistical analysis . 
Although mean creatinine ratio remained higher in infants with positive 
Figlu tests at 4.9 months, this was not a statistically significant 
relationship . 
The higher creatinine ratio found in infants with positive Figlu 
tests implied that urine collection was either as , or more complete than 
that of infants with negative Figlu tests . Thus , positive Figlu tests 
could not be ascribed to incomplete collection of urine . 
b) Urine concentration and the results of the Figlu tests 
after oral histidine . 
Method A (Table 78) . 
A statistical relationship between Figlu excretion and 24 hour 
urine volume could not be proved . 
THE EFFECT OF 
URINE CONCENTRATION ON THE VALIDITY OF FIGLU RESULTS 
.ug./ ml. & mg./ 24 hrs. IN THE COMBINED THERAPEUTIC GROUPS. 
. EFFECT NO EFFECT 
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THE EFFECT OF 
URINE CONCENTRATION ON THE VALIDITY OF FIGLU RESULTS 
[µg./ml. & mg.I 24 hrs.] 
IRON THERAPY IRON & FOLIC ACIO THERAPY 
1,0001---------~--------~ 
n: 
-E 500 ....... n=J 
250 
370 625 0 '-----L-.....L.--Llo.~.1....-..---1---'---J....-~~I--....J 
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~"@ 3 weeks after treatment . 
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162 . 
Method B (Fig . 38; Fig . 39) . 
In the controlled therapeutic trial , the Figlu test was repeated 
3 weeks after the administration of folic acid and oral iron . Large 
differences in 24 hour urine output on the two occasions were noted in 
some infants . The effect of urine volume on Figlu excretion was assessed 
in these infants in spite of the therapy administered in the int er i m, 
because it had been previously shown that this did not have any significant 
effect on Figlu excretion . 
In one group of infants (5) a significant decrease in urine volume 
resulted in an increase in mean Figlu excretion expressed in concentration 
(fg . /ml . ) while total output of Figlu (mg . /24 hrs . ) was little changed 
(Fig . 38 - "effect" column) . Because quantity of Figlu output was 
unaltered, the rise in Figlu concentration ( f g . /ml . ) was almost certainly 
spurious and the result of urine concentration. This pattern was similar 
in the 5 infants whether it was analysed according to therapy administered 
(Fig . 39) or not (Fig . 38 - "effect" column) . The increase in Figlu 
excretion in fg . /ml . under these circumstances was statistically significant 
in the combined therapeutic group and also in the group of infants given 
only iron . The failure to demonstrate a statistically significant rise 
in Figlu excretion in the infants given folic acid and iron , might have 
been related to the smaller number of infants investigated in this group . 
In another group of infants , 4 of whom received folic acid and iron , 
and 2 of whom were given only iron (Fig . 38 - "no effect" column) a signi -
ficant decrease in urine volume was associated with a decrease in Figlu 
excretion in fg . /ml . and mg . /24 hours . This was not statistically 
significant . 
TABLK 79 
THE SIGNIFICANCE OF EXCESSIVE EXCRETION OF FIGLU 
(a) Relationship to haemoglobin levels 
Age 
(months) 
Range of Figlu 
excretion 
_µg./ml. 
2t; - 4i < 30 
30 - 44 . 9 
45 - 80 
> 80 
4i - 7i < 30 
30 - 44.9 
45 - 80 
>80 
7i - lOi- < 30 
30 - 45 
>45 
lOi - 16 < 30 
30 - 45 
> 45 
Mean haemoglobin 
g . /100 ml . 





10 . 6 
10 . 6 
10.6 
10 . 6 
10 . 2 
10 . 1 
9. 9 
10 . 3 
10 . 1 
n = 39 
n = 18 
n = 33 
n = 11 
n = !f,o 
n = 17 
n = 15 
n = 10 
n = 18 
n = 4 
n = 3 
n = 23 
n = 4 











F = 0 . 33 
P > 0.05 
F = 0 . 01 
P > 0.05 
F = 0 . 20 
P > 0 . 05 
F = 0 . 17 
P >0 . 05 
Conclusion : There is no relationship between these two parameters. 
(b) Relationship to growth (weight percentile) 
Age 
(months) 
Range of Figlu 
excretion 
pg . /ml. 
2t; - 4i < 30 
30 - 44 . 9 
45 - 80 
>80 
4i - 7i < 30 
30 - 44 . 9 
45 - 80 
>80 
7t - 10-a- <30 
30 - 45 
>45 
lOf - 16 <30 


















n = 44 
n = 22 
n = 37 
n = 11 
n = 47 
n = 18 
n = 19 
n = 13 
n = 25 
.n = 5 
n = 5 
n = 26 
n = 6 










F = 3 . 32 
0 . 01 < P < 0 . 05 
F = 0 . 19 
P > 0 . 05 
F = 0 . 25 
P > 0 . 05 
F = 3. 31 
P < 0 . 05 
Conclusion: Growth is not consistently retarded in infants excreting 
Figlu in excess , although this is the case in infants in the age group 
2f - 4i and lOf - 16 months. It is unlikely that the result has any 
meaning because (i) of the lack of consistency in this association , and 
(ii) the analysis of individual differences shows that the results of 
Group 4 (>80) differ significantly from all other groups at age 
2t - 4t months but at lOf - 16 months the result of Group 3 ( > 45) is 
only significantly lower than Group 2 (30 - 45) . 
TABLE 79 (Contd.) 
(c) Relationship to infection score 
Ragge of Figlu Test 
Age excretion Mean of Significance 
(months) pg./ml. Infection score significance 
2t - 4} <30 1.3 n = 44 Analysis F = 0.00 30 - 44.9 1.2 n = 22 of 45 - 80 1.3 n = 37 variance p > .80 1.3 n = 10 >0.05 
4} - 7i <30 1.5 n = 46 F = 0 . 93 30 - 44.9 1.4 n = 18 
" 45 - 80 2.1 n = 19 p > 80 1.7 n = 12 >0.05 
7i - loi < 30 l.9 n = 22 
F = o.44 30 - 45 2.0 n = 5 11 
>45 1.,3 n = 4 P > 0. 05 
101 - l6 < 30 1.6 n = 11 F: 3 .17 
30 - 45 1.9 n = 5 II 
> 45 4.2 n = 3 p· > 0.05 
Conclusion: 
Excessive excretion of Figlu does not have a consistent effect on 
infection score and there is no statistical relationship between 
these two parameters •. 
TABLE 80 
SIGNIFICANCE OF FIGLU EXCRETION 
Relationship of Figlu excretion to mean haemoglobin levels. 






n = 25 
Analysis F = 0.60 
Borderline 9.9 of 
n • ' P > 0.05 
variance 
Positive 10.6 
n .. 6 
Conclusion: Infants with excessive excretion of Figlu do not have lower 
mean haemoglobin levels. 
None of the differences between mean haemoglobin levels in 
the, groups are statistically significant. 
163 . 
From this it seemed that in individual infants significant urine 
concentration might result in spurious positive Figlu tests if the results 
were expresseu in fg . /ml . and if both urine concentration and total Figlu 
output were great enough . From this, it seemed more valid to express Figlu 
results of infants as total output (mg . /24 hrs) rather than concentration 
of Figlu output (fg . /ml . ) . This was therefore done when the results of 
the Figlu excretion test , using method B, were analysed . 
THE SIGNIFICANCE OF THE POSITIVE FIGLU TEST 
AFTER ORAL HISTIDINE . 
There was no statistical relationship between Figlu excretion andt 
a) Mean haemoglobin concentration 
Method A (Table 79) . 
Method B (Table 80) . 
b) Infant growth 
Method A (Table 79) . 
There was no consistent effect of excessive Figlu excretion on 
mean weight percentile . 
c) Infection score 
Method A (Table 79) . 
There was no statistical rel a tionship between positive Figlu tests 
and mean infection score . 
The administration of folic acid did not produce 
a) Convincing evidence of symptomatic benefit 
Method A. 
More infants with negative Figlu tests (6 of 15) had unequivocal 
symptomatic benefit from folic acid therapy than had · infants with positive 
Figlu tests (3 of 13) . 
TABLE 81. 
THE EFFECT OF 
FOLIC ACID TREATMENT ON PERCENTILE AND H~MOGLOBIN VALUES IN 
INFANTS EXCRETING EXCESSIVE CONCENTRATIONS OF FIGLU ( > 45 µg./ml.) 
I 
Mean value Me an vaI.ue. Test 
Parameter prior to post of Significance. 
treatment treatment significance 
Haemoglobin 9.9 10.1 'STUDENT'S' 0.364 
level. t-Test 
g./lOCl ml.. n = 9 n = 9 0.70 < P' < 0.80 
Percentile 42 32: 
(weightl 
n = 9 n = 9 
Concl.usion: 
Neither haemogiobin level nor percentile v~lue were improved by folic 
acid therapy 
THK EFFECT OF FOLIC ACTD TREATMENT 
ON INFA'NTS EXCRETING NORMAL CONCENTRATIONS OF FIGLU. 
Mean value Mean value 
Paramete:r prior to post 
treatment treatment 
Haemoglobin 8.9 8.9 
level 
g./100 ml. n = 3 n = 3 
Percentil.e 39 34 
(weight) n = 2 n =- 2' 
Conclusion: 
Folic acid therapy had no effect on mean haemoglobin or 
percentile values. 
TABLE 69. 
RELATIONSHIP OF FIGLU EXCRETION TO DISTURBANCES OF FOLKTE METEBOLISM~ 
(a) Relationship of Figl.u exc~etion to iron deficiency .. 
(i) 







n = l..4 
58 .. 7 
n = 3 
63 .. 4 




F = 0.04 
P > 0 .. 05 
Conclusion:_ There is no relations-hip. between Figlu excretion a:nd mean 
oerum iron levels. The, overa:ll differences, are not 
statistically significant. 
Interrelationships of therapy, , serum iron levels, and Figl.u excretion 











26 .. 6 
Before treatment 
48.o. 
74 .. o 
After treatment 
50.a 
38 .. 0 
Therapy with oral iron and folic acid. 
Figlu mg./24 hrs. 
Before treatment After treatment 
S.erum iron µg./100 ml.. 
Before treatment Kfter treatment 
57 .. 0 
59 • .2 
68.z 
36 •. Q 
Conclusion: Mean Figlu excretion in 
(A .. G.) increases while degree of iron defici_ency is unchanged:';. 
(B..R.) increaseo with increasing iron deficiency; 
(D.E .. ) decreases with improvement in serum iron levels; 
(M.J.} decreases with increasing iron deficiency. 
There is no constant relationship between serum iron levels and Figlu 
excretion •. 
TABLE 69 (Contd.) 
RELATIONSHIP OF FIGLU EXCRETION TO DISTURBANCES OF FOL.fl'E METABOLISM. 






Mean Figlu excretion 
mg./24 hrs. 
8.,3 
n = 38 
4.L 
n = 7 
Test of significance 
'STUDENT'S t-test 
S:ignificance, 
t = 1 .. 842 
0 .. O 5 < P < 0. lO 
aonclusion: Mean Figlu excretion is· higher in infant~ with infection than 
those without infection at the time of investigation. The 




















































































































































































































































































































































































































































































































































































































































































































































































































































































b) Iron deficiency. 
157. 
Range of vitamin B12 levels 
336 - 1640 pg./ml. 
301 - 388 pg./ml. 
272 - 928 pg./ml. 
(i) The relationship of Figlu excretion to mean serum iron levels. 
Method A (Fig. 35) 
Method B (Table 69) 
There was no demonstrable statistical relationship between Figlu 
excretion in excess and mean serum iron levels. 
(ii) Therapeutic trials with iron. 
Method A (Table 70). 
There was an overall decrease in mean Figlu excretion (fg./ml. 
and mg./24 hrs.) after intramuscular iron therapy. This was not a 
statistically significant difference probably because Figlu excretion 
was not reduced in all infants. 
An inference drawn from this result was probably justified 
although the administration of iron did not cure the iron deficiency in 
all cases. There was evidence in only one case (R.L.) that cure of the 
iron deficiency might further have reduced Figlu excretion. In the others, 
A.P., B.M. and T.J., the change in Figlu excretion had no relation to the 
pattern of the serum iron levels. 
Method B (Table 69) 
A therapeutic trial with oral iron was relatively ineffective 
in improving serum iron levels. In individual infants the changes in 
Figlu excretion did not have a consistent relationship to the changes 
in the serum iron levels. 
TABLE 7l 
SERUM GLUTAMIC-OXA.LOACETIC TRANSAMINASE AND BLOOD UREA. 
ESTIMATIONS IN RELATION TO FIGLU EXCRETION. 
Infant Age Figl.u result S:: •• G .O. T •. Blood urea::. (months) pg./mi. (units) mg. % 
R..K- 9 .. 0 63 •. 9 is.a 
R.S. 3.5 80.3 29.0 
p_c., 14.0 34.1 10.0 l6.7 
N .. S. 9.3 41. .. 0 22.0 29.,8 
a .. c. 3.5 l].8.o 34.o 
F-U .. 12.8 74.2, 20.0 12.9 
B. W. 12~8 32.,5 15.0 19.9 
T.de B. 9 .. 0 l22.4 20.2. 35.9 
c.v. 14.5 J4 •. 9 25.0 29.0 
S.B. ]3.5 53.4 . 30.0 23.9 
M-R .. 13.0 9.1 4o.o 14.o 
Lv.D .• 4.,8 64.o 2.8.0 
LH •. 3.0 47.4. 5.0 34.A 
..IL.M. 5.3 96.,7 15.0 l9.2 
N.H. 3.0 48.,2. 35.0 
O .. M. 4.3 33.6 18.0 2.1 .o 
L.O. 7.0 52..0 1.5.0 21.0 
w .. s::. 3.3 60.5 33.0 
TABLE 72 
THERAPEUTIC TRIAL WITH PHARMACOLOGICAL DOSES OF FOLIC ACID 
IN THE PROSPECTIVE STUDY 
(a ) Composite data 
Infants given folic acid 
Figlu p g . /ml . 
* 
Before treatment After treatment 
Mean age Mean age 
6. 0 months 7. 7 months 
60 .7 
n = 9 
(b) Individual results 
29 .1 
n = 9 
Infants not given folic acid* 
Figlu p g . /ml. 
Before treatment After treatment 
Me an age Mean age 
6. 0 months 8. 4 months 
71.5 
n = 22 
29 . 3 




Figlu _ Age Figlu Therapy 
p g . /ml . (months) p g . /ml . 
----- - -------·-----------
53 . 3 9.8 35 . 5 J .A. 
R. J . 
D. Br . 
E. L. 










32 . 6 8. o 33 . 5 
92 . 6 8 . o 19 . 9 
Oral folic acid 1 . 25 mg . 
daily for 10 days or 









T. deB . 
E . D. 




N . S . 
V. B. 
K. M. 
N.v . W. 
B. C. 
N. D. 
F . U. 
c .v. 
D. Bz . 
J .E. 
























128 .8 6. 5 42 . 7 
64 . 9 8 . 5 34 . 2 
35 . 8 8 . o 33 .8 
77 . 7 8 .8 20 . 3 
35 . 3 5 .3 18.1 




38 . 5 





65 . 2 
45.1 
60 . 2 
4o . 8 
57 ,4 
64 . 4 
54 . 4 
55 .2 
96 .2 
68 . 4 
106 . 6 
36 . 2 
19 . 6 
9. 0 



















8 . 5 
9. 5 
8. 6 
18 . 7 




42 . 9 
39 . 4 
61.8 





29 . 7 
10 . 4 
17 .0 
12 .4 
16 . 9 
24 . 4 
14 .3 
34 .3 
5 mg . b . d . in the pres-
ence of gastroenteritis . 
Infants were tested 





With one exception in the therapeutic group , this only refers t o 
infants excreting excessive or borderline amounts of Figlu , 




c) Infection at the time of investigation . 
Method A (Fig . 36) . 
Method B (Table 69) . 
There was no statistical relationship between infection at the 
time of investigation and mean Figlu excretion . 
d) Hepatic and renal dysfunction . 
Method A (Table 71) . 
Infants did not show clinical evidence of hepatic or renal dys -
function . Serum glutamic- oxaloacetic transaminase levels (SGOT) and 
blood urea estimations were normal when these tests were performed . 
The Effect of Pharmacological Doses of Folio Acid 
on Figlu Excretion . 
(i) Infants older than 6 months . 
Method A (Table 72) . 
The mean Figlu excretion decreased whether therapy was administered 
or not . Because of this , reduction in Figlu excretion in the therapeutic 
group could not be attributed to the effect of therapy . However , all 
individual results were less than 45 pg . /ml . in the therapeutic group 
although 4 infants in the non- therapeutic group still excreted Figlu in 
excess of this amount . 
It seemed possible that coincidental physiological improvement 
stemming from growth and development might have contributed to the decrease 
in Figlu excretion . It was therefore necessary to repeat the therapeutic 
trial in younger infants . 
By the end of the prospective study, 3 infants still had positive 
tests . They received a standard dose of oral folic acid , except in the 
case of one infant who received 100 f g • of intramuscular folio acid daily . 
RELATIONSHIP OF INFECTION AT TIME OF INVESTIGATION TO 
MEAH FIGLU EXCRETION 
INFANTS 2h to 41,lz months 







:z: 40 C) -I.LI ac .... - 30 I.LI 
= ~








0·05 <P<0· 10 
INFANTS 7Yz to103/4months 







t::; 4 0 










Fi . 36 . 
INFANTS 4h to 71/i months 
infection 
t = 1-083 
0·20<P<0·30 
no infection 
INFANTS 10J14to 16 months 
infection 
t = 1 · S78 
0·10<P<0·20 
no infection 







EFFECT OF THERAPY ON FIGLU EXCRETION 







-E 500 ....... n=7 
250 
388 
t= O· 94 S O ·50<P<0 ·40 
before treatment --
~~ J week!. after treatment 
Fig . 37 
164 . 
Method B. 
One of 4 infants given folic acid and iron , and one of 7 infants 
given only oral iron , showed unequivocal symptomatic benefit . This was 
not a statistically significant difference ( ~
2 • 0.196 ; 0. 50 < P < 0. 70) . 
b) Significant improvement of haemoglobin concentration 
Method A (Table 81) . 
The administration of folic acid did not produce any significant 
improvement of haemoglobin concentration in infants with positive Figlu 
tests . It did not improve haemoglobin concentration in infants with 
negative Figlu tests . 
Method B (Table 74) . 
Mean haemoglobin concentration decreased in infants receiving folic 
acid and iron . 
c) Improvement of mean weight percentile 
Method A (Table 81) . 
Folic acid therapy did not improve the mean weight percentile of 
infants who had normal or abnormal Figlu tests . 
This probably confirmed that the inconsistent relationship between 
excessive Figlu excretion and nutrition previously noted in the statistical 
analysis , had little meaning . 
Method B (Table 74) . 
The mean weight percentile was not improved by folic acid and iron 
therapy . 
d) Improvement of resistance to infection 
The effect of folic acid therapy on resistance to infection in 
infants with positive Figlu tests could not be assessed . 
From the combined results of the statistical analysis and the direct 
assessment of the effect of folic acid therapy it seemed that there was no 
relationship between excessive Figlu excretion and infant health . 
165. 
SUMMARY 
Two methods were used to estimate Figlu excretion. With both these 
methods it was found that a considerable number of healthy underprivileged 
infants excreted 
(a) Figlu (fg./ml.) in excess of the accepted normal values. 
(b) Figlu (mg./24 hrs.) in excess of normal according to criteria defined 
in this study. 
Figlu excretion was maximal in young infants and then decreased 
with growth. 
Disturbances of histidine metabolism did not significantly interfere 
with the interpretation of the Figlu test after oral histidine in the 
infants studied. 
There was no relationship between positive Figlu tests after oral 
histidine and other parameters of folate deficiency. There was no relation-
ship between Figlu excretion and an aetiology for folate deficiency. These 
applied whether Figlu results were expressed in terms of concentration 
(fg./ml.) or quantity (mg./24 hrs.). The administration of small doses of 
folic acid to infants with positive Figlu tests did not produce significant 
reduction in Figlu excretion. 
There was no definite relationship between Figlu excretion and the 
S.faecalis folic acid clearance test. No cause for a disturbance of folate 
metabolism could be demonstrated. Pharmacological doses of folic acid and or 
iron did not produce significant reduction of Figlu excretion. 
There was no relationship between- positive Figlu tests and non-specific 
factors such as incomplete urine collections. However, if Figlu excretion was 
expressed as concentration (fg./ml.)then in a small number of infants si~-
nificant urine concentration might lead to spurious positive Figlu tests. 




In measuring Figlu by two methods (Tabor and Wyngarden, 1958; 
Chanarin and Bennett, 1962a), it was shown that a fair percentage of healthy, 
underprivileged infants had positive Figlu tests after oral histidine . The 
maximum incidence and highest mean total Figlu output was noted in infants 
of under 7! months. The incidence and mean total Figlu output declined 
with growth and only a small percentage of infants in the lOi - 16 month 
age - group had positive Figlu tests after oral histidine. 
The Figlu Test after Oral Histidine and Folate Deficiency . 
It was necessary first to determine whether these positive tests 
could be attributed to biochemical folate deficiency fChapter III). 
In this study there was no agreement between the results of the 
Figlu test after oral histidine and those of the other parameters ~sed to 
investigate folate deficiency. 
Hoffbrand, Newcombe and Mallin (1966) confirmed Herbert's obser-
vations (1962a) that the Figlu test after oral histidine was a satisfactory 
test of adult folate stores, comparable in sensitivity to the red cell 
L. casei folate assay . It was a less sensitive parameter of folate 
deficiency than the following: 
a) serum L. casei folate assay (Herbert, 1962a); 
b) S. faecalis folic acid clearance test (Chanarin , Bennett and Berry , 1962); 
c) hypersegmentation of the neutrophils (Herbert , 1962a) . 
However , in the infants in this study, the results obtained wi t h 
these sensitive parameters did not provide evidence for attributing the 
positive Figlu tests after oral histidine to folate deficiency . On these 
grounds , it might have been concluded that the positive Figlu tests after 
oral histidine were not manifest of biochemical folate deficiency . 
However,, this conclusion was not then reached because the validity of 
these parameters a ppeared controversial or were unproved in infants and 
children. Also some of t h e pa rameters used for investigating folate 
deficiency in this study were believed to be less sensitive tha n the Figlu 
test after oral histidine. This will be discussed below. 
Figlu excretion wi t h out an oral histidine load was found to be a less 
sensitive test of folate deficiency than Figlu after oral histidine (Luhby, 
Cooperman and Teller, 1959a). This was a pparently supported by the findings 
in this study. The use of a technique of concentrating urine without con-
centrating Figlu (Lewis and Moore, 1962a, b; Lovric and Kenrick, 1965) 
would have improved the value of the non-histidine loading Figlu test as a 
parameter of folate deficiency. 
The diagnostic value of the serum L.casei folate assay in infancy was 
controversial. It was found that the serum L.casei folate assay was not 
always a reliable index of folate deficiency (Lovric and Kenrick, 1965) or 
megaloblastic anaemia due to folate deficiency, in infants and children (Luhby, 
Cooperman, Maciver and Mont g omery, 1962; Pereira and Baker, 1966). Other 
investigators found the serum L.casei folate assay a good test of folate 
deficiency (Shojania and Gross, 1964a; Dormandy, Waters and Mollin, 1963; 
Vanier and Tyas, 1966) and noted a good agreement between serum L.casei 
folate levels and megaloblastic anaemia in infants and children (Dormandy, 
Waters and Mallin, 1963). This finding waa confirmed by S pector and Metz 
(1966 ), provided infection was not present when the tests were p erformed. 
The validity of hypersegmentation of the neutrophils as an index of 
folate deficiency in infancy was equally controversial. It was reported that 
in infants,, up to 4% of neutrophils could be hyp ersegmented in the absence 
of other evidence of folate deficiency (Vanier and Tyas, 1966). Ifu 
megaloblastosis in premature i"nfants (Gray and Butler, 1965) and in 
infants and children ( Wise, Lovric and O'Gorman Hughes, 1963),, hyperseg-
mentation of the neutrophils was an inconsistent finding. But other 
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investigators found a good agreement between hypersegmentation of the neutro-
phils and other parameters of folate deficiency in premature infants (Vanier 
and Tyas, 1967) and in children (Shojania and Gross, 1964b). In children with 
kwashiorkor and megaloblastic anaemia there was a good agreement between 
neutrophil lobe average and other parameters of folate deficiency (Allen and 
Whitehead, 1965). 
The sensitivity of hypersegmentation of the neutrophils as a parameter 
of folate deficiency also appeared uncertain. Earlier, Herbert (1962a) had 
found this a sensitive parameter of folate deficiency present before folate 
stores were depleted. However, Chanarin, Hutchinson, McLean and Moule (1966) 
showed that in the presence of reduced hepatic folate stores, low serum 
L.casei folate levels and excessive Figlu excretion, hypersegmentation of 
the neutrophils was not found. 
Little had been reported on the validity of the red cell L.casei folate 
assay as a parameter of folate deficiency in infancy. From the data collec-
ted by Vanier and Tyas (1966), it appeared that in normal infants the red 
cell L.casei folate assay was a more sensitive parameter of folate deficiency 
than the Figlu test after oral histidine. However, in premature infants it 
was found that the Figlu test after oral histidine was a slightly more sen-
sitive index of folate deficiency than the red oell L.casei folate assay 
(Vanier and Tyas, 1967). From the little evidence available it seemed that 
in infants, as in adults, the Figlu test after oral histidine and the red 
cell L.casei folate assay might be comparable as parameters of folate defici-
ency. If this were so, the failure to find supportive evidence for the Figlu 
test after oral histidine by studying red cell L.casei folate assays was sound 
evidence for not attributing the results of the Figlu test to folate deficiency. 
The only information found on the use of the folio acid clearance 
tests in infancy was not helpful in determining the interpretation of the 
Figlu test after oral histidine. Hirata and Arakawa (1965) reported that 
in infants and children the basal serum L.casei folate levels correlated 
well with the level of folate in circulation 4 hours after the injection 
of folic acid. It was believed that the pattern of the L.casei folic acid 
clearance curves in adults was a reflection of the degree to which injected 
folic acid displaced folate from the stores (Chanarin and McLean, 1967). 
In patients with low folate stores, less folate was displaced and the curves 
appeared faster. Since the L.casei folic acid clearance curves were com-
parable in infants who had positive and negative Figlu tests after oral 
histidine it seemed that the folate stores in these two groups of infants 
should also be comparable. If this were so, this again was evidence against 
the value of the Figlu test after oral histidine as a parameter of folate 
deficiency and depleted folate stores in these infants. 
In infants, (Luhby, Cooperman, Maciver and Montgomery, 1962; Shojania 
and Gross, 1964a; Lovric 1964) as in adults, (Herbert, 1962a; Chanarin,1964) 
there was agreement that positive Figlu tests after oral histidine might 
indicate the presence of folate deficiency before megaloblastosis developed. 
In this study, infants under 7t months had positive Figlu tests which were 
not associated with morphological evidence of folate deficiency in the bone 
marrow. Although this was a situation compatible with folate deficiency, 
this result did not in any way clarify the interpretation of the positive 
Figlu tests. One infant, M.R., later (at 13 months of age) developed a 
megaloblastic bone marrow, and in her case the positive Figlu test after oral 
histidine might have reflected the presence of folate deficiency. However, 
this could not be proved on the evidence available. 
The negative evidence collected from the above studies appeared con-
siderable but was not regarded as conclusive because the validity of the 
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other comparable or more sensitive parameters used for diagnosing folate 
deficiency in infants and children were either controversial or unproven. 
For this reason, other methods of investigating a relationship) between 
positive Figlu tests after oral histidine and biochemical folate defici-
ency were pursued. This wa$ done also because other investigators had 
reported that the Figlu test after oral histidine (Luhby, Cooperman, 
Maciver and Montgomery, 1962) and without oral histidine (Lovric and 
Kenrick, 1965) was a very reliable parameter of folate deficiency in 
infancy. 
Infants with positive Figlu tests after oral histidine did not 
appear to have any reason for folate deficiency because excessive Figlu 
excretion could not be related to an aetiology for folate deficiency. 
There was no apparent relationship to maternal folate nutrition, dietary 
factors,, nutrition, malabsorption and increased demand for folate. A 
relationship to socio-economic circumstances might have existed but could 
not be proved . This aetiological study was complicated by certain factors. 
The best criterion for assessing maternal folate deficiency in pregnancy 
(megaloblastosis with supportive evidence for folate deficiency) was not 
employeill in this study. Actual daily fol~te intake could not be measured 
and absorption was measured with xylose or folic acid. It is not known 
whether these results necessarily reflect ability to absorb food folate 
under physiological conditions. 
Last, neither the administration~f small physiological doses of 
folic acid known to be effective in correcting most positive Figlu 
tests after oral histidine resulting from folate deficiency (Hansen 
and Weinfeld, 1962); nor the administration of pharmacological doses 
of folic acid which should have converted positive Figlu tests due to 
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folate deficiency, resulted in a statistically significant decrease in 
Figlu excretion after oral histidine. Although the therapeutic trials 
with folio acid were conducted on an out-patient basis, there was no evi-
dence that the infants did not receive the folio acid therapy. 
In view of the failure to find support for the results of the posi-
tive Figlu tests after oral histidine from those of other parameters of 
folate deficiency, the failure to find an aetiology for folate deficiency 
in infants with positive Figlu tests and the failure of a therapeutic 
trial both with small and pharmacological doses of folio acid, it was 
concluded that positive Figlu tests after oral histidine were not the 
result of biochemical folate deficiency. The one method of establishing 
this beyond any doubt would have been to assay liver for folate content 
(Chanarin, Hutchinson, McLean and Moule, 1966). This was not justifiable 
in this study. 
The Positive Figlu Tests after Oral Histidine and 
Secondary Disturbance of Foiate Metabolism. 
There was much to suggest that a disturbance of folate metabolism 
accounted for the positive Figlu tests. 
First in contrast to the findings in normal infants (Luhby and Cooper-
man, 1964; Vanier and Tyas, 1966), other investigators had reported that 
underprivileged infants and infants with miscellaneous diseases had positive 
Figlu tests after oral histidine in the absence of supportive evidence of 
folate deficiency (Naiman, 1966; Arakawa, Ohara, Fujii, Hirata ana Takahashi, 
1965). 
Second,in all except the last study, serum and red cell L.casei folate 
levels were higher, though not significantly so, in infants with positive 
Figlu tests after oral histidine. Elevated serum L.casei folate levels and 
172. 
positive Figlu tests were described in other conditions where folate 
metabolism was disturbed: vitamin B12 deficiency (Herbert and Zalusky, 
1962), infection (Spector, Falcke, Yoffe and Metz, 1966) and enzymatic 
disturbances such as congenital glutamate formiminotransferase (Arakawa, 
Ohara, Takahashi, Ogasawara, Hayashi, Chiba, Wada, Tada, Mizuno, Qkamura 
and Yoshida, 1965) and transmethylase deficiency (Arakawa, Narisawa, Tanno, 
Ohara, Higashi, Honda, Tamura, Wada, Mizuno, Hayashi, Hirooka, Ohno and 
Ikeda, 1967). Of these conditions, infection and possibly immature 
enzyme function,particularly of glutamate formiminotransferase (Arakawa 
and Fujii, 1966) seemed most applicable to the infants in this study. 
Another possible cause for a disturbance of folate metabolism in these 
infants was iron deficiency. It was believed that iron deficiency could 
result in a diminution of glutamate formiminotransferase function and so 
lead to positive Figlu tests after oral histidine. However, raised 
serum L.casei folate levels were not reported to be a feature of this 
disturbance (Vitale, Streiff and Hellerstein, 1965; Vitale, Restrepo, 
Velez, Riker and Hellerstein, 1966). 
Third, in conditions where folate metabolism was disturbed, it was 
noted that the administration of folic acid in pharmacological doses 
might result in a decrease in Figlu excretion after oral histidine without 
necessarily returning this to normal (Knowles, Shaldon and Fleming, 1963). 
This was similar to the findings in this study. 
The relationship of positive Figlu tests to a secondary disturbance 
of folate metabolism was investigated by means of 
(a) the folic acid clearance tests using S.faecalis as the 
assay organism; 
(b) aetiological studies. 
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The use of the L.casei and S .faecalis folic acid clearance curves 
to try to relate positive Figlu tests to a disturbance of folate metabolism, 
arose from conclusions drawn by Hogan ,, Maniatis and Moloney (1964) from the 
following data of Herbert and Zalusky (1962). In the study performed by 
Herbert and Zalusky ( 1962) , , both the S. faecalis and L .. casei clearance curves 
of injected folic acid were very rapid over the period of Oto 30 minutes 
in patients with folate deficiency. Yet, over the same period in patients 
with vitamin B
12 
deficiency, the S.faecalis folic acid clearance test was 
as rapid as before but the L.casei folic acid clearance curve was within or 
slightly lower than the normal range. It was al.so believed (Herbert and 
Zalusky, 1962} that injected f olic acid was converted to N5-methyl FH4 and 
that in vitamin B
12 
deficiency the conversion of N5- methyl FH4 to FH4 was 
blocked. Since there was no alternative metabolic pathway for N5-methyl FH4 , 
it accumulated and was trapped in the circulation. N5-methyl FH4 was 
available to L.casei and not S .faecalis so resulting in an apparently 'normal' 
folic acid clearance curve when L.caa,ei was used as the assay organism in 
vitamin B
12 
deficiency. Presumably the rapid folic acid clearance curve 
with S.faecalis in vitamin B
12 
deficiency was the result of associated 
tissue folate deficiency. Thus, , Hogan, Maniatis and Moloney (1964) inferred 
that the L.casei folic acid clearance curve could be used as a satisfactory 
test of folate deficiency particularly because it app eared to be relatively 
unaffected by secondary disturbances of folate metabolism. On the other 
hand, the S.faecalis folic acid clearance curve reflected both folate 
deficiency and disturbances of folate metabolism . 
In a later study Chanarin and McLean (1967) used the L.casei and 
S. faecalis folic acid clearance tests in folat e deficient, . vitamin B
12 
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deficient and control subjects , to investigate the methyl folate block 
hypothesis in vitamin B12 deficiency . It was possible to make observations 
from their findings which were relevant to this study . At the 15 and 
30 minute levels , the mean folic acid clearance curves with S. faecalis 
were comparable in folate and vitamin B12 deficiency but were much lower 
than in control subjects . However , when L. casei was used as the assay 
organism the mean folio acid clearance levels at 15 and 30 minutes in 
vitamin B12 deficiency were only slightly higher than those in folate 
deficiency and both were substantially l ower than those found in normal 
controls . From this , it seemed that the L. casei folic acid clearance curve 
could also be rapid in vitamin B12 deficiency and that the difference in 
the mean L. casei folate levels in folate and vitamin B
12 
deficiency was 
unimpressive . It seemed doubtful whether this difference had any meaning 
in relation to folate metabolism and whether differential folic acid 
clearance curves could be used to distinguish between folio acid deficiency 
and disturbances of folate metabolism particularly that found in vitamin 
B12 deficiency . 
In this study the L. casei folic acid clearance curves were comparable 
in infants with positive and negative Figlu tests after oral histidine , 
whereas the S . faecalis folio acid clearance curves in infants with positive 
Figlu tests after oral histidine were slightly faster than those with 
negative Figlu tests . The difference was slight , the numbers investigated 
small and the test is associated with a high variance . Moreover , the 
contribution of associated iron deficiency to the rapidity of the S. faecalis 
folic acid clearance curves was unknown . Thus the observations were regarded 
as inconclusive and did not help in the identification of a possible dis -• 
turbance of folate metabolism in infants with positive Figlu tests . It 
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was unfortunate that infants with high serum L. casei folate levels and 
positive Figlu tests after oral histidine could not be investigated with 
both the S . faecalis and L. casei folic acid clearance tests . 
The data were further analysed to determine whether the positive 
Figlu tests could be attributed to iron deficiency , infection at the time 
of investigation , vitamin B12 deficiency or hepatic dysfunction . 
Positive Figlu tests were previously reported in iron deficiency 
(Knowles, 1962; Chanarin , Bennett and Berry, 1962) but were not observed 
by Kohn, Mallin and Rosenbach (1961) and Stone , Luhby , Feldman , Gordon and 
Cooperman (1967) . It was believed that iron deficiency might lead to 
folate deficiency (Chanarin, Rothman and Berry, 1965 ; Velez , Restrepo , 
Vitale and Hellerstein, 1966) or a secondary disturbance of folate meta-
bolism (Vitale , Streiff and Hellerstein, 1965 ; Vitale , Restrepo , Velez, 
Riker and Hellerstein , 1966) . Bo t h these mechanisms might have resulted 
in positive Figlu tests after oral histidine . 
Iron deficiency was a common occurrence in the group of infants 
investigated in this study, but no evidence could be found for attributing 
the positive Figlu results after oral histidine to this deficiency . There 
was no relationship between serum iron levels and Figlu excretion and 
t herapy with intramuscular iron did not significantly improve Figlu 
excretion . As the infants grew older , Figlu excretion decreased in 
parallel to an increasing incidence and severity of iron deficiency . 
Following in- vitro studies , Panders and Rupert (1965) reported that 
0 at a temperature of 39 C. the conversion of folio acid to tetrahydrofolate 
was inhibited . Subsequently , Spector, Falcke, Yaffe and Metz (1966) showed 
that malnourished infants with febrile conditions had higher Figlu 
176. 
excretion than those infants without pyrexia . In this study a possible 
relationship between infection at the time of investigation and excessive 
Figlu excretion could not be demonstrated with a statistical analysis of 
the data . The failure to demonstrate a relationship between po~itive 
Figlu tests and infection did not contradict previous observations because 
none of the infants was investigated when the pyrexia was as much as 39°c 
(102 . 2°F) . 
Unequivocal vitamin B12 
deficiency was not encountered in this 
study . One infant with a positive Figlu test after oral histidine had a 
slightly subnormal serum vitamin B12 
level . This deficiency could not 
have accounted for all the positive Figlu tests . 
There was no clinical reason for suspecting hepatic insufficiency 
in the infants studied . SGOT levels were normal when estimated . The 
incidence of rickets precluded the use of the alkaline phosphatase test 
and reported fatalities with the Bromsulphthalein test discouraged the 
use of this as a test of hepatic function (Astin , 1965) . 
The role of vitamin C and E deficiency in producing a disturbance 
of folate metabolism was not specifically investigated . On the strength 
of dietary information wgich might not have been completely reliable; no 
statistical relationship was found between the administration of vitamin C 
and Figlu excretion . 
Arakawa and Fujii (1966) showed that glutamate formiminotransferase 
function was low in rats and mice at birth . It increased rapidly until 
it reached a constant level comparable to that found in mature animals 
(7/52) at 5 weeks or later . It was possible that the positive Figlu tests 
after oral histidine could be attributed to greater immaturity of 
glutamate formiminotransferase function in infants with positive Figlu 
* This data has not beeri presented . 
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tests. Estimation of glutamate formiminotransferase function was success-
fully performed on liver biopsy material (Arakawa, Ohara, Kudo, Tada, 
Hayashi and Mizuno, 1963). This was not justified in this investigation, 
but a method of estimating the enzyme function in erythrocyte haemolysates 
seemed to offer a suitable alternative (Arakawa, Fujii and Ohara, 1966). 
Unfortunately this study could ultimately not be undertaken. Later 
experience with the use of this method of estimating glutamate formimino-
transferase function apparently proved disappointing (Konno, 1968). 
The result of the therapeutic trial with pharmacological doses of 
folio acid was compatible with, but did not in any way prove a secondary 
disturbance of folate metabolism in infants with positive Figlu tests. 
It was concluded that with the possible exception of immature glu-
tamate formiminotransferase function, a secondary disturbance of folate 
metabolism was an unlikely explanation for the positive Figlu tests 
after oral histidine. Failure to demonstrate an aetiology for the dis-
turbance of folate metabolism was the main reason for this conclusion. 
The Figlu Test after Oral Histidine and Non-specific Factors . 
A relationship between Figlu excretion after oral histidine and 
non-specific factors was sought in a further attempt to clarify the 
interpretation of the Figlu ~est after oral histidine. 
The first factor considered was that of incomplete urine collection 
which might have occurred either because of leakage or incomplete voidi ng 
of urine when the collection was discontinued. However, when there was 
a loss of urine in excess of 10% - 15% of the total 24-hour urine volume, 
the urine collection was regarded as incomplete and excluded from the 
study (Chapter IV). Cooperman (1967) accepted a urine collection as 
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satisfactory if it was representative of the total urine passed during 
the 24- hour period . In order to examine the relationship of positive 
Figlu tests after oral histidine to incomplete urine collections which 
might have occurred as a result of incomplete voiding , creatinine was 
estimated in urine . This test was used because Arroyave and Wilson (1961) 
reported that 24 - hour urine creatinine estimations could b e used as a 
measure of ' completeness ' of urine collection . 
Although measurement of creatinine in serum or plasma could be 
inaccurate , the measurement of c reatinine in urine was regarded aw a 
satisfactory technique ( Wrong , 1962) . This was apparently confirmed by 
the reproducibility found between repeat estimations for creatinine in 
urine in this laboratory (Table 45) . In this study creatinine in urine 
was expressed as a percentage of expected creatinine output per pound/kg . 
bodyweight in order to compensate for differences in the weight of the 
infants . When the results of tne Figlu test after oral histidine were 
compared with those of creatinine excretion , it was found that the 
positive Figlu tests after oral histidine could not be attributed to 
incomplete urine collections . 
The second non- specific factor considered in relation to positive 
Figlu tests after oral histidine , was that of urinary concentration . It 
was shown that a small percentage of infants could have spurious positive 
Figlu tests after oral histidine as a result of urine concentration if the 
level of the normality was set at 30 f g · per ml . This was established 
using method B. 
Even when spurious positive Figlu tests were excluded by using 
quantitative Figlu output rather than Figlu concentration (fg . /ml . ) as 
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a criterion of normality , it was still not possible to attribute positive 
Figlu tests after oral histidine to folate deficiency or to most of the 
factors that might have disturbed folate metabolism . 
The relationship of the Figlu Test after.Oral 
Histidine to Infant Health . 
Positive Figlu tests after oral histidine were not associated with 
any measurable effect on infant health . 
The Interpretation of Positive Figlu Tests after Oral Histidine . 
Because there was no aetiology for the positive Figlu tests after 
oral histidine and because excessive Figlu excretion did not produce any 
detectable effect on infant health , it seemed important to re - examine the 
criterion used for determining normal Figlu excretion in this study . 
Luhby and Cooperm~n (1964) reported that normal infants and adults 
excreted less than 30 pg . per ml . or 35 mg . per 24 hours of Figlu . They 
preferred to use the criterion of 30 pg. per ml . in infants (Cooperman , 
1967) . Since the val idity of 30 f g • per ml . (45 f g • per ml . ) was now 
being questioned, the value of 35 mg . per 24 hours as a criterion of 
normality was examined . It was previously shown that the results of 
assays for Figlu in Cape Town were approximately 30% to 40% higher than 
those in New York (Chapter V) . When the results in this study (mg . per 
24 hours) were modified to compensate for this difference , it was found 
that Figlu excretion exceeded 35 mg . per 24 hours in only three instances . 
The highest level encountered was approximately 40 mg . per 24 hours 
(65 .9 mg . per 24 hours reduced by 35%) . None of the three infants showed 
any evidence of folate deficiency as assessed by the results of other 
parameters used for the investigation of this deficiency . 
180. 
Noeypatimanond, Watson-Williams and Israels,(1966) showed that 
normal adults excreted up to 40 mg. per 24 hours of histidine derivatives 
when: 
a) they were given a 15 g. load of histidine in three divided doses; 
b) urine was collected for 24 hours thereafter; 
c) the method of Chanarin and Bennett (1962a) was used to determine Figlu 
excretion. 
This experimental procedure was comparable to that used in this study. 
Because Vanier and Tyas (1966) confirmed that normal infants and adults 
excreted comparable total amounts of Figlu (mg./24 hrs), the result in this 
study could be compared with the above normal adult values for quantitative 
excretion of Figlu. In this study, the total output of histidine deri-
vatives excreted by infants did not exceed 31.4 mg. per 24 hours when the 
method of Chanarin and Bennett (1962a) was used and total Figlu output 
did not exceed 27.2 mg. per 24 hours. 
Thus, by using both methods of Figlu estimation and the above-
mentioned criteria for normality it seemed likely that the Figlu excretion 
by the infants participating in this study was within normal limits for 
the experimental conditions pertaining here. By the use of the Figlu test 
after oral histidine, biochemical folate deficiency was not demonstrated 
in the infants studied. 
This required a re-examination of the use of Figlu concentration as 
a criterion of normality in infants. There seemed to be agreement that 
total quantitative Figlu output in young infants was comparable to that 
in adults. Also, it was known that the average daily urine output in 
infants under a year was approximately a third of the average daily adult 
urinary output. It therefore seemed inconceivable that infants and adults 
could have the same criterion of normality for Figlu excretion expressed in 
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terms of concentration (fg• per ml.). As an example, the urine of A.P. 
contained 80.0 fg• per ml. when assayed by Dr. Cooperman. Total 24 hour 
urine output by this infant was 420 ml. i.e. within the normal range 
(400 to 500 ml.) for infants in this age group (Ruoin, 1964). His total 
Figlu output was 33.6 mg. per 24 hours. The result of his Figlu test was 
not supported by other evidence for folate deficiency. It seemed clear 
that in his case, and in the case of other infants, a level of 80.0 fg· 
per ml. or more of Figlu was to be expected if infants were to excrete as 
much as 35 mg. per 24 hours in their smaller urine volumes. Moreover , the 
greater the urine concentration, the higher the concentration of Figlu was 
likely to be. 
It therefore follows that if Figlu concentration is to be used as 
a valid criterion of folate deficiency, particularly for healtµy, under-
privileged infants under 7t months, normal levels must be determined for 
them. Such levels should not be comparable to normal adult levels. In 
this study levels of as much as 181.5 pg• per ml. of Figlu were encountered 
without there being other evidence of folate deficiency. 
It is not clear how Luhby and Cooperman (1964) found 30 µg. per ml. 
of Figlu a valid criterion of normality. If they used some method for 
producing diuresis, infants could have excreted large amounts of Figlu 
without this resulting in a Figlu concentration in excess of 30 pg. per ml. 
It is not known whether the conduct of this study in a hospital environment 
strange to the infants in any way contributed to the fact that some of the 
infants studied, passed highly concentrated urines. This may have contri-
buted to a slightly higher incidence of positive Figlu tests (45 fg./ml.). 
The relatively high total Figlu output by healthy infants, especially 
those under 7t months of age, and the use of a criterion of normality for 
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Figlu excretion comparable to that used in adults, might partially explain 
the high incidence of positive results previously reported in infants 
(Friedman, McKenzie, Turner, Wittmann, 1964a; Dormandy, Waters and Mallin, 
1963) (Chapter 111). It might also have explained why Naiman (1966) found 
that underprivileged infants under 2 years could have positive Figlu tests 
:ii.n the absence of supportive evidence for folate deficiency.* 
From the results in this study it seemed clear that quantitative 
Figlu output (mg./24 hrs) progressively decreased as the infants grew older. 
The same pattern for Figlu excretionecpressed as concentrationvas reported 
by Vanier and Tyas (1966) and attributed to parallel maturation ~f hepatic 
function . From experiments performed on rats and mice it seemed that this 
could have resulted from coincident maturation of glutamate formiminotrans-
ferase function (Arakawa and Fujii, 1966). Accordingly, normal values in 
infants , at least in those under 16 months, should be determined on the 
basis of infant age. 
Moreover, the use of a criterion of normality for Figlu concentra-
tion based on adult standards might become more valid as infants mature 
and total Figlu output decreases. This couI1d explain the decrease in the 
incidence of positive results (pg./ml.) in infants in this study and might 
have contributed to the explanation for the apparent efficacy of folic 
acid therapy in the earlier study performed on infants in Cape Town, 
(Friedman, McKenzie , Turner and Wittmann, 1964a) (Chapter 111) . 
It was originally recommended that Figlu excretion in infants 
should be expressed as concentration (pg ./ml . ) rather than quantity of 
Figlu excreted (mg./24 hrs) (Dormandy, Waters and Mbllin,, 1963; Cooperman, 
1967; Vanier and Tyas, 1966). This was suggested because it was difficult 
*It would seem that all these investigator$ used standard semiquantitative 
methods for determining excessive Figlu excretion in urine but did not 
first establish the concentration of Figlu excretion passed by normal 
infants in these circumstances. 
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to obtain complete urine collections from infants. However, Figlu excretion 
reaches a maximum at some time between 3 and 10 hours after the admini-
stration of oral histidine, and then declines (Kohn, Mollin and Rosenbach, 
1961; Knowles, 1962; Chanarin, 1964). It is difficult to understand the 
preference for expressing Figlu results as concentration because, after the 
administration of oral histidine, Figlu is not excreted at a uniform rate. 
From this it seems that the Figlu result obtained from a substantially 
incomplete urine collection would be inaccurate regardless of expression 
(rg./ml. or mg./24 hrs). 
In this study it was found that urine concentration could result in 
spurious positive Figlu tests, using 30 fg./ml. as the criterion of nor-
mality. If the maximum Figlu excretion in fg./ml. (181.5 fg./ml.) found 
in this study is regarded as the maximum normality, it is clear that urine 
concentration could not have resulted in any false positive Figlu tests 
(the greatest rise was from 17.4 fg./ml. - 58.4 fg./ml.). Thus, provided 
normal levels are determined for infants, Figlu excretion can be assessed 
with equal validity, either as concentration, or as quantity of Figlu 
output. 
In this study there was little opportunity for investigating the 
value of the Figlu test in the diagnosis of megaloblastosis. It might be 
that this test would have the same value in infants as it has in adults, 
provided normal values for infants are adequately defined. 
There are still a few aspects to be discussed. First was the 
difference in the results of assays for Figlu performed in New York and 
Cape Town using the method of Tabor and Wyngarden (1958). The reason for 
this could not be determined, but it was noted that differencew in assay 
techniques for Figlu might exist between different laboratories. The 
normal range for the excretion of histidine derivatives in an 8-hour urine 
sample collected from adults given a 15 g. load of histidine and using the 
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method of Chanarin and Bennett (1962a) was reported to be O - 17 mg. by 
some investigators (Chanarin, Bennett and Berry, 1962; Hoffbrand, Neale, 
Hines and Mollin, 1966), and O - 25 mg. by others (Dymock, 1964; Bashir 
and Biro, 1966). Although the reasons for the technical difference in 
this study remained unexplained, compensation was made for this when the 
results were expressed in pg./ml. (30 rg./ml. increased to 45 pg./ml.) and 
when the results in mg. per 24 hours were discussed (result reduced by 35%). 
Second, the incidence of positive Figlu tests (45 rg./ml.) obtained 
with method A was higher than that obt~ined with method B ( > 30 fg./ml. 
and > 10 mg./24 hrs). A possible reason for the higher incidence obtained 
with method A was the number of spurious positive tests which might have 
resulted from the effect of urine concentration. This was not the sole 
explanation because: 
(a) when the results obtained with method B were expressed only 
in terms of concentration, the incidence of positive results 
was still lower than those obtained with method A; 
(b) when method A was used to measure quantitative Figlu excretion 
in infants, the results were higher than those obtained with 
method B. This is tabulated below. 
Maximum Figlu excretion (mg./24 hours) 
Method A Method B 
40.0 mg.(65.9 reduced by 35%) 27.7 
Mean Figlu excretion (mg./24 hours) 
Method A Method B 
2t to 4! months 9.0 (13.9 reduced 2} - 5.0 months 7.6 
by 35%) 
4! to 7t months a.3 (12. 8 reduced 3t - 5-i- months 6.9 
by 35%) 
1e5 . 
Greater numbers of infants were invewtigated with method A, so that 
it was possible that the difference in maximum and mean Figlu excretion 
obtained with the two methods might have reflected a difference in the 
samples studied . More infants whose urines were examined with method A 
might have excreted total quantities of Figlu in the higher normal range . 
Another less likely possibility was Cooperman ' s (1967) claim that the 
method of Chanarin and Bennett (1962a) was less sensitive than that of 
Tabor and Wyngarden (1958) and not suitable for use in children. While 
there might be a difference in sensitivity between the two methods (Cooper-
man and Luhby, 1962) there is as yet no proof that the two methods should 
not produce comparable results . It was not possible to compare the two 
methods in this study . 
Third , the reason for the change from negative to positive Figlu 
tests noted in some infants was of interest. It was apparent that this 
was largely attributable to the effect of urine concentration as judged by 
an incorrect criterion of normality for concentration of Figlu excretion . 
However , this was not the case in all instances , because in a small pro -
portion of infants total Figlu output also increased . There mi gh t be 
another explanation for this . It was observed that as infants grew older 
there was a significant improvement in creatinine ratio . This was not 
related to improved nutrition and there were no clinical reas9ns for 
believing that there had been previous hepatic or renal insufficiency . 
It was possible that the improvement in creatinine ratio resulted from 
maturation of glomerular filtration function , as growth occurred . It has 
been stated that glomerular filtration function in infants reaches adult 
levels at about a year of age(McCancg, 1962) . Since Figlu excretion was 
higher in infants with higher creatinine ratios, it seemed possible that 
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normal Figlu output in individual infants might, to some extent, be 
influenced by the maturity of glomerular filtration function. Clearly 
at this stage any inference regarding the relationship of Figlu excretion 
to glomerular filtration function is highly speculative and requires 
confirmation by further investigation using more refined techniques. 
Caution is especially necessary in view of the fact that Figlu is known 
to have a high clearance rate (Knowles, Prankerd and Westall, 1961). 
Although there is strong experimental evidence for believing that 
normal Figlu excretion in infants might depend on maturity of glutamate 
formiminotransferase function, it is as yet unknown to what extent maturity 
of glomerular filtration function may influence normal Figlu excretion. 
Disturbances of Histidine Metabolism. 
In this study no attempt was made to investigate histidine meta-
bolism in infancy. Urocanic acid and other imidazoles were estimated 
only in so far as these might have affected the interpretation of the 
Figlu test. The degree of disturbance of histidine metabolism was rarely 
severe enough to interfere with the interpretation of the Figlu test. 
The number of infants excreting excessive urocanic acid was too 
small to allow investigation of the interrelationships between histidine 
metabolism,hepatic dysfunction and undernutrition (Dean and Whitehead, 
1963; Friedman, · Mckenzie, Turner and Wittmann, 1964b; Spector, Falcke, 
Yoffe and Metz, 1966; Davis and Kelly, 1963; Hoffbrand, Neale, Rines 
and Mallin, 1966). 
Histidinuria had been reported in rickets (Chisholm and Harrison, 
1960), but did not apparently interfere with the interpretation of the 
Figlu test. 
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SUMMARY AND CONCLUSIONS. 
1. By means of two methods for estimating Figlu, it was shown that a fair 
proportion of healthy, underprivileged infants excreted Figlu in excess 
after oral histidine. When the method of Tabor and Wyngarden (1958) 
and an accepted criterion of normality for concentration of Figlu in 
urine were used, approximately 42% of infants under 4t months had 
positive Figlu tests. These tests were not the result of folate 
deficiency, nor the result of a disturbance of folate metabolism as 
far as this could be ascertained, nor entirely the result of non-
specific factors. Positive Figlu tests were not associated with any 
detrimental effect on infant health. 
2. When the method of Chanarin and Bennett (1962a) was used, a criterion 
of normality for quantity of Figlu excretion (mg./24 hrs) was derived, 
using 30 rg./ml. as the standard of reference. In this way, spurious 
positive Figlu tests resulting from urine concentration, were elimi-
nated. Even under these circumstances 17.8% of infants under 5 months 
had positive Figlu tests which could not be attributed to any of the 
causes above. Nor was there any relationship between these positive 
Figlu tests and infant health. 
3. It was found that the total quantitative Figlu output in all but three 
infants with positive Figlu tests after oral histidine did not exceed 
the normal values found in adults. Because it had been reported that 
total Figlu output in normal infants was comparable to that of adults, 
it was concluded that the Figlu excretion found in the infants in this 
study was within normal limits for the experimental conditions of this 
study. It reached 181.5 fg./ml. and 65.9 mg./24 hours without being 
indicative of folate deficiency. Accordingly the results of this 
test did not reveal unequivocal biochemical folate deficiency. 
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4. The previously accepted criterion of normality for infant Figlu 
excretion expressed as concentration was the same as that of adults. 
It was concluded that this was invalid because it did not allow for 
the smaller urine volume passed by infants and that this explained 
the "positive Figlu tests" (expressed as pg./ml.) found in this study. 
5. Total Figlu output declined with growth. This meant: 
(a) that the use of a criterion of normality such as 30 fg./ml. 
(45 fg./ml.) became more valid with growth; 
(b) normal Figlu excretion in infants should be related to age. 
6. The application of the Figlu test as a diagnostic parameter of megalo-
blastosis must still be established. It might have a similar appli-
cation to that in adults, provided normal levels are adequately defined. 
7. In this study, disturbances in histidine metabolism were not investi-
gated as such. They were rarely severe enough to result in a signi-
ficant decrease of Figlu excretion in healthy underprivileged infants. 
8. Two methods were used for estimating Figlu. The method of Chanarin 
and Bennett (1962a) appeared to have two advantages over the method 
of Tabor and Wyngarden (1958): 
(i) The enzyme was more easily prepared in greater amounts during 
a shorter period of time; 
(ii) the method allows for the separate and combined estimation of 
urocanic acid and Figlu. This may be an advantage when this 
test is used to investigate folate deficiency in malmourished 
infants. 
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HYPERSEGMENTATION OF THE NEUTROPHILS 
AS A PARAMETER OF FOLATE DEFICIENCY. 
Arneth (1904) was the first investigator to consider the importance 
of the number of nuclei present in polymorphs and to recognise the increased 
segmentation of polymorphs evident in pernicious anaemia (Arneth, 1907). 
This shift to t he right in nuclear segmentation was later confirmed by 
v.Decastello (1913), Brosamlen (1913), Briggs (1914), Naegeli (lj17) and 
Cooke (1927, 1929). 
At first it was believed that the number of nuclei in polymorphs 
was a manifestation of the age of the cell (Arneth, 1904). Although there 
was further speculation about the origin of the hypersegmented cells 
(Cooke, 1927~ 1929), the first positive contribution was made when Tempka 
and Braun (1932) noted pathological white cell precursors in the bone 
marrow in pernicious anaemia. Later Segerdahl (1935) and Jones (1937) 
showed that the hypersegmented neutrophils developed from these patholo-
gical white cell precursors in the bone marrow. 
The original method of assessing hypersegmentation was both detailed 
and complex (Arneth, 1904), but was later modified (Briggs, 1914; Cooke 
and Ponder, 1927) and simplified (Hynek, 1909). Despite the improvement 
in the method and the recognition of the diagnostic value of the test 
Briggs, 1914; Heck and Watkins, 1933; Cooke, 1927; 1929; Jones, 1937) this 
parameter was apparently little used. 
In 1959 the value of the test as an index of folate and vitamin B12 
deficiency was again emphasised (Herbert, 1959). Thereafter, two methods 
for assessing nuclear segmentation were frequently used. One of these was 
the lobe average (Herbert, 1962a), and the other the percentage of 
Age 
(months) 
2:t - 4t 
4t - 7t 
7t - loi 
lo! - 16 
TA:BLE 82. 
INCIDENCE AND PATTERN OF BYPERSEGMENTATION 
OF THE NEUTROPHILS IN INFANTS 
Positive results Numbers of Percentage of 
Investigations infants with 
Infant % Hyperseg- Hypersegmentation 
men ta ti on 
R.J. 5 











J.E. 8 32 12.5 
C.H. 6 
c.v. 1 
A. :B. 4 
T.F. 10 35 8.6 
s.n. 1 
RELATIONSHIP OF MEAH SERUM FOLATE LEVELS TO HYPERSEGMENT-
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0·60< P< 0-70 
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A COMPARISON OF PERCENTAGE SEGMENTATION OF NEUTROPHILS AND 
BONE MARROW EXAMINATION AS PARAMETERS OF FOLATE DEFICIENCY. 
(a) Morphology of the bone marrow in infants 













(b) Percentage hypersegmentation of neutrophils in infants 
with megaloblastic changes in the bone marrow. 
Infant % Hypersegmentation Bone marrow morphology 
M.R. Gradel megaloblastosis 
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neutrophils with five or more lobes - percentage hypersegmentation 
(Chanarin, Rothman and Berry, 1965). In this study, percentage hyper-
segmentation was used as an index and its validity as a parameter of 
folate deficiency will be evaluated in this chapter. 
RESULTS. 
Incidence of Hypersegmentation (Table 82). 
In the four age groups, from 6.2% - 12.5% of infants had hyper-
segmented neutrophils. 
Pattern of Hypersegmentation (Table 82). 
Hypersegmented neutrophils were consistently found only in T.F. 
However, this could not be adequately assessed in A.B., s.w., J.E., J.C. 
and N.M . because blood films taken from these infants were not always 
technically satisfactory. 
HYPERSEGMENTATION OF THE NEUTROPHILS 
AS A PARAMETER OF FOLATE DEFICIENCY. 
mentation of the Neutro 
There was no statistical relationship between mean serum L.casei 
folate levels and hypersegmentation of the neutrophils. 
A Com arison of H the Neutro hils 
Three infants who had hypersegmented neutrophils did not have megalo-
blastosis. One infant with megaloblastosis did not have hypersegmented 
neutrophils. 
In all other instances (22), where bone marrow examinations were 
performed and where these two parameters could be compared, there was 






























































































































































































































































































































































































































































































































THE EFFECT OF THE NUMBER & SEVERITY OF INFECTIOHS [I NFE CTI ON SCORE ] 
















INF ANTS 2114 to 41/2 months. 
hypers·egmentati an normal ·segmentation 
n=60 
t=1 ·111- 0·20<P<0·30. 
) 
INFANTS 71/2 to 10J/4months 
hypersegment at ion normal segmentation 
n= 25 











t= 0·408,; 0·60< P<0-70 
INFANTS 10~ to 16 months 
h t t. normo ypersegmen ° ,on segmentation 
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NEUTROPHILS IN INFANTS . 
INFANTS 2h to 4112 months 
. normal 









t= 0·106; P >0 ·90 











I= 1 839, 0·05 < P< 0·10 




1 = 2 · 625, 0·01 < P < 0-02 




t= 0 572 , 0 · 5 0 < P < 0 · 60 
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AETIOLOGICAL POSSIBILITIES FOR FOLATE DEFICIENCY 
IN INFANTS WITH HYPERSEGMENTED NEUTROPHILS 
Maternal Factors (Fig. 41). 
There was no statistical relationship between hypersegmentation of 
the neutrophils in infants and 
(a) mean maternal serum L.casei folate levels; 
(b) hypersegmentation of the neutrophils in their mothers; 
(c) mean cord serum L.casei folate levels. 
None of the infants whose mothers excreted excessive Figlu had 
hypersegmented neutrophils. 
Dietary Factors. 
From 2t - 4t months all infants with hypersegmented neutrophils 
received virtually the same diet. This consisted of a combination of 
breast and formula milk and, in three of the four infants, cereal and 
a mixed diet. This did not provide any evidence for further investigation 
along these lines. 
Malabsorption. 
Xylose excretion was normal in one infant who had hypersegmented 
neutrophils. 
Increased Demand for Folate. 
1. Infection Score (Fig. 42). There was no statistical relationship 
between hypersegmentation of the neutrophils in infants and mean 
infection score. 
2. Growth and Nutrition (Fig. 43). 
Infants with hypersegmented neutrophils had higher mean weight 
percentiles. This relationship was statistically significant only 
in infants from 4t - 7t months. 
RELATIONSHIP OF SERUM IRON LEVELS 
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41/ - 71/: months 
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Difference of means 
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Difference of means 
t = 2 ·035 
Fig. 44 . 0 ·05 < P<0·10 
THE EFFECT OF INFECTION AT THE TIME OF INVESTIGATION ON 



















INFANTS 2.!( - 4 / 2 MONTHS 
With Without 
Hypersegmentot ion Hypersegmentot ion 
Significance of difference 
X2= o ·710 
0·30<P<0 ·50 
60 
INFANTS 7~ - 10~ MONTHS 
Signif icance of difference 

























0 ·30< P<0·50 
~ Infect ion 
~ No infect ion 
Fig. 45 
INFANTS 4f2- 7;'2 MONTHS· 
With Wi thout 
Hypersegmentot ion Hypersegmentot ion 
6 
Significance of difference 
-x.2 = 1·278 
0·20<P<0 ·30 
INFANTS 10,'A - 16 MONTHS 
H perse 
3 
Sign ificance of d ifference 
x2= o . 430 




























OF HYPERSEGMENTATION OF 
IN INFANTS TO HAEMOGLOBIN 
THE 
LEVELS 
INFANTS 2)4-4~ MONTH S 
With W ithout 
Hypersegmentation Hypersegmentation 
Difference of means 
t = 0·600 
O· 50<P < 0·60 
INFANTS 7~ -10~ MONTHS 
With Without 
H persegmentation Hyperse mentation 
n=5 
n • 22 
Difference of means 
t = 0·279 








































Fig . 46 
INFANTS 4 ~ - 7~ MON THS 
W ith Without 
Hypersegmentat ion Hypersegmentat ion 
H 
Difference of means 
t =0·808 
0·40 < P <0 ·50 
INFANTS 10 74 -16 tv10NTHS 
Difference of means 
t = 0·494 
0 ·60<P< 0· 70 
mentotion 
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From these findings it appeared that rapid growth leading to increased 
demand for folate was the only possible aetiology for folate deficiency in 
infants with hypersegmented neutrophils. However , there was statistical sup-
port for this only in infants of one age group . Thus, the possibility that 
rapid growth had resulted in increased demand for folate and therefore caused 
folate deficiency in infants with hypersegmented neutrophils was doubtful. 
THE RELATIONSHIP OF HYEERSEGMENTA~ION 
TO O~HER POSSIBLE AETIOLOGICAT, FACTORS 
Iron Deficiency (Fig. 44). 
There was no statistical relationship between hypersegmentation of the 
neutrophils and mean serum iron levels. 
Iinfection at the time of investigation (Fig. 45). 
A statistical relationship between infection at the time of investigation 
and hypersegmentation of the neutrophils in infants could not be demonstrated •. 
Cong~nital Hypersegmentation . 
The parents of the infant who consistently showed evidence of hyper-
segmentation did not have hypersegmented neutrophils. 
None of the infants with hypersegmented neutrophils had an increase of 
4-lobed neutrophils greater than 50%. 
HAEMATOLOGICAL IMPORTANCE OF HYPERSEGMENTATION OF THE NEUTROPHILS 
Relationship to Haemoglobin Concentration (Fig. 46). 
There was no statistical relationship between mean haemoglobin concen-
tration and hypersegmentation of the neutrophils. 
HYPERSEGMENTATION AS ASSESSED WITH BRIGGS' (1914) CRITERION 
The highest count noted was 5% and only 3 infants had counts in excess 
of 3% (4%; 4% and 5%). Serum L.casei folate levels and the Figlu test after 
oral histidine were normal in the infants with 4% hypersegmented neutrophils 
but were notarailable for comparison in the infant with 5% hypersegmented 
cells. These 5% hypersegmented neutrophils were not associated with 
megaloblastosis. The serum iron level was low in one infant (4% hyper-
segmented cells) where this was available. 
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DISCUSSION. 
Hypersegmentation of the neutrophils was not often present in the 
infants in this investigation and in most cases was an inconsistent finding. 
Even in the presence of megaloblastosis, hypersegmentation of the neutro-
phils could be a transient finding (Chanarin, Rothman, Ardeman and Berry, 
1965). 
The hypersegmented neutrophils noted in this study did not show any 
of the following morphological changes: 
(a) increase in size of the cells (Cooke, 1927; 1929); 
(b) increased nuclear-cytoplasmic ratio (Herbert, 1964); 
(c) multiple bridging between nuclear lobes (Luhby and Cooperman, 
1964). 
Furthermore there was no proof that the hypersegmented neutrophils 
noted in this study were a manifestation of folate deficiency. The 
relationship of hypersegmented neutrophils to the serum L.casei folate 
assays and bone marrow morphology was poor. Also there was no unequivocal 
aetiology for folate deficiency in the infants with hypersegmented neutro-
phils. 
From other studies it appeared that hypersegmentation of the neutro-
phils was not always a successful parameter of folate deficiency. In 
adults, when hypersegmentation was defined as an increase of neutrophils 
having more than 4 lobes to their nuclei, a poor relationship between this 
parameter and serum L.casei folate assays was found (Hurdle and Picton 
Williams , 1966; Kremenchuzky and Hoffbrand, 1965). However, when 6 or 
more lobed neutrophils were compared with the serum L.casei folate assays, 
there was agreement between these parameters (Kremenchuzky and Hoffbrand, 
1965; Roberts, Hoffbrand and Mellin, 1966). 
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There was a poor relationship between hypersegmented neutro-
phils and megaloblastosis (Reynolds, Milner, Matthews and Chanarin, 1966). 
In infants, the value of percentage hypersegmentation of the neutro-
phils was controversial. Some investigators round agreement between hyper-
segmentation of the neutrophils and the serum L.casei folate assays 
(Vanier and Tyas, 1967; Shojania and Gross, 1964b) while others found a 
poor agreement (Vanier and Tyas, 1966). Hypersegmentation was reported as 
both a consistent (Vanier and Tyas, 1967) and an inconsistent association 
(Gray and Butler, 1965; Wise , Lovric and O'Gorman Hughes, 1963) of megalo-
blastosis due to folate deficiency. 
It was believed that hypersegmentation of t he neutrophils was not 
pathognomonic of folate and vitamin B12 deficiency (Cooke, 1929; Tempka 
and Braun, 1932; Herbert , 1964; Edwin, 1967; Hansen, 1967). This might 
partly have explained the conflicting reports of this test. 
In this study, other possible aetiologies for hypersegmentation of 
the neutrophils were iron deficiency, infection and a congenital abnormality 
of nuclear segmentation. There was no statistical evidence for attributing 
hypersegmentation of the neutrophils to either iron deficiency or infection . 
However, it was asserted that hypersegmented neutrophils might remain in 
the circulation long after the pathological cause had been treated (Neu-
berger, 1927; Watkins and Berglund, 1927) although this was not confirmed 
by Fleming (1929) . If t his were so, it might have complicated the inter-
pretation of the statistical data. Only a direct study of the effe~t of 
infection and iron deficiency on nuclear segmentation conducted under 
controlled conditions would have provided conclusive evidence with which 
to assess a relationship between percentage hypersegmentation and iron 
deficiency and infection. 
FIG. 4.-T ypica l h ypcrscgmcntcd po l~mo rph o nu clcar lcukoqtc~ due lo , i1a111i11 [a] 
B,, 
Fig 3 'Twinning deformity' next to four-lobed neutrophi/ 
(peripheral blood of normal man after seventy-eight [ b ] 
days of deprivation of dietary Jo/ate) 
Plate 3:- Illustrations of hypersegmented neutrophils 
according to 
(a) Herbert, 1959; 
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4:- Illustrations of hypersegmented neutrophils according to 
(a) Arneth's classification (Wintrobe, 1956); 











A congenital cause for hypersegmentation was excluded in most 
infants because the finding was an inconsistent one and because there 
was no associated increase in four-lobed neutrophils (Undritz, 1958; 
Herbert, 1965). It could also be excluded in the one infant in whom 
hypersegmentation was consistently found, because his parents did not 
show evidence of this anomaly (Undritz, 1958). 
From the data in this study, iron deficiency and infection could 
not be entirely excluded as causes for hypersegmentation but there was 
a likelier explanation for this finding. This concerned the lack of 
clarity regarding the definition of separate lobulation. This diffi-
culty prompted Herbert (1964) to suggest that each laboratory determine 
their own normal values. The wide range of reported normal values for 
percentage hypersegmentation is probably a measure of the disagreement 
which exists concerning separate lobulation. The upper limit of hyper-
segmented neutrophils in normal subjects was set at 2% by Arneth (1904) 
and Cooke (1927; 1929), at 3% by Heck and Watkins (1933) and Herbert 
1959), at 4% by Hurdle and Picton Williams (1966) and Willoughby (1967), 
and at 5% by Lowenstein, Cantlie, Ramos and Brunton (1966) and Herbert 
(1967). 
In attempting to define separate lobulation in this study it was 
found that investigators differed about the width of the inter-lobular 
chromatin bridge necessary for individual lobe-counting. Nuclear lobes 
were individually counted when they were separated by a thin chromatin 
thread (Briggs, 1914; Heck and Watkins, 1933; Chanarin, Rothman and 
Berry, 1965) or a bridge of chromatin not greater than 50% of the 
largest diameter of the lobes on either side (Edwin, 1967). Moreover, 
illustrations of nuclear segmentation such as those depicted in Plates 
3 and 4 were confusing. 
[a] 
[b] 
Plate 5:- Examples of neutrophils which were 
regarded as hypersegmented but which 
would not qualify for this if Briggs' 
(1914) criterion were used. 
Plate 6:- Examples of neutrophils which were 
regarded as hypersegmented but which 
would not qualify for this if Briggs' 




From a study of some of the above reports and the illustrations 
presented here, it was decided to define separate lobulation as lobes 
separated by a definite bridge of chromatin. This seemed a reasonable 
way of satisfying most definitions. However, it was too flexible a 
definition resulting in inconsistent application especially because long 
periods of time elapsed between repeat counts of percentage hypersegmen-
tation. Thus, initial reproducibility between repeat counts was poor 
(Table 12). When the definition was applied with greater consistency, 
reproducibility improved but was still occasionally disappointing. When 
the cause for percentage hypersegmentation of the neutrophils in this 
study was not clear, smears showing hypersegmented neutrophils were 
recounted using Briggs' (1914) criterion for nuclear separation. Briggs 
(1914) counted nuclear lobes as single if they were not clearly separate 
or if they were connected by anything more than the finest chromatin thread: 
doubtful cells were not counted. With the use of this criterion none of the 
infants had hypersegmented neutrophils in excess of 5%• In Plates 5 and 6, 
examples of neutrophils are shown which were regarded as hypersegmented 
but which would not qualify for this de•cription using Briggs' (1914) 
criterion. It seems clear that the levels obtained with this method will 
vary according to the definition of hypersegmentation! 
The criterion for nuclear segmentation used by Briggs (1914) was 
preferred to that used in the beginning of the study, because it is less 
equivocal and therefore provides greater possibilities for reproducible 
results. These could possibly be further improved by counting more than 
100 cells on each occasion. With the use of this criterion, up to 4% 
(perhaps 5%) of hypersegmented neutrophils could be present in the absence 
of folate deficiency, and with this parameter folate deficiency was not 
diagnosed in the infants studied. The upper limit of normal has been set 
* separate lobulation. 
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at 3% by investigators who used a similar criterion of nuclear separation 
(Heck and Watkins, 1933; Chanarin, Rothman and Berry, 1965). The slightly 
higher levels found here of 4% (perhaps 5%) might have resulted from 
associated iron deficiency or infection. The numbers concerned were too 
few to allow clarification of this possibility. 
SUMMARY 
By means of percentage hypersegmentation as a parameter, it was not 
possible to establish that infants in this study had morphological folate 
deficiency. The use of a criterion for nuclear separation suggested by 
Briggs (1914) prgvided the best opportunity for reproducible results with 
this method. Up to 4% (possibly 5%) of neutrophils could be hypersegmented 
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It was not possible to prove the presence of biochemical folate 
deficiency in the infants in this study, using either the Figlu Test after 
oral histidine or hypersegmentation of the neutrophils as parameters of 
folate deficiency. In this chapter the results of microbiological assays 
for folate particularly in serum will be assessed. In the light of these 
findings the incidence, aetiology, significance and need for prophylaxis 
of folate deficiency in healthy underprivileged infants will be discussed. 
RESULTS OF THE SERUM L~CASEI FOLATE ASSAYS. 
Pattern of serum L.casei folate estimations (Fig.47). 
(i) All infants. 
The mean serum L.casei folate level in infants from 2t - 41 months 
was higher (10.5 ng./ml.) than that in adults (6.9 ng./ml.). The mean 
serum L.casei folate level showed a fluctuating decline with growth until 
loi - 16 months, when it fell below the mean adult L.casei folate level. 
(ii) Ten Infants. 
A gradual decline of mean serum L.casei folate levels was noted 
in association with ~rowth in ten infants from whom serum was obtained for 
L.casei folate assays on all four occasions of investigation. Because 
there was no fluctuation in the decline of the mean serum L.casei folate 
level in this group, the fluctuation noted above was ascribed to selection 
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Range of serum L.casei folate levels (Fig.47). 
The range of serum L.casei folate levels found in infants extended 
below (0.9 ng./ml.) and above (46.8 ng./ml.) the normal range found in 
adults (3.0 - 17.3 ng./ml.). 
HIGH SERUM L.CAWEI FOLATE LEVELS. 
Incidence (Table 84). 
The maximum incidence of high serum L.casei folate levels occurred 
in the youngest group of infants. The percentage incidence was as follows: 
2t - 4i months - 18% (19 of 106) 
4i - 7i months - 8% (7 of 91) 
7! - lo! months - 10% (3 of 28). 
No infant of more than lo! months had a serum L.casei folate level 
above the normal adult range. 
Aetiology of high serum folate levels. 
With the exception of 
(a) the folio acid absorption tests 
(b) infection at the time of investigation 
the aetiology was first assessed only in infants from 2t - 4! months. 
It was further assessed amongst the older infants only where the 
numbers allowed it and where a definite cause for the high serum L.casei 
folate levels had been found. 
It was found that high serum L.casei folate levels could be related 
to dietary factors. 
Milk feeding (Fig.48). 
Breast-fed infants who received no other milk supplements had 
significantly higher mean serum L.casei folate levels than infants who 
RELATIONSHIP OF HIGH SERUM FOLATE LEVELS TO MILK FEEDING 




















INFANTS 21/4 to 4 Vz months 
b . l breast+ reast 
+ 
reast ori Y occasional bottle bottle 
b o t tl e + b tt l l occasional breast O e on Y 
SJ 
7 
~ INFANTS WITH HIGH SERUM FOLATE LEVELS 
0 INFANTS WITH NORMAL DI LOW SERUM FDLATE LEVELS 
INFANTS 41/2 to 71/z months 










~J~ ~J~ f 
TABLE 85 
THE RELATIONSHIP OF DIETARY FACTORS TO MEAN SERUM FOLATE LEVELS 
IN INFANTS 2t - 4t MONTHS. 
Dietary Me~n serum Significance Significance 
factor folate level test 
ng./mL 
Infants given 8.3 n • 39 t • 2.342 cereal 
'STUDENTS' 
Infants not given 12.0 n • 65 t-test 0.02< P < 0.05 cereal 
Infants given 8.2 n • 21 t • 1.600 mixed diet 
" 
Infants not given 11.2 n • 83 0.10< P < o. 20 mixed diet 
Infants given 
orange juice or 8.8 n • 11 t • 0.800 Vitamin C 
" 
Infants not given 
orange juice or 10.8 n • 93 o.4o<p < 0.50 Vitamin C 
Infants given 10.0 n • 38 t • 0.635 cod liver oil 
" 
Infants not given 11.0 n • 66 O. 50 < P < 0. 60 cod liver oil 
Infants given 9.5 n = 16 t • 0.619 vitamin syrup 
" 
Infants not given 10.8 n • 88 o.5o < P < 0.60 vitamin syrup 
Infants given 11.0 n • 18 t • 0.350 patent medicines 
" 
Infants not given 10.5 n • 86 o. 1o < P < o.ao patent medicines 
Conclusions The mean serum folate level is not significantly 
higher in infants receiving any of these dietary 
factors. 
Infants not receiving cereal have significantly higher 
mean serum folate levels than those receiving cereal. 
• 
TABLE 86 
* COMPARISDN OF FOLATE CONTENT OF BREAST MILK WITH 
THAT OF MILKS PREPARED BY THE MOTHERS". 
C-lassification :'@a,nge Mean Test e>)f 
signific:ance 
Significance 
Brea'St milk 8 .. 4 - 58.8 28 .. 7 
n = 21 
t = 2.633 
Prepared milk 3.1. - 40.A 20.8 · 
n = 49 
'STUDENT Is' 
t-test 0 .. 01 < P < 0.02 
* All were assessed as total. milk folate. True milk folate values· were 
determined on 39 of the milks .. However the range of non-folate growth 
factors was negligible (0.1 - 1.4 ng./m1..) 
Conclusion: The total folate content of breast milk was signif~cantly 
higher than that of prepared milks •. 
* FOLATE ASSAYS PERFORMED ON MILK PREPARED IN THE 
* 











Preparation of formula milks-:- The powdered milk was 
re constituted in boil..ed water after c.ooling this· to a 
suitable temperature. This was: bottleQ and then 
autoclaved for 3-4 minutes at 5 l.b./s:q .. in .. at 228°F. 
Preparation of cows milk feeds:- Pasteurized milk was: 






THE EFFECT OF AUTOCLAVING ON FOLATE ACTIVITY 
IN SERA (L.CASEI) NOT PROTECTED WITH 









RELATIONSHIP OF INFECTION AT TIME OF INVESTIGATION TO 
MEAN SERUM FOLATE LEVELS 
IN FAN TS 2YI. to 4'tz months 






u., 6 -C 
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IN FAN TS 7Yz to 103,1. months 




-C 4 u., 
:a: 
2 
D - ....... ~i...--......__.a.;i~~__, 
t = 0 · 922 
D·30<P<0·40 
INFANTS 4h to 7112 months 
infection no infection 
t=O ·462 
0·60<P<O ·70 
INFANTS 1011,.to 16 months 
infection no infection 
·t= 0 ·358 
0 ·70<P<0-90 
Fig. 50 . I.--.--------~~--- ------------m.--J 
CORD SERUM FOLATE, HAEtv10GLOBIN, RELATIONSHIP OF MEAN 
URINARY FIGLU At-0 SERUM 





















CORD SERUM FOLATES 
Infants with high 
!olota levels 
Infants with normal 
or low folate levels 
Difference of means t = 1 · 407 
0 ·1<P<0· 2 
FIGLU EXCRETION 
Infants w i th high 
folate le1191s 
Infants with normal 
or low folata levels 
n• 82 
Difference of means t = 0 · 253 
0·8<P<0·9 











Fig. 51 : 
HAEMOGLOBIN 
Infants with high 
folate levels 
Difference of means 
lnfonts with normal 
or low folata levels 
t = 1·600 
0 ·1<P<0·2 
SERUM IRON LEVELS 
Infants with high 
folat. levels 
Difference of rneais 
Infants with normal 
or low tolate lewis 
t:1•6 35 
0· 10 <p< 0·20 
200. 
received a combination of breast and artificial milk feeding or artificial 
milk feeding alone. This applied to infants from 21 - 4t months and 
4t - 7i months. 
In the same age group the greatest incidence of high serum L.casei 
folate levels was found in infants who received breast milk and no other 
milk supplements (Fig.49). 
Supplementary Feeding (Table 85) 
None of the additional dietary supplements given to the infants 
produced a significant rise in mean serum L.casei folate levels. 
Folate Content of Milk (Table 86) 
The mean L.casei folate content of breast milk (28.7 ng./ml.) was 
significantly higher than that of prepared milk (20.8 ng./ml.). 
The L.casei folate content of some of the proprietary milk feeds 
prepared in the Red Cross War Memorial Children's Hospital's diet kitchen 
ranged from 5.2 ng./ml. - 29.2 ng./ml. 
High serum L.casei folate levels could not be related to: 
(a) Contamination with folic acid (Table 87). 
Two sera containing high concentrations of L.casei folate 
activity were later assayed without ascorbic acid protection. This 
resulted in a great reduction of measurable folate. 
(b) Infection at the time of investigation (Fig.50). 
There was no statistical difference between mean serum L.casei 
folate levels in infants with and without infection at the time of 
investigation. 
(c) Cord serum L.casei folate levels (Fig.51). 
The mean cord serum L.casei folate levels were not statistically 
different in infants with and without high serum L.casei folate levels. 
MEAN and RANGE of FOLIC ACID ABSORPTION REL ATED to 
210 SERUM FOLATE LEVELS 
RAL P.G.A. RAL P.G.A. 
180 180 
INFANTS with NORMAL SERUM FOLATES INFANTS with LOW SERUM FOLATES 
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Fi g. 52 
MEAN and RANGE of FOLIC ACID ABSORPTION RELATED to 
SERUM FOLATE LEVELS 
INFANTS with NORMAL SERUM FOLATES 
SUBJECT 
FOLATE . LEVELS ng./ ml. 
FoCiTE BASAL I Hr. 2 Hrs. 
M.dr L. 10.6 26 102 73 RISE 1nS.FOLATES 
M.E. 6.1 60 135 128 
B.S. 8.0 18 I I 2 98 BASAL to I HOUR 
MEAN 35 II 6 100 
DATA 
NORMAL LOW HIGH 
FOL ATE FOLATE FOLATE 
RANGE 75 -94 79-103 93-112 
MEAN 82 91 103 
IN FAN TS with LOW SERUM FOLATES 
SIGNIFICANCE of DIFFERENCES of MEANS 
FOLATE LEVELS ng./ ml. 
SUBJECT Sr. 
FOLATE BASAL 
- I Hr. 2 Hrs. 
F= 1.48 P > 0.05 
BASAL to 2 HOURS 
J.P. ,., 14 II 7 98 
M. L . 2.3 72 I 5 I 134 
NORMAL LOW HIGH 
DATA FOLATE FOLATE FOLATE 
MEAN 43 134 II 6 RANGE 46-81 62-84 58 -76 
MEAN 65 73 67 
SIGNIFICANCE of DIFFERENCES of MEANS 
F: 0 .13 P> 0 .05 
INFANTS with HIGH SERUM FOLATES 
FOLATE LEVELS n g./ ml. 
SUBJECT 
FoClrE BASAL I Hr.
 2 Hrs. 
C.E 19.1 75 187 13 4 
L . F. 20.5 gs I 78 160 
MEAN 80 I 83 14 7 
TABLE 88 
TABLE 89 
RELATIONSHIP OF NUTRITION TO HEIGHT 
OF SERUM FOLATE LEVEL IN INFANTS AT 
2t - 4t MONTHS OF AGE. 
Height of serum folate 
levels in infants 
High serum folate levels 
Normal or low serum 
folate levels 
P Mean. 1 ercen'til. e 
(weight) 
42.0 
n = 19 
42.0 
n = 87 
No relationship between growth and height of 
serum folate level. 
RELATIONSHIP OF ERYTHROPOIESIS AS ASSESSED BY 
RETICULOCYTE COUNT TO HEIGHT OF SERUM FOLATE 
IN INFANTS 2t • 4t MONTHS OF AGE. 
Infant serum folate 
level 
High 




1.1 - 2.5 
n = 3 
0.5 - 4.1 






There is no obvious relationship between decreased 
erythropoietic activity and height of serum folate 
level. 
TABLE 90 




Normal or low 
serum fola-te 
levels 
TO SERUM VITKMIN B12 LEVEL 
Mean serum vitamin B12 pg./ml. .. 
445 
n = 19 
474 
n = 85 
Test of 
significance 
'STUDENT ' S ' 
t-test 
Significance 
t = 0.550 
0 .. 50 <P'<0.60 
Conclusion: Mean serum vitamin Bi2: levels are J.ower in infants, with 
high serum fol.ate Levels, but this. is not a statisticaliy 
significant result. 
201. 
(d) Felic acid absorption (Fig.52: Table 88). 
There was no statistically significant difference in the absorp-
tion of folic acid between infants with high serum L.casei folate levels and 
those with serum L.casei folate levels in the normal or low range. 
(e) Decreased demand for folate. 
(i) Growth (Table 89): There was no relationship between high 
serum L.casei folate levels and poor growth. Mean percen-
tile levels were the same in infants with and without high 
serum L.casei folate levels. 
(ii) Erythropoiesis: A relationship between high serum L.casei 
folate levels and decreased erythropoiesis was not demon-
strated. 
(a) Mean reticulocyte count in infants with high serum 
L.casei folate levels was similar (2%) to that found 
in infants with normal or low serum L.casei folate 
levels (1.8%) (Table 89). 
(b) There was no statistical difference between mean 
haemoglobin concentration in infants with and without 
high serum L.casei folate levels. (Fig. 51) 
(f) Secondary disturbance of folate metabolism. 
There was no statistical difference between 
(i) mean Figlu excretion (Fig.51); 
(ii) mean serum iron levels (Fig.51); 
(iii)mean serum vitamin B12 levels (Table 90) 
in infants with and without high serum L.casei folate levels. 
E








































































































































































































































































































































































INCIDENCE OF LOW SERUM FOLATE LEVELS IN INFANTS. 
Age Number of Number of low Nature of Study (months) estimations, estimations 
< 3.0 ng./mL 
2t-4t 71 4 
Prospective 4t-7f 56 4 
Study 7f-Ioi- 28 l 
3 104-16 32 4 
.Additional 2~7t 112 8 Studies 
202. 
Pattern of L.casei folio acid clearance test in infants 
with high serum folate levels (Fig.53). 
The rate of clearance of folic acid was different in the two infants 
with high serum L.casei folate levels. In one infant, A.H.A., the clearance 
of folic acid was slower and in the other, D.A., the clearance of folic acid 
was faster than in infants with normal folate nutrition. No inference 
could be drawn from these findings. 
LOW SERUM L.CASEI FOLATE LEVELS 
Incidence. 
Prospective Study (Table 91). 
Only an approximate incidence of low serum L.casei folate levels 
can be given in this study because of several complicating factors: 
(i) Serum L.casei folate estimations could not be performed on all 
infants at all times of investigation. 
(ii) Twenty-nine (29) of the original 86 infants were withdrawn 
from the study at the end of the second visit. 
Of the 86 infants, 10 had low serum L.casei folate levels only once 
or more often. On this basis (10 of 86) the approximate incidence was 11.6%. 
Additional Studies (Table 91). 
Of the infants under 7! months of age om whom investigations were 
performed only once, 7.1% (8 of 112 estimations) had low serum L.casei 
folate levels. 
THE SERUM L.CASEI FOLATE ASSAY AS 
A PARAMETER OF FOLATE DEFICIENCY. 
Comparison with L.casei Folic Acid Clearance Test (Fig.53). 
The L.casei folic acid clearance curve in the infant with a low serum 
L.casei folate level was comparable to those in infants with normal serum 
L.casei folate levels. 
TABLE 92 
RELATIONSHIP OF LOvr SERUML.CASEI FOLATE LEVELS TO 




Bone Marrow Morphology 
S.R. 2.4 No megaloblastosis 
R.J ~ 2.4 No megaloblastosis 
B. C. 2.9 No megaloblastosis 
C.F- i .. 4 No megaloblastosis 
F.U .. 2.0 No megaloblastosis 
S .. B. l.4 No megaloblastosis 
T.de B. 1.9 No megaloblastosis 
M.R .. 0 •. 9 Grada i Megaloblastosis 
TABLE 93 (C~ntd. I 
(c) The relationship of maternal Figlu excretion 
to infant serum folate level. 
Age 
(months) 






serum folate level 
11.2 
n • 4 
11.2 
n • 66 
There is no relationship between these two parameters. 
TADLE 94 
RELATIONSHIP OF SOCIO-ECONOMIC FACTORS TO SERUM FOLATE LEVELS 
Age 
(months) 
2t - 4t 
4t - 7t 
1t - 10-f 































n • 9 
n • 11 
n • 3 
n • 8 
n • 9 
n • 1 
n • 4 
n .. 1 
n • l 
n • 9 
n • 11 










F • 2.00 
P > 0.05 
F • 1.21 
P > 0.05 
F • 0.05 
P > 0.05 
F • 0.65 
P > 0.05 
There is no consistent relationship or statistical association between 
socio-economic conditions and serum folate levels. 
!ETIOLOGY OF LOW SERUM FOLATES 
TABLE 93 
RELATIONSHIP OF MATERNAL FOLATE NUTRITION TO INFANT SERUM 
FOLATE LEVELS 
(a) Correlation between maternal and infant serum folates. 
Age 
(months) 
41" - 7! 
1t - lOf 









r = -0.081 
n • 70 
r • -0.053 
n • 55 
r .. +0.073 
n • 28 
r • -0.006 
n • 32 
Significance 







P > 0.10 
Conclusion: There is no statistical correlation between 
these two parameters. 
(b) The relationship of cord to infant serum folate levels. 
Age 
(months) 
7t - lot 









r • +0.131 
n • 56 
r • -0.117 
n • 45 
r • -0.220 
n • 22 
r • +0-314 
n • 28 
Significance 






P > 0.10 
Conclusion: There is no statistical correlation between 
these two parameters. 
202A. 
Comparison with Red Cell L.casei Folate Assays. 
Red cell L.casei folate assays were performed on 6 infants with 
low serum L.casei folate levels. One of the 6 infants had a low red cell 
L.casei folate level (67.0 ng./ml.). However, red cell and serum L.casei 
folate levels were available for comparison in a further 80 infants who 
had normal serum L.casei folate levels. The red cell L.casei folate level 
was low (63.0 ng./ml.) in one of these infants who had a serum L.casei 
folate level of 4.0 ng./ml. 
Comparison with Bone Marrow Morphology (Table 92). 
One infant with a megaloblastic bone marrow had a low serum L.casei 
folate level (0.9 ng./ml.). This was the lowest level found in this study. 
Seven other infants with low serum L.casei folate levels did not show 
unequivocal evidence of megaloblastosis on examination of the bone marrow • 
• 
AETIOLOGY OF LOW SERUM L.CASEI FOLATE LEVELS. 
l. A statistical analysis of the relationship between aetiological 
factors for folate deficiency and low serum L.casei folate levels. 
A statistical rel a tionship between low serum L.casei folate levels 
and the following factors could not be demonstrated: 
(a) Maternal folate nutrition (Table 93). 
There was no correlation between 
(i) maternal and infant serum L.casei folate levels; 
(ii) cord and infant serum L.casei folate levels. 
There was no statistical relationship between maternal Figlu 
excretion and mean infant serum L.casei folate levels. 
None of the infants with low serum L.casei folate levels (2i-4t months) 
had mothers whose neutrophils were hypersegmented. 
(b) Socio-economic circumstances (Table 94). 
There was no statistical relationship between socio-economic 
conditions and mean serum L.casei folate levels in the infants. 
TABLE 95 
RELATIONSHIP OF NUTRITION TO SERUM FOLATE LEVEL 
Age Nutritional Mean serum Test of Significance 
(months) development folate ng./ml. significance (weight percentile) 
2t - 4t 2nd & 3rd degree malnutrition 11.8 n • 10 
1st degree malnutrition 10.5 n • 29 
Analysis 
of F .. 0.62 
10 - 25th percentile 9.6 n • 14 variance P > 0.05 
26 - 50th percentile 13.2 n • 14 
> 50th percentile 9.7 n • 39 
4t - 7t 2nd & 3rd degree malnutrition 5.1 n • 1 
1st degree malnutrition 7.9 n • 22 
F • 0.96 
10 - 25th percentile 9.e n • 10 " P > 0.05 
26 - 50th percentile e.4 n • 13 
>50th percentile 9.5 n • 38 
7t - loi 2nd & 3rd degree malnutrition 7.2 n • 4 
lat degree malnutrition 5.e n • 8 
F • 3.99 
10 - 25th percentile 11.3 n • 2 IJ P < 0.05 
26 - 50th percentile 13.9 n • 8 
>50th percentile 11.5 n • 6 
loi - 16 2nd & 3rd degree malnutrition 4.a n • 6 
lat degree malnutrition 5.3 n • 7 
F • 1.66 
10 - 25th percentile 5.1 n • 5 IJ P > 0.05 
26 - 50th percentile 7.9 n • 8 
>50th percentile 8.0 n ,.. 6 
There is no consistent relationship between nutrition and mean serum folate 
level but the overall differences become significant in the age group 7f-loi. 
In this group the only significant individual difference is that between 
2nd and 3rd degree malnourished infants and those in the 26-50th percentile. 
In view of this inconsistent pattern it is unlikely that the result has any 
meaning. 
TABLE 96 
RELATIONSHIP OF INC REAS.ED DEMAND FOR 
FOLATE TO SERUM FOLATE LEVELS. 
Ca) Relationship of infection score to serum folate levels. 
Age 
Infection 
Mean serum Test of 
Significance (months) score folate levels significance 
2t - 4t 0 10.0 n = 25 Analysis of F = 0.85 
1 2 11.4 n = 66 2 -
2t 4t 8.7 n = 12 variance p >0.05 
5 &> 2.0 n = 1 
4t - 7t 0 9.3 n = 17 Analysis of F = 0 .21 
1 2 9.0 2 - n = 48 
2t 4t 7.9 n = 20 variance P > 0.05 
5 &> 8.7 n = 3 
7t - 10-] 0 6.9 n = 3 Analysis of F = 3.91 
1 2 10.4 n = 19 2 -
2t 4t 6.6 n = 3 variance P < 0.05 
5 &> 24.o n = 1 
10 t - 16 0 12.4 n = 1 Analysis of F =· 4.46 
1 2 6 .1 n = 8 2 -
2t 4t 4.5 n = 4 variance P< 0.05 
5 &> 0.9 n = 1 
There is no consistent relationship between infection score and mean serum 
folate levels. The overall differences in the age groups 7f-1~ and 
10t-16 are statistically significant. 
In the age group 7f-10t mean serum folate levels are significantly lower 
in infants with an infection score of O than in infants with an infection 
score of 5 & >. This does not therefore suggest a relationship between 
increased demand for folate caused by infection and low serum folate levels . 
~n the age group 10!-16 months the only significant difference is that 
between infants with an infection score of O and f -2. 
The maldistribution of numbers in ~he groups may account for these 
statistical results. It is unlikely that the inconsistent associations 
shown here have any meaning . 
TABLE 96 (Contd.) 
(b) Relationship between low serum folate levels and increased erytbropoiesis 




levels in infants 
Low 
Normal or high 
Range of 
reticulocyte count% 
0.5 - 1.9 n • 4 





There is no relationship between increased erythropoiesis (mean reticulocyte 
count) and low serum folate levels. 
TABLE 97 
RELATIONSHIP OF IRON DEFICIENCY TO SERUM FOLATE LEVELS 
Age Serum folate levels Mean serum iron Test of Significance 
(months) ;ug./100 ml. significance 
f 
2t - 4f Low 76.0 n = 4 'STUDENT'S' t = 1.110 
Normal 62 .9 n = 60 t-test 0.20< P<0.30 
4f - 7f Low 68.3 n = 4 t = 0 . 623 
II 
Normal 58.2 n = 64 0.50< P< 0.60 
10t - 16 Low 56.8 n = 3 t = 0.767 
" 
Normal 49.9 n = 22 o.4o< P<o .50 
Conclusion: Mean serum iron levels were higher in the infants with low serum 
folate levels at all a ges. 
The differences were not statistically significant. 
The infant with a low serum folate level at 7f - 1oi months 
did not have a serum iron estimation. 
203. 
(c) Nutrition (Table 95). 
A convincing statistical relationship was not demonstrated 
between nutrition and mean serum L.casei folate levels in the infants. 
(d) Increased demand for folate. 
(i) Growth (Table 95). 
There was no apparent relationship between rapid growth 
in infants and low mean serum L.casei folate levels. On 
the contrary, after 4! months the better nourished infants 
had higher mean serum L.casei folate levels. 
(ii) Infection (Table 96). 
There was no convincing statistical evidence for attributing 
low mean serum L.casei folate levels to the effect of 
increased demand for folate as the result of infection. 
(iii) Erythropoiesis (Table 96). 
Infants with low serum L.casei folate levels did not have 
increased erythropoiesis as assessed by mean reticulocyte 
counts. 
None of the infants with low serum L.casei folate levels 
had positive occult blood tests. 
(e) Secondary disturbances of folate metabolism (Table 97). 
There was no statistical relationship between low serum L.casei 
folate levels and mean serum iron levels. 
II. Aetiological factors for folate deficiency in individual infants (18) 
(Table 98: 99). 
Dietary Factors. 
Of the 18 infants whose serum L.casei folate levels were low, none 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































might have been l ower in these infants , so resulting in , or contributing 
t o the development of biochemical folate deficiency . 
Also , there was circumstantial evidence for dietary folate 
deficiency in 3 infants . In 2 ( M. R. and S . B. ) there was a clear history 
of deprivation of food and therefore folate . In the other infant ( S . D. ) 
serum L . casei folate levels declined as nutrition deteriorated . 
Nutrition . 
There was no consistent relationship to nutritional development . 
Seven of the 10 infants in the prospective study were undernourished 
while only one of the eight infants investigated in the additional studies 
was undernourishe d . 
Ma.labsorpt'ion . 
This was investigated in seven infants with low serum L . casei 
folate levels . The folic acid absorption test was used in two , and the 
d- xylose absorption test in five . 
(i) Folic acid absorption test (Table 99, 88; Fig . 52) . 
There was no statistical difference in the mean absorption of 
folic acid between infants with low serum L . casei folate levels and 
infants with normal or high serum L.casei folate levels. 
(ii) D-Xylose absorp tion test (Table 100, 98, 99). 
Four of five infa nts with low serum L . casei folate levels excreted 
a normal percentage of xylose . 
The fifth infa nt (F . U.) who had a low serum L.cas:ei folate level 
and associated c h ronic gastroenteritis , excreted an abnormally low 
percentag e of xylose (6%) . This returned to normal (25 . 3%) when the 
associated gastroenteritis had been effectively treated . In this infant 
similar changes were observed in blood xylose levels . 
205. 
Because, in F.U., gastroenteritis was shown to have been associated 
with malabworption, it was possible that this contributed to the development 
of the low serum L.casei folate level. At the time that their serum L.casei 
folate levels were low, another two infants (T.de B. and C.F.) had chronic 
gastroenteritis (Table 98). From this it was inferred that malabsorption 
associated with chronic gastroenteritis might have contributed to the bio-
chemical folate deficiency. 
Parasitic infestation was found in two infants with low serum L.casei 
folate levels. No relationship was demonstrated between parasitic infes-
tation and malabsorption in M.R. (Table 100). 
Recurrent infection (Table 98). 
In two infants with low serum L.casei folate levels the incidence 
and severity of infection (S.B. 8, and M.R.13 ) much of which was gastro-
intestinal, was much greater than that found in other infants of a similar 
age group (mean infection score in the age group 2.5). In these two infants 
(M.R. and S.B.) it was probable that recurrent infection contributed to the 
development of low serum L.casei folate levels. This could have occurred 
as a result of restricted folate intake, increased demand for folate or 
malabsorption of folate when the infection was gastrointestinal. 
Maternal Folate Deficiency, Socio-economic circumstances, 
Iron Deficiency (Table 98, Table 99). 
The role of these factors in producing low serum L.casei folate levels 
in the infants was uncertain. 
Conclusion. 
From the study of the aetiological factors that might have contributed 
to the development of low serum L.casei folate levels in individual infants, 
there was evidence that: 
TABLE 101 
SIGNIFICANCE OF LOW SERUM FOLATE LEVELS 
(a) Effect of low serum folate levels on haemoglobin levels. 
Age Folate levels Mean haemoglobin Test of 
(months) in infants levels significance Significance 
2t - 4t Low 10.7 n • 7 'STUDENT'S' t • 0.790 
Normal or high 11.0 93 t-test O. 40 < P < 0. 50 n ... 
4t - 7t Low 11.2 n • 4 t = 0.678 
11 
Normal or high 10.8 n • 78 0.50 < P < 0.60 
1t - lo! Low 8.5 n • 1 t • 1.467 
II 
Normal or high 10.5 n .. 25 0.10 <P <0.20 
lo! - 16 Low 9.5 n • 4 t = 2.014 
II 
Normal or high 10.4 n • 25 0.05 < P < 0.10 
There is no consistent relationship or statistically significant association 
between these two parameters. 
TABLE 101 (C~nt,)_ 
(b) The effect of low serum folate levels on nutrition . 
Age Serum folate levels 
(months) in infants 
2t - 4t Low 
Normal or high 
4t - 7t Low 
Normal or high 
7t - 1oi Low 
Normal or high 
1oi - 16 Low 
Normal or high 
Mean percentile 
(weight) 
41 n = 7 
42 n = 99 
27 n = 4 
46 n = 86 
7 n = 1 
n = 27 
6 n = 4 
32 n = 28 
Test of 
significance Significance 
' STUDENT'S ' 




t = 0 . 074 
P > 0 . 90 
t = 1 . 098 
0 . 20 < P < 0 .30 
t = 0 . 282 
O. 70< P < 0 . 80 
t = 1 . 257 
In all age groups infants with low serum folate levels have a lower mean 
weight percentile . None of the differences are statistically significant . 
(c) The effect of low serum folate levels on infection score . 
Age Serum folate levels 
(months) in infants 
2t - 4t Low 
Normal or high 
4t - 7t Low 
Normal or high 
7t - 1oi Low 
Normal or high 
1Qi - 16 Low 
Normal or high 
Mean infection 
score 
n = 7 
1 . 2 n = 97 
1 . 2 n = 3 
1 . 6 n = 85 
2 . 0 n = 1 
1.6 n = 25 
n = , 3 








t = 2 . 771 
0 . 001< P < 0 . 01 
t = 0 . 552 
0 . 50< P< 0.60 
t = 0 . 320 
0 .. 70< P < 0 . 80 
t = 5 . 667 
P < 0 . 001 
In all age groups infection score is higher in infants with low serum 
folate levels . The differences become significant at 2t- 4t and 
1 oi - 16 months of age •. 
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(i) dietary deficiency existed. This was based on the following 
findings:-
(a) None of the infants received breast milk without other milk 
supplements at the time that serum L.casei folate levels were low. 
(b) There was a clear history of dietary deprivation in two infants. 
(ii) malabsorption of folate might have contributed to the development 
of low serum L.casei folate levels in three infants. 
(iii) recurrent infection apparently contributed to the development of 
low serum L.casei folate levels in two infants. 
SIGNIFICANCE OF LOW SERUM L.CASEI FOLATE LEVELS 
Statistical Assessment (Table 101). 
There was no statistical relationship between low serum L.casei 
folate levels and 
(a) mean haemoglobin concentration; 
(b) mean weight percentile. 
Although infants with low serum L.casei folate levels had a higher 
incidence and severity of infection, this was statistically significant 
only in infants from 21 -4t months and loi -16 months. There may be a 
statistical association between these two factors but this has not been 
proved. 
Therapeutic Assessment. 
(a) Infants with low serum L.casei folate levels 
without morphological folate deficiency. 
Symptomatic Improvement. 
Four of seven infants with low serum L.casei folate levels had 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FOLIC ACID THERAPY IN AN INFANT WITH MORPHOLOGICAL 
FOLATE DEFICIENCY AND ASSOCIATED IRON DEFICIENCY 
Parameter Before treatment After treatment 
Haemoglobin 9.2 8.5 g ./100 ml. 
Percentile 2 3 (weight) 
Bone marrow Megaloblastosis 
Scanty giant 
morphology metamyelocytes 
* Folic acid 100 pg. intramuscularly daily for 10 days 
assessed 3 weeks after treatment commenced. 
Conclusion: 
Felic acid therapy did not affect haemoglobin level 
but did greatly improve bone marrow morphology. The 
improvement in weight cannot be dissociated from the 




2t - 4t 
4t - 7t 
TABLE 104 
PATTERN OF RED BLOOD CELL FOLATE LEVELS 
IN INFANTS OF 2t - 7t MONTHS OF AGE 
Range of Standard red blood cell Mean 
fo~te deviation ng. ml. 
148 - 1250 320 + 202.3 -
n • 27 
105 - 2520 ,62 + 456.3 -





+ - 87.8 
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normal serum L.casei folate levels enjoyed the same benefit from this 
therapy. This was not a statistically significant result ( ~= 2.674; 
0.10 < P. < 0.20). 
Objective Improvement (Table 102). 
Therapy with folio acid did not improve mean haemoglobin concen-
tration, nor did it have a substantial effect on weight percentile. The 
mean haemoglobin concentration and mean weight percentile were not affected 
when a group of infants with low serum L.casei folate levels were not given 
folio acid . in the absence of iron deficiency. 
(b) Folio acid therapy in an infant with biochemical and 
morphological folate deficiency (Table 103). 
Following folic acid therapy there was considerable improvement of 
the morphological changes in the bone marrow. Folic acid therapy did not 
produce a beneficial effect 'on haemoglobin concentration and the apparent 
improvement in weight percentile following this therapy could not be dis-
sociated from a coincident effect of improved feeding and treatment of 
associated infection. 
RESULTS OF THE RED CELL L.CASEI FOLATE LEVELS 
Pattern of Red Cell L.casei Folate Levels (Table 104). 
Eighty-nine red cell L.casei folate estimations were performed. The 
mean range and standard error of this investigation were analysed in 
55 infants in the earlier additional studies. As with the serum L.casei 
folate assays,. the mean values in infants under 7t months were higher than 
that of the adult mean (208ng./ml. in White and 241 ng./ml. in Coloured 
adults). 
208. 
Red cell L.casei estimations were also performed on a further 
34 infants who participated in a controlled therapeutic study. The 
range of the red cell L.casei folate assays encountered here was 
63.0 ng./ml. - 632.0 ng./ml. and the mean was 295 ng./ml. 
In this last group only one infant from whom blood could be taken 
for folate estimations received breast milk without other milk supplements. 
This might have explained these generally lower red cell folate levels. 
Red cell L.casei folate assay as a parameter of folate deficiency. 
Red cell L.casei folate levels were low in two of the 89 infants. 
In one of these infants, the red cell L.casei folate level was associated 
with a low serum L.casei folate level but not in the other. 
Aetiology of low red cell L.casei folate levels (Table 99). 
Neither of the two infants who had a low red cell L.casei folate 
level, received breast milk without other milk supplements. There was 
no other cause for these low red cell L.casei folate levels. 
DISCUSSION 
Pattern of serum L.casei folate estimations. 
In this study it was noted that the mean serum L.casei folate level 
was high in young infants. It declined with growth to approximate the 
mean adult level. This pattern had been described by Vanier and Tyas (1966) 
using the serum L.casei folate assay, and Matoth, Pinkas, Zamir, Mooallem 
and Grossowicz (1964) using the whole blood L.casei folate assay. 
A point of difference between the three studies was the age at which 
the mean L.casei folate levels dropped below mean adult levels. This was 
reported to have occurred at 8 weeks by Matoth, Pinkas, Zamir, Mooallem 
and Grossowicz (1964) and at 3~4 months by Vanier and Tyas (1966). In 
this study it was noted only after loi months. 
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The serum L.casei folate levels of some of the infants in this 
investigation were either higher or lower than the normal adult range in 
Cape Town. The cause for the high serum L.casei folate levels found in some 
infants was investigated. 
High serum L.casei folate levels. 
It was shown that infants who received breast milk without other 
milk supplements had statistically significantly higher mean serum L.casei 
folate levels than infants who received the following: 
a) formula milks; 
b) a combination of formula and breast milk; 
c) breast milk and cow's milk. Three (3) infants received this 
last combination, but in none of these infants was the serum L.casei 
folate level high. 
It was previously noted that the serum (Vanier and Tyas, 1966) and 
the whole blood (Matoth, Pinkas, Zamir, Mooallem and Grossowicz, 1964) 
L.casei folate levels of breast-fed infants were higher than those of 
infants fed wit~ formula milks. 
The higher mean serum L.casei folate levels found in breast-fed 
infants in this study appeared to be due to the higher concentratiom of 
folate present in breast milk. It was found that the mean L.casei folate 
content of breast milk was significantly higher than that of reconstituted 
formula milks prepared by the mothers for their infants. Similarly, recon-
stituted powdered milk feeds prepared in the diet kitchen of the Red Cross 
War Memorial Children's Hospital showed a lower range of L.casei folate 
content than that found in breast milk. 
This confirmed an earlier finding by Matoth, Pinkas, and Sroka (1965), 
who noted that breast milk had a higher L.casei folate content than recon-
stituted powdered milks. This finding was contradicted by Nicol and 
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Davis (1967) who reported higher L.casei folate levels in reconstituted 
powdered milk than in breast milk. Also the levels of L.casei activity 
in breast milk found by Ramasastri (1965) were lower than those reported 
in this study and by Matoth, Pinkas and Sroka (1965). Karlin, Hours, 
Bertoye, Vallier and Berry (1967) showed that the L.casei folate content 
of breast milk was initially low and reached its maximum in the fourth 
month of lactation. This might be one likely explanation for some of the 
above differences. 
Although the range of L.casei folate content of breast milk was 
higher than that of reconstituted powdered milk, high values of up to 
40.4 ng./ml. were obtained with some powdered milks. Conversely, values 
as low as s.4 ng./ml. werefound in breast milk. This was probably why 
infants who received formula milks occasionally had high serum L.casei 
folate levels and also why breast-fed infants did not always have high 
serum L.casei folate levels. 
Apart from the higher L.casei folate content of breast milk 
compared to formula milks, it might be that two other factors contributed 
to the high serum L.casei folate levels found in breast-fed infants. 
First, the folate in breast milk might have greater biological 
accessibility for the infants because of a more favourable folate compo-
sition. Although the biological availability of food folate must still 
be determined (Herbert, 1967; Chanarin, Rothman, Perry and Stratfull,1968) 
it is believed that "free folate" (folate immediately available to L.casei 
without conjugase treatment) is available to humans (Herbert, 1967). Since 
the free L.casei folate activity in fresh cow's milk was higher than that 
in breast milk (Matoth, Pinkas and Sroka, 1965) it seemed unlikely that 
breast milk contained folate of greater biological availability. This 
possibility might finally be excluded when more is known of the exact folate 
composition of the different milks and of the biological availability of the 
different forms of folate. 
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The second possibility for the apparently greater efficacy of breast 
milk was a suggestion made by Matoth, Pinkas, Zamir, Mooallem and Grosso-
wicz (1964) and Matoth, Pinkas and Sroka (1965). They considered that the 
intestinal bacterial population of breast-fed infants might have a greater 
capacity to synthesisefolate or less tendency to consume folate than the 
bacterial population found in artificially fed infants. It was known that 
intestinal bacteria could synthesise folate (Donaldson, 1964), and that 
this could occur in humans (Hoffbrand, Tabaqchali and Mollin, 1966; Klip-
stein and Samloff, 1966). Moreover, in pathological conditions, serum 
L.casei folate levels could be elevated as a result of the synthesis of 
folate by intestinal bacteria (Hoffbrand, Tabaqchali and Mollin, 1966). 
However, the role of intestinal bacteria in infant folate nutrition is 
uncertain and in general the extent to which the synthesis of folate by 
intestinal bacteria contributes to the nutrition of the host, remains to 
be determined (Klipstein and Samloff, 1966). 
Apart from breast-feeding, no cause for the high serum L.casei 
folate levels could be found. They were not related to coincident supple-
aentary feeding, contamination of serum with folic acid, or to the effect 
of trivial infection at the time of investigation. It had been reported 
that serum L.casei folate levels could be elevated in the presence of 
infection (Spector and Metz, 1966; Spector, Falcke, Yoffe and Metz, 1966). 
The high serum L.casei folate levels could also not be ascribed to: 
a) differences in the initial cord serum L.casei folate levels; 
b) increased absorption of folic acid; 
c) decreased demand for folate; 
d) a secondary disturbance of folate metabolism as a result of 
(i) vitamin B12 deficiency; 
(ii) iron deficiency. 
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The higher serum L.casei folate levels were therefore attributed 
to the effect of breast-feeding. The slow decline in mean serum L.casei 
folate levels with growth could be attributed to the higher incidence of 
breast-feeding found in this study (23 of 119; 19.3%) as compared to the 
following: 
(a) 8.4% - 23 of 373 (Matoth, Pinkas, Zamir, Mooallem and Grossowicz,1964); 
(b) 8.3% - 2 of 24 (Vanier and Tyas, 1966). 
The satisfactory L.casei folate content of breast milk (Matoth, 
Pinkas and Sroka, 1965) and of fresh cow's milk (Naiman and Oski, 1963; 
Luhby and Cooperman, 1963) was unexpected in the light of earlier beliefs 
regarding the low folate content of milk (Zuelzer and Rutzky, 1953; 
Luhby, 1959). Luhby (1959) believea that normal infants might have low 
folate reserves and in some instances biochemical folate deficiency because 
milk was a poor source of folate. These concepts were partially based on 
the results of folate assays performed on milk at that time (Collins, 
Harper, Schreiber and Elvehjem, 1951). 
Shortly after this study had commenced, Naiman and Oski (1963) 
disproved the results of previous assays for folate in milk. They 
improved the assay technique by using: 
a) L.casei as the assay organism, and 
b) ascorbic acid as protection for the labile folate during assay. 
By this method they showed that fresh cow's milk contained approximately 
60 fg• of folate/quart ~ and not the previously reported 2.2 fg• of 
folate/quart ~. The surprisingly satisfactory folate content of milk 
made widespread biochemical folate deficiency in infancy seem a much 
less likely possibility. 
~ These are the stated figures but are probably meant to be fg./litre. 
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Afterwards many investigators confirmed the satisfactory L.casei 
folate content of fresh cow's milk (Naiman and Oski, 1964; Matoth, Pinkas 
and Sroka, 1965; Ghitis, 1966; Becroft and Holland, 1966) and found that 
it was higher than that of breast milk (Matoth, Pinkas and Sroka, 1965). 
However, it seemed that the folate content of milk could be markedly 
reduced by boiling (Ghitis, 1966; Matoth, Pinkas and Sroka, 1965) and by 
autoclaving (Naiman and Oski, 1964; Ghitis, 1967) but was little affected 
by --pasteurisation (Matoth, Pinkas and Sroka, 1965; Ghitis, 1966). Thus, 
depending on the procedure employed, folate could be lost during the manu-
facture of powdered milks (Matoth, Pinkas and Sroka, 1965; Ghitis, 1966). 
This was the probable explanation for the generally lower folate content 
of reconstituted powdered milk when compared to that of fresh cow's milk 
(Naiman and Oski, 1964; Matoth, Pinkas and Sroka, 1965; Ghitis, 1966; 
Becroft and Holland, 1966) or breast milk (Matoth, Pinkas and Sroka, 1965). 
The folate content of cow's milk and reconstituted powdered milk might 
further be reduced by feeding practices such as overdilution or boiling 
of milk. However, the labile folate could be protected during autoclaving 
and boiling by the addition of vitamin C in sufficient concentration. 
This was found to be 10 mg./100 ml. for autoclaving (Ghitis, 1967) and 
40 mg./litre for boiling (Nicol and Davis, 1967). 
The daily total folate requirements of infants have not been deter-
mined. It was found that the daily therapeutic requirements of folio acid 
for infants not receiving a folate free diet were 5-20 fg• (Velez, Ghitis, 
Pradilla and Vitale, 1963) or 50 fg· (Sullivan, Luhby and Streiff, 1966). 
It had been inferred that the physiological daily requirements of folio 
acid were 20-50 fg• (Sullivan, Luhby and Streiff, 1966) and that the daily 
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folate requirements of infants might be 20 fg• (Matoth, Pinkas and Sroka, 
1965) or less than 50 pg. (Becraft and Holland, 1966). From Table 86, it 
appeared that on average a litre per day of breast milk provided 28.7 pg. 
of folate to infants exclusively receiving breast milk. This figure 
represented only the "free folate" content of breast milk and was there-
fore probably an underestimation. Karlin, Hours, Bertoye, Vallier and 
Berry (1967) showed that approximately a third of the total folate content 
of breast milk consisted of folate polyglutamates which would be available 
to L.casei only after treatment of milk with conjugase. Although there 
is some information about the biological availability of certain folate 
polyglutamates (Herbert, 1968) nothing is known of those in milk. If all 
were available to the infant, a litre of breast milk would have provided 
the average infant with approximately 43 f-g• of folate daily. Since none 
of the infants who received breast milk without other milk supplements 
developed low serum L.casei folate levels, this amount appeared to be 
adequate for the needs of these healthy underprivileged infants. It seemed 
probable that normal daily requirements were less than 43 fg./day because -
a) the concentration of folate in breast milk was sometimes much 
lower than the average of 28.7 ng./ml. Also, all infants would 
not have received as much as a litre of milk; 
b) the fo'late content of breast milk was not constant throughout 
lactation. It was found to be low immediately postpartum, to 
rise rapidly by the end of the first month, and to reach a maximum 
in the 4th month of lactation (Karlin, Hours, Bertoye, Vallier 
and Berry, 1967). During the first month when breast milk folate 
levels are low, the high serum L.casei folate levels (derived 
* 
from the mothers) may provide protection against folate deficiency. 
* most cord serum folate levels we r e high 
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A small proportion of infants who received reconstituted powdered 
milk or a combination of milk feeds developed low serum L.casei folate 
levels. Their folate intake, especially those receiving only redonstituted 
milk feeds, might have been inadequate. Some might have received less than 
5 /g. of total folate daily (Table 86). 
LOW SERUM L.CASEI FOLATE LEVELS 
The serum L.casei folate levels of a small number of infants were 
lower than those found in nofmal adults. Should the serum L.casei folate 
assay be accepted as a valid parameter of folate deficiency, these low 
levels may be attributed to biochemical folate deficiency. 
The serum L.casei folate assay as a parameter of folate deficiency. 
It was established that the serum L.casei folate assay was a sensi-
tive parameter of folate deficiency which could indicate the presence of 
this deficiency before 
a) neutrophils became hypersegmented, 
b) Figlu excretion after oral histidine became excessive, 
c) red cell L.casei folate levels iacreased, 
d) bone marrow morphology became megaloblastic (Herbert, 1962a; 
Mollin and Hoffbrand, 1965). 
In most instances it was also a more sensitive parameter of folate 
deficiency than the L.casei folic acid clearance test (Hogan, Maniatis 
and Moloney, 1964). 
For the above reason, the validity of the serum L.casei folate 
assay could not be gainsaid by negative results obtained with other para-
meters for folate deficiency. 
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It was known that some non-specific factors could spuriously lower 
serum L.casei folate levels (Reizenstein, 1965). Of these, the admini-
stration of antibiotics was the only relevant factor in this study and 
even this was excluded (Chapter V). In infants, unexplained spuriously 
low serum L.casei folate levels had not been reported. The low serum L.casei 
folate levels were unlikely to have been a manifestation of inhibitors in the 
serum of the infants because a serum-extraction method of estimating L.casei 
folate activity was used in this study (Cowan, Hoffbrand and Mallin, 1966). 
Because there was no other reason for the low serum L.casei folate 
levels, and because there was a good relationship between serum L.casei 
folate levels and dietary folate intake, low serum L.casei folate levels were 
attributed to biochemical folate deficiency. This finding is of some impor-
tance as Leevy(l967) showed that there was a good relationship between serum 
L.casei folate levels and hepatic folate content. Also, serum L.casei folate 
levels were found to provide a better index of hepatic folate content than 
red cell L.casei folate levels (Leevy, 1967). Similarly it was found that in 
folate deficiency of recent onset in pregnant women,red cell L.casei folate 
levels underestimated the frequency and degree of folate deficiency. This 
might have been because folate was locked in red cells till the end of their 
life span (Chanarin, Rothman, Ward and Perry, 1968). 
The reliability of the serum L.casei folate assay as an index of folate 
deficiency in infancy was controversial because normal serum L.casei folate 
levels were reported in the presence of folate deficiency(Lovric and Kenrick, 
1965) and megaloblastosis not due to vitamin B12 deficiency (Luhby,Cooperman, 
Maclver and Montgomery,1962; Pereira and Baker,1966). In this study the only 
infant who had a megaloblastic bone marrow had a low serum L.casei folate level 
(0 .9 ng./ml.- the lowest level encountered). However, the agreement between 
serum L.casei folate assays and red cell L.casei folate assays was disap-
pointing. Two infants had red cell L.casei folate levels below the normal 
range but in only one was the serum L.casei folate level low. Vanier and Tyas 
(1966) reported a similar experience. They stated that the interpretation oflow 
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red cell L.casei folate levels (whole blood/ml. of red cells) was 
difficult unless these were very low because an occasional normal 
patient had a red cell L.casei folate level (whole blood/ml. of red 
cells) which was below the normal range. They cited Hansen (1964) who 
had made similar observations. Thus the lack of agreement between red 
cell L.casei folate levels and the serum L.casei folate levels found 
in this study did not prove the serum L.casei folate assay to be an 
unreliable index of folate deficiency. The reliability of the serum 
L.casei folate assay in the diagnosis of megaloblastosis in infancy must 
still be established. 
INCIDENCE OF BIOCHEMICAL FOLATE DEFICIENCY 
This could not be accurately determined in the prospective study 
because t~e same sample could not be studied at all times. Of the 
original 86 infants, 10 showed evidence of biochemical folate deficiency 
resulting in an approximate incidence of 11.6%. 
Of the infants under 71 months who were investigated, only once 
7-1%, had low serum L.casei folate levels. 
Furthermore, the incidence of biochemical folate deficiency might 
have been inaccurate for two reasons. The infants participating in the 
study were selected on the basis of health and parent co-operation. 
For these reasons it was not known whether these figures are represen-
tative of all healthy underprivileged infants in Cape Town, particularly 
the less privileged members of this population group. Also, because ~lie 
incidence of biochemical folate deficiency was determined solely from 
the serum L.casei folate assay, the inherent margin of error of the 
serum L.casei folate method must be considered. 
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Vanier and Tyas (1966) carried out a prospective investigation 
on 24 normal European infants whose mothers received folio acid supple-
ments during pregnancy. Under these optimum circumstances, 4 of the 
24 infants(! 16.7%) showed evidence of biochemical folate deficiency 
(low serum L.casei folate levels) at some stage of the first year of life. 
The lower incidence,in this study, of 11.6%, in infants in poorer circum-
stances might have resulted from: 
data. 
a) changes in the sample studied prospectively; or 
b) the higher incidence of breast-feeding in healthy 
underprivileged infants in Cape Town. 
AETIOLOGY OF BIOCHEMICAL FOLATE DEFICIENCY 
This was first investigated by a statistical analysis of the 
It was not possible to demonstrate a relationship between maternal 
and infant folate nutrition. However, of the parameters used for inves-
tigating maternal folate deficiency, probably only the serum L.casei 
folate assay had validity (Chapter VI). This was a sensitive criterion 
of folate deficiency and was not necessarily related to significant 
maternal folate deficiency. From the findings in this study it could 
therefore be concluded only that there was no relationship between minimal 
maternal biochemical folate deficiency and the development of folate 
deficiency in infants whose dietary folate intake was not controlled. 
Accordingly, this study did not exclude the possibility that signi-
ficant maternal folate deficiency might 
a) contribute to the development of folate deficiency in infants 
receiving an inadequate folate intake; 
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b) be primarily responsible for the development of folate 
deficiency in infants receiving an adequate folate intake. 
This seemed less likely if it were correct that infant folate 
stores were formed to the detriment of maternal folate nutrition • • 
Recently Luhby, Feldman, Gordon and Cooperman (1967) claimed that 
significant folate deficiency in mothers resulted in reduced folate stores 
in their infants (birth - 12 weeks). Although a control group of infants 
apparently did not show this abnormality, the results might have been more 
convincing had there been further evidence of folate deficiency as support 
for the positive Figlu tests in 4 of the 5 infants. The only infant who 
did have supportive evidence for the Figlu test also had erythroblastosis 
foetalis. Moreover, it was not clear whether these infants had received 
adequate folate intake up to the time the investigation was undertaken. 
Willoughby (1967) investigated the relationship between maternal 
and infant folate status. He assessed the effect of maternal folic acid 
supplementation on the whole blood L.casei folate levels in their infants 
at 6 weeks of age. He concluded that if the daily diets of pregnant women 
were supplemented with 300 - 450 pg. of folic acid and iron, the whole 
blood folate levels in their infants were significantly higher than in 
those whose mothers had been supplemented with iron and smaller doses of 
folic acid. However, these results were based on whole blood folate levels 
which do not make allowance for differences in haematocrit. Furthermore, 
the daily folate intake of the infants was not controlled and might have 
varied widely. Last, it was not clear, from his data (Table), whether 
the whole blood folate levels in the infants whose mothers had received 
daily folic acid (300 - 450 pg.) and iron were statistically significantly 
higher than those of infants whose mothers did not receive any supplementa~ion 
at all du~ing pregnancy. 
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It is apparent that the relationship of significant maternal folate 
deficiency to the development of folate deficiency in infants requires 
further investigation under controlled conditions. 
There was no demonstrable relationship between biochemical folate 
deficiency and socio-economic differences within the group of under-
privileged infants. A relationship between whole blood L.casei folate 
levels and socio-economic circumstances in a group of infants who were 
mainly artificially fed was demonstrated by Matoth, Pinkas, Zamir, 
Mooallem and Grossowicz (1964). They were not able to demonstrate the 
same relationship in breast-fed infants (Matoth, Pinkas and Sroka, 1965). 
The poor dietary intake which is often associated with poor socio-economic 
circumstances might have been offset in this study by the high incidence 
of breast feeding which provided a satisfactory folate intake. 
Similarly, a relationship between nutrition and biochemical folate 
deficiency could not be established. It could be inferred, from the 
findings of Vanier and Tyas (1966), that a diet which provided sufficient 
calories might be deficient in folate. Conversely, from the findings in 
this study, it became evident that a calorie restricted diet, such as 
a limited supply of breast milk, might still contain enough folate to 
maintain normal serum L.casei folate levels. This was seen in under-
nourished infants receiving breast milk without other milk supplements. 
F0r this reason it might not be possible to demonstrate a statistical 
relationship even though folate deficiency was dietary. Matoth, Zamir, 
Bar-Shani and Grossowicz (1964) demonstrated a relationship between 
whole blood L.casei folate levels and undernutrition in infants who, 
for the most part, received reconstituted formula milk. 
It was generally recognised that increased demand for folate from 
infection (Roberts, Hoffbrand and Mollin, 1966; Hoffbrand, Stewart, 
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Booth and Mollin, 1968), or increased haemopoiesis (Lindenbaum and 
Klipstein, 1963; Alperin, 1967; Forshaw, Moorhouse and Harwood, 1964; 
Kremenchuzky and Hoffbrand, 1965) could result in folate deficiency. 
Recently, the increased demand for folate associijted with increased 
haemopoiesis (Izak, Rachmilewitz, Chirasiri and Grossowicz, 1966) or 
DNA synthesis (Leevy, 1967) was demonstrated experimentally. It was 
not possible to demonstrate a statistical relationship between biochemical 
folate deficiency and increased demand for folate resulting from rapid 
growth or recurrent infection. This did not negate such a relationship 
because dietary folate intake was variable in the group of infants studied 
and some infants might have compensated for the increased demand for folate 
by increased dietary intake where this was available. 
It was shown, that in the presence of iron deficiency serum L.casei 
folate levels might be low in the absence of supporting evidence for folate 
deficiency (Hansen, 1967). It was believed that iron deficiency might lead 
to folate deficiency (Chanarin, Rothman and Berry, 1965) possibly by inter-
fering with folate metabolism (Vitale, Streiff and Hellerstein, 1965). 
In this study, no statistical relationship between serum iron and serum 
L.casei folate levels was found. 
In view of all the factors which might have invalidated a statis-
tical investigation, it was deemed necessary to examine aetiological 
possibilities in the individual infants with biochemical folate deficiency. 
In the 18 infants with low serum L.casei folate levels and in the 
2 infants with low red cell L.casei folate levels, one consistent aetio-
logical factor was noted: none of these infants received breast milk 
without other milk supplements at the time biochemical folate deficiency 
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was diagnosed. Since the concentration of folate in reconstituted 
powdered milk was lower than that in breast milk, it seemed probable 
that dietary deficiency was either primarily responsible for or contri-
buted to the development of biochemical folate deficiency in these infants. 
Also in 2 infants, there was a clear history of deprivation of food and 
therefore folate. Furthermore, in some of these infants there was circum-
stantial evidence for dietary folate deficiency based on 
a) an association with under nutrition (in infants who did not 
receive breast milk without other milk supplements), or 
b) increasingly poor nutrition in association with developing 
biochemical folate deficiency. 
The concept of a dietary cause for folate deficiency was recently 
emphasised (Forshaw, Moorhouse and Harwood, 1964; Gough, Read, McCarthy 
and Waters, 1963; Read, Gough, Pardoe and Nicholas, 1965; Hurdle and 
Picton Williams, 1966). However, the frequency of its occurrence was 
uncertain (Girdwood, 1964; Girdwood, Thomson and Williams, 1967). It 
had previously been found that dietary folate deficiency could result in 
the production of megaloblastosis in man under experimental conditions 
(Herbert, 1962a),but a recent experiment did not confirm this (Velez, 
Restrepo, Vitale and Hellerstein, 1966). 
Folic acid and d-xylose absorption tests were used as parameters 
for assessing absorption in infants with biochemical folate deficiency. 
Of these, the folic acid absorption test was believed to be the better 
test, especially when xylose absorbed was measured as percentage urinary 
excretion rather than blood-xylose (Chanarin and Bennett, 19620). They 
achieved their results using S.faecalis as the folate assay organism. 
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Presumably the same conclusion would apply if L . casei were used as the 
assay organism. As the folic acid absorption test necessitated the admini-
stration of a therapeutic dose of folic acid, it could not be used as a test 
of absorption in the prospective study . 
Aosorption studies were performed on 7 infants with low serum L . casei 
folate levels . Folic acid absorption was within "normal limits" in ,two 
infants even though the tests were performed in the convalescent phase of 
gastroenteritis (Table 33), Xylose excretion was normal in 4 of 5 infants . 
In the 5th infant xylose excretion was ahnormal in association with chronic 
gastroente r itis. Cure of the gastroenteritis resulted in the return to 
normality of the xylose absorption test. It seemed probable that temporary 
malabsorption of folate might have contributed to biochemical folate 
deficiency in this infant (F . U. ) It was inferred that this was also the 
case in 2 other infants , T . de B. and C. F . , who had chronic gastroenteritis 
at the time of diagnosis of biochemical folate deficiency . Only in these 
3 infants was there evidence for attributing the development of bio chemical 
folate deficiency to malabsorption of folate . 
In the absence of chronic gastroenteritis there was no relationship 
between malabsorption and.the development of biochemical folate deficiency 
in healthy underprivileged infants . However, this could not be entirely 
excluded by the evidence in this study because the absorption of folate 
under physiological conditions was not investigated . Until more is known 
of the nature of folate absorbed under physiological conditions , absorption 
studies performed with food folate (Markkanen , 1968) might provide more 
accurate information than those performed with synthetic PGA. 
It seemed probable that recurrent infection contributed to the 
development of biochemical folate deficiency in 2 infants (M . R. and S . B. ) 
because their infection score was much higher than the mean for infants 
of a similar age. 
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The study of aetiological factors in individual infants did not· 
provide any convincing evidence for attributing biochemical folate 
deficiency to the effects of maternal folate deficiency or iron deficiency. 
Dietary folate deficiency apart, no other cause was evident for the 
low red cell L.casei folate leyels in C.S. and V.L. 
Thus in all the infants with biochemical folate deficiency, dietary 
deficiency was the only consistent aetiological factor. It appeared to be 
primarily responsible for the folate deficiency in approximately 13 of the 
18 infants with low serum L.casei folate levels. In three infants, bio-
chemical folate deficiency might have resulted from a combination of 
dietary folate deficiency and malabsorption. In the other two infants, 
dietary folate deficiency, recurrent infection and, perhaps, malabsorption 
from recurrent gastrointestinal infection might have contributed to the 
development of folate deficiency. 
AETIOLOGY OF FOLATE DEFICIENCY IN THE 
INFANT WITH MEGALOBLASTOSIS 
One (1) of the 18 infants with biochemical folate deficiency also 
had morphological evidence of folate deficiency. In this infant (M.R.) 
the biochemical and morphological evidence of folate deficiency developed 
a) after a period of severe deprivation of virtually all 
food and therefore folate, and 
b) in association with the effect of recurrent infection, 
at least half of which was gastrointestinal . 
The folate deficiency developed in parallel with clinical evidence of 
marasmus which was objectively confirmed (less than 60% of the expected 
body weight) shortly after the megaloblastosis had been diagnosed . 
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SIGNIFICANCE OF BIOCHEMICAL FOLATE DEFICIENCY 
An attempt was made to assess the importance of biochemical folate 
deficiency in these infants by studying its haematological and clinical 
effects. 
Fourteen (14) of the 18 infants with biochemical folate deficiency 
were investigated for evidence of depleted haematological folate stores. 
One (1) .of 6 infants had a low red cell L.casei folate level and in 1 of 
the other 8 infants the bone marrow was megaloblastic. As it was uncertain 
whether the low red cell L.casei folate levels could be used as concrete 
evidence of depleted red cell L.casei folate stores, it was concluded that 
in only 1 of 14 infants was there unequivocal evidence for significant 
haematological folate depletion. Moreover, there was no relationship 
between biochemical folate deficiency and haemoglobin concentration. 
Biochemical folate deficiency apparently did not have any adverse 
clinical effects. The administration ,of folic acid to infants with bio-
chemical folate deficiency did not produce symptomatic benefit or 
detectable improvement of haemoglobin concentration or weight percentile. 
There was a clinical impression which could not be further assessed, that 
the administration of folic acid to these infants did not produce any 
effect on resistance to infection. Conversely, when folio acid was not 
administered to infants with biochemical folate deficiency, there was no 
adverse effect on haemoglobin concentration, weight percentile or 
apparently on resistance to infection. 
Biochemical folate deficiency could not be statistically related to: 
a) haemoglobin concentration, and 
b) weight percentile. 
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However, the infection score was always highest in infants with low serum 
L.casei folate levels and the statistical association was significant in 
some age groups. This might have been due to a lowered resistance to 
infection caused by biochemical folate deficiency but the evidence from 
the therapeutic studies with folio acid did not support this. The other 
possible explanation for the association was that infection contributed to 
low serum folate levels in some infants. 
A relationship between biochemical folate deficiency and haemoglobin 
concentration was not demonstrated by Shojania and Gross (1964a), Vanier 
and Tyas (1967) and Matoth, Zamir, Bar-Shani and Grossowicz (1964). Shojania 
and Gross (1964a) could not demonstrate any clinical effect of biochemical 
folate deficiency in premature infants but Matoth, Zamir, Bar-Shani and 
Grossowicz (1964) were impressed by the symptomatic benefit of folio acid 
therapy in infants with biochemical folate deficiency. Some of these 
infants might have had associated morphological folate deficiency. 
The effect of folio acid therapy on the infant with megaloblas~osis 
was more difficult to assess because improvement could not be dissociated 
from a coincidental improvement eaused by better feeding and treatment of 
infection. Considerable improvement of the megaloblastosis was associated 
with the administration of folie acid. 
PROPHYLAXIS 
The incidence of biochemical folate deficiency in healthy under-
privileged infants (11.6%) foll0wed prospectively, was not high. It might 
conceivably have been higher had the study been more fully representative 
and the same sample studied at all times. 
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The condition had little demonstrable clinical and haematological 
importance and in this study did not lead to the subsequent development 
of megaloblastic anaemia. However, under adverse circumstances megalo-
blastic anaemia would be more likely to develop in such infants than in 
those with normal folate nutrition. 
It would seem that, in South Africa, healthy underprivileged infants 
with or without biochemical folate deficiency are particularly likely to 
develop megaloblastic anaemia under two common sets of circumstances: 
a) chronic gastroenteritis; a relationship between biochemical 
folate deficiency and chronic gastroenteritis was shown in this study. 
However, because gastroenteritis was promptly treated it was not possible 
to demonstrate its relationship to megaloblastosis. 
b) Underfeeding and incorrect feeding: one infant from very poor 
socio-economic circumstances, developed megaloblastosis in parallel with 
the development of marasmus. Both probably occurred for the same reasons -
deprivation and the effect of associated infection. 
Chronic gastroenteritis, marasmus and kwashiorkor are still important 
medico-socio-economic problems in South Africa. The association of megalo-
blastic anaemia with kwashiorkor and marasmus has been frequently reported 
in South Africa (Adams, 1964; Walt, Holman and Naidoo, 1957; Shni'er and 
Metz, 1959; Metz, Brandt and Stevens, 1962). 
Until malnutrition and gastroenteritis are no longer public health 
problems in South Africa, it would seem reasonable to suggest that all 
healthy underprivileged infants receive milk containing adequate amounts 
of folate. This could be achieved by: 
a) encouraging breast feeding; 
b) prevention of overboiling and overdilution of powdered and 
cow's milk feeds and; 
c) the addition of folio acid to formula milks. 
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This was shown to be effective both in vitro (Ghitis, 1967) and in viTo, 
as was inferred from the effect of a folio acid supplemented proprietary food, 
in a study by Vanier and Tyas (1966). A similar but less acceptable Effect 
might be achieved by adding ascorbic acid in sufficient concentration to 
the milk before processing. In infants from poor socio-economic circum-
stances it would be of greater practical benefit to suggest the addition of 
folio acid to milk rather than to vitamin syrups. It is believed that the 
addition of folio acid to milk could be achieved without adding to the cost 
of preparation for the consumer (Hager, 1968). 
If the above suggestions were realized, the folate stores of under-
privileged infants might be maintained sufficiently to prevent the develop-
ment of megaloblastic anaemia in those infants who are likely to develop 
chronic gastroenteritis, kwashiorkor and marasmus but who are not completely 
deprived of milk. Simultaneously the unnecessary condition of biochemical 
folate deficiency in healthy underprivileged infants would be eliminated. 
SUMMARY AND CONCLUSIONS 
The serum L.casei folate assay appeared to be a satisfactory and the 
most sensitive criterion of biochemical folate deficiency. Latent folate 
deficiency was diagnosed using this parameter in 11.6% of infants investi-
gated prospectively and 7.1% of infants investigated on one occasion. 
Conclusions regarding aetiology, significance and need for prophylaxis of 
latent folate deficiency appeared to be as follows: 
1) Infants who received breast milk without other milk supplements had 
significantly higher mean serum L.casei folate levels than those who received 
formula or a combination of milk feeds. 
2) It was found that the folate content of breast milk was significantly 
higher than that of formula milk. 
3) Healthy, underprivileged infants who received breast milk and no 
other milk supplements, r eceived enough folate for normal growth, development 
and overcoming recurrent trivial infections. 
4) The lower folate content of form~la milk feeds probably con-
tributed to the development of biochemical folate deficiency in a small 
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percentage of healthy underprivileged infants who received either formula 
milks or a combination of milk feeds. 
5) Other factors which appeared to contribute to the development of 
biochemical deficiency in some infants were 
a) deprivation of food; 
b) malabsorption; 
c) recurrent infection. 
The relationship of maternal folate deficiency and iron deficiency in the 
infants to the development of biochemical folate deficiency in infants 
could not be determined in this study. 
6) The condition of biochemical folate deficiency was not associated 
with unequivocal clinical or haematological effects and did not progress 
to the development of significant folate deficiency. 
7) One (1) infant from very adverse socio-economic circumstances 
developed biochemical and morphological folate deficiency in association 
with the development of marasmus. This was certainly the result of 
deprivation to which the effects of infection might have been added. 
8) Because many infants in underprivileged population groups in 
South Africa are likely to develop chronic gastroenteritis, kwashiorkor 
or marasmus, all of which could be associated with the development of 
megaloblastosis, it is suggested that attempts be made to prevent bio-
chemical folate deficiency. 
9) Prevention of biochemical deficiency could be achieved by: 
a) encouraging breast feeding; 
b) discouraging the overboiling and overdilution of milks, and 
c) the addition of small quantities of folio acid to artificially 
prepared formula milks, especially those with low folate content. 
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CHAPTER X 
' # , 
RESUME 
This study was undertaken because it was believed that there might 
be a high incidence of biochemical folate deficiency in healthy under-
privileged infants in Cape Town. This belief was based on the results 
of a preliminary study in which the Figlu test after oral histidine was 
used. Although it became increasingly evident that the Figlu test after 
oral histidine was not a specific test of folate deficiency, the concept 
of biochemical folate deficiency in healthy underprivileged infants was 
encouraged by other theories held at that time. These were that: 
a) milk (the major dietary constituent of the infants) had a low folate 
concentration (Zuelzer and Rutzky, 1953; Luhby, 1959); 
b) a condition of biochemical folate deficiency existed in infants under 
a year who were used as controls. They were healthy infants but were 
suffering or convalescing from mild infections (Dormandy, Waters and 
Mollin, 1963); 
c) low whole blood L.casei folate assays indicative of biochemical folate 
deficiency were demonstrated in healthy infants and related to poor 
socio-economic circumstances (Kende, Ramot and Grossowicz, 1963). 
Because it was believed that the state of biochemical folate deficiency 
might render the infants liable to the development of megaloblastic 
anaemia, it was decided to investigate the following: 
a) the incidence, aetiology, significance and need for prophylaxis of 
biochemical (latent) folate deficiency in healthy underprivileged 
infants; 
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Moreover, because there was uncertainty regarding the specificity 
and application of the Figlu test after oral histidine as a diagnostic 
parameter of biochemical folate deficiency in infancy: 
b) The validity of this test as a parameter of biochemical folate 
deficiency was investigated in healthy underprivileged infants. 
Two groups of infants were investigated for biochemical folate 
deficiency. The first group of infants was studied prospectively at four 
intervals up to the 16th month of life. Their mothers had been previously 
investigated for folate deficiency in late pregnancy. The second group of 
infants were investigated on only one occasion. 
Serum and red cell L.casei folate assays, folio acid clearance tests 
and the Figlu test after oral histidine were used to diagnose biochemical 
folate deficiency. Hypersegmentation of the neutrophils and bone marrow 
morphology were the criteria used to establish the presence of morpho-
logical folate deficiency. The clinical effects of folate deficiency were 
assessed in relation to haemoglobin concentration, growth and infection. 
The conclusions drawn from the investigation were as follows: 
The Figlu test after oral histidine. 
By means of sensitive methods for measuring Figlu and using the 
recommended dose of oral histidine, it was found that a considerable number 
of infants under 7! months had positive Figlu tests using an accepted 
criterion of normality for concentration of Figlu excretion. These results 
could not be attributed either to biochemical folate deficiency or to a 
disturbance of folate metabolism. 
The results of this study confirmed that healthy infants under 
7i months without folate deficiency could excrete total quantities of 
Figlu comparable to that found in adults. Although it is known that 
the 24 hour urine volume of infants under a year of age is considerably 
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smaller than that of the average adult, the accepted criterion of 
normality for concentration of Figlu excretion is the same for both 
infants and adults. Accordingly if infants excrete the same total 
quantity of Figlu as adults do, but in smaller urine volumes, it fol-
lows that the normal concentration of Figlu excreted by infants must be 
greater than that in adults. From this it is clear that the criterion 
of normal concentration of Figlu excretion should not be the same in 
infants and adults and must be determined for infants before the Figlu 
test after oral histidine (fg./ml.) can be used as a valid diagnostic 
parameter of folate deficiency. The high incidence of "positive Figlu 
tests" (pg./ml.) after oral histidine, obtained in this study from infants 
who were not folate deficient, has been accepted as evidence of this 
belief. 
The total 24 hour Figlu excretion (mg./24 hours) after oral histi-
dine, found in the infants in this study, appeared to be within normal 
limits and therefore unequivocal biochemical folate deficiency was not 
found by means of this test. 
Figlu excretion declined with growth; actual Figlu output within 
the range of normality might have depended on the maturity of glutamate 
formiminotransferase function. This suggested that the standards of 
normal Figlu excretion (fg./ml. and mg./24 hours) might depend on infant 
age. Accordingly this should be considered when the Figlu test after 
oral histidine is used in the diagnosis of megaloblastic anaemia in 
infants, particularly those under 16 months. 
Hypersegmentation of the neutrophils. 
Morphological folate deficiency could not be demonstrated using 
this parameter. It was found that this parameter could be used with 
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accuracy and reproducibility only when nuclear separation was defined 
according to criteria used by Briggs (1914). Using this criterion it 
was found that up to 4% neutrophils could be present without there 
being evidence of folate deficiency. 
Folate microbiological assays. 
The serum L.casei folate assay was found to be the most sensitive 
index of biochemical deficiency in this study. Low levels were attri-
buted to this deficiency. However, it was uncertain whether low red cell 
L.casei folate levels found in 2 of 89 infants could be used as evidence 
of biochemical folate deficiency. This deficiency was not evident from 
the results of the L.oasei folio acid clearance tests, but definitive 
conclusions could not be drawn as normal values for infants could not be 
established. 
Incidence of latent folate deficiency. 
The incidence of this deficiency was determined from the results 
of the serum L.casei folate assays. It was approximately 11.6% in 
infants followed prospectively and 7.1% in infants under 7t months 
investigated on one occasion. 
The aetiology of latent folate deficiency. 
The folate content of breast milk was found to be generally higher 
than that of reconstituted powdered milks. This confirmed the findings 
of certain investigators. It appeared that the lower folate content of 
most powdered milks could be attributed to the loss of folate during 
processing. 
The higher folate content of breast milk appeared to account for 
the significantly higher mean serum L.casei folate levels in infants who 
received breast milk without other milk supplements. This also confirmed 
a finding established by other investigators in the interim. The folate 
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content of breast milk appeared to be adequate for the normal growth 
and development of healthy underprivileged infants because none of those 
who received breast milk without other milk supplements developed bio-
chemical folate deficiency. On the other hand the folate present in 
reconstituted 'powdered milk and boiled cow's milk might not always have 
been sufficient for infants in similar circumstances, because a small 
percentage of those who did not receive breast milk as the sole source 
of milk, developed biochemical folate deficiency. This was in accordance 
with the very low folate content found in some of the prepared milks in 
which the folate content might have been further reduced by overdilution 
and boiling. Because of the apparently adequate folate content of most 
milk and especially of breast milk, and the high incidence of breast-
feeding among the underprivileged, the incidence of biochemical folate 
deficiency might have been lower than was anticipated. 
In this study, other factors which apparently contributed to the 
development of biochemical folate deficiency were malabsorption from 
associated gastroenteritis and recurrent infection. The effect of 
maternal folate nutrition on the subsequent folate nutrition of their 
infants could not be established in this study. In an infant with bio-
chemical and morphological folate deficiency, deprivation and probably 
infection appeared responsible for the condition. 
The significance of latent folate deficiency. 
The condition of biochemical folate deficiency was not associated 
with: 
a) significant haematological folate deficiency in the majority of cases; 
b) detectable adverse clinical effects. 
Although, in this study the condition of biochemical folate deficiency did 
not appear significant in itself, infants with this condition are probably 
more prone to the development of megaloblastic anaemia than those with 
normal folate nutrition. 
235. 
Significant folate deficiency. 
However, one infant developed megaloblastosis and therefore 
significant folate deficiency. In this infant who came from very 
poor socio-economic circumstances, the diagnoses of marasmus, and 
biochemical and morphological folate deficiency were made simultane-
ously. Both the folate deficiency and the marasmus appeared to result 
from the effects of deprivation and probably also the effect of recur-
rent infections. Thus it might be that significant folate deficiency 
develops in kwashiorkor and marasmus because the conditions have a 
similar aetiology. 
Prophylaxis of latent folate deficiency. 
The addition of folio acid to milk and improved feeding practices 
are recommended as prophylactic measures against the development of bio-
chemical and overt folate deficiency in underprivileged infants because 
megaloblastosis is still an important problem in South Africa. By 
these means folate stores in infants who are not totally deprived of 
milk might be sufficiently maintained to prevent the development of 
megaloblastic anaemia, despite the prevalence of malnutrition and stress 
factors (viz. infection and chronic gastroenteritis) in South Africa. 
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